id	sid	tid	token	lemma	pos
fnp-3166	1	1	neuroinflammation	neuroinflammation	NOUN
fnp-3166	1	2	:	:	PUNCT
fnp-3166	1	3	2021	2021	NUM
fnp-3166	1	4	update	update	NOUN
fnp-3166	1	5	feel	feel	VERB
fnp-3166	1	6	free	free	ADJ
fnp-3166	1	7	to	to	PART
fnp-3166	1	8	add	add	VERB
fnp-3166	1	9	comments	comment	NOUN
fnp-3166	1	10	by	by	ADP
fnp-3166	1	11	clicking	click	VERB
fnp-3166	1	12	these	these	DET
fnp-3166	1	13	icons	icon	NOUN
fnp-3166	1	14	on	on	ADP
fnp-3166	1	15	the	the	DET
fnp-3166	1	16	sidebar	sidebar	NOUN
fnp-3166	1	17	free	free	PROPN
fnp-3166	1	18	neuropathology	neuropathology	PROPN
fnp-3166	1	19	2:1	2:1	NUM
fnp-3166	1	20	(	(	PUNCT
fnp-3166	1	21	2021	2021	NUM
fnp-3166	1	22	)	)	PUNCT
fnp-3166	1	23	review	review	VERB
fnp-3166	1	24	neuroinflammation	neuroinflammation	NOUN
fnp-3166	1	25	:	:	PUNCT
fnp-3166	1	26	2021	2021	NUM
fnp-3166	1	27	update	update	NOUN
fnp-3166	1	28	hans	hans	PROPN
fnp-3166	1	29	lassmann	lassmann	PROPN
fnp-3166	1	30	center	center	PROPN
fnp-3166	1	31	for	for	ADP
fnp-3166	1	32	brain	brain	NOUN
fnp-3166	1	33	research	research	NOUN
fnp-3166	1	34	,	,	PUNCT
fnp-3166	1	35	medical	medical	ADJ
fnp-3166	1	36	university	university	PROPN
fnp-3166	1	37	of	of	ADP
fnp-3166	1	38	vienna	vienna	PROPN
fnp-3166	1	39	,	,	PUNCT
fnp-3166	1	40	austria	austria	PROPN
fnp-3166	1	41	corresponding	correspond	VERB
fnp-3166	1	42	author	author	NOUN
fnp-3166	1	43	:	:	PUNCT
fnp-3166	1	44	hans	hans	PROPN
fnp-3166	1	45	lassmann	lassmann	PROPN
fnp-3166	1	46	·	·	PUNCT
fnp-3166	1	47	center	center	NOUN
fnp-3166	1	48	for	for	ADP
fnp-3166	1	49	brain	brain	NOUN
fnp-3166	1	50	research	research	NOUN
fnp-3166	1	51	·	·	PUNCT
fnp-3166	1	52	medical	medical	ADJ
fnp-3166	1	53	university	university	PROPN
fnp-3166	1	54	of	of	ADP
fnp-3166	1	55	vienna	vienna	PROPN
fnp-3166	1	56	·	·	PUNCT
fnp-3166	2	1	spitalgasse	spitalgasse	NOUN
fnp-3166	2	2	4	4	NUM
fnp-3166	2	3	·	·	SYM
fnp-3166	2	4	1090	1090	NUM
fnp-3166	2	5	wien	wien	PROPN
fnp-3166	2	6	·	·	PUNCT
fnp-3166	2	7	austria	austria	PROPN
fnp-3166	2	8	hans.lassmann@meduniwien.ac.at	hans.lassmann@meduniwien.ac.at	VERB
fnp-3166	2	9	submitted	submit	VERB
fnp-3166	2	10	:	:	PUNCT
fnp-3166	2	11	18	18	NUM
fnp-3166	2	12	december	december	PROPN
fnp-3166	2	13	2020	2020	NUM
fnp-3166	2	14	accepted	accept	VERB
fnp-3166	2	15	:	:	PUNCT
fnp-3166	2	16	08	08	NUM
fnp-3166	2	17	january	january	PROPN
fnp-3166	2	18	2021	2021	NUM
fnp-3166	2	19	copyedited	copyedit	VERB
fnp-3166	2	20	by	by	ADP
fnp-3166	2	21	:	:	PUNCT
fnp-3166	2	22	aivi	aivi	PROPN
fnp-3166	2	23	nguyen	nguyen	PROPN
fnp-3166	2	24	published	publish	VERB
fnp-3166	2	25	:	:	PUNCT
fnp-3166	2	26	12	12	NUM
fnp-3166	2	27	january	january	NOUN
fnp-3166	2	28	2021	2021	NUM
fnp-3166	3	1	https://doi.org/10.17879/freeneuropathology-2021-3166	https://doi.org/10.17879/freeneuropathology-2021-3166	PROPN
fnp-3166	3	2	keywords	keyword	NOUN
fnp-3166	3	3	:	:	PUNCT
fnp-3166	3	4	brain	brain	NOUN
fnp-3166	3	5	inflammation	inflammation	NOUN
fnp-3166	3	6	,	,	PUNCT
fnp-3166	3	7	covid-19	covid-19	PROPN
fnp-3166	3	8	,	,	PUNCT
fnp-3166	3	9	multiple	multiple	ADJ
fnp-3166	3	10	sclerosis	sclerosis	NOUN
fnp-3166	3	11	,	,	PUNCT
fnp-3166	3	12	alzheimer	alzheimer	PROPN
fnp-3166	3	13	’s	’s	PART
fnp-3166	3	14	disease	disease	NOUN
fnp-3166	3	15	,	,	PUNCT
fnp-3166	3	16	mogad	mogad	VERB
fnp-3166	3	17	abstract	abstract	ADJ
fnp-3166	3	18	key	key	ADJ
fnp-3166	3	19	requirements	requirement	NOUN
fnp-3166	3	20	for	for	ADP
fnp-3166	3	21	the	the	DET
fnp-3166	3	22	validity	validity	NOUN
fnp-3166	3	23	of	of	ADP
fnp-3166	3	24	a	a	DET
fnp-3166	3	25	neuropathological	neuropathological	ADJ
fnp-3166	3	26	study	study	NOUN
fnp-3166	3	27	are	be	AUX
fnp-3166	3	28	the	the	DET
fnp-3166	3	29	inclusion	inclusion	NOUN
fnp-3166	3	30	of	of	ADP
fnp-3166	3	31	large	large	ADJ
fnp-3166	3	32	numbers	number	NOUN
fnp-3166	3	33	of	of	ADP
fnp-3166	3	34	biopsy	biopsy	NOUN
fnp-3166	3	35	or	or	CCONJ
fnp-3166	3	36	autopsy	autopsy	ADJ
fnp-3166	3	37	cases	case	NOUN
fnp-3166	3	38	and	and	CCONJ
fnp-3166	3	39	proper	proper	ADJ
fnp-3166	3	40	controls	control	NOUN
fnp-3166	3	41	,	,	PUNCT
fnp-3166	3	42	the	the	DET
fnp-3166	3	43	rigorous	rigorous	ADJ
fnp-3166	3	44	classification	classification	NOUN
fnp-3166	3	45	of	of	ADP
fnp-3166	3	46	the	the	DET
fnp-3166	3	47	basic	basic	ADJ
fnp-3166	3	48	neuropathology	neuropathology	NOUN
fnp-3166	3	49	and	and	CCONJ
fnp-3166	3	50	the	the	DET
fnp-3166	3	51	selection	selection	NOUN
fnp-3166	3	52	of	of	ADP
fnp-3166	3	53	the	the	DET
fnp-3166	3	54	most	most	ADV
fnp-3166	3	55	suitable	suitable	ADJ
fnp-3166	3	56	technologies	technology	NOUN
fnp-3166	3	57	for	for	ADP
fnp-3166	3	58	investigation	investigation	NOUN
fnp-3166	3	59	.	.	PUNCT
fnp-3166	4	1	whether	whether	SCONJ
fnp-3166	4	2	the	the	DET
fnp-3166	4	3	studies	study	NOUN
fnp-3166	4	4	are	be	AUX
fnp-3166	4	5	performed	perform	VERB
fnp-3166	4	6	with	with	ADP
fnp-3166	4	7	the	the	DET
fnp-3166	4	8	fanciest	fancy	ADJ
fnp-3166	4	9	,	,	PUNCT
fnp-3166	4	10	new	new	ADJ
fnp-3166	4	11	,	,	PUNCT
fnp-3166	4	12	and	and	CCONJ
fnp-3166	4	13	state	state	NOUN
fnp-3166	4	14	of	of	ADP
fnp-3166	4	15	the	the	DET
fnp-3166	4	16	art	art	NOUN
fnp-3166	4	17	technology	technology	NOUN
fnp-3166	4	18	or	or	CCONJ
fnp-3166	4	19	with	with	ADP
fnp-3166	4	20	rather	rather	ADV
fnp-3166	4	21	conventional	conventional	ADJ
fnp-3166	4	22	methodology	methodology	NOUN
fnp-3166	4	23	is	be	AUX
fnp-3166	4	24	of	of	ADP
fnp-3166	4	25	minor	minor	ADJ
fnp-3166	4	26	importance	importance	NOUN
fnp-3166	4	27	.	.	PUNCT
fnp-3166	5	1	following	follow	VERB
fnp-3166	5	2	these	these	DET
fnp-3166	5	3	criteria	criterion	NOUN
fnp-3166	5	4	,	,	PUNCT
fnp-3166	5	5	a	a	DET
fnp-3166	5	6	spectrum	spectrum	NOUN
fnp-3166	5	7	of	of	ADP
fnp-3166	5	8	neuropathological	neuropathological	ADJ
fnp-3166	5	9	studies	study	NOUN
fnp-3166	5	10	has	have	AUX
fnp-3166	5	11	been	be	AUX
fnp-3166	5	12	published	publish	VERB
fnp-3166	5	13	in	in	ADP
fnp-3166	5	14	2020	2020	NUM
fnp-3166	5	15	,	,	PUNCT
fnp-3166	5	16	which	which	PRON
fnp-3166	5	17	provides	provide	VERB
fnp-3166	5	18	new	new	ADJ
fnp-3166	5	19	insights	insight	NOUN
fnp-3166	5	20	on	on	ADP
fnp-3166	5	21	important	important	ADJ
fnp-3166	5	22	questions	question	NOUN
fnp-3166	5	23	related	relate	VERB
fnp-3166	5	24	to	to	ADP
fnp-3166	5	25	neurological	neurological	ADJ
fnp-3166	5	26	disease	disease	NOUN
fnp-3166	5	27	.	.	PUNCT
fnp-3166	6	1	they	they	PRON
fnp-3166	6	2	include	include	VERB
fnp-3166	6	3	the	the	DET
fnp-3166	6	4	pathological	pathological	ADJ
fnp-3166	6	5	substrate	substrate	NOUN
fnp-3166	6	6	of	of	ADP
fnp-3166	6	7	brain	brain	NOUN
fnp-3166	6	8	disease	disease	NOUN
fnp-3166	6	9	in	in	ADP
fnp-3166	6	10	covid-19	covid-19	PROPN
fnp-3166	6	11	infected	infected	ADJ
fnp-3166	6	12	patients	patient	NOUN
fnp-3166	6	13	,	,	PUNCT
fnp-3166	6	14	the	the	DET
fnp-3166	6	15	nature	nature	NOUN
fnp-3166	6	16	of	of	ADP
fnp-3166	6	17	the	the	DET
fnp-3166	6	18	adaptive	adaptive	ADJ
fnp-3166	6	19	and	and	CCONJ
fnp-3166	6	20	innate	innate	ADJ
fnp-3166	6	21	inflammatory	inflammatory	ADJ
fnp-3166	6	22	response	response	NOUN
fnp-3166	6	23	,	,	PUNCT
fnp-3166	6	24	or	or	CCONJ
fnp-3166	6	25	the	the	DET
fnp-3166	6	26	type	type	NOUN
fnp-3166	6	27	and	and	CCONJ
fnp-3166	6	28	mechanisms	mechanism	NOUN
fnp-3166	6	29	of	of	ADP
fnp-3166	6	30	tissue	tissue	NOUN
fnp-3166	6	31	injury	injury	NOUN
fnp-3166	6	32	and	and	CCONJ
fnp-3166	6	33	repair	repair	NOUN
fnp-3166	6	34	in	in	ADP
fnp-3166	6	35	multiple	multiple	ADJ
fnp-3166	6	36	sclerosis	sclerosis	NOUN
fnp-3166	6	37	,	,	PUNCT
fnp-3166	6	38	and	and	CCONJ
fnp-3166	6	39	diagnostically	diagnostically	ADV
fnp-3166	6	40	relevant	relevant	ADJ
fnp-3166	6	41	or	or	CCONJ
fnp-3166	6	42	mechanistic	mechanistic	ADJ
fnp-3166	6	43	new	new	ADJ
fnp-3166	6	44	insights	insight	NOUN
fnp-3166	6	45	into	into	ADP
fnp-3166	6	46	antibody	antibody	NOUN
fnp-3166	6	47	-	-	PUNCT
fnp-3166	6	48	mediated	mediate	VERB
fnp-3166	6	49	diseases	disease	NOUN
fnp-3166	6	50	of	of	ADP
fnp-3166	6	51	the	the	DET
fnp-3166	6	52	central	central	ADJ
fnp-3166	6	53	nervous	nervous	ADJ
fnp-3166	6	54	system	system	NOUN
fnp-3166	6	55	.	.	PUNCT
fnp-3166	7	1	other	other	ADJ
fnp-3166	7	2	studies	study	NOUN
fnp-3166	7	3	describe	describe	VERB
fnp-3166	7	4	in	in	ADP
fnp-3166	7	5	detail	detail	NOUN
fnp-3166	7	6	the	the	DET
fnp-3166	7	7	dynamic	dynamic	ADJ
fnp-3166	7	8	changes	change	NOUN
fnp-3166	7	9	of	of	ADP
fnp-3166	7	10	brain	brain	NOUN
fnp-3166	7	11	inflammation	inflammation	NOUN
fnp-3166	7	12	in	in	ADP
fnp-3166	7	13	patients	patient	NOUN
fnp-3166	7	14	with	with	ADP
fnp-3166	7	15	trisomy	trisomy	NOUN
fnp-3166	7	16	21	21	NUM
fnp-3166	7	17	as	as	ADP
fnp-3166	7	18	a	a	DET
fnp-3166	7	19	disease	disease	NOUN
fnp-3166	7	20	model	model	NOUN
fnp-3166	7	21	for	for	ADP
fnp-3166	7	22	alzheimer	alzheimer	PROPN
fnp-3166	7	23	’s	’s	PART
fnp-3166	7	24	disease	disease	NOUN
fnp-3166	7	25	,	,	PUNCT
fnp-3166	7	26	or	or	CCONJ
fnp-3166	7	27	the	the	DET
fnp-3166	7	28	presence	presence	NOUN
fnp-3166	7	29	and	and	CCONJ
fnp-3166	7	30	consequences	consequence	NOUN
fnp-3166	7	31	of	of	ADP
fnp-3166	7	32	vascular	vascular	ADJ
fnp-3166	7	33	comorbidities	comorbiditie	NOUN
fnp-3166	7	34	in	in	ADP
fnp-3166	7	35	a	a	DET
fnp-3166	7	36	chronic	chronic	ADJ
fnp-3166	7	37	inflammatory	inflammatory	ADJ
fnp-3166	7	38	disease	disease	NOUN
fnp-3166	7	39	,	,	PUNCT
fnp-3166	7	40	such	such	ADJ
fnp-3166	7	41	as	as	ADP
fnp-3166	7	42	multiple	multiple	ADJ
fnp-3166	7	43	sclerosis	sclerosis	NOUN
fnp-3166	7	44	.	.	PUNCT
fnp-3166	8	1	all	all	DET
fnp-3166	8	2	these	these	DET
fnp-3166	8	3	contributions	contribution	NOUN
fnp-3166	8	4	have	have	AUX
fnp-3166	8	5	provided	provide	VERB
fnp-3166	8	6	important	important	ADJ
fnp-3166	8	7	,	,	PUNCT
fnp-3166	8	8	highly	highly	ADV
fnp-3166	8	9	relevant	relevant	ADJ
fnp-3166	8	10	clues	clue	NOUN
fnp-3166	8	11	for	for	ADP
fnp-3166	8	12	basic	basic	ADJ
fnp-3166	8	13	and	and	CCONJ
fnp-3166	8	14	translational	translational	ADJ
fnp-3166	8	15	neuroscience	neuroscience	NOUN
fnp-3166	8	16	.	.	PUNCT
fnp-3166	9	1	1	1	X
fnp-3166	9	2	)	)	PUNCT
fnp-3166	9	3	what	what	PRON
fnp-3166	9	4	was	be	AUX
fnp-3166	9	5	the	the	DET
fnp-3166	9	6	brain	brain	NOUN
fnp-3166	9	7	pathology	pathology	NOUN
fnp-3166	9	8	in	in	ADP
fnp-3166	9	9	patients	patient	NOUN
fnp-3166	9	10	who	who	PRON
fnp-3166	9	11	died	die	VERB
fnp-3166	9	12	during	during	ADP
fnp-3166	9	13	the	the	DET
fnp-3166	9	14	course	course	NOUN
fnp-3166	9	15	of	of	ADP
fnp-3166	9	16	covid-19	covid-19	PROPN
fnp-3166	9	17	?	?	PUNCT
fnp-3166	10	1	the	the	DET
fnp-3166	10	2	covid-19	covid-19	PROPN
fnp-3166	10	3	pandemic	pandemic	NOUN
fnp-3166	10	4	has	have	AUX
fnp-3166	10	5	been	be	AUX
fnp-3166	10	6	a	a	DET
fnp-3166	10	7	major	major	ADJ
fnp-3166	10	8	challenge	challenge	NOUN
fnp-3166	10	9	for	for	ADP
fnp-3166	10	10	society	society	NOUN
fnp-3166	10	11	and	and	CCONJ
fnp-3166	10	12	particularly	particularly	ADV
fnp-3166	10	13	for	for	ADP
fnp-3166	10	14	health	health	NOUN
fnp-3166	10	15	care	care	NOUN
fnp-3166	10	16	institutions	institution	NOUN
fnp-3166	10	17	during	during	ADP
fnp-3166	10	18	the	the	DET
fnp-3166	10	19	last	last	ADJ
fnp-3166	10	20	year	year	NOUN
fnp-3166	10	21	.	.	PUNCT
fnp-3166	11	1	although	although	SCONJ
fnp-3166	11	2	covid-19	covid-19	PROPN
fnp-3166	11	3	primarily	primarily	ADV
fnp-3166	11	4	affects	affect	VERB
fnp-3166	11	5	the	the	DET
fnp-3166	11	6	respiratory	respiratory	ADJ
fnp-3166	11	7	system	system	NOUN
fnp-3166	11	8	and	and	CCONJ
fnp-3166	11	9	the	the	DET
fnp-3166	11	10	major	major	ADJ
fnp-3166	11	11	cause	cause	NOUN
fnp-3166	11	12	of	of	ADP
fnp-3166	11	13	death	death	NOUN
fnp-3166	11	14	is	be	AUX
fnp-3166	11	15	pneumonia	pneumonia	NOUN
fnp-3166	11	16	with	with	ADP
fnp-3166	11	17	respiratory	respiratory	ADJ
fnp-3166	11	18	failure	failure	NOUN
fnp-3166	11	19	,	,	PUNCT
fnp-3166	11	20	other	other	ADJ
fnp-3166	11	21	organs	organ	NOUN
fnp-3166	11	22	,	,	PUNCT
fnp-3166	11	23	such	such	ADJ
fnp-3166	11	24	as	as	ADP
fnp-3166	11	25	the	the	DET
fnp-3166	11	26	renal	renal	ADJ
fnp-3166	11	27	,	,	PUNCT
fnp-3166	11	28	cardiovascular	cardiovascular	ADJ
fnp-3166	11	29	system	system	NOUN
fnp-3166	11	30	,	,	PUNCT
fnp-3166	11	31	or	or	CCONJ
fnp-3166	11	32	the	the	DET
fnp-3166	11	33	digestive	digestive	ADJ
fnp-3166	11	34	tract	tract	NOUN
fnp-3166	11	35	,	,	PUNCT
fnp-3166	11	36	are	be	AUX
fnp-3166	11	37	affected	affect	VERB
fnp-3166	11	38	(	(	PUNCT
fnp-3166	11	39	paterson	paterson	PROPN
fnp-3166	11	40	et	et	PROPN
fnp-3166	11	41	al	al	PROPN
fnp-3166	11	42	.	.	PROPN
fnp-3166	11	43	2020	2020	NUM
fnp-3166	11	44	)	)	PUNCT
fnp-3166	11	45	.	.	PUNCT
fnp-3166	12	1	most	most	ADV
fnp-3166	12	2	relevant	relevant	ADJ
fnp-3166	12	3	for	for	ADP
fnp-3166	12	4	neuropathology	neuropathology	NOUN
fnp-3166	12	5	is	be	AUX
fnp-3166	12	6	that	that	SCONJ
fnp-3166	12	7	the	the	DET
fnp-3166	12	8	nervous	nervous	ADJ
fnp-3166	12	9	system	system	NOUN
fnp-3166	12	10	,	,	PUNCT
fnp-3166	12	11	too	too	ADV
fnp-3166	12	12	,	,	PUNCT
fnp-3166	12	13	can	can	AUX
fnp-3166	12	14	be	be	AUX
fnp-3166	12	15	a	a	DET
fnp-3166	12	16	target	target	NOUN
fnp-3166	12	17	,	,	PUNCT
fnp-3166	12	18	reflected	reflect	VERB
fnp-3166	12	19	for	for	ADP
fnp-3166	12	20	instance	instance	NOUN
fnp-3166	12	21	by	by	ADP
fnp-3166	12	22	anosmia	anosmia	NOUN
fnp-3166	12	23	and	and	CCONJ
fnp-3166	12	24	ageusia	ageusia	NOUN
fnp-3166	12	25	,	,	PUNCT
fnp-3166	12	26	encephalopathy	encephalopathy	ADJ
fnp-3166	12	27	,	,	PUNCT
fnp-3166	12	28	focal	focal	ADJ
fnp-3166	12	29	ischemic	ischemic	ADJ
fnp-3166	12	30	stroke	stroke	NOUN
fnp-3166	12	31	,	,	PUNCT
fnp-3166	12	32	encephalitis	encephalitis	NOUN
fnp-3166	12	33	,	,	PUNCT
fnp-3166	12	34	meningitis	meningitis	NOUN
fnp-3166	12	35	,	,	PUNCT
fnp-3166	12	36	or	or	CCONJ
fnp-3166	12	37	polyneuritis	polyneuritis	PROPN
fnp-3166	12	38	(	(	PUNCT
fnp-3166	12	39	li	li	PROPN
fnp-3166	12	40	et	et	PROPN
fnp-3166	12	41	al	al	PROPN
fnp-3166	12	42	.	.	PROPN
fnp-3166	12	43	2020	2020	NUM
fnp-3166	12	44	,	,	PUNCT
fnp-3166	12	45	paterson	paterson	PROPN
fnp-3166	12	46	et	et	PROPN
fnp-3166	12	47	al	al	PROPN
fnp-3166	12	48	.	.	PROPN
fnp-3166	12	49	2020	2020	NUM
fnp-3166	12	50	,	,	PUNCT
fnp-3166	12	51	liu	liu	PROPN
fnp-3166	12	52	et	et	PROPN
fnp-3166	12	53	al	al	PROPN
fnp-3166	12	54	.	.	PROPN
fnp-3166	12	55	2020	2020	NUM
fnp-3166	12	56	,	,	PUNCT
fnp-3166	12	57	hernandez	hernandez	PROPN
fnp-3166	12	58	-	-	PUNCT
fnp-3166	12	59	fernandez	fernandez	PROPN
fnp-3166	12	60	et	et	PROPN
fnp-3166	12	61	al	al	PROPN
fnp-3166	12	62	.	.	PROPN
fnp-3166	12	63	2020	2020	NUM
fnp-3166	12	64	)	)	PUNCT
fnp-3166	12	65	.	.	PUNCT
fnp-3166	13	1	to	to	ADP
fnp-3166	13	2	what	what	DET
fnp-3166	13	3	extent	extent	NOUN
fnp-3166	13	4	these	these	DET
fnp-3166	13	5	neurological	neurological	ADJ
fnp-3166	13	6	deficits	deficit	NOUN
fnp-3166	13	7	are	be	AUX
fnp-3166	13	8	due	due	ADJ
fnp-3166	13	9	to	to	ADP
fnp-3166	13	10	direct	direct	ADJ
fnp-3166	13	11	sars	sar	NOUN
fnp-3166	13	12	-	-	PUNCT
fnp-3166	13	13	cov2	cov2	PROPN
fnp-3166	13	14	infection	infection	NOUN
fnp-3166	13	15	of	of	ADP
fnp-3166	13	16	the	the	DET
fnp-3166	13	17	nervous	nervous	ADJ
fnp-3166	13	18	tissue	tissue	NOUN
fnp-3166	13	19	,	,	PUNCT
fnp-3166	13	20	immune	immune	NOUN
fnp-3166	13	21	-	-	PUNCT
fnp-3166	13	22	mediated	mediate	VERB
fnp-3166	13	23	brain	brain	NOUN
fnp-3166	13	24	damage	damage	NOUN
fnp-3166	13	25	in	in	ADP
fnp-3166	13	26	the	the	DET
fnp-3166	13	27	course	course	NOUN
fnp-3166	13	28	of	of	ADP
fnp-3166	13	29	a	a	DET
fnp-3166	13	30	systemic	systemic	ADJ
fnp-3166	13	31	cytokine	cytokine	NOUN
fnp-3166	13	32	storm	storm	NOUN
fnp-3166	13	33	,	,	PUNCT
fnp-3166	13	34	or	or	CCONJ
fnp-3166	13	35	are	be	AUX
fnp-3166	13	36	secondary	secondary	ADJ
fnp-3166	13	37	complications	complication	NOUN
fnp-3166	13	38	of	of	ADP
fnp-3166	13	39	respiratory	respiratory	ADJ
fnp-3166	13	40	failure	failure	NOUN
fnp-3166	13	41	,	,	PUNCT
fnp-3166	13	42	the	the	DET
fnp-3166	13	43	intensive	intensive	ADJ
fnp-3166	13	44	care	care	NOUN
fnp-3166	13	45	setting	setting	NOUN
fnp-3166	13	46	,	,	PUNCT
fnp-3166	13	47	or	or	CCONJ
fnp-3166	13	48	comorbidities	comorbiditie	NOUN
fnp-3166	13	49	is	be	AUX
fnp-3166	13	50	not	not	PART
fnp-3166	13	51	clear	clear	ADJ
fnp-3166	13	52	(	(	PUNCT
fnp-3166	13	53	liu	liu	PROPN
fnp-3166	13	54	et	et	PROPN
fnp-3166	13	55	al	al	PROPN
fnp-3166	13	56	.	.	PROPN
fnp-3166	13	57	2020	2020	NUM
fnp-3166	13	58	)	)	PUNCT
fnp-3166	13	59	.	.	PUNCT
fnp-3166	14	1	neuropathology	neuropathology	NOUN
fnp-3166	14	2	plays	play	VERB
fnp-3166	14	3	a	a	DET
fnp-3166	14	4	critical	critical	ADJ
fnp-3166	14	5	role	role	NOUN
fnp-3166	14	6	in	in	ADP
fnp-3166	14	7	answering	answer	VERB
fnp-3166	14	8	these	these	DET
fnp-3166	14	9	questions	question	NOUN
fnp-3166	14	10	.	.	PUNCT
fnp-3166	15	1	the	the	DET
fnp-3166	15	2	first	first	ADJ
fnp-3166	15	3	approach	approach	NOUN
fnp-3166	15	4	to	to	PART
fnp-3166	15	5	answer	answer	VERB
fnp-3166	15	6	these	these	DET
fnp-3166	15	7	questions	question	NOUN
fnp-3166	15	8	was	be	AUX
fnp-3166	15	9	to	to	PART
fnp-3166	15	10	analyze	analyze	VERB
fnp-3166	15	11	whether	whether	SCONJ
fnp-3166	15	12	molecules	molecule	NOUN
fnp-3166	15	13	,	,	PUNCT
fnp-3166	15	14	which	which	PRON
fnp-3166	15	15	are	be	AUX
fnp-3166	15	16	involved	involve	VERB
fnp-3166	15	17	in	in	ADP
fnp-3166	15	18	cellular	cellular	ADJ
fnp-3166	15	19	virus	virus	NOUN
fnp-3166	15	20	infection	infection	NOUN
fnp-3166	15	21	or	or	CCONJ
fnp-3166	15	22	propagation	propagation	NOUN
fnp-3166	15	23	,	,	PUNCT
fnp-3166	15	24	are	be	AUX
fnp-3166	15	25	expressed	express	VERB
fnp-3166	15	26	within	within	ADP
fnp-3166	15	27	the	the	DET
fnp-3166	15	28	nervous	nervous	ADJ
fnp-3166	15	29	system	system	NOUN
fnp-3166	15	30	.	.	PUNCT
fnp-3166	16	1	angiotensin	angiotensin	NOUN
fnp-3166	16	2	concerting	concerting	NOUN
fnp-3166	16	3	enzyme	enzyme	NOUN
fnp-3166	16	4	2	2	NUM
fnp-3166	16	5	(	(	PUNCT
fnp-3166	16	6	ace2	ace2	PROPN
fnp-3166	16	7	)	)	PUNCT
fnp-3166	16	8	is	be	AUX
fnp-3166	16	9	one	one	NUM
fnp-3166	16	10	of	of	ADP
fnp-3166	16	11	the	the	DET
fnp-3166	16	12	cellular	cellular	ADJ
fnp-3166	16	13	receptors	receptor	NOUN
fnp-3166	16	14	recognized	recognize	VERB
fnp-3166	16	15	by	by	ADP
fnp-3166	16	16	sars	sar	NOUN
fnp-3166	16	17	-	-	PUNCT
fnp-3166	16	18	cov2	cov2	PROPN
fnp-3166	16	19	,	,	PUNCT
fnp-3166	16	20	when	when	SCONJ
fnp-3166	16	21	docking	dock	VERB
fnp-3166	16	22	to	to	ADP
fnp-3166	16	23	the	the	DET
fnp-3166	16	24	cell	cell	NOUN
fnp-3166	16	25	surface	surface	NOUN
fnp-3166	16	26	.	.	PUNCT
fnp-3166	17	1	thus	thus	ADV
fnp-3166	17	2	,	,	PUNCT
fnp-3166	17	3	the	the	DET
fnp-3166	17	4	presence	presence	NOUN
fnp-3166	17	5	of	of	ADP
fnp-3166	17	6	ace2	ace2	NOUN
fnp-3166	17	7	on	on	ADP
fnp-3166	17	8	brain	brain	NOUN
fnp-3166	17	9	cells	cell	NOUN
fnp-3166	17	10	,	,	PUNCT
fnp-3166	17	11	such	such	ADJ
fnp-3166	17	12	as	as	ADP
fnp-3166	17	13	neurons	neuron	NOUN
fnp-3166	17	14	,	,	PUNCT
fnp-3166	17	15	glia	glia	NOUN
fnp-3166	17	16	or	or	CCONJ
fnp-3166	17	17	cerebral	cerebral	ADJ
fnp-3166	17	18	endothelial	endothelial	ADJ
fnp-3166	17	19	cells	cell	NOUN
fnp-3166	17	20	suggests	suggest	VERB
fnp-3166	17	21	that	that	SCONJ
fnp-3166	17	22	brain	brain	NOUN
fnp-3166	17	23	infections	infection	NOUN
fnp-3166	17	24	is	be	AUX
fnp-3166	17	25	possible	possible	ADJ
fnp-3166	17	26	(	(	PUNCT
fnp-3166	17	27	kabbani	kabbani	NOUN
fnp-3166	17	28	and	and	CCONJ
fnp-3166	17	29	olds	old	NOUN
fnp-3166	17	30	2020	2020	NUM
fnp-3166	17	31	,	,	PUNCT
fnp-3166	17	32	kanwar	kanwar	PROPN
fnp-3166	17	33	et	et	PROPN
fnp-3166	17	34	al	al	PROPN
fnp-3166	17	35	.	.	PROPN
fnp-3166	17	36	2020	2020	NUM
fnp-3166	17	37	)	)	PUNCT
fnp-3166	17	38	.	.	PUNCT
fnp-3166	18	1	another	another	DET
fnp-3166	18	2	docking	dock	VERB
fnp-3166	18	3	molecule	molecule	NOUN
fnp-3166	18	4	for	for	ADP
fnp-3166	18	5	sars	sar	NOUN
fnp-3166	18	6	-	-	PUNCT
fnp-3166	18	7	cov2	cov2	PROPN
fnp-3166	18	8	is	be	AUX
fnp-3166	18	9	neuropilin	neuropilin	PROPN
fnp-3166	18	10	1	1	NUM
fnp-3166	18	11	(	(	PUNCT
fnp-3166	18	12	nrp1	nrp1	PROPN
fnp-3166	18	13	)	)	PUNCT
fnp-3166	18	14	and	and	CCONJ
fnp-3166	18	15	a	a	DET
fnp-3166	18	16	high	high	ADJ
fnp-3166	18	17	expression	expression	NOUN
fnp-3166	18	18	of	of	ADP
fnp-3166	18	19	this	this	DET
fnp-3166	18	20	molecule	molecule	NOUN
fnp-3166	18	21	has	have	AUX
fnp-3166	18	22	been	be	AUX
fnp-3166	18	23	found	find	VERB
fnp-3166	18	24	in	in	ADP
fnp-3166	18	25	virus	virus	NOUN
fnp-3166	18	26	infected	infect	VERB
fnp-3166	18	27	cells	cell	NOUN
fnp-3166	18	28	in	in	ADP
fnp-3166	18	29	the	the	DET
fnp-3166	18	30	nasal	nasal	ADJ
fnp-3166	18	31	cavity	cavity	NOUN
fnp-3166	18	32	in	in	ADP
fnp-3166	18	33	covid-19	covid-19	PROPN
fnp-3166	18	34	patients	patient	NOUN
fnp-3166	18	35	(	(	PUNCT
fnp-3166	18	36	cantuti	cantuti	PROPN
fnp-3166	18	37	-	-	PUNCT
fnp-3166	18	38	castelvetri	castelvetri	NOUN
fnp-3166	18	39	et	et	PROPN
fnp-3166	18	40	al	al	PROPN
fnp-3166	18	41	.	.	PROPN
fnp-3166	18	42	2020	2020	NUM
fnp-3166	18	43	)	)	PUNCT
fnp-3166	18	44	.	.	PUNCT
fnp-3166	19	1	early	early	ADJ
fnp-3166	19	2	neuropathological	neuropathological	ADJ
fnp-3166	19	3	studies	study	NOUN
fnp-3166	19	4	in	in	ADP
fnp-3166	19	5	the	the	DET
fnp-3166	19	6	covid-19	covid-19	PROPN
fnp-3166	19	7	pandemic	pandemic	NOUN
fnp-3166	19	8	were	be	AUX
fnp-3166	19	9	restricted	restrict	VERB
fnp-3166	19	10	to	to	ADP
fnp-3166	19	11	single	single	ADJ
fnp-3166	19	12	case	case	NOUN
fnp-3166	19	13	reports	report	NOUN
fnp-3166	19	14	or	or	CCONJ
fnp-3166	19	15	investigations	investigation	NOUN
fnp-3166	19	16	in	in	ADP
fnp-3166	19	17	very	very	ADV
fnp-3166	19	18	small	small	ADJ
fnp-3166	19	19	patient	patient	ADJ
fnp-3166	19	20	cohorts	cohort	NOUN
fnp-3166	19	21	,	,	PUNCT
fnp-3166	19	22	and	and	CCONJ
fnp-3166	19	23	they	they	PRON
fnp-3166	19	24	were	be	AUX
fnp-3166	19	25	generally	generally	ADV
fnp-3166	19	26	restricted	restrict	VERB
fnp-3166	19	27	to	to	ADP
fnp-3166	19	28	some	some	DET
fnp-3166	19	29	basic	basic	ADJ
fnp-3166	19	30	neuropathological	neuropathological	ADJ
fnp-3166	19	31	investigations	investigation	NOUN
fnp-3166	19	32	(	(	PUNCT
fnp-3166	19	33	kantonen	kantonen	PROPN
fnp-3166	19	34	et	et	PROPN
fnp-3166	19	35	al	al	PROPN
fnp-3166	19	36	.	.	PROPN
fnp-3166	19	37	2020	2020	NUM
fnp-3166	19	38	,	,	PUNCT
fnp-3166	19	39	reichard	reichard	PROPN
fnp-3166	19	40	et	et	PROPN
fnp-3166	19	41	al	al	PROPN
fnp-3166	19	42	.	.	PROPN
fnp-3166	19	43	2020	2020	NUM
fnp-3166	19	44	,	,	PUNCT
fnp-3166	19	45	jensen	jensen	PROPN
fnp-3166	19	46	et	et	PROPN
fnp-3166	19	47	al	al	PROPN
fnp-3166	19	48	.	.	PROPN
fnp-3166	19	49	2020	2020	NUM
fnp-3166	19	50	,	,	PUNCT
fnp-3166	19	51	younger	young	ADJ
fnp-3166	19	52	2020	2020	NUM
fnp-3166	19	53	,	,	PUNCT
fnp-3166	19	54	liu	liu	PROPN
fnp-3166	19	55	et	et	PROPN
fnp-3166	19	56	al	al	PROPN
fnp-3166	19	57	.	.	PROPN
fnp-3166	19	58	2020	2020	NUM
fnp-3166	19	59	)	)	PUNCT
fnp-3166	19	60	.	.	PUNCT
fnp-3166	20	1	the	the	DET
fnp-3166	20	2	results	result	NOUN
fnp-3166	20	3	were	be	AUX
fnp-3166	20	4	diverse	diverse	ADJ
fnp-3166	20	5	and	and	CCONJ
fnp-3166	20	6	controversial	controversial	ADJ
fnp-3166	20	7	,	,	PUNCT
fnp-3166	20	8	mainly	mainly	ADV
fnp-3166	20	9	providing	provide	VERB
fnp-3166	20	10	evidence	evidence	NOUN
fnp-3166	20	11	for	for	ADP
fnp-3166	20	12	brain	brain	NOUN
fnp-3166	20	13	damage	damage	NOUN
fnp-3166	20	14	that	that	PRON
fnp-3166	20	15	was	be	AUX
fnp-3166	20	16	not	not	PART
fnp-3166	20	17	directly	directly	ADV
fnp-3166	20	18	linked	link	VERB
fnp-3166	20	19	to	to	ADP
fnp-3166	20	20	sars	sar	NOUN
fnp-3166	20	21	-	-	PUNCT
fnp-3166	20	22	cov2	cov2	PROPN
fnp-3166	20	23	infection	infection	NOUN
fnp-3166	20	24	.	.	PUNCT
fnp-3166	21	1	the	the	DET
fnp-3166	21	2	first	first	ADJ
fnp-3166	21	3	systematic	systematic	ADJ
fnp-3166	21	4	study	study	NOUN
fnp-3166	21	5	on	on	ADP
fnp-3166	21	6	this	this	DET
fnp-3166	21	7	issue	issue	NOUN
fnp-3166	21	8	appeared	appear	VERB
fnp-3166	21	9	on	on	ADP
fnp-3166	21	10	october	october	PROPN
fnp-3166	21	11	2020	2020	NUM
fnp-3166	21	12	in	in	ADP
fnp-3166	21	13	lancet	lancet	PROPN
fnp-3166	21	14	neurology	neurology	NOUN
fnp-3166	21	15	(	(	PUNCT
fnp-3166	21	16	matschke	matschke	PROPN
fnp-3166	21	17	et	et	PROPN
fnp-3166	21	18	al	al	PROPN
fnp-3166	21	19	.	.	PROPN
fnp-3166	21	20	2020	2020	NUM
fnp-3166	21	21	)	)	PUNCT
fnp-3166	21	22	,	,	PUNCT
fnp-3166	21	23	and	and	CCONJ
fnp-3166	21	24	this	this	DET
fnp-3166	21	25	study	study	NOUN
fnp-3166	21	26	combined	combine	VERB
fnp-3166	21	27	classical	classical	ADJ
fnp-3166	21	28	neuropathology	neuropathology	NOUN
fnp-3166	21	29	with	with	ADP
fnp-3166	21	30	virology	virology	NOUN
fnp-3166	21	31	and	and	CCONJ
fnp-3166	21	32	molecular	molecular	ADJ
fnp-3166	21	33	studies	study	NOUN
fnp-3166	21	34	on	on	ADP
fnp-3166	21	35	gene	gene	NOUN
fnp-3166	21	36	expression	expression	NOUN
fnp-3166	21	37	.	.	PUNCT
fnp-3166	22	1	in	in	ADP
fnp-3166	22	2	a	a	DET
fnp-3166	22	3	first	first	ADJ
fnp-3166	22	4	set	set	NOUN
fnp-3166	22	5	of	of	ADP
fnp-3166	22	6	data	datum	NOUN
fnp-3166	22	7	the	the	DET
fnp-3166	22	8	authors	author	NOUN
fnp-3166	22	9	describe	describe	VERB
fnp-3166	22	10	that	that	SCONJ
fnp-3166	22	11	different	different	ADJ
fnp-3166	22	12	molecules	molecule	NOUN
fnp-3166	22	13	,	,	PUNCT
fnp-3166	22	14	involved	involve	VERB
fnp-3166	22	15	in	in	ADP
fnp-3166	22	16	virus	virus	NOUN
fnp-3166	22	17	docking	docking	NOUN
fnp-3166	22	18	and	and	CCONJ
fnp-3166	22	19	propagation	propagation	NOUN
fnp-3166	22	20	,	,	PUNCT
fnp-3166	22	21	show	show	VERB
fnp-3166	22	22	a	a	DET
fnp-3166	22	23	preferential	preferential	ADJ
fnp-3166	22	24	expression	expression	NOUN
fnp-3166	22	25	in	in	ADP
fnp-3166	22	26	different	different	ADJ
fnp-3166	22	27	cells	cell	NOUN
fnp-3166	22	28	of	of	ADP
fnp-3166	22	29	the	the	DET
fnp-3166	22	30	central	central	ADJ
fnp-3166	22	31	nervous	nervous	ADJ
fnp-3166	22	32	system	system	NOUN
fnp-3166	22	33	.	.	PUNCT
fnp-3166	23	1	for	for	ADP
fnp-3166	23	2	example	example	NOUN
fnp-3166	23	3	,	,	PUNCT
fnp-3166	23	4	ace2	ace2	PROPN
fnp-3166	23	5	was	be	AUX
fnp-3166	23	6	mainly	mainly	ADV
fnp-3166	23	7	found	find	VERB
fnp-3166	23	8	in	in	ADP
fnp-3166	23	9	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	23	10	.	.	PUNCT
fnp-3166	24	1	the	the	DET
fnp-3166	24	2	highest	high	ADJ
fnp-3166	24	3	expression	expression	NOUN
fnp-3166	24	4	of	of	ADP
fnp-3166	24	5	transmembrane	transmembrane	ADJ
fnp-3166	24	6	protease	protease	NOUN
fnp-3166	24	7	serine	serine	NOUN
fnp-3166	24	8	subtype	subtype	NOUN
fnp-3166	24	9	2	2	NUM
fnp-3166	24	10	and	and	CCONJ
fnp-3166	24	11	4	4	NUM
fnp-3166	24	12	(	(	PUNCT
fnp-3166	24	13	tmprss2	tmprss2	X
fnp-3166	24	14	/	/	SYM
fnp-3166	24	15	4	4	X
fnp-3166	24	16	)	)	PUNCT
fnp-3166	24	17	was	be	AUX
fnp-3166	24	18	seen	see	VERB
fnp-3166	24	19	in	in	ADP
fnp-3166	24	20	neurons	neuron	NOUN
fnp-3166	24	21	,	,	PUNCT
fnp-3166	24	22	and	and	CCONJ
fnp-3166	24	23	nrp-1	nrp-1	NUM
fnp-3166	24	24	was	be	AUX
fnp-3166	24	25	mainly	mainly	ADV
fnp-3166	24	26	present	present	ADJ
fnp-3166	24	27	in	in	ADP
fnp-3166	24	28	endothelial	endothelial	ADJ
fnp-3166	24	29	cells	cell	NOUN
fnp-3166	24	30	and	and	CCONJ
fnp-3166	24	31	astrocytes	astrocyte	NOUN
fnp-3166	24	32	.	.	PUNCT
fnp-3166	25	1	these	these	DET
fnp-3166	25	2	data	datum	NOUN
fnp-3166	25	3	suggest	suggest	VERB
fnp-3166	25	4	different	different	ADJ
fnp-3166	25	5	mechanisms	mechanism	NOUN
fnp-3166	25	6	of	of	ADP
fnp-3166	25	7	infection	infection	NOUN
fnp-3166	25	8	in	in	ADP
fnp-3166	25	9	different	different	ADJ
fnp-3166	25	10	brain	brain	NOUN
fnp-3166	25	11	cells	cell	NOUN
fnp-3166	25	12	.	.	PUNCT
fnp-3166	26	1	the	the	DET
fnp-3166	26	2	neuropathological	neuropathological	ADJ
fnp-3166	26	3	studies	study	NOUN
fnp-3166	26	4	documented	document	VERB
fnp-3166	26	5	the	the	DET
fnp-3166	26	6	presence	presence	NOUN
fnp-3166	26	7	of	of	ADP
fnp-3166	26	8	focal	focal	ADJ
fnp-3166	26	9	and	and	CCONJ
fnp-3166	26	10	diffuse	diffuse	VERB
fnp-3166	26	11	ischemic	ischemic	ADJ
fnp-3166	26	12	lesions	lesion	NOUN
fnp-3166	26	13	and	and	CCONJ
fnp-3166	26	14	diffuse	diffuse	ADJ
fnp-3166	26	15	astrogliosis	astrogliosis	NOUN
fnp-3166	26	16	.	.	PUNCT
fnp-3166	27	1	microglia	microglia	ADJ
fnp-3166	27	2	activation	activation	NOUN
fnp-3166	27	3	with	with	ADP
fnp-3166	27	4	microglia	microglia	ADJ
fnp-3166	27	5	nodules	nodule	NOUN
fnp-3166	27	6	and	and	CCONJ
fnp-3166	27	7	inflammation	inflammation	NOUN
fnp-3166	27	8	were	be	AUX
fnp-3166	27	9	mainly	mainly	ADV
fnp-3166	27	10	seen	see	VERB
fnp-3166	27	11	in	in	ADP
fnp-3166	27	12	the	the	DET
fnp-3166	27	13	lower	low	ADJ
fnp-3166	27	14	brain	brain	NOUN
fnp-3166	27	15	stem	stem	NOUN
fnp-3166	27	16	.	.	PUNCT
fnp-3166	28	1	in	in	ADP
fnp-3166	28	2	about	about	ADV
fnp-3166	28	3	half	half	NOUN
fnp-3166	28	4	of	of	ADP
fnp-3166	28	5	the	the	DET
fnp-3166	28	6	patients	patient	NOUN
fnp-3166	28	7	,	,	PUNCT
fnp-3166	28	8	virus	virus	NOUN
fnp-3166	28	9	was	be	AUX
fnp-3166	28	10	found	find	VERB
fnp-3166	28	11	either	either	CCONJ
fnp-3166	28	12	by	by	ADP
fnp-3166	28	13	pcr	pcr	NOUN
fnp-3166	28	14	or	or	CCONJ
fnp-3166	28	15	immunocytochemistry	immunocytochemistry	NOUN
fnp-3166	28	16	.	.	PUNCT
fnp-3166	29	1	however	however	ADV
fnp-3166	29	2	,	,	PUNCT
fnp-3166	29	3	the	the	DET
fnp-3166	29	4	virus	virus	NOUN
fnp-3166	29	5	load	load	NOUN
fnp-3166	29	6	was	be	AUX
fnp-3166	29	7	very	very	ADV
fnp-3166	29	8	low	low	ADJ
fnp-3166	29	9	and	and	CCONJ
fnp-3166	29	10	by	by	ADP
fnp-3166	29	11	immunohistochemistry	immunohistochemistry	NOUN
fnp-3166	29	12	only	only	ADV
fnp-3166	29	13	a	a	DET
fnp-3166	29	14	very	very	ADV
fnp-3166	29	15	small	small	ADJ
fnp-3166	29	16	number	number	NOUN
fnp-3166	29	17	of	of	ADP
fnp-3166	29	18	virus	virus	NOUN
fnp-3166	29	19	infected	infect	VERB
fnp-3166	29	20	cells	cell	NOUN
fnp-3166	29	21	became	become	VERB
fnp-3166	29	22	apparent	apparent	ADJ
fnp-3166	29	23	.	.	PUNCT
fnp-3166	30	1	this	this	DET
fnp-3166	30	2	study	study	NOUN
fnp-3166	30	3	is	be	AUX
fnp-3166	30	4	the	the	DET
fnp-3166	30	5	first	first	ADJ
fnp-3166	30	6	to	to	PART
fnp-3166	30	7	describe	describe	VERB
fnp-3166	30	8	the	the	DET
fnp-3166	30	9	basic	basic	ADJ
fnp-3166	30	10	neuropathology	neuropathology	NOUN
fnp-3166	30	11	seen	see	VERB
fnp-3166	30	12	in	in	ADP
fnp-3166	30	13	covid-19	covid-19	PROPN
fnp-3166	30	14	patients	patient	NOUN
fnp-3166	30	15	and	and	CCONJ
fnp-3166	30	16	is	be	AUX
fnp-3166	30	17	,	,	PUNCT
fnp-3166	30	18	thus	thus	ADV
fnp-3166	30	19	,	,	PUNCT
fnp-3166	30	20	very	very	ADV
fnp-3166	30	21	important	important	ADJ
fnp-3166	30	22	and	and	CCONJ
fnp-3166	30	23	groundbreaking	groundbreaking	ADJ
fnp-3166	30	24	.	.	PUNCT
fnp-3166	31	1	however	however	ADV
fnp-3166	31	2	,	,	PUNCT
fnp-3166	31	3	it	it	PRON
fnp-3166	31	4	also	also	ADV
fnp-3166	31	5	has	have	VERB
fnp-3166	31	6	important	important	ADJ
fnp-3166	31	7	limitations	limitation	NOUN
fnp-3166	31	8	.	.	PUNCT
fnp-3166	32	1	it	it	PRON
fnp-3166	32	2	is	be	AUX
fnp-3166	32	3	based	base	VERB
fnp-3166	32	4	on	on	ADP
fnp-3166	32	5	autopsies	autopsy	NOUN
fnp-3166	32	6	of	of	ADP
fnp-3166	32	7	43	43	NUM
fnp-3166	32	8	patients	patient	NOUN
fnp-3166	32	9	,	,	PUNCT
fnp-3166	32	10	which	which	PRON
fnp-3166	32	11	is	be	AUX
fnp-3166	32	12	likely	likely	ADJ
fnp-3166	32	13	not	not	PART
fnp-3166	32	14	sufficient	sufficient	ADJ
fnp-3166	32	15	to	to	PART
fnp-3166	32	16	cover	cover	VERB
fnp-3166	32	17	the	the	DET
fnp-3166	32	18	entire	entire	ADJ
fnp-3166	32	19	neuropathological	neuropathological	ADJ
fnp-3166	32	20	spectrum	spectrum	NOUN
fnp-3166	32	21	of	of	ADP
fnp-3166	32	22	the	the	DET
fnp-3166	32	23	disease	disease	NOUN
fnp-3166	32	24	.	.	PUNCT
fnp-3166	33	1	another	another	DET
fnp-3166	33	2	limitation	limitation	NOUN
fnp-3166	33	3	is	be	AUX
fnp-3166	33	4	that	that	SCONJ
fnp-3166	33	5	it	it	PRON
fnp-3166	33	6	does	do	AUX
fnp-3166	33	7	not	not	PART
fnp-3166	33	8	contain	contain	VERB
fnp-3166	33	9	data	datum	NOUN
fnp-3166	33	10	regarding	regard	VERB
fnp-3166	33	11	the	the	DET
fnp-3166	33	12	neurological	neurological	ADJ
fnp-3166	33	13	status	status	NOUN
fnp-3166	33	14	of	of	ADP
fnp-3166	33	15	the	the	DET
fnp-3166	33	16	patients	patient	NOUN
fnp-3166	33	17	.	.	PUNCT
fnp-3166	34	1	thus	thus	ADV
fnp-3166	34	2	,	,	PUNCT
fnp-3166	34	3	it	it	PRON
fnp-3166	34	4	remains	remain	VERB
fnp-3166	34	5	unclear	unclear	ADJ
fnp-3166	34	6	,	,	PUNCT
fnp-3166	34	7	to	to	ADP
fnp-3166	34	8	what	what	DET
fnp-3166	34	9	extent	extent	NOUN
fnp-3166	34	10	patients	patient	NOUN
fnp-3166	34	11	with	with	ADP
fnp-3166	34	12	specific	specific	ADJ
fnp-3166	34	13	neurological	neurological	ADJ
fnp-3166	34	14	disease	disease	NOUN
fnp-3166	34	15	manifestations	manifestation	NOUN
fnp-3166	34	16	have	have	AUX
fnp-3166	34	17	been	be	AUX
fnp-3166	34	18	included	include	VERB
fnp-3166	34	19	.	.	PUNCT
fnp-3166	35	1	the	the	DET
fnp-3166	35	2	third	third	ADJ
fnp-3166	35	3	limitation	limitation	NOUN
fnp-3166	35	4	is	be	AUX
fnp-3166	35	5	that	that	SCONJ
fnp-3166	35	6	it	it	PRON
fnp-3166	35	7	does	do	AUX
fnp-3166	35	8	not	not	PART
fnp-3166	35	9	include	include	VERB
fnp-3166	35	10	a	a	DET
fnp-3166	35	11	proper	proper	ADJ
fnp-3166	35	12	patient	patient	NOUN
fnp-3166	35	13	control	control	NOUN
fnp-3166	35	14	group	group	NOUN
fnp-3166	35	15	and	and	CCONJ
fnp-3166	35	16	,	,	PUNCT
fnp-3166	35	17	particularly	particularly	ADV
fnp-3166	35	18	,	,	PUNCT
fnp-3166	35	19	patients	patient	NOUN
fnp-3166	35	20	with	with	ADP
fnp-3166	35	21	similarly	similarly	ADV
fnp-3166	35	22	severe	severe	ADJ
fnp-3166	35	23	systemic	systemic	ADJ
fnp-3166	35	24	immune	immune	ADJ
fnp-3166	35	25	activation	activation	NOUN
fnp-3166	35	26	.	.	PUNCT
fnp-3166	36	1	this	this	DET
fnp-3166	36	2	particular	particular	ADJ
fnp-3166	36	3	question	question	NOUN
fnp-3166	36	4	has	have	AUX
fnp-3166	36	5	been	be	AUX
fnp-3166	36	6	addressed	address	VERB
fnp-3166	36	7	in	in	ADP
fnp-3166	36	8	another	another	DET
fnp-3166	36	9	study	study	NOUN
fnp-3166	36	10	on	on	ADP
fnp-3166	36	11	covid-19	covid-19	PROPN
fnp-3166	36	12	neuropathology	neuropathology	NOUN
fnp-3166	36	13	,	,	PUNCT
fnp-3166	36	14	which	which	PRON
fnp-3166	36	15	revealed	reveal	VERB
fnp-3166	36	16	that	that	SCONJ
fnp-3166	36	17	the	the	DET
fnp-3166	36	18	degree	degree	NOUN
fnp-3166	36	19	of	of	ADP
fnp-3166	36	20	inflammation	inflammation	NOUN
fnp-3166	36	21	and	and	CCONJ
fnp-3166	36	22	microglia	microglia	ADJ
fnp-3166	36	23	activation	activation	NOUN
fnp-3166	36	24	seen	see	VERB
fnp-3166	36	25	in	in	ADP
fnp-3166	36	26	covid-19	covid-19	PROPN
fnp-3166	36	27	patients	patient	NOUN
fnp-3166	36	28	is	be	AUX
fnp-3166	36	29	similar	similar	ADJ
fnp-3166	36	30	to	to	ADP
fnp-3166	36	31	that	that	PRON
fnp-3166	36	32	of	of	ADP
fnp-3166	36	33	patients	patient	NOUN
fnp-3166	36	34	who	who	PRON
fnp-3166	36	35	died	die	VERB
fnp-3166	36	36	under	under	ADP
fnp-3166	36	37	septic	septic	ADJ
fnp-3166	36	38	conditions	condition	NOUN
fnp-3166	36	39	(	(	PUNCT
fnp-3166	36	40	deigendesch	deigendesch	INTJ
fnp-3166	36	41	et	et	PROPN
fnp-3166	36	42	al	al	PROPN
fnp-3166	36	43	.	.	PROPN
fnp-3166	36	44	2020	2020	NUM
fnp-3166	36	45	)	)	PUNCT
fnp-3166	36	46	,	,	PUNCT
fnp-3166	36	47	thus	thus	ADV
fnp-3166	36	48	suggesting	suggest	VERB
fnp-3166	36	49	that	that	SCONJ
fnp-3166	36	50	it	it	PRON
fnp-3166	36	51	may	may	AUX
fnp-3166	36	52	at	at	ADP
fnp-3166	36	53	least	least	ADJ
fnp-3166	36	54	in	in	ADP
fnp-3166	36	55	part	part	NOUN
fnp-3166	36	56	be	be	AUX
fnp-3166	36	57	a	a	DET
fnp-3166	36	58	secondary	secondary	ADJ
fnp-3166	36	59	consequence	consequence	NOUN
fnp-3166	36	60	of	of	ADP
fnp-3166	36	61	systemic	systemic	ADJ
fnp-3166	36	62	immune	immune	ADJ
fnp-3166	36	63	activation	activation	NOUN
fnp-3166	36	64	.	.	PUNCT
fnp-3166	37	1	another	another	DET
fnp-3166	37	2	study	study	NOUN
fnp-3166	37	3	,	,	PUNCT
fnp-3166	37	4	also	also	ADV
fnp-3166	37	5	based	base	VERB
fnp-3166	37	6	on	on	ADP
fnp-3166	37	7	a	a	DET
fnp-3166	37	8	large	large	ADJ
fnp-3166	37	9	sample	sample	NOUN
fnp-3166	37	10	of	of	ADP
fnp-3166	37	11	autopsies	autopsy	NOUN
fnp-3166	37	12	,	,	PUNCT
fnp-3166	37	13	mainly	mainly	ADV
fnp-3166	37	14	focused	focus	VERB
fnp-3166	37	15	on	on	ADP
fnp-3166	37	16	the	the	DET
fnp-3166	37	17	possible	possible	ADJ
fnp-3166	37	18	routes	route	NOUN
fnp-3166	37	19	of	of	ADP
fnp-3166	37	20	cns	cns	NOUN
fnp-3166	37	21	infection	infection	NOUN
fnp-3166	37	22	(	(	PUNCT
fnp-3166	37	23	meinhardt	meinhardt	PROPN
fnp-3166	37	24	et	et	PROPN
fnp-3166	37	25	al	al	PROPN
fnp-3166	37	26	.	.	PROPN
fnp-3166	37	27	2020	2020	NUM
fnp-3166	37	28	)	)	PUNCT
fnp-3166	37	29	.	.	PUNCT
fnp-3166	38	1	it	it	PRON
fnp-3166	38	2	shows	show	VERB
fnp-3166	38	3	high	high	ADJ
fnp-3166	38	4	virus	virus	NOUN
fnp-3166	38	5	load	load	NOUN
fnp-3166	38	6	in	in	ADP
fnp-3166	38	7	the	the	DET
fnp-3166	38	8	olfactory	olfactory	NOUN
fnp-3166	38	9	epithelium	epithelium	NOUN
fnp-3166	38	10	,	,	PUNCT
fnp-3166	38	11	including	include	VERB
fnp-3166	38	12	the	the	DET
fnp-3166	38	13	olfactory	olfactory	ADJ
fnp-3166	38	14	sensory	sensory	ADJ
fnp-3166	38	15	neurons	neuron	NOUN
fnp-3166	38	16	,	,	PUNCT
fnp-3166	38	17	and	and	CCONJ
fnp-3166	38	18	in	in	ADP
fnp-3166	38	19	the	the	DET
fnp-3166	38	20	olfactory	olfactory	NOUN
fnp-3166	38	21	pathways	pathway	NOUN
fnp-3166	38	22	within	within	ADP
fnp-3166	38	23	the	the	DET
fnp-3166	38	24	cns	cns	NOUN
fnp-3166	38	25	,	,	PUNCT
fnp-3166	38	26	supporting	support	VERB
fnp-3166	38	27	the	the	DET
fnp-3166	38	28	view	view	NOUN
fnp-3166	38	29	of	of	ADP
fnp-3166	38	30	a	a	DET
fnp-3166	38	31	neuronal	neuronal	ADJ
fnp-3166	38	32	route	route	NOUN
fnp-3166	38	33	of	of	ADP
fnp-3166	38	34	virus	virus	NOUN
fnp-3166	38	35	entry	entry	NOUN
fnp-3166	38	36	into	into	ADP
fnp-3166	38	37	the	the	DET
fnp-3166	38	38	cns	cns	NOUN
fnp-3166	38	39	.	.	PUNCT
fnp-3166	39	1	additionally	additionally	ADV
fnp-3166	39	2	,	,	PUNCT
fnp-3166	39	3	however	however	ADV
fnp-3166	39	4	,	,	PUNCT
fnp-3166	39	5	virus	virus	NOUN
fnp-3166	39	6	antigen	antigen	NOUN
fnp-3166	39	7	was	be	AUX
fnp-3166	39	8	also	also	ADV
fnp-3166	39	9	present	present	ADJ
fnp-3166	39	10	in	in	ADP
fnp-3166	39	11	cerebral	cerebral	ADJ
fnp-3166	39	12	endothelial	endothelial	ADJ
fnp-3166	39	13	cells	cell	NOUN
fnp-3166	39	14	,	,	PUNCT
fnp-3166	39	15	associated	associate	VERB
fnp-3166	39	16	with	with	ADP
fnp-3166	39	17	micro	micro	NOUN
fnp-3166	39	18	-	-	NOUN
fnp-3166	39	19	thrombosis	thrombosis	NOUN
fnp-3166	39	20	and	and	CCONJ
fnp-3166	39	21	cerebral	cerebral	ADJ
fnp-3166	39	22	microinfarcts	microinfarct	NOUN
fnp-3166	39	23	.	.	PUNCT
fnp-3166	40	1	in	in	ADP
fnp-3166	40	2	summary	summary	NOUN
fnp-3166	40	3	,	,	PUNCT
fnp-3166	40	4	current	current	ADJ
fnp-3166	40	5	pathological	pathological	ADJ
fnp-3166	40	6	studies	study	NOUN
fnp-3166	40	7	show	show	VERB
fnp-3166	40	8	that	that	SCONJ
fnp-3166	40	9	the	the	DET
fnp-3166	40	10	central	central	ADJ
fnp-3166	40	11	nervous	nervous	ADJ
fnp-3166	40	12	system	system	NOUN
fnp-3166	40	13	can	can	AUX
fnp-3166	40	14	be	be	AUX
fnp-3166	40	15	infected	infect	VERB
fnp-3166	40	16	with	with	ADP
fnp-3166	40	17	sars	sar	NOUN
fnp-3166	40	18	-	-	PUNCT
fnp-3166	40	19	cov2	cov2	PROPN
fnp-3166	40	20	,	,	PUNCT
fnp-3166	40	21	that	that	SCONJ
fnp-3166	40	22	local	local	ADJ
fnp-3166	40	23	infection	infection	NOUN
fnp-3166	40	24	can	can	AUX
fnp-3166	40	25	be	be	AUX
fnp-3166	40	26	associated	associate	VERB
fnp-3166	40	27	with	with	ADP
fnp-3166	40	28	nervous	nervous	ADJ
fnp-3166	40	29	system	system	NOUN
fnp-3166	40	30	damage	damage	NOUN
fnp-3166	40	31	,	,	PUNCT
fnp-3166	40	32	but	but	CCONJ
fnp-3166	40	33	the	the	DET
fnp-3166	40	34	extent	extent	NOUN
fnp-3166	40	35	of	of	ADP
fnp-3166	40	36	infection	infection	NOUN
fnp-3166	40	37	is	be	AUX
fnp-3166	40	38	low	low	ADJ
fnp-3166	40	39	.	.	PUNCT
fnp-3166	41	1	a	a	DET
fnp-3166	41	2	large	large	ADJ
fnp-3166	41	3	part	part	NOUN
fnp-3166	41	4	of	of	ADP
fnp-3166	41	5	the	the	DET
fnp-3166	41	6	neuropathological	neuropathological	ADJ
fnp-3166	41	7	changes	change	NOUN
fnp-3166	41	8	seems	seem	VERB
fnp-3166	41	9	to	to	PART
fnp-3166	41	10	be	be	AUX
fnp-3166	41	11	secondary	secondary	ADJ
fnp-3166	41	12	to	to	ADP
fnp-3166	41	13	systemic	systemic	ADJ
fnp-3166	41	14	immune	immune	ADJ
fnp-3166	41	15	activation	activation	NOUN
fnp-3166	41	16	and	and	CCONJ
fnp-3166	41	17	cytokine	cytokine	NOUN
fnp-3166	41	18	storm	storm	NOUN
fnp-3166	41	19	,	,	PUNCT
fnp-3166	41	20	critical	critical	ADJ
fnp-3166	41	21	-	-	PUNCT
fnp-3166	41	22	illness	illness	NOUN
fnp-3166	41	23	related	relate	VERB
fnp-3166	41	24	encephalopathy	encephalopathy	NOUN
fnp-3166	41	25	,	,	PUNCT
fnp-3166	41	26	or	or	CCONJ
fnp-3166	41	27	hypoxia	hypoxia	NOUN
fnp-3166	41	28	and	and	CCONJ
fnp-3166	41	29	comorbidities	comorbiditie	NOUN
fnp-3166	41	30	.	.	PUNCT
fnp-3166	42	1	2	2	X
fnp-3166	42	2	)	)	PUNCT
fnp-3166	42	3	what	what	PRON
fnp-3166	42	4	new	new	ADJ
fnp-3166	42	5	insights	insight	NOUN
fnp-3166	42	6	have	have	AUX
fnp-3166	42	7	emerged	emerge	VERB
fnp-3166	42	8	into	into	ADP
fnp-3166	42	9	phenotype	phenotype	NOUN
fnp-3166	42	10	and	and	CCONJ
fnp-3166	42	11	disease	disease	NOUN
fnp-3166	42	12	mechanisms	mechanism	NOUN
fnp-3166	42	13	of	of	ADP
fnp-3166	42	14	antibody	antibody	NOUN
fnp-3166	42	15	mediated	mediate	VERB
fnp-3166	42	16	autoimmune	autoimmune	ADJ
fnp-3166	42	17	diseases	disease	NOUN
fnp-3166	42	18	of	of	ADP
fnp-3166	42	19	the	the	DET
fnp-3166	42	20	central	central	ADJ
fnp-3166	42	21	nervous	nervous	ADJ
fnp-3166	42	22	system	system	NOUN
fnp-3166	42	23	?	?	PUNCT
fnp-3166	43	1	the	the	DET
fnp-3166	43	2	discovery	discovery	NOUN
fnp-3166	43	3	that	that	PRON
fnp-3166	43	4	autoantibodies	autoantibody	NOUN
fnp-3166	43	5	against	against	ADP
fnp-3166	43	6	neuronal	neuronal	ADJ
fnp-3166	43	7	ion	ion	NOUN
fnp-3166	43	8	channels	channel	NOUN
fnp-3166	43	9	or	or	CCONJ
fnp-3166	43	10	neurotransmitter	neurotransmitter	NOUN
fnp-3166	43	11	receptors	receptor	NOUN
fnp-3166	43	12	are	be	AUX
fnp-3166	43	13	associated	associate	VERB
fnp-3166	43	14	with	with	ADP
fnp-3166	43	15	a	a	DET
fnp-3166	43	16	spectrum	spectrum	NOUN
fnp-3166	43	17	of	of	ADP
fnp-3166	43	18	acute	acute	ADJ
fnp-3166	43	19	and	and	CCONJ
fnp-3166	43	20	chronic	chronic	ADJ
fnp-3166	43	21	neurological	neurological	ADJ
fnp-3166	43	22	diseases	disease	NOUN
fnp-3166	43	23	,	,	PUNCT
fnp-3166	43	24	has	have	AUX
fnp-3166	43	25	revolutionized	revolutionize	VERB
fnp-3166	43	26	neurological	neurological	ADJ
fnp-3166	43	27	disease	disease	NOUN
fnp-3166	43	28	research	research	NOUN
fnp-3166	43	29	(	(	PUNCT
fnp-3166	43	30	höftberger	höftberger	NOUN
fnp-3166	43	31	and	and	CCONJ
fnp-3166	43	32	lassmann	lassmann	PROPN
fnp-3166	43	33	2017	2017	NUM
fnp-3166	43	34	)	)	PUNCT
fnp-3166	43	35	.	.	PUNCT
fnp-3166	44	1	it	it	PRON
fnp-3166	44	2	has	have	AUX
fnp-3166	44	3	been	be	AUX
fnp-3166	44	4	shown	show	VERB
fnp-3166	44	5	that	that	SCONJ
fnp-3166	44	6	these	these	DET
fnp-3166	44	7	diseases	disease	NOUN
fnp-3166	44	8	,	,	PUNCT
fnp-3166	44	9	which	which	PRON
fnp-3166	44	10	had	have	AUX
fnp-3166	44	11	before	before	ADV
fnp-3166	44	12	been	be	AUX
fnp-3166	44	13	regarded	regard	VERB
fnp-3166	44	14	as	as	ADP
fnp-3166	44	15	functional	functional	ADJ
fnp-3166	44	16	diseases	disease	NOUN
fnp-3166	44	17	,	,	PUNCT
fnp-3166	44	18	neurodegenerative	neurodegenerative	ADJ
fnp-3166	44	19	disorders	disorder	NOUN
fnp-3166	44	20	or	or	CCONJ
fnp-3166	44	21	toxic	toxic	ADJ
fnp-3166	44	22	conditions	condition	NOUN
fnp-3166	44	23	,	,	PUNCT
fnp-3166	44	24	are	be	AUX
fnp-3166	44	25	immune	immune	NOUN
fnp-3166	44	26	-	-	PUNCT
fnp-3166	44	27	mediated	mediate	VERB
fnp-3166	44	28	and	and	CCONJ
fnp-3166	44	29	can	can	AUX
fnp-3166	44	30	be	be	AUX
fnp-3166	44	31	successfully	successfully	ADV
fnp-3166	44	32	treated	treat	VERB
fnp-3166	44	33	with	with	ADP
fnp-3166	44	34	immunosuppression	immunosuppression	NOUN
fnp-3166	44	35	.	.	PUNCT
fnp-3166	45	1	the	the	DET
fnp-3166	45	2	number	number	NOUN
fnp-3166	45	3	of	of	ADP
fnp-3166	45	4	diseases	disease	NOUN
fnp-3166	45	5	falling	fall	VERB
fnp-3166	45	6	into	into	ADP
fnp-3166	45	7	this	this	DET
fnp-3166	45	8	category	category	NOUN
fnp-3166	45	9	has	have	AUX
fnp-3166	45	10	profoundly	profoundly	ADV
fnp-3166	45	11	increased	increase	VERB
fnp-3166	45	12	during	during	ADP
fnp-3166	45	13	the	the	DET
fnp-3166	45	14	last	last	ADJ
fnp-3166	45	15	years	year	NOUN
fnp-3166	45	16	(	(	PUNCT
fnp-3166	45	17	höftberger	höftberger	NOUN
fnp-3166	45	18	and	and	CCONJ
fnp-3166	45	19	lassmann	lassmann	PROPN
fnp-3166	45	20	2017	2017	NUM
fnp-3166	45	21	)	)	PUNCT
fnp-3166	45	22	.	.	PUNCT
fnp-3166	46	1	one	one	NUM
fnp-3166	46	2	reason	reason	NOUN
fnp-3166	46	3	,	,	PUNCT
fnp-3166	46	4	which	which	PRON
fnp-3166	46	5	may	may	AUX
fnp-3166	46	6	in	in	ADP
fnp-3166	46	7	part	part	NOUN
fnp-3166	46	8	explain	explain	VERB
fnp-3166	46	9	the	the	DET
fnp-3166	46	10	increase	increase	NOUN
fnp-3166	46	11	in	in	ADP
fnp-3166	46	12	prevalence	prevalence	NOUN
fnp-3166	46	13	,	,	PUNCT
fnp-3166	46	14	is	be	AUX
fnp-3166	46	15	the	the	DET
fnp-3166	46	16	introduction	introduction	NOUN
fnp-3166	46	17	of	of	ADP
fnp-3166	46	18	immunological	immunological	ADJ
fnp-3166	46	19	checkpoint	checkpoint	NOUN
fnp-3166	46	20	inhibitor	inhibitor	NOUN
fnp-3166	46	21	therapies	therapy	NOUN
fnp-3166	46	22	in	in	ADP
fnp-3166	46	23	oncology	oncology	NOUN
fnp-3166	46	24	.	.	PUNCT
fnp-3166	47	1	immunological	immunological	ADJ
fnp-3166	47	2	checkpoints	checkpoint	NOUN
fnp-3166	47	3	are	be	AUX
fnp-3166	47	4	critical	critical	ADJ
fnp-3166	47	5	steps	step	NOUN
fnp-3166	47	6	in	in	ADP
fnp-3166	47	7	t	t	NOUN
fnp-3166	47	8	-	-	PUNCT
fnp-3166	47	9	cell	cell	NOUN
fnp-3166	47	10	activation	activation	NOUN
fnp-3166	47	11	,	,	PUNCT
fnp-3166	47	12	which	which	PRON
fnp-3166	47	13	prohibit	prohibit	VERB
fnp-3166	47	14	the	the	DET
fnp-3166	47	15	development	development	NOUN
fnp-3166	47	16	of	of	ADP
fnp-3166	47	17	auto	auto	NOUN
fnp-3166	47	18	-	-	PUNCT
fnp-3166	47	19	reactive	reactive	ADJ
fnp-3166	47	20	t	t	PROPN
fnp-3166	47	21	-	-	PUNCT
fnp-3166	47	22	cells	cell	NOUN
fnp-3166	47	23	and	and	CCONJ
fnp-3166	47	24	auto	auto	NOUN
fnp-3166	47	25	-	-	PUNCT
fnp-3166	47	26	antibodies	antibodie	VERB
fnp-3166	47	27	.	.	PUNCT
fnp-3166	48	1	when	when	SCONJ
fnp-3166	48	2	these	these	DET
fnp-3166	48	3	checkpoints	checkpoint	NOUN
fnp-3166	48	4	are	be	AUX
fnp-3166	48	5	inhibited	inhibit	VERB
fnp-3166	48	6	,	,	PUNCT
fnp-3166	48	7	immune	immune	ADJ
fnp-3166	48	8	reactions	reaction	NOUN
fnp-3166	48	9	against	against	ADP
fnp-3166	48	10	antigens	antigen	NOUN
fnp-3166	48	11	of	of	ADP
fnp-3166	48	12	malignant	malignant	ADJ
fnp-3166	48	13	neoplasms	neoplasm	NOUN
fnp-3166	48	14	can	can	AUX
fnp-3166	48	15	be	be	AUX
fnp-3166	48	16	triggered	trigger	VERB
fnp-3166	48	17	,	,	PUNCT
fnp-3166	48	18	but	but	CCONJ
fnp-3166	48	19	this	this	PRON
fnp-3166	48	20	may	may	AUX
fnp-3166	48	21	occur	occur	VERB
fnp-3166	48	22	at	at	ADP
fnp-3166	48	23	the	the	DET
fnp-3166	48	24	expense	expense	NOUN
fnp-3166	48	25	of	of	ADP
fnp-3166	48	26	autoimmunity	autoimmunity	NOUN
fnp-3166	48	27	,	,	PUNCT
fnp-3166	48	28	which	which	PRON
fnp-3166	48	29	is	be	AUX
fnp-3166	48	30	frequently	frequently	ADV
fnp-3166	48	31	directed	direct	VERB
fnp-3166	48	32	against	against	ADP
fnp-3166	48	33	neuronal	neuronal	ADJ
fnp-3166	48	34	antigens	antigen	NOUN
fnp-3166	48	35	(	(	PUNCT
fnp-3166	48	36	sechi	sechi	NOUN
fnp-3166	48	37	et	et	PROPN
fnp-3166	48	38	al	al	PROPN
fnp-3166	48	39	.	.	PROPN
fnp-3166	48	40	2020	2020	NUM
fnp-3166	48	41	)	)	PUNCT
fnp-3166	48	42	.	.	PUNCT
fnp-3166	49	1	on	on	ADP
fnp-3166	49	2	this	this	DET
fnp-3166	49	3	basis	basis	NOUN
fnp-3166	49	4	it	it	PRON
fnp-3166	49	5	is	be	AUX
fnp-3166	49	6	not	not	PART
fnp-3166	49	7	surprising	surprising	ADJ
fnp-3166	49	8	that	that	SCONJ
fnp-3166	49	9	auto	auto	NOUN
fnp-3166	49	10	-	-	PUNCT
fnp-3166	49	11	antibody	antibody	NOUN
fnp-3166	49	12	-	-	PUNCT
fnp-3166	49	13	associated	associate	VERB
fnp-3166	49	14	diseases	disease	NOUN
fnp-3166	49	15	of	of	ADP
fnp-3166	49	16	the	the	DET
fnp-3166	49	17	central	central	ADJ
fnp-3166	49	18	nervous	nervous	ADJ
fnp-3166	49	19	system	system	NOUN
fnp-3166	49	20	remained	remain	VERB
fnp-3166	49	21	in	in	ADP
fnp-3166	49	22	the	the	DET
fnp-3166	49	23	focus	focus	NOUN
fnp-3166	49	24	of	of	ADP
fnp-3166	49	25	research	research	NOUN
fnp-3166	49	26	interest	interest	NOUN
fnp-3166	49	27	in	in	ADP
fnp-3166	49	28	2020	2020	NUM
fnp-3166	49	29	.	.	PUNCT
fnp-3166	50	1	the	the	DET
fnp-3166	50	2	respective	respective	ADJ
fnp-3166	50	3	studies	study	NOUN
fnp-3166	50	4	provided	provide	VERB
fnp-3166	50	5	novel	novel	ADJ
fnp-3166	50	6	insights	insight	NOUN
fnp-3166	50	7	into	into	ADP
fnp-3166	50	8	the	the	DET
fnp-3166	50	9	function	function	NOUN
fnp-3166	50	10	of	of	ADP
fnp-3166	50	11	nmda	nmda	ADJ
fnp-3166	50	12	and	and	CCONJ
fnp-3166	50	13	glycine	glycine	NOUN
fnp-3166	50	14	receptor	receptor	NOUN
fnp-3166	50	15	directed	direct	VERB
fnp-3166	50	16	antibodies	antibody	NOUN
fnp-3166	50	17	in	in	ADP
fnp-3166	50	18	relation	relation	NOUN
fnp-3166	50	19	to	to	ADP
fnp-3166	50	20	the	the	DET
fnp-3166	50	21	clinical	clinical	ADJ
fnp-3166	50	22	disease	disease	NOUN
fnp-3166	50	23	spectrum	spectrum	NOUN
fnp-3166	50	24	(	(	PUNCT
fnp-3166	50	25	matute	matute	NOUN
fnp-3166	50	26	et	et	PROPN
fnp-3166	50	27	al	al	PROPN
fnp-3166	50	28	.	.	PROPN
fnp-3166	50	29	2020	2020	NUM
fnp-3166	50	30	,	,	PUNCT
fnp-3166	50	31	carceles	carcele	NOUN
fnp-3166	50	32	-	-	PUNCT
fnp-3166	50	33	cordon	cordon	NOUN
fnp-3166	50	34	et	et	PROPN
fnp-3166	50	35	al	al	PROPN
fnp-3166	50	36	.	.	PROPN
fnp-3166	50	37	2020	2020	NUM
fnp-3166	50	38	,	,	PUNCT
fnp-3166	50	39	rauschenberger	rauschenberger	ADJ
fnp-3166	50	40	et	et	PROPN
fnp-3166	50	41	al	al	PROPN
fnp-3166	50	42	.	.	PROPN
fnp-3166	50	43	2020	2020	NUM
fnp-3166	50	44	)	)	PUNCT
fnp-3166	50	45	or	or	CCONJ
fnp-3166	50	46	how	how	SCONJ
fnp-3166	50	47	autoantibodies	autoantibody	NOUN
fnp-3166	50	48	against	against	ADP
fnp-3166	50	49	iglon	iglon	NOUN
fnp-3166	50	50	5	5	NUM
fnp-3166	50	51	may	may	AUX
fnp-3166	50	52	trigger	trigger	VERB
fnp-3166	50	53	intracellular	intracellular	ADJ
fnp-3166	50	54	accumulation	accumulation	NOUN
fnp-3166	50	55	of	of	ADP
fnp-3166	50	56	tau	tau	NOUN
fnp-3166	50	57	-	-	PUNCT
fnp-3166	50	58	tangles	tangle	NOUN
fnp-3166	50	59	(	(	PUNCT
fnp-3166	50	60	landa	landa	PROPN
fnp-3166	50	61	et	et	PROPN
fnp-3166	50	62	al	al	PROPN
fnp-3166	50	63	.	.	PROPN
fnp-3166	50	64	2020	2020	NUM
fnp-3166	50	65	)	)	PUNCT
fnp-3166	50	66	.	.	PUNCT
fnp-3166	51	1	here	here	ADV
fnp-3166	51	2	,	,	PUNCT
fnp-3166	51	3	i	i	PRON
fnp-3166	51	4	focus	focus	VERB
fnp-3166	51	5	on	on	ADP
fnp-3166	51	6	one	one	NUM
fnp-3166	51	7	study	study	NOUN
fnp-3166	51	8	,	,	PUNCT
fnp-3166	51	9	which	which	PRON
fnp-3166	51	10	deals	deal	VERB
fnp-3166	51	11	with	with	ADP
fnp-3166	51	12	an	an	DET
fnp-3166	51	13	interesting	interesting	ADJ
fnp-3166	51	14	but	but	CCONJ
fnp-3166	51	15	also	also	ADV
fnp-3166	51	16	controversial	controversial	ADJ
fnp-3166	51	17	aspect	aspect	NOUN
fnp-3166	51	18	of	of	ADP
fnp-3166	51	19	these	these	DET
fnp-3166	51	20	diseases	disease	NOUN
fnp-3166	51	21	.	.	PUNCT
fnp-3166	52	1	pitsch	pitsch	PROPN
fnp-3166	52	2	et	et	PROPN
fnp-3166	52	3	al	al	PROPN
fnp-3166	52	4	.	.	PROPN
fnp-3166	52	5	(	(	PUNCT
fnp-3166	52	6	2020	2020	NUM
fnp-3166	52	7	)	)	PUNCT
fnp-3166	52	8	identified	identify	VERB
fnp-3166	52	9	antibodies	antibody	NOUN
fnp-3166	52	10	against	against	ADP
fnp-3166	52	11	the	the	DET
fnp-3166	52	12	postsynaptic	postsynaptic	ADJ
fnp-3166	52	13	actin	actin	NOUN
fnp-3166	52	14	binding	bind	VERB
fnp-3166	52	15	protein	protein	NOUN
fnp-3166	52	16	drebrin	drebrin	NOUN
fnp-3166	52	17	in	in	ADP
fnp-3166	52	18	patients	patient	NOUN
fnp-3166	52	19	with	with	ADP
fnp-3166	52	20	severe	severe	ADJ
fnp-3166	52	21	epileptic	epileptic	ADJ
fnp-3166	52	22	seizures	seizure	NOUN
fnp-3166	52	23	,	,	PUNCT
fnp-3166	52	24	which	which	PRON
fnp-3166	52	25	were	be	AUX
fnp-3166	52	26	associated	associate	VERB
fnp-3166	52	27	with	with	ADP
fnp-3166	52	28	encephalopathy	encephalopathy	ADJ
fnp-3166	52	29	and	and	CCONJ
fnp-3166	52	30	neuropsychiatric	neuropsychiatric	ADJ
fnp-3166	52	31	symptoms	symptom	NOUN
fnp-3166	52	32	,	,	PUNCT
fnp-3166	52	33	including	include	VERB
fnp-3166	52	34	depression	depression	NOUN
fnp-3166	52	35	and	and	CCONJ
fnp-3166	52	36	cognitive	cognitive	ADJ
fnp-3166	52	37	impairment	impairment	NOUN
fnp-3166	52	38	.	.	PUNCT
fnp-3166	53	1	the	the	DET
fnp-3166	53	2	antibodies	antibody	NOUN
fnp-3166	53	3	,	,	PUNCT
fnp-3166	53	4	identified	identify	VERB
fnp-3166	53	5	by	by	ADP
fnp-3166	53	6	selective	selective	ADJ
fnp-3166	53	7	binding	binding	NOUN
fnp-3166	53	8	to	to	ADP
fnp-3166	53	9	the	the	DET
fnp-3166	53	10	neuropil	neuropil	NOUN
fnp-3166	53	11	and	and	CCONJ
fnp-3166	53	12	by	by	ADP
fnp-3166	53	13	western	western	ADJ
fnp-3166	53	14	blot	blot	NOUN
fnp-3166	53	15	and	and	CCONJ
fnp-3166	53	16	sequencing	sequencing	NOUN
fnp-3166	53	17	,	,	PUNCT
fnp-3166	53	18	were	be	AUX
fnp-3166	53	19	specific	specific	ADJ
fnp-3166	53	20	for	for	ADP
fnp-3166	53	21	these	these	DET
fnp-3166	53	22	patients	patient	NOUN
fnp-3166	53	23	,	,	PUNCT
fnp-3166	53	24	and	and	CCONJ
fnp-3166	53	25	the	the	DET
fnp-3166	53	26	specificity	specificity	NOUN
fnp-3166	53	27	for	for	ADP
fnp-3166	53	28	the	the	DET
fnp-3166	53	29	target	target	NOUN
fnp-3166	53	30	antigen	antigen	NOUN
fnp-3166	53	31	was	be	AUX
fnp-3166	53	32	proven	prove	VERB
fnp-3166	53	33	by	by	ADP
fnp-3166	53	34	the	the	DET
fnp-3166	53	35	lack	lack	NOUN
fnp-3166	53	36	of	of	ADP
fnp-3166	53	37	binding	bind	VERB
fnp-3166	53	38	in	in	ADP
fnp-3166	53	39	drebrin	drebrin	NOUN
fnp-3166	53	40	knock	knock	VERB
fnp-3166	53	41	out	out	ADP
fnp-3166	53	42	mice	mouse	NOUN
fnp-3166	53	43	.	.	PUNCT
fnp-3166	54	1	drebrin	drebrin	NOUN
fnp-3166	54	2	is	be	AUX
fnp-3166	54	3	an	an	DET
fnp-3166	54	4	intracellular	intracellular	ADJ
fnp-3166	54	5	antigen	antigen	NOUN
fnp-3166	54	6	,	,	PUNCT
fnp-3166	54	7	which	which	PRON
fnp-3166	54	8	is	be	AUX
fnp-3166	54	9	not	not	PART
fnp-3166	54	10	exposed	expose	VERB
fnp-3166	54	11	on	on	ADP
fnp-3166	54	12	the	the	DET
fnp-3166	54	13	extracellular	extracellular	ADJ
fnp-3166	54	14	surface	surface	NOUN
fnp-3166	54	15	of	of	ADP
fnp-3166	54	16	neurons	neuron	NOUN
fnp-3166	54	17	or	or	CCONJ
fnp-3166	54	18	synapses	synapsis	NOUN
fnp-3166	54	19	.	.	PUNCT
fnp-3166	55	1	for	for	ADP
fnp-3166	55	2	this	this	DET
fnp-3166	55	3	reason	reason	NOUN
fnp-3166	55	4	,	,	PUNCT
fnp-3166	55	5	the	the	DET
fnp-3166	55	6	antibodies	antibody	NOUN
fnp-3166	55	7	themselves	themselves	PRON
fnp-3166	55	8	may	may	AUX
fnp-3166	55	9	not	not	PART
fnp-3166	55	10	be	be	AUX
fnp-3166	55	11	pathogenic	pathogenic	ADJ
fnp-3166	55	12	,	,	PUNCT
fnp-3166	55	13	but	but	CCONJ
fnp-3166	55	14	just	just	ADV
fnp-3166	55	15	represent	represent	VERB
fnp-3166	55	16	a	a	DET
fnp-3166	55	17	diagnostically	diagnostically	ADV
fnp-3166	55	18	useful	useful	ADJ
fnp-3166	55	19	marker	marker	NOUN
fnp-3166	55	20	for	for	ADP
fnp-3166	55	21	an	an	DET
fnp-3166	55	22	autoimmune	autoimmune	ADJ
fnp-3166	55	23	attack	attack	NOUN
fnp-3166	55	24	of	of	ADP
fnp-3166	55	25	cytotoxic	cytotoxic	ADJ
fnp-3166	55	26	t	t	PROPN
fnp-3166	55	27	-	-	PUNCT
fnp-3166	55	28	cells	cell	NOUN
fnp-3166	55	29	,	,	PUNCT
fnp-3166	55	30	as	as	SCONJ
fnp-3166	55	31	it	it	PRON
fnp-3166	55	32	occurs	occur	VERB
fnp-3166	55	33	in	in	ADP
fnp-3166	55	34	many	many	ADJ
fnp-3166	55	35	classical	classical	ADJ
fnp-3166	55	36	paraneoplastic	paraneoplastic	ADJ
fnp-3166	55	37	diseases	disease	NOUN
fnp-3166	55	38	.	.	PUNCT
fnp-3166	56	1	the	the	DET
fnp-3166	56	2	pathology	pathology	NOUN
fnp-3166	56	3	,	,	PUNCT
fnp-3166	56	4	described	describe	VERB
fnp-3166	56	5	in	in	ADP
fnp-3166	56	6	a	a	DET
fnp-3166	56	7	biopsy	biopsy	NOUN
fnp-3166	56	8	of	of	ADP
fnp-3166	56	9	one	one	NUM
fnp-3166	56	10	of	of	ADP
fnp-3166	56	11	the	the	DET
fnp-3166	56	12	cases	case	NOUN
fnp-3166	56	13	,	,	PUNCT
fnp-3166	56	14	is	be	AUX
fnp-3166	56	15	in	in	ADP
fnp-3166	56	16	line	line	NOUN
fnp-3166	56	17	with	with	ADP
fnp-3166	56	18	this	this	DET
fnp-3166	56	19	assumption	assumption	NOUN
fnp-3166	56	20	,	,	PUNCT
fnp-3166	56	21	showing	show	VERB
fnp-3166	56	22	infiltrating	infiltrate	VERB
fnp-3166	56	23	t	t	PROPN
fnp-3166	56	24	-	-	PUNCT
fnp-3166	56	25	cells	cell	NOUN
fnp-3166	56	26	in	in	ADP
fnp-3166	56	27	close	close	ADJ
fnp-3166	56	28	contact	contact	NOUN
fnp-3166	56	29	with	with	ADP
fnp-3166	56	30	neurons	neuron	NOUN
fnp-3166	56	31	.	.	PUNCT
fnp-3166	57	1	however	however	ADV
fnp-3166	57	2	,	,	PUNCT
fnp-3166	57	3	the	the	DET
fnp-3166	57	4	study	study	NOUN
fnp-3166	57	5	further	far	ADV
fnp-3166	57	6	describes	describe	VERB
fnp-3166	57	7	neurophysiological	neurophysiological	ADJ
fnp-3166	57	8	experiments	experiment	NOUN
fnp-3166	57	9	,	,	PUNCT
fnp-3166	57	10	which	which	PRON
fnp-3166	57	11	show	show	VERB
fnp-3166	57	12	that	that	SCONJ
fnp-3166	57	13	the	the	DET
fnp-3166	57	14	antibodies	antibody	NOUN
fnp-3166	57	15	induce	induce	VERB
fnp-3166	57	16	altered	altered	ADJ
fnp-3166	57	17	neuronal	neuronal	ADJ
fnp-3166	57	18	activity	activity	NOUN
fnp-3166	57	19	patterns	pattern	NOUN
fnp-3166	57	20	and	and	CCONJ
fnp-3166	57	21	increased	increase	VERB
fnp-3166	57	22	firing	firing	NOUN
fnp-3166	57	23	and	and	CCONJ
fnp-3166	57	24	bursting	bursting	NOUN
fnp-3166	57	25	rates	rate	NOUN
fnp-3166	57	26	in	in	ADP
fnp-3166	57	27	neuronal	neuronal	ADJ
fnp-3166	57	28	networks	network	NOUN
fnp-3166	57	29	in	in	ADP
fnp-3166	57	30	vitro	vitro	NOUN
fnp-3166	57	31	.	.	PUNCT
fnp-3166	58	1	these	these	DET
fnp-3166	58	2	data	datum	NOUN
fnp-3166	58	3	suggest	suggest	VERB
fnp-3166	58	4	that	that	SCONJ
fnp-3166	58	5	auto	auto	NOUN
fnp-3166	58	6	-	-	PUNCT
fnp-3166	58	7	antibodies	antibody	NOUN
fnp-3166	58	8	directed	direct	VERB
fnp-3166	58	9	against	against	ADP
fnp-3166	58	10	a	a	DET
fnp-3166	58	11	cytoplasmic	cytoplasmic	ADJ
fnp-3166	58	12	protein	protein	NOUN
fnp-3166	58	13	in	in	ADP
fnp-3166	58	14	synapses	synapsis	NOUN
fnp-3166	58	15	may	may	AUX
fnp-3166	58	16	reach	reach	VERB
fnp-3166	58	17	their	their	PRON
fnp-3166	58	18	specific	specific	ADJ
fnp-3166	58	19	target	target	NOUN
fnp-3166	58	20	and	and	CCONJ
fnp-3166	58	21	induce	induce	VERB
fnp-3166	58	22	functional	functional	ADJ
fnp-3166	58	23	changes	change	NOUN
fnp-3166	58	24	.	.	PUNCT
fnp-3166	59	1	the	the	DET
fnp-3166	59	2	authors	author	NOUN
fnp-3166	59	3	suggest	suggest	VERB
fnp-3166	59	4	that	that	SCONJ
fnp-3166	59	5	extensive	extensive	ADJ
fnp-3166	59	6	exocytosis	exocytosis	NOUN
fnp-3166	59	7	and	and	CCONJ
fnp-3166	59	8	endocytosis	endocytosis	NOUN
fnp-3166	59	9	,	,	PUNCT
fnp-3166	59	10	which	which	PRON
fnp-3166	59	11	takes	take	VERB
fnp-3166	59	12	place	place	NOUN
fnp-3166	59	13	in	in	ADP
fnp-3166	59	14	active	active	ADJ
fnp-3166	59	15	synapses	synapsis	NOUN
fnp-3166	59	16	,	,	PUNCT
fnp-3166	59	17	facilitates	facilitate	VERB
fnp-3166	59	18	the	the	DET
fnp-3166	59	19	entry	entry	NOUN
fnp-3166	59	20	of	of	ADP
fnp-3166	59	21	the	the	DET
fnp-3166	59	22	antibodies	antibody	NOUN
fnp-3166	59	23	into	into	ADP
fnp-3166	59	24	the	the	DET
fnp-3166	59	25	intracellular	intracellular	ADJ
fnp-3166	59	26	compartment	compartment	NOUN
fnp-3166	59	27	,	,	PUNCT
fnp-3166	59	28	but	but	CCONJ
fnp-3166	59	29	this	this	DET
fnp-3166	59	30	proposed	propose	VERB
fnp-3166	59	31	mechanism	mechanism	NOUN
fnp-3166	59	32	does	do	AUX
fnp-3166	59	33	not	not	PART
fnp-3166	59	34	explain	explain	VERB
fnp-3166	59	35	how	how	SCONJ
fnp-3166	59	36	the	the	DET
fnp-3166	59	37	antibodies	antibody	NOUN
fnp-3166	59	38	leave	leave	VERB
fnp-3166	59	39	the	the	DET
fnp-3166	59	40	endosomal	endosomal	ADJ
fnp-3166	59	41	compartment	compartment	NOUN
fnp-3166	59	42	and	and	CCONJ
fnp-3166	59	43	access	access	VERB
fnp-3166	59	44	the	the	DET
fnp-3166	59	45	cytosol	cytosol	NOUN
fnp-3166	59	46	.	.	PUNCT
fnp-3166	60	1	this	this	DET
fnp-3166	60	2	important	important	ADJ
fnp-3166	60	3	cell	cell	NOUN
fnp-3166	60	4	biological	biological	ADJ
fnp-3166	60	5	question	question	NOUN
fnp-3166	60	6	with	with	ADP
fnp-3166	60	7	important	important	ADJ
fnp-3166	60	8	disease	disease	NOUN
fnp-3166	60	9	relevance	relevance	NOUN
fnp-3166	60	10	has	have	VERB
fnp-3166	60	11	to	to	PART
fnp-3166	60	12	be	be	AUX
fnp-3166	60	13	clarified	clarify	VERB
fnp-3166	60	14	in	in	ADP
fnp-3166	60	15	future	future	ADJ
fnp-3166	60	16	studies	study	NOUN
fnp-3166	60	17	.	.	PUNCT
fnp-3166	61	1	3	3	X
fnp-3166	61	2	)	)	PUNCT
fnp-3166	61	3	what	what	PRON
fnp-3166	61	4	is	be	AUX
fnp-3166	61	5	the	the	DET
fnp-3166	61	6	pathological	pathological	ADJ
fnp-3166	61	7	difference	difference	NOUN
fnp-3166	61	8	between	between	ADP
fnp-3166	61	9	mog	mog	NOUN
fnp-3166	61	10	antibody	antibody	NOUN
fnp-3166	61	11	associated	associate	VERB
fnp-3166	61	12	inflammatory	inflammatory	ADJ
fnp-3166	61	13	demyelinating	demyelinate	VERB
fnp-3166	61	14	disease	disease	NOUN
fnp-3166	61	15	(	(	PUNCT
fnp-3166	61	16	mogad	mogad	PROPN
fnp-3166	61	17	)	)	PUNCT
fnp-3166	61	18	and	and	CCONJ
fnp-3166	61	19	multiple	multiple	ADJ
fnp-3166	61	20	sclerosis	sclerosis	NOUN
fnp-3166	61	21	(	(	PUNCT
fnp-3166	61	22	ms	ms	NOUN
fnp-3166	61	23	)	)	PUNCT
fnp-3166	61	24	?	?	PUNCT
fnp-3166	62	1	focal	focal	ADJ
fnp-3166	62	2	plaques	plaque	NOUN
fnp-3166	62	3	of	of	ADP
fnp-3166	62	4	demyelination	demyelination	NOUN
fnp-3166	62	5	with	with	ADP
fnp-3166	62	6	axonal	axonal	ADJ
fnp-3166	62	7	preservation	preservation	NOUN
fnp-3166	62	8	and	and	CCONJ
fnp-3166	62	9	reactive	reactive	ADJ
fnp-3166	62	10	gliosis	gliosis	NOUN
fnp-3166	62	11	developing	develop	VERB
fnp-3166	62	12	in	in	ADP
fnp-3166	62	13	the	the	DET
fnp-3166	62	14	context	context	NOUN
fnp-3166	62	15	of	of	ADP
fnp-3166	62	16	a	a	DET
fnp-3166	62	17	chronic	chronic	ADJ
fnp-3166	62	18	inflammatory	inflammatory	ADJ
fnp-3166	62	19	reaction	reaction	NOUN
fnp-3166	62	20	in	in	ADP
fnp-3166	62	21	the	the	DET
fnp-3166	62	22	central	central	ADJ
fnp-3166	62	23	nervous	nervous	ADJ
fnp-3166	62	24	system	system	NOUN
fnp-3166	62	25	has	have	AUX
fnp-3166	62	26	been	be	AUX
fnp-3166	62	27	regarded	regard	VERB
fnp-3166	62	28	as	as	ADP
fnp-3166	62	29	the	the	DET
fnp-3166	62	30	specific	specific	ADJ
fnp-3166	62	31	hallmark	hallmark	NOUN
fnp-3166	62	32	of	of	ADP
fnp-3166	62	33	ms	ms	PROPN
fnp-3166	62	34	pathology	pathology	PROPN
fnp-3166	62	35	.	.	PUNCT
fnp-3166	63	1	however	however	ADV
fnp-3166	63	2	,	,	PUNCT
fnp-3166	63	3	a	a	DET
fnp-3166	63	4	new	new	ADJ
fnp-3166	63	5	disease	disease	NOUN
fnp-3166	63	6	entity	entity	NOUN
fnp-3166	63	7	has	have	AUX
fnp-3166	63	8	recently	recently	ADV
fnp-3166	63	9	emerged	emerge	VERB
fnp-3166	63	10	,	,	PUNCT
fnp-3166	63	11	which	which	PRON
fnp-3166	63	12	is	be	AUX
fnp-3166	63	13	an	an	DET
fnp-3166	63	14	inflammatory	inflammatory	ADJ
fnp-3166	63	15	demyelinating	demyelinate	VERB
fnp-3166	63	16	disease	disease	NOUN
fnp-3166	63	17	associated	associate	VERB
fnp-3166	63	18	with	with	ADP
fnp-3166	63	19	antibodies	antibody	NOUN
fnp-3166	63	20	directed	direct	VERB
fnp-3166	63	21	against	against	ADP
fnp-3166	63	22	myelin	myelin	NOUN
fnp-3166	63	23	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	63	24	glycoprotein	glycoprotein	NOUN
fnp-3166	63	25	(	(	PUNCT
fnp-3166	63	26	reindl	reindl	NOUN
fnp-3166	63	27	and	and	CCONJ
fnp-3166	63	28	waters	water	NOUN
fnp-3166	63	29	2019	2019	NUM
fnp-3166	63	30	)	)	PUNCT
fnp-3166	63	31	.	.	PUNCT
fnp-3166	64	1	not	not	PART
fnp-3166	64	2	all	all	DET
fnp-3166	64	3	anti	anti	ADJ
fnp-3166	64	4	-	-	ADJ
fnp-3166	64	5	mog	mog	ADJ
fnp-3166	64	6	antibodies	antibody	NOUN
fnp-3166	64	7	are	be	AUX
fnp-3166	64	8	pathogenic	pathogenic	ADJ
fnp-3166	64	9	,	,	PUNCT
fnp-3166	64	10	but	but	CCONJ
fnp-3166	64	11	only	only	ADV
fnp-3166	64	12	those	those	PRON
fnp-3166	64	13	that	that	PRON
fnp-3166	64	14	are	be	AUX
fnp-3166	64	15	directed	direct	VERB
fnp-3166	64	16	against	against	ADP
fnp-3166	64	17	a	a	DET
fnp-3166	64	18	conformational	conformational	ADJ
fnp-3166	64	19	epitope	epitope	NOUN
fnp-3166	64	20	,	,	PUNCT
fnp-3166	64	21	which	which	PRON
fnp-3166	64	22	is	be	AUX
fnp-3166	64	23	accessible	accessible	ADJ
fnp-3166	64	24	on	on	ADP
fnp-3166	64	25	the	the	DET
fnp-3166	64	26	surface	surface	NOUN
fnp-3166	64	27	of	of	ADP
fnp-3166	64	28	native	native	ADJ
fnp-3166	64	29	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	64	30	or	or	CCONJ
fnp-3166	64	31	on	on	ADP
fnp-3166	64	32	mog	mog	NOUN
fnp-3166	64	33	-	-	PUNCT
fnp-3166	64	34	transfected	transfecte	VERB
fnp-3166	64	35	cell	cell	NOUN
fnp-3166	64	36	lines	line	NOUN
fnp-3166	64	37	.	.	PUNCT
fnp-3166	65	1	using	use	VERB
fnp-3166	65	2	these	these	DET
fnp-3166	65	3	diagnostic	diagnostic	ADJ
fnp-3166	65	4	tests	test	NOUN
fnp-3166	65	5	,	,	PUNCT
fnp-3166	65	6	it	it	PRON
fnp-3166	65	7	became	become	VERB
fnp-3166	65	8	clear	clear	ADJ
fnp-3166	65	9	that	that	SCONJ
fnp-3166	65	10	mog	mog	NOUN
fnp-3166	65	11	antibody	antibody	NOUN
fnp-3166	65	12	-	-	PUNCT
fnp-3166	65	13	associated	associate	VERB
fnp-3166	65	14	disease	disease	NOUN
fnp-3166	65	15	(	(	PUNCT
fnp-3166	65	16	mogad	mogad	PROPN
fnp-3166	65	17	)	)	PUNCT
fnp-3166	65	18	differs	differ	VERB
fnp-3166	65	19	from	from	ADP
fnp-3166	65	20	ms	ms	NOUN
fnp-3166	65	21	by	by	ADP
fnp-3166	65	22	its	its	PRON
fnp-3166	65	23	clinical	clinical	ADJ
fnp-3166	65	24	manifestation	manifestation	NOUN
fnp-3166	65	25	and	and	CCONJ
fnp-3166	65	26	course	course	NOUN
fnp-3166	65	27	as	as	ADV
fnp-3166	65	28	well	well	ADV
fnp-3166	65	29	as	as	ADP
fnp-3166	65	30	by	by	ADP
fnp-3166	65	31	its	its	PRON
fnp-3166	65	32	response	response	NOUN
fnp-3166	65	33	to	to	ADP
fnp-3166	65	34	immunomodulatory	immunomodulatory	ADJ
fnp-3166	65	35	treatment	treatment	NOUN
fnp-3166	65	36	(	(	PUNCT
fnp-3166	65	37	fujihara	fujihara	NOUN
fnp-3166	65	38	and	and	CCONJ
fnp-3166	65	39	cook	cook	VERB
fnp-3166	65	40	2020	2020	NUM
fnp-3166	65	41	)	)	PUNCT
fnp-3166	65	42	.	.	PUNCT
fnp-3166	66	1	to	to	PART
fnp-3166	66	2	explain	explain	VERB
fnp-3166	66	3	these	these	DET
fnp-3166	66	4	clinical	clinical	ADJ
fnp-3166	66	5	differences	difference	NOUN
fnp-3166	66	6	,	,	PUNCT
fnp-3166	66	7	a	a	DET
fnp-3166	66	8	neuropathological	neuropathological	ADJ
fnp-3166	66	9	comparison	comparison	NOUN
fnp-3166	66	10	of	of	ADP
fnp-3166	66	11	these	these	DET
fnp-3166	66	12	diseases	disease	NOUN
fnp-3166	66	13	is	be	AUX
fnp-3166	66	14	mandatory	mandatory	ADJ
fnp-3166	66	15	,	,	PUNCT
fnp-3166	66	16	but	but	CCONJ
fnp-3166	66	17	respective	respective	ADJ
fnp-3166	66	18	knowledge	knowledge	NOUN
fnp-3166	66	19	on	on	ADP
fnp-3166	66	20	mogad	mogad	PROPN
fnp-3166	66	21	was	be	AUX
fnp-3166	66	22	restricted	restrict	VERB
fnp-3166	66	23	to	to	ADP
fnp-3166	66	24	few	few	ADJ
fnp-3166	66	25	biopsies	biopsy	NOUN
fnp-3166	66	26	with	with	ADP
fnp-3166	66	27	very	very	ADV
fnp-3166	66	28	limited	limited	ADJ
fnp-3166	66	29	tissue	tissue	NOUN
fnp-3166	66	30	samples	sample	NOUN
fnp-3166	66	31	.	.	PUNCT
fnp-3166	67	1	this	this	PRON
fnp-3166	67	2	changed	change	VERB
fnp-3166	67	3	in	in	ADP
fnp-3166	67	4	2020	2020	NUM
fnp-3166	67	5	,	,	PUNCT
fnp-3166	67	6	with	with	ADP
fnp-3166	67	7	two	two	NUM
fnp-3166	67	8	studies	study	NOUN
fnp-3166	67	9	describing	describe	VERB
fnp-3166	67	10	the	the	DET
fnp-3166	67	11	neuropathological	neuropathological	ADJ
fnp-3166	67	12	changes	change	NOUN
fnp-3166	67	13	in	in	ADP
fnp-3166	67	14	large	large	ADJ
fnp-3166	67	15	cohorts	cohort	NOUN
fnp-3166	67	16	of	of	ADP
fnp-3166	67	17	mogad	mogad	ADJ
fnp-3166	67	18	patients	patient	NOUN
fnp-3166	67	19	(	(	PUNCT
fnp-3166	67	20	höftberger	höftberger	NOUN
fnp-3166	67	21	et	et	PROPN
fnp-3166	67	22	al	al	PROPN
fnp-3166	67	23	.	.	PROPN
fnp-3166	67	24	2020	2020	NUM
fnp-3166	67	25	,	,	PUNCT
fnp-3166	67	26	takai	takai	PROPN
fnp-3166	67	27	et	et	PROPN
fnp-3166	67	28	al	al	PROPN
fnp-3166	67	29	.	.	PROPN
fnp-3166	67	30	2020	2020	NUM
fnp-3166	67	31	)	)	PUNCT
fnp-3166	67	32	.	.	PUNCT
fnp-3166	68	1	the	the	DET
fnp-3166	68	2	lesions	lesion	NOUN
fnp-3166	68	3	in	in	ADP
fnp-3166	68	4	mogad	mogad	PROPN
fnp-3166	68	5	differ	differ	VERB
fnp-3166	68	6	from	from	ADP
fnp-3166	68	7	those	those	PRON
fnp-3166	68	8	seen	see	VERB
fnp-3166	68	9	in	in	ADP
fnp-3166	68	10	ms	ms	NOUN
fnp-3166	68	11	in	in	ADP
fnp-3166	68	12	many	many	ADJ
fnp-3166	68	13	aspects	aspect	NOUN
fnp-3166	68	14	,	,	PUNCT
fnp-3166	68	15	including	include	VERB
fnp-3166	68	16	their	their	PRON
fnp-3166	68	17	topographical	topographical	ADJ
fnp-3166	68	18	distribution	distribution	NOUN
fnp-3166	68	19	in	in	ADP
fnp-3166	68	20	the	the	DET
fnp-3166	68	21	cns	cns	NOUN
fnp-3166	68	22	,	,	PUNCT
fnp-3166	68	23	the	the	DET
fnp-3166	68	24	type	type	NOUN
fnp-3166	68	25	of	of	ADP
fnp-3166	68	26	demyelination	demyelination	NOUN
fnp-3166	68	27	,	,	PUNCT
fnp-3166	68	28	and	and	CCONJ
fnp-3166	68	29	the	the	DET
fnp-3166	68	30	nature	nature	NOUN
fnp-3166	68	31	of	of	ADP
fnp-3166	68	32	the	the	DET
fnp-3166	68	33	inflammatory	inflammatory	ADJ
fnp-3166	68	34	response	response	NOUN
fnp-3166	68	35	.	.	PUNCT
fnp-3166	69	1	in	in	ADP
fnp-3166	69	2	ms	ms	PROPN
fnp-3166	69	3	,	,	PUNCT
fnp-3166	69	4	new	new	ADJ
fnp-3166	69	5	lesions	lesion	NOUN
fnp-3166	69	6	are	be	AUX
fnp-3166	69	7	formed	form	VERB
fnp-3166	69	8	by	by	ADP
fnp-3166	69	9	simultaneous	simultaneous	ADJ
fnp-3166	69	10	demyelination	demyelination	NOUN
fnp-3166	69	11	in	in	ADP
fnp-3166	69	12	large	large	ADJ
fnp-3166	69	13	,	,	PUNCT
fnp-3166	69	14	focal	focal	ADJ
fnp-3166	69	15	areas	area	NOUN
fnp-3166	69	16	or	or	CCONJ
fnp-3166	69	17	by	by	ADP
fnp-3166	69	18	the	the	DET
fnp-3166	69	19	peripheral	peripheral	ADJ
fnp-3166	69	20	expansion	expansion	NOUN
fnp-3166	69	21	of	of	ADP
fnp-3166	69	22	pre	pre	ADJ
fnp-3166	69	23	-	-	ADJ
fnp-3166	69	24	existing	existing	ADJ
fnp-3166	69	25	lesions	lesion	NOUN
fnp-3166	69	26	located	locate	VERB
fnp-3166	69	27	throughout	throughout	ADP
fnp-3166	69	28	the	the	DET
fnp-3166	69	29	brain	brain	NOUN
fnp-3166	69	30	and	and	CCONJ
fnp-3166	69	31	spinal	spinal	ADJ
fnp-3166	69	32	cord	cord	NOUN
fnp-3166	69	33	.	.	PUNCT
fnp-3166	70	1	in	in	ADP
fnp-3166	70	2	contrast	contrast	NOUN
fnp-3166	70	3	,	,	PUNCT
fnp-3166	70	4	mogad	mogad	VERB
fnp-3166	70	5	demyelination	demyelination	NOUN
fnp-3166	70	6	occurs	occur	VERB
fnp-3166	70	7	by	by	ADP
fnp-3166	70	8	confluence	confluence	NOUN
fnp-3166	70	9	of	of	ADP
fnp-3166	70	10	small	small	ADJ
fnp-3166	70	11	perivenous	perivenous	ADJ
fnp-3166	70	12	lesions	lesion	NOUN
fnp-3166	70	13	,	,	PUNCT
fnp-3166	70	14	generally	generally	ADV
fnp-3166	70	15	resulting	result	VERB
fnp-3166	70	16	in	in	ADP
fnp-3166	70	17	a	a	DET
fnp-3166	70	18	demyelination	demyelination	NOUN
fnp-3166	70	19	pattern	pattern	NOUN
fnp-3166	70	20	similar	similar	ADJ
fnp-3166	70	21	to	to	ADP
fnp-3166	70	22	that	that	PRON
fnp-3166	70	23	seen	see	VERB
fnp-3166	70	24	in	in	ADP
fnp-3166	70	25	acute	acute	NOUN
fnp-3166	70	26	disseminated	disseminate	VERB
fnp-3166	70	27	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	70	28	(	(	PUNCT
fnp-3166	70	29	figure	figure	NOUN
fnp-3166	70	30	1	1	NUM
fnp-3166	70	31	)	)	PUNCT
fnp-3166	70	32	.	.	PUNCT
fnp-3166	71	1	demyelination	demyelination	NOUN
fnp-3166	71	2	in	in	ADP
fnp-3166	71	3	mogad	mogad	PROPN
fnp-3166	71	4	is	be	AUX
fnp-3166	71	5	associated	associate	VERB
fnp-3166	71	6	with	with	ADP
fnp-3166	71	7	complement	complement	NOUN
fnp-3166	71	8	deposition	deposition	NOUN
fnp-3166	71	9	at	at	ADP
fnp-3166	71	10	the	the	DET
fnp-3166	71	11	site	site	NOUN
fnp-3166	71	12	of	of	ADP
fnp-3166	71	13	active	active	ADJ
fnp-3166	71	14	myelin	myelin	NOUN
fnp-3166	71	15	injury	injury	NOUN
fnp-3166	71	16	,	,	PUNCT
fnp-3166	71	17	but	but	CCONJ
fnp-3166	71	18	the	the	DET
fnp-3166	71	19	degree	degree	NOUN
fnp-3166	71	20	of	of	ADP
fnp-3166	71	21	complement	complement	NOUN
fnp-3166	71	22	activation	activation	NOUN
fnp-3166	71	23	is	be	AUX
fnp-3166	71	24	much	much	ADV
fnp-3166	71	25	less	less	ADJ
fnp-3166	71	26	compared	compare	VERB
fnp-3166	71	27	to	to	ADP
fnp-3166	71	28	that	that	PRON
fnp-3166	71	29	seen	see	VERB
fnp-3166	71	30	in	in	ADP
fnp-3166	71	31	patients	patient	NOUN
fnp-3166	71	32	with	with	ADP
fnp-3166	71	33	aquaporin	aquaporin	NOUN
fnp-3166	71	34	4	4	NUM
fnp-3166	71	35	antibody	antibody	NOUN
fnp-3166	71	36	associated	associate	VERB
fnp-3166	71	37	neuromyelitis	neuromyelitis	PROPN
fnp-3166	71	38	optica	optica	PROPN
fnp-3166	71	39	(	(	PUNCT
fnp-3166	71	40	nmo	nmo	PROPN
fnp-3166	71	41	)	)	PUNCT
fnp-3166	71	42	.	.	PUNCT
fnp-3166	72	1	in	in	ADP
fnp-3166	72	2	both	both	DET
fnp-3166	72	3	conditions	condition	NOUN
fnp-3166	72	4	,	,	PUNCT
fnp-3166	72	5	ms	ms	NOUN
fnp-3166	72	6	as	as	ADV
fnp-3166	72	7	well	well	ADV
fnp-3166	72	8	as	as	ADP
fnp-3166	72	9	mogad	mogad	NOUN
fnp-3166	72	10	,	,	PUNCT
fnp-3166	72	11	the	the	DET
fnp-3166	72	12	basic	basic	ADJ
fnp-3166	72	13	lesion	lesion	NOUN
fnp-3166	72	14	is	be	AUX
fnp-3166	72	15	characterized	characterize	VERB
fnp-3166	72	16	by	by	ADP
fnp-3166	72	17	inflammatory	inflammatory	ADJ
fnp-3166	72	18	demyelination	demyelination	NOUN
fnp-3166	72	19	,	,	PUNCT
fnp-3166	72	20	partial	partial	ADJ
fnp-3166	72	21	axonal	axonal	ADJ
fnp-3166	72	22	preservation	preservation	NOUN
fnp-3166	72	23	and	and	CCONJ
fnp-3166	72	24	reactive	reactive	ADJ
fnp-3166	72	25	astrocytic	astrocytic	ADJ
fnp-3166	72	26	gliosis	gliosis	NOUN
fnp-3166	72	27	.	.	PUNCT
fnp-3166	73	1	however	however	ADV
fnp-3166	73	2	,	,	PUNCT
fnp-3166	73	3	the	the	DET
fnp-3166	73	4	inflammatory	inflammatory	ADJ
fnp-3166	73	5	reaction	reaction	NOUN
fnp-3166	73	6	is	be	AUX
fnp-3166	73	7	fundamentally	fundamentally	ADV
fnp-3166	73	8	different	different	ADJ
fnp-3166	73	9	.	.	PUNCT
fnp-3166	74	1	while	while	SCONJ
fnp-3166	74	2	in	in	ADP
fnp-3166	74	3	ms	ms	PROPN
fnp-3166	74	4	the	the	DET
fnp-3166	74	5	dominant	dominant	ADJ
fnp-3166	74	6	inflammatory	inflammatory	ADJ
fnp-3166	74	7	reaction	reaction	NOUN
fnp-3166	74	8	is	be	AUX
fnp-3166	74	9	seen	see	VERB
fnp-3166	74	10	around	around	ADP
fnp-3166	74	11	the	the	DET
fnp-3166	74	12	larger	large	ADJ
fnp-3166	74	13	drainage	drainage	NOUN
fnp-3166	74	14	veins	vein	NOUN
fnp-3166	74	15	in	in	ADP
fnp-3166	74	16	the	the	DET
fnp-3166	74	17	periventricular	periventricular	ADJ
fnp-3166	74	18	tissue	tissue	NOUN
fnp-3166	74	19	and	and	CCONJ
fnp-3166	74	20	the	the	DET
fnp-3166	74	21	meninges	meninge	NOUN
fnp-3166	74	22	,	,	PUNCT
fnp-3166	74	23	in	in	ADP
fnp-3166	74	24	mogad	mogad	VERB
fnp-3166	74	25	the	the	DET
fnp-3166	74	26	smaller	small	ADJ
fnp-3166	74	27	veins	vein	NOUN
fnp-3166	74	28	and	and	CCONJ
fnp-3166	74	29	venules	venule	NOUN
fnp-3166	74	30	are	be	AUX
fnp-3166	74	31	mainly	mainly	ADV
fnp-3166	74	32	affected	affect	VERB
fnp-3166	74	33	.	.	PUNCT
fnp-3166	75	1	finally	finally	ADV
fnp-3166	75	2	,	,	PUNCT
fnp-3166	75	3	in	in	ADP
fnp-3166	75	4	mogad	mogad	NOUN
fnp-3166	75	5	,	,	PUNCT
fnp-3166	75	6	infiltrating	infiltrating	ADJ
fnp-3166	75	7	lymphocytes	lymphocyte	NOUN
fnp-3166	75	8	are	be	AUX
fnp-3166	75	9	mainly	mainly	ADV
fnp-3166	75	10	cd4	cd4	PROPN
fnp-3166	75	11	+	+	PROPN
fnp-3166	75	12	t	t	PROPN
fnp-3166	75	13	-	-	PUNCT
fnp-3166	75	14	cells	cell	NOUN
fnp-3166	75	15	with	with	ADP
fnp-3166	75	16	low	low	ADJ
fnp-3166	75	17	numbers	number	NOUN
fnp-3166	75	18	of	of	ADP
fnp-3166	75	19	cd8	cd8	PROPN
fnp-3166	75	20	+	+	PROPN
fnp-3166	75	21	t	t	PROPN
fnp-3166	75	22	-	-	PUNCT
fnp-3166	75	23	cells	cell	NOUN
fnp-3166	75	24	and	and	CCONJ
fnp-3166	75	25	b	b	NOUN
fnp-3166	75	26	-	-	PUNCT
fnp-3166	75	27	cells	cell	NOUN
fnp-3166	75	28	;	;	PUNCT
fnp-3166	75	29	the	the	DET
fnp-3166	75	30	dominant	dominant	ADJ
fnp-3166	75	31	lymphocytes	lymphocyte	NOUN
fnp-3166	75	32	in	in	ADP
fnp-3166	75	33	active	active	ADJ
fnp-3166	75	34	ms	ms	ADJ
fnp-3166	75	35	lesions	lesion	NOUN
fnp-3166	75	36	are	be	AUX
fnp-3166	75	37	tissue	tissue	NOUN
fnp-3166	75	38	resident	resident	ADJ
fnp-3166	75	39	cd8	cd8	PROPN
fnp-3166	75	40	+	+	PROPN
fnp-3166	75	41	effector	effector	NOUN
fnp-3166	75	42	memory	memory	NOUN
fnp-3166	75	43	t	t	PROPN
fnp-3166	75	44	-	-	PUNCT
fnp-3166	75	45	cells	cell	NOUN
fnp-3166	75	46	and	and	CCONJ
fnp-3166	75	47	b	b	NOUN
fnp-3166	75	48	-	-	PUNCT
fnp-3166	75	49	cells	cell	NOUN
fnp-3166	75	50	/	/	SYM
fnp-3166	75	51	plasma	plasma	NOUN
fnp-3166	75	52	cells	cell	NOUN
fnp-3166	75	53	.	.	PUNCT
fnp-3166	76	1	all	all	DET
fnp-3166	76	2	these	these	DET
fnp-3166	76	3	data	datum	NOUN
fnp-3166	76	4	indicate	indicate	VERB
fnp-3166	76	5	that	that	PRON
fnp-3166	76	6	mogad	mogad	NOUN
fnp-3166	76	7	and	and	CCONJ
fnp-3166	76	8	ms	ms	NOUN
fnp-3166	76	9	are	be	AUX
fnp-3166	76	10	fundamentally	fundamentally	ADV
fnp-3166	76	11	different	different	ADJ
fnp-3166	76	12	diseases	disease	NOUN
fnp-3166	76	13	.	.	PUNCT
fnp-3166	77	1	figure	figure	NOUN
fnp-3166	77	2	1	1	NUM
fnp-3166	77	3	:	:	PUNCT
fnp-3166	77	4	key	key	ADJ
fnp-3166	77	5	neuropathological	neuropathological	ADJ
fnp-3166	77	6	features	feature	NOUN
fnp-3166	77	7	,	,	PUNCT
fnp-3166	77	8	distinguishing	distinguish	VERB
fnp-3166	77	9	multiple	multiple	ADJ
fnp-3166	77	10	sclerosis	sclerosis	NOUN
fnp-3166	77	11	(	(	PUNCT
fnp-3166	77	12	ms	ms	PROPN
fnp-3166	77	13	)	)	PUNCT
fnp-3166	77	14	from	from	ADP
fnp-3166	77	15	the	the	DET
fnp-3166	77	16	inflammatory	inflammatory	ADJ
fnp-3166	77	17	demyelinating	demyelinate	VERB
fnp-3166	77	18	disease	disease	NOUN
fnp-3166	77	19	,	,	PUNCT
fnp-3166	77	20	which	which	PRON
fnp-3166	77	21	is	be	AUX
fnp-3166	77	22	associated	associate	VERB
fnp-3166	77	23	with	with	ADP
fnp-3166	77	24	auto	auto	NOUN
fnp-3166	77	25	-	-	PUNCT
fnp-3166	77	26	antibodies	antibody	NOUN
fnp-3166	77	27	against	against	ADP
fnp-3166	77	28	myelin	myelin	NOUN
fnp-3166	77	29	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	77	30	glycoprotein	glycoprotein	NOUN
fnp-3166	77	31	(	(	PUNCT
fnp-3166	77	32	mogad	mogad	PROPN
fnp-3166	77	33	)	)	PUNCT
fnp-3166	77	34	in	in	ADP
fnp-3166	77	35	the	the	DET
fnp-3166	77	36	forebrain	forebrain	NOUN
fnp-3166	77	37	.	.	PUNCT
fnp-3166	78	1	a	a	PRON
fnp-3166	78	2	)	)	PUNCT
fnp-3166	78	3	in	in	ADP
fnp-3166	78	4	ms	ms	PROPN
fnp-3166	78	5	,	,	PUNCT
fnp-3166	78	6	the	the	DET
fnp-3166	78	7	lesions	lesion	NOUN
fnp-3166	78	8	(	(	PUNCT
fnp-3166	78	9	blue	blue	ADJ
fnp-3166	78	10	areas	area	NOUN
fnp-3166	78	11	)	)	PUNCT
fnp-3166	78	12	are	be	AUX
fnp-3166	78	13	located	locate	VERB
fnp-3166	78	14	around	around	ADP
fnp-3166	78	15	large	large	ADJ
fnp-3166	78	16	cerebral	cerebral	ADJ
fnp-3166	78	17	veins	vein	NOUN
fnp-3166	78	18	with	with	ADP
fnp-3166	78	19	a	a	DET
fnp-3166	78	20	predilection	predilection	NOUN
fnp-3166	78	21	site	site	NOUN
fnp-3166	78	22	around	around	ADP
fnp-3166	78	23	the	the	DET
fnp-3166	78	24	ventricle	ventricle	NOUN
fnp-3166	78	25	and	and	CCONJ
fnp-3166	78	26	the	the	DET
fnp-3166	78	27	subcortical	subcortical	ADJ
fnp-3166	78	28	white	white	ADJ
fnp-3166	78	29	matter	matter	NOUN
fnp-3166	78	30	.	.	PUNCT
fnp-3166	79	1	they	they	PRON
fnp-3166	79	2	are	be	AUX
fnp-3166	79	3	sharply	sharply	ADV
fnp-3166	79	4	demarcated	demarcate	VERB
fnp-3166	79	5	from	from	ADP
fnp-3166	79	6	the	the	DET
fnp-3166	79	7	surrounding	surround	VERB
fnp-3166	79	8	peri	peri	NOUN
fnp-3166	79	9	-	-	PUNCT
fnp-3166	79	10	plaque	plaque	NOUN
fnp-3166	79	11	white	white	ADJ
fnp-3166	79	12	matter	matter	NOUN
fnp-3166	79	13	and	and	CCONJ
fnp-3166	79	14	frequently	frequently	ADV
fnp-3166	79	15	display	display	VERB
fnp-3166	79	16	finger	finger	NOUN
fnp-3166	79	17	like	like	ADP
fnp-3166	79	18	perivenous	perivenous	ADJ
fnp-3166	79	19	extensions	extension	NOUN
fnp-3166	79	20	into	into	ADP
fnp-3166	79	21	the	the	DET
fnp-3166	79	22	deep	deep	ADJ
fnp-3166	79	23	white	white	ADJ
fnp-3166	79	24	matter	matter	NOUN
fnp-3166	79	25	.	.	PUNCT
fnp-3166	80	1	in	in	ADP
fnp-3166	80	2	the	the	DET
fnp-3166	80	3	cortex	cortex	NOUN
fnp-3166	80	4	,	,	PUNCT
fnp-3166	80	5	band	band	NOUN
fnp-3166	80	6	like	like	ADP
fnp-3166	80	7	subpial	subpial	ADJ
fnp-3166	80	8	lesions	lesion	NOUN
fnp-3166	80	9	(	(	PUNCT
fnp-3166	80	10	red	red	ADJ
fnp-3166	80	11	areas	area	NOUN
fnp-3166	80	12	)	)	PUNCT
fnp-3166	80	13	dominate	dominate	VERB
fnp-3166	80	14	,	,	PUNCT
fnp-3166	80	15	mainly	mainly	ADV
fnp-3166	80	16	located	locate	VERB
fnp-3166	80	17	in	in	ADP
fnp-3166	80	18	the	the	DET
fnp-3166	80	19	deep	deep	ADJ
fnp-3166	80	20	sulci	sulci	NOUN
fnp-3166	80	21	of	of	ADP
fnp-3166	80	22	the	the	DET
fnp-3166	80	23	cortical	cortical	ADJ
fnp-3166	80	24	ribbon	ribbon	NOUN
fnp-3166	80	25	.	.	PUNCT
fnp-3166	81	1	b	b	X
fnp-3166	81	2	)	)	PUNCT
fnp-3166	81	3	in	in	ADP
fnp-3166	81	4	mogad	mogad	NOUN
fnp-3166	81	5	,	,	PUNCT
fnp-3166	81	6	lesions	lesion	NOUN
fnp-3166	81	7	are	be	AUX
fnp-3166	81	8	mainly	mainly	ADV
fnp-3166	81	9	located	locate	VERB
fnp-3166	81	10	in	in	ADP
fnp-3166	81	11	the	the	DET
fnp-3166	81	12	optic	optic	ADJ
fnp-3166	81	13	nerves	nerve	NOUN
fnp-3166	81	14	and	and	CCONJ
fnp-3166	81	15	spinal	spinal	NOUN
fnp-3166	81	16	cord	cord	NOUN
fnp-3166	81	17	,	,	PUNCT
fnp-3166	81	18	but	but	CCONJ
fnp-3166	81	19	their	their	PRON
fnp-3166	81	20	structural	structural	ADJ
fnp-3166	81	21	details	detail	NOUN
fnp-3166	81	22	have	have	AUX
fnp-3166	81	23	so	so	ADV
fnp-3166	81	24	far	far	ADV
fnp-3166	81	25	not	not	PART
fnp-3166	81	26	been	be	AUX
fnp-3166	81	27	clearly	clearly	ADV
fnp-3166	81	28	outlined	outline	VERB
fnp-3166	81	29	.	.	PUNCT
fnp-3166	82	1	when	when	SCONJ
fnp-3166	82	2	lesions	lesion	NOUN
fnp-3166	82	3	are	be	AUX
fnp-3166	82	4	present	present	ADJ
fnp-3166	82	5	in	in	ADP
fnp-3166	82	6	the	the	DET
fnp-3166	82	7	hemispheres	hemisphere	NOUN
fnp-3166	82	8	of	of	ADP
fnp-3166	82	9	the	the	DET
fnp-3166	82	10	forebrain	forebrain	NOUN
fnp-3166	82	11	,	,	PUNCT
fnp-3166	82	12	a	a	DET
fnp-3166	82	13	type	type	NOUN
fnp-3166	82	14	of	of	ADP
fnp-3166	82	15	tissue	tissue	NOUN
fnp-3166	82	16	injury	injury	NOUN
fnp-3166	82	17	is	be	AUX
fnp-3166	82	18	seen	see	VERB
fnp-3166	82	19	,	,	PUNCT
fnp-3166	82	20	which	which	PRON
fnp-3166	82	21	resembles	resemble	VERB
fnp-3166	82	22	acute	acute	NOUN
fnp-3166	82	23	disseminated	disseminate	VERB
fnp-3166	82	24	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	82	25	.	.	PUNCT
fnp-3166	83	1	it	it	PRON
fnp-3166	83	2	consists	consist	VERB
fnp-3166	83	3	of	of	ADP
fnp-3166	83	4	perivenous	perivenous	ADJ
fnp-3166	83	5	sleeves	sleeve	NOUN
fnp-3166	83	6	of	of	ADP
fnp-3166	83	7	demyelination	demyelination	NOUN
fnp-3166	83	8	around	around	ADP
fnp-3166	83	9	small	small	ADJ
fnp-3166	83	10	veins	vein	NOUN
fnp-3166	83	11	and	and	CCONJ
fnp-3166	83	12	venules	venule	NOUN
fnp-3166	83	13	(	(	PUNCT
fnp-3166	83	14	blue	blue	ADJ
fnp-3166	83	15	dotted	dotted	ADJ
fnp-3166	83	16	areas	area	NOUN
fnp-3166	83	17	)	)	PUNCT
fnp-3166	83	18	,	,	PUNCT
fnp-3166	83	19	which	which	PRON
fnp-3166	83	20	show	show	VERB
fnp-3166	83	21	confluence	confluence	NOUN
fnp-3166	83	22	in	in	ADP
fnp-3166	83	23	the	the	DET
fnp-3166	83	24	lesion	lesion	NOUN
fnp-3166	83	25	center	center	NOUN
fnp-3166	83	26	(	(	PUNCT
fnp-3166	83	27	dark	dark	ADJ
fnp-3166	83	28	blue	blue	ADJ
fnp-3166	83	29	area	area	NOUN
fnp-3166	83	30	)	)	PUNCT
fnp-3166	83	31	.	.	PUNCT
fnp-3166	84	1	when	when	SCONJ
fnp-3166	84	2	the	the	DET
fnp-3166	84	3	cortex	cortex	NOUN
fnp-3166	84	4	is	be	AUX
fnp-3166	84	5	affected	affect	VERB
fnp-3166	84	6	small	small	ADJ
fnp-3166	84	7	perivenous	perivenous	ADJ
fnp-3166	84	8	intra	intra	ADJ
fnp-3166	84	9	-	-	ADJ
fnp-3166	84	10	cortical	cortical	ADJ
fnp-3166	84	11	demyelination	demyelination	NOUN
fnp-3166	84	12	is	be	AUX
fnp-3166	84	13	seen	see	VERB
fnp-3166	84	14	most	most	ADV
fnp-3166	84	15	frequently	frequently	ADV
fnp-3166	84	16	(	(	PUNCT
fnp-3166	84	17	red	red	ADJ
fnp-3166	84	18	dotted	dotted	ADJ
fnp-3166	84	19	areas	area	NOUN
fnp-3166	84	20	)	)	PUNCT
fnp-3166	84	21	.	.	PUNCT
fnp-3166	85	1	c	c	X
fnp-3166	85	2	)	)	PUNCT
fnp-3166	85	3	in	in	ADP
fnp-3166	85	4	ms	ms	PROPN
fnp-3166	85	5	,	,	PUNCT
fnp-3166	85	6	the	the	DET
fnp-3166	85	7	lesions	lesion	NOUN
fnp-3166	85	8	form	form	VERB
fnp-3166	85	9	around	around	ADP
fnp-3166	85	10	larger	large	ADJ
fnp-3166	85	11	veins	vein	NOUN
fnp-3166	85	12	with	with	ADP
fnp-3166	85	13	prominent	prominent	ADJ
fnp-3166	85	14	perivascular	perivascular	ADJ
fnp-3166	85	15	spaces	space	NOUN
fnp-3166	85	16	.	.	PUNCT
fnp-3166	86	1	the	the	DET
fnp-3166	86	2	perivascular	perivascular	ADJ
fnp-3166	86	3	spaces	space	NOUN
fnp-3166	86	4	contain	contain	VERB
fnp-3166	86	5	mainly	mainly	ADV
fnp-3166	86	6	b	b	NOUN
fnp-3166	86	7	-	-	PUNCT
fnp-3166	86	8	cells	cell	NOUN
fnp-3166	86	9	(	(	PUNCT
fnp-3166	86	10	red	red	ADJ
fnp-3166	86	11	dots	dot	NOUN
fnp-3166	86	12	)	)	PUNCT
fnp-3166	86	13	and	and	CCONJ
fnp-3166	86	14	cd8	cd8	PROPN
fnp-3166	86	15	+	+	PROPN
fnp-3166	86	16	t	t	PROPN
fnp-3166	86	17	-	-	PUNCT
fnp-3166	86	18	lymphocytes	lymphocyte	NOUN
fnp-3166	86	19	(	(	PUNCT
fnp-3166	86	20	blue	blue	ADJ
fnp-3166	86	21	dots	dot	NOUN
fnp-3166	86	22	)	)	PUNCT
fnp-3166	86	23	,	,	PUNCT
fnp-3166	86	24	the	the	DET
fnp-3166	86	25	latter	latter	NOUN
fnp-3166	86	26	also	also	ADV
fnp-3166	86	27	disperse	disperse	VERB
fnp-3166	86	28	into	into	ADP
fnp-3166	86	29	the	the	DET
fnp-3166	86	30	plaque	plaque	NOUN
fnp-3166	86	31	parenchyma	parenchyma	NOUN
fnp-3166	86	32	.	.	PUNCT
fnp-3166	87	1	cd4	cd4	PROPN
fnp-3166	87	2	+	+	PROPN
fnp-3166	87	3	t	t	PROPN
fnp-3166	87	4	-	-	PUNCT
fnp-3166	87	5	cells	cell	NOUN
fnp-3166	87	6	(	(	PUNCT
fnp-3166	87	7	green	green	ADJ
fnp-3166	87	8	dots	dot	NOUN
fnp-3166	87	9	)	)	PUNCT
fnp-3166	87	10	are	be	AUX
fnp-3166	87	11	very	very	ADV
fnp-3166	87	12	sparse	sparse	ADJ
fnp-3166	87	13	.	.	PUNCT
fnp-3166	88	1	a	a	DET
fnp-3166	88	2	characteristic	characteristic	ADJ
fnp-3166	88	3	feature	feature	NOUN
fnp-3166	88	4	of	of	ADP
fnp-3166	88	5	active	active	ADJ
fnp-3166	88	6	ms	ms	ADJ
fnp-3166	88	7	lesions	lesion	NOUN
fnp-3166	88	8	is	be	AUX
fnp-3166	88	9	the	the	DET
fnp-3166	88	10	radial	radial	ADJ
fnp-3166	88	11	expansion	expansion	NOUN
fnp-3166	88	12	,	,	PUNCT
fnp-3166	88	13	reflected	reflect	VERB
fnp-3166	88	14	by	by	ADP
fnp-3166	88	15	a	a	DET
fnp-3166	88	16	rim	rim	NOUN
fnp-3166	88	17	of	of	ADP
fnp-3166	88	18	activated	activate	VERB
fnp-3166	88	19	macrophages	macrophage	NOUN
fnp-3166	88	20	at	at	ADP
fnp-3166	88	21	the	the	DET
fnp-3166	88	22	lesion	lesion	NOUN
fnp-3166	88	23	edge	edge	NOUN
fnp-3166	88	24	(	(	PUNCT
fnp-3166	88	25	blue	blue	ADJ
fnp-3166	88	26	dotted	dotted	ADJ
fnp-3166	88	27	area	area	NOUN
fnp-3166	88	28	)	)	PUNCT
fnp-3166	88	29	.	.	PUNCT
fnp-3166	89	1	d	d	X
fnp-3166	89	2	)	)	PUNCT
fnp-3166	89	3	in	in	ADP
fnp-3166	89	4	contrast	contrast	NOUN
fnp-3166	89	5	,	,	PUNCT
fnp-3166	89	6	in	in	ADP
fnp-3166	89	7	mogad	mogad	NOUN
fnp-3166	89	8	,	,	PUNCT
fnp-3166	89	9	numerous	numerous	ADJ
fnp-3166	89	10	small	small	ADJ
fnp-3166	89	11	perivenous	perivenous	ADJ
fnp-3166	89	12	sheaths	sheath	NOUN
fnp-3166	89	13	of	of	ADP
fnp-3166	89	14	demyelination	demyelination	NOUN
fnp-3166	89	15	are	be	AUX
fnp-3166	89	16	present	present	ADJ
fnp-3166	89	17	,	,	PUNCT
fnp-3166	89	18	which	which	PRON
fnp-3166	89	19	arise	arise	VERB
fnp-3166	89	20	around	around	ADP
fnp-3166	89	21	small	small	ADJ
fnp-3166	89	22	veins	vein	NOUN
fnp-3166	89	23	and	and	CCONJ
fnp-3166	89	24	venules	venule	NOUN
fnp-3166	89	25	(	(	PUNCT
fnp-3166	89	26	blue	blue	ADJ
fnp-3166	89	27	dotted	dotted	ADJ
fnp-3166	89	28	areas	area	NOUN
fnp-3166	89	29	)	)	PUNCT
fnp-3166	89	30	.	.	PUNCT
fnp-3166	90	1	in	in	ADP
fnp-3166	90	2	the	the	DET
fnp-3166	90	3	inflammatory	inflammatory	ADJ
fnp-3166	90	4	infiltrates	infiltrate	VERB
fnp-3166	90	5	the	the	DET
fnp-3166	90	6	cd4	cd4	PROPN
fnp-3166	90	7	+	+	PROPN
fnp-3166	90	8	t	t	PROPN
fnp-3166	90	9	-	-	PUNCT
fnp-3166	90	10	cells	cell	NOUN
fnp-3166	90	11	dominate	dominate	VERB
fnp-3166	90	12	,	,	PUNCT
fnp-3166	90	13	while	while	SCONJ
fnp-3166	90	14	there	there	PRON
fnp-3166	90	15	is	be	VERB
fnp-3166	90	16	a	a	DET
fnp-3166	90	17	much	much	ADV
fnp-3166	90	18	lower	low	ADJ
fnp-3166	90	19	contribution	contribution	NOUN
fnp-3166	90	20	of	of	ADP
fnp-3166	90	21	cd8	cd8	PROPN
fnp-3166	90	22	+	+	PROPN
fnp-3166	90	23	t	t	PROPN
fnp-3166	90	24	-	-	PUNCT
fnp-3166	90	25	cells	cell	NOUN
fnp-3166	90	26	(	(	PUNCT
fnp-3166	90	27	blue	blue	ADJ
fnp-3166	90	28	dots	dot	NOUN
fnp-3166	90	29	)	)	PUNCT
fnp-3166	90	30	or	or	CCONJ
fnp-3166	90	31	b	b	X
fnp-3166	90	32	-	-	PUNCT
fnp-3166	90	33	cells	cell	NOUN
fnp-3166	90	34	and	and	CCONJ
fnp-3166	90	35	plasma	plasma	NOUN
fnp-3166	90	36	cells	cell	NOUN
fnp-3166	90	37	(	(	PUNCT
fnp-3166	90	38	red	red	ADJ
fnp-3166	90	39	dots	dot	NOUN
fnp-3166	90	40	)	)	PUNCT
fnp-3166	90	41	.	.	PUNCT
fnp-3166	91	1	confluence	confluence	NOUN
fnp-3166	91	2	of	of	ADP
fnp-3166	91	3	the	the	DET
fnp-3166	91	4	perivenous	perivenous	ADJ
fnp-3166	91	5	lesions	lesion	NOUN
fnp-3166	91	6	results	result	NOUN
fnp-3166	91	7	in	in	ADP
fnp-3166	91	8	larger	large	ADJ
fnp-3166	91	9	demyelinated	demyelinated	ADJ
fnp-3166	91	10	plaques	plaque	NOUN
fnp-3166	91	11	.	.	PUNCT
fnp-3166	92	1	interestingly	interestingly	ADV
fnp-3166	92	2	,	,	PUNCT
fnp-3166	92	3	the	the	DET
fnp-3166	92	4	pathology	pathology	NOUN
fnp-3166	92	5	of	of	ADP
fnp-3166	92	6	mogad	mogad	PROPN
fnp-3166	92	7	closely	closely	ADV
fnp-3166	92	8	resembles	resemble	VERB
fnp-3166	92	9	the	the	DET
fnp-3166	92	10	pathology	pathology	NOUN
fnp-3166	92	11	seen	see	VERB
fnp-3166	92	12	in	in	ADP
fnp-3166	92	13	experimental	experimental	ADJ
fnp-3166	92	14	models	model	NOUN
fnp-3166	92	15	of	of	ADP
fnp-3166	92	16	autoimmune	autoimmune	ADJ
fnp-3166	92	17	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	92	18	(	(	PUNCT
fnp-3166	92	19	eae	eae	PROPN
fnp-3166	92	20	)	)	PUNCT
fnp-3166	92	21	,	,	PUNCT
fnp-3166	92	22	induced	induce	VERB
fnp-3166	92	23	by	by	ADP
fnp-3166	92	24	immunization	immunization	NOUN
fnp-3166	92	25	of	of	ADP
fnp-3166	92	26	rats	rat	NOUN
fnp-3166	92	27	,	,	PUNCT
fnp-3166	92	28	guinea	guinea	NOUN
fnp-3166	92	29	pigs	pig	NOUN
fnp-3166	92	30	,	,	PUNCT
fnp-3166	92	31	or	or	CCONJ
fnp-3166	92	32	primates	primate	NOUN
fnp-3166	92	33	with	with	ADP
fnp-3166	92	34	cns	cns	NOUN
fnp-3166	92	35	tissue	tissue	NOUN
fnp-3166	92	36	myelin	myelin	NOUN
fnp-3166	92	37	or	or	CCONJ
fnp-3166	92	38	recombinant	recombinant	ADJ
fnp-3166	92	39	mog	mog	NOUN
fnp-3166	92	40	(	(	PUNCT
fnp-3166	92	41	höftberger	höftberger	NOUN
fnp-3166	92	42	et	et	PROPN
fnp-3166	92	43	al	al	PROPN
fnp-3166	92	44	.	.	PROPN
fnp-3166	92	45	2020	2020	NUM
fnp-3166	92	46	)	)	PUNCT
fnp-3166	92	47	.	.	PUNCT
fnp-3166	93	1	thus	thus	ADV
fnp-3166	93	2	,	,	PUNCT
fnp-3166	93	3	eae	eae	PROPN
fnp-3166	93	4	appears	appear	VERB
fnp-3166	93	5	to	to	PART
fnp-3166	93	6	be	be	AUX
fnp-3166	93	7	a	a	DET
fnp-3166	93	8	very	very	ADV
fnp-3166	93	9	suitable	suitable	ADJ
fnp-3166	93	10	model	model	NOUN
fnp-3166	93	11	for	for	ADP
fnp-3166	93	12	mogad	mogad	NOUN
fnp-3166	93	13	,	,	PUNCT
fnp-3166	93	14	but	but	CCONJ
fnp-3166	93	15	much	much	ADV
fnp-3166	93	16	less	less	ADJ
fnp-3166	93	17	for	for	SCONJ
fnp-3166	93	18	ms	ms	PROPN
fnp-3166	93	19	.	.	PROPN
fnp-3166	93	20	support	support	NOUN
fnp-3166	93	21	of	of	ADP
fnp-3166	93	22	this	this	DET
fnp-3166	93	23	view	view	NOUN
fnp-3166	93	24	is	be	AUX
fnp-3166	93	25	provided	provide	VERB
fnp-3166	93	26	in	in	ADP
fnp-3166	93	27	a	a	DET
fnp-3166	93	28	recent	recent	ADJ
fnp-3166	93	29	study	study	NOUN
fnp-3166	93	30	,	,	PUNCT
fnp-3166	93	31	on	on	ADP
fnp-3166	93	32	archival	archival	NOUN
fnp-3166	93	33	material	material	NOUN
fnp-3166	93	34	from	from	ADP
fnp-3166	93	35	a	a	DET
fnp-3166	93	36	patient	patient	NOUN
fnp-3166	93	37	,	,	PUNCT
fnp-3166	93	38	who	who	PRON
fnp-3166	93	39	died	die	VERB
fnp-3166	93	40	in	in	ADP
fnp-3166	93	41	the	the	DET
fnp-3166	93	42	1950s	1950	NOUN
fnp-3166	93	43	with	with	ADP
fnp-3166	93	44	an	an	DET
fnp-3166	93	45	acute	acute	ADJ
fnp-3166	93	46	ms	ms	NOUN
fnp-3166	93	47	-	-	PUNCT
fnp-3166	93	48	like	like	ADJ
fnp-3166	93	49	inflammatory	inflammatory	ADJ
fnp-3166	93	50	demyelinating	demyelinate	VERB
fnp-3166	93	51	disease	disease	NOUN
fnp-3166	93	52	after	after	ADP
fnp-3166	93	53	misguided	misguided	ADJ
fnp-3166	93	54	repeated	repeat	VERB
fnp-3166	93	55	immunization	immunization	NOUN
fnp-3166	93	56	with	with	ADP
fnp-3166	93	57	brain	brain	NOUN
fnp-3166	93	58	tissue	tissue	NOUN
fnp-3166	93	59	(	(	PUNCT
fnp-3166	93	60	höftberger	höftberger	NOUN
fnp-3166	93	61	et	et	PROPN
fnp-3166	93	62	al	al	PROPN
fnp-3166	93	63	.	.	PROPN
fnp-3166	93	64	2015	2015	NUM
fnp-3166	93	65	)	)	PUNCT
fnp-3166	93	66	.	.	PUNCT
fnp-3166	94	1	new	new	ADJ
fnp-3166	94	2	molecular	molecular	ADJ
fnp-3166	94	3	biology	biology	NOUN
fnp-3166	94	4	technologies	technology	NOUN
fnp-3166	94	5	allowed	allow	VERB
fnp-3166	94	6	resurrection	resurrection	NOUN
fnp-3166	94	7	of	of	ADP
fnp-3166	94	8	a	a	DET
fnp-3166	94	9	pathogenic	pathogenic	ADJ
fnp-3166	94	10	auto	auto	NOUN
fnp-3166	94	11	-	-	PUNCT
fnp-3166	94	12	antibody	antibody	NOUN
fnp-3166	94	13	from	from	ADP
fnp-3166	94	14	the	the	DET
fnp-3166	94	15	archival	archival	NOUN
fnp-3166	94	16	formaldehyde	formaldehyde	NOUN
fnp-3166	94	17	fixed	fix	VERB
fnp-3166	94	18	and	and	CCONJ
fnp-3166	94	19	paraffin	paraffin	NOUN
fnp-3166	94	20	embedded	embed	VERB
fnp-3166	94	21	tissue	tissue	NOUN
fnp-3166	94	22	,	,	PUNCT
fnp-3166	94	23	which	which	PRON
fnp-3166	94	24	was	be	AUX
fnp-3166	94	25	found	find	VERB
fnp-3166	94	26	to	to	PART
fnp-3166	94	27	be	be	AUX
fnp-3166	94	28	directed	direct	VERB
fnp-3166	94	29	against	against	ADP
fnp-3166	94	30	a	a	DET
fnp-3166	94	31	conformational	conformational	ADJ
fnp-3166	94	32	epitope	epitope	NOUN
fnp-3166	94	33	of	of	ADP
fnp-3166	94	34	mog	mog	NOUN
fnp-3166	94	35	and	and	CCONJ
fnp-3166	94	36	induced	induce	VERB
fnp-3166	94	37	demyelination	demyelination	NOUN
fnp-3166	94	38	after	after	ADP
fnp-3166	94	39	transfer	transfer	NOUN
fnp-3166	94	40	in	in	ADP
fnp-3166	94	41	vivo	vivo	NOUN
fnp-3166	94	42	(	(	PUNCT
fnp-3166	94	43	beltran	beltran	PROPN
fnp-3166	94	44	et	et	PROPN
fnp-3166	94	45	al	al	PROPN
fnp-3166	94	46	.	.	PROPN
fnp-3166	94	47	2020	2020	NUM
fnp-3166	94	48	)	)	PUNCT
fnp-3166	94	49	.	.	PUNCT
fnp-3166	95	1	4	4	X
fnp-3166	95	2	)	)	PUNCT
fnp-3166	95	3	is	be	AUX
fnp-3166	95	4	subpial	subpial	ADJ
fnp-3166	95	5	demyelination	demyelination	NOUN
fnp-3166	95	6	a	a	DET
fnp-3166	95	7	unique	unique	ADJ
fnp-3166	95	8	feature	feature	NOUN
fnp-3166	95	9	of	of	ADP
fnp-3166	95	10	multiple	multiple	ADJ
fnp-3166	95	11	sclerosis	sclerosis	NOUN
fnp-3166	95	12	pathology	pathology	NOUN
fnp-3166	95	13	?	?	PUNCT
fnp-3166	96	1	for	for	ADP
fnp-3166	96	2	a	a	DET
fnp-3166	96	3	long	long	ADJ
fnp-3166	96	4	time	time	NOUN
fnp-3166	96	5	,	,	PUNCT
fnp-3166	96	6	ms	ms	PROPN
fnp-3166	96	7	has	have	AUX
fnp-3166	96	8	been	be	AUX
fnp-3166	96	9	regarded	regard	VERB
fnp-3166	96	10	a	a	DET
fnp-3166	96	11	demyelinating	demyelinate	VERB
fnp-3166	96	12	disease	disease	NOUN
fnp-3166	96	13	affecting	affect	VERB
fnp-3166	96	14	the	the	DET
fnp-3166	96	15	white	white	ADJ
fnp-3166	96	16	matter	matter	NOUN
fnp-3166	96	17	.	.	PUNCT
fnp-3166	97	1	however	however	ADV
fnp-3166	97	2	,	,	PUNCT
fnp-3166	97	3	with	with	ADP
fnp-3166	97	4	the	the	DET
fnp-3166	97	5	availability	availability	NOUN
fnp-3166	97	6	of	of	ADP
fnp-3166	97	7	highly	highly	ADV
fnp-3166	97	8	sensitive	sensitive	ADJ
fnp-3166	97	9	immunocytochemical	immunocytochemical	ADJ
fnp-3166	97	10	methods	method	NOUN
fnp-3166	97	11	,	,	PUNCT
fnp-3166	97	12	which	which	PRON
fnp-3166	97	13	allow	allow	VERB
fnp-3166	97	14	staining	stain	VERB
fnp-3166	97	15	of	of	ADP
fnp-3166	97	16	the	the	DET
fnp-3166	97	17	very	very	ADV
fnp-3166	97	18	thin	thin	ADJ
fnp-3166	97	19	myelinated	myelinated	ADJ
fnp-3166	97	20	fibers	fiber	NOUN
fnp-3166	97	21	within	within	ADP
fnp-3166	97	22	the	the	DET
fnp-3166	97	23	grey	grey	ADJ
fnp-3166	97	24	matter	matter	NOUN
fnp-3166	97	25	(	(	PUNCT
fnp-3166	97	26	peterson	peterson	PROPN
fnp-3166	97	27	et	et	PROPN
fnp-3166	97	28	al	al	PROPN
fnp-3166	97	29	.	.	PROPN
fnp-3166	97	30	2000	2000	NUM
fnp-3166	97	31	)	)	PUNCT
fnp-3166	97	32	,	,	PUNCT
fnp-3166	97	33	it	it	PRON
fnp-3166	97	34	became	become	VERB
fnp-3166	97	35	clear	clear	ADJ
fnp-3166	97	36	that	that	SCONJ
fnp-3166	97	37	demyelination	demyelination	NOUN
fnp-3166	97	38	in	in	ADP
fnp-3166	97	39	the	the	DET
fnp-3166	97	40	grey	grey	ADJ
fnp-3166	97	41	matter	matter	NOUN
fnp-3166	97	42	in	in	ADP
fnp-3166	97	43	the	the	DET
fnp-3166	97	44	ms	ms	PROPN
fnp-3166	97	45	brain	brain	NOUN
fnp-3166	97	46	is	be	AUX
fnp-3166	97	47	extensive	extensive	ADJ
fnp-3166	97	48	(	(	PUNCT
fnp-3166	97	49	kutzelnigg	kutzelnigg	PROPN
fnp-3166	97	50	et	et	PROPN
fnp-3166	97	51	al	al	PROPN
fnp-3166	97	52	.	.	PROPN
fnp-3166	97	53	2005	2005	NUM
fnp-3166	97	54	)	)	PUNCT
fnp-3166	97	55	and	and	CCONJ
fnp-3166	97	56	may	may	AUX
fnp-3166	97	57	even	even	ADV
fnp-3166	97	58	give	give	VERB
fnp-3166	97	59	rise	rise	NOUN
fnp-3166	97	60	to	to	ADP
fnp-3166	97	61	cortico	cortico	NOUN
fnp-3166	97	62	-	-	PUNCT
fnp-3166	97	63	spinal	spinal	ADJ
fnp-3166	97	64	or	or	CCONJ
fnp-3166	97	65	pure	pure	ADJ
fnp-3166	97	66	cortical	cortical	ADJ
fnp-3166	97	67	variants	variant	NOUN
fnp-3166	97	68	of	of	ADP
fnp-3166	97	69	the	the	DET
fnp-3166	97	70	disease	disease	NOUN
fnp-3166	97	71	in	in	ADP
fnp-3166	97	72	a	a	DET
fnp-3166	97	73	subset	subset	NOUN
fnp-3166	97	74	of	of	ADP
fnp-3166	97	75	patients	patient	NOUN
fnp-3166	97	76	(	(	PUNCT
fnp-3166	97	77	trapp	trapp	PROPN
fnp-3166	97	78	et	et	PROPN
fnp-3166	97	79	al	al	PROPN
fnp-3166	97	80	.	.	PROPN
fnp-3166	97	81	2018	2018	NUM
fnp-3166	97	82	)	)	PUNCT
fnp-3166	97	83	.	.	PUNCT
fnp-3166	98	1	three	three	NUM
fnp-3166	98	2	types	type	NOUN
fnp-3166	98	3	of	of	ADP
fnp-3166	98	4	cortical	cortical	ADJ
fnp-3166	98	5	lesions	lesion	NOUN
fnp-3166	98	6	have	have	AUX
fnp-3166	98	7	been	be	AUX
fnp-3166	98	8	identified	identify	VERB
fnp-3166	98	9	:	:	PUNCT
fnp-3166	98	10	the	the	DET
fnp-3166	98	11	cortico	cortico	NOUN
fnp-3166	98	12	-	-	PUNCT
fnp-3166	98	13	subcortical	subcortical	ADJ
fnp-3166	98	14	lesions	lesion	NOUN
fnp-3166	98	15	(	(	PUNCT
fnp-3166	98	16	type	type	NOUN
fnp-3166	98	17	1	1	NUM
fnp-3166	98	18	)	)	PUNCT
fnp-3166	98	19	,	,	PUNCT
fnp-3166	98	20	the	the	DET
fnp-3166	98	21	intracortical	intracortical	ADJ
fnp-3166	98	22	lesions	lesion	NOUN
fnp-3166	98	23	(	(	PUNCT
fnp-3166	98	24	type	type	NOUN
fnp-3166	98	25	2	2	NUM
fnp-3166	98	26	)	)	PUNCT
fnp-3166	98	27	,	,	PUNCT
fnp-3166	98	28	and	and	CCONJ
fnp-3166	98	29	the	the	DET
fnp-3166	98	30	subpial	subpial	ADJ
fnp-3166	98	31	lesions	lesion	NOUN
fnp-3166	98	32	(	(	PUNCT
fnp-3166	98	33	type	type	NOUN
fnp-3166	98	34	3	3	NUM
fnp-3166	98	35	)	)	PUNCT
fnp-3166	98	36	(	(	PUNCT
fnp-3166	98	37	bo	bo	PROPN
fnp-3166	98	38	et	et	PROPN
fnp-3166	98	39	al	al	PROPN
fnp-3166	98	40	.	.	PROPN
fnp-3166	98	41	2003	2003	NUM
fnp-3166	98	42	)	)	PUNCT
fnp-3166	98	43	.	.	PUNCT
fnp-3166	99	1	the	the	DET
fnp-3166	99	2	third	third	ADJ
fnp-3166	99	3	type	type	NOUN
fnp-3166	99	4	is	be	AUX
fnp-3166	99	5	most	most	ADV
fnp-3166	99	6	abundant	abundant	ADJ
fnp-3166	99	7	in	in	ADP
fnp-3166	99	8	ms	ms	NOUN
fnp-3166	99	9	and	and	CCONJ
fnp-3166	99	10	is	be	AUX
fnp-3166	99	11	related	relate	VERB
fnp-3166	99	12	to	to	ADP
fnp-3166	99	13	focal	focal	ADJ
fnp-3166	99	14	inflammatory	inflammatory	ADJ
fnp-3166	99	15	aggregates	aggregate	NOUN
fnp-3166	99	16	in	in	ADP
fnp-3166	99	17	the	the	DET
fnp-3166	99	18	leptomeninges	leptomeninge	NOUN
fnp-3166	99	19	(	(	PUNCT
fnp-3166	99	20	magliozzi	magliozzi	NOUN
fnp-3166	99	21	et	et	PROPN
fnp-3166	99	22	al	al	PROPN
fnp-3166	99	23	.	.	PROPN
fnp-3166	99	24	2010	2010	NUM
fnp-3166	99	25	;	;	PUNCT
fnp-3166	99	26	figure	figure	NOUN
fnp-3166	99	27	2	2	NUM
fnp-3166	99	28	)	)	PUNCT
fnp-3166	99	29	.	.	PUNCT
fnp-3166	100	1	several	several	ADJ
fnp-3166	100	2	previous	previous	ADJ
fnp-3166	100	3	studies	study	NOUN
fnp-3166	100	4	have	have	AUX
fnp-3166	100	5	indicated	indicate	VERB
fnp-3166	100	6	that	that	SCONJ
fnp-3166	100	7	subpial	subpial	ADJ
fnp-3166	100	8	demyelinated	demyelinate	VERB
fnp-3166	100	9	lesions	lesion	NOUN
fnp-3166	100	10	in	in	ADP
fnp-3166	100	11	the	the	DET
fnp-3166	100	12	cortex	cortex	NOUN
fnp-3166	100	13	may	may	AUX
fnp-3166	100	14	be	be	AUX
fnp-3166	100	15	specific	specific	ADJ
fnp-3166	100	16	for	for	ADP
fnp-3166	100	17	ms	ms	PROPN
fnp-3166	100	18	(	(	PUNCT
fnp-3166	100	19	moll	moll	PROPN
fnp-3166	100	20	et	et	PROPN
fnp-3166	100	21	al	al	PROPN
fnp-3166	100	22	.	.	PROPN
fnp-3166	100	23	2008	2008	NUM
fnp-3166	100	24	,	,	PUNCT
fnp-3166	100	25	fischer	fischer	PROPN
fnp-3166	100	26	et	et	PROPN
fnp-3166	100	27	al	al	PROPN
fnp-3166	100	28	.	.	PROPN
fnp-3166	100	29	2013	2013	NUM
fnp-3166	100	30	)	)	PUNCT
fnp-3166	100	31	,	,	PUNCT
fnp-3166	100	32	but	but	CCONJ
fnp-3166	100	33	this	this	DET
fnp-3166	100	34	view	view	NOUN
fnp-3166	100	35	was	be	AUX
fnp-3166	100	36	based	base	VERB
fnp-3166	100	37	on	on	ADP
fnp-3166	100	38	a	a	DET
fnp-3166	100	39	rather	rather	ADV
fnp-3166	100	40	limited	limited	ADJ
fnp-3166	100	41	sample	sample	NOUN
fnp-3166	100	42	of	of	ADP
fnp-3166	100	43	neuropathological	neuropathological	ADJ
fnp-3166	100	44	conditions	condition	NOUN
fnp-3166	100	45	other	other	ADJ
fnp-3166	100	46	than	than	ADP
fnp-3166	100	47	ms	ms	PROPN
fnp-3166	100	48	.	.	PROPN
fnp-3166	100	49	this	this	PRON
fnp-3166	100	50	has	have	AUX
fnp-3166	100	51	now	now	ADV
fnp-3166	100	52	been	be	AUX
fnp-3166	100	53	changed	change	VERB
fnp-3166	100	54	in	in	ADP
fnp-3166	100	55	a	a	DET
fnp-3166	100	56	very	very	ADV
fnp-3166	100	57	comprehensive	comprehensive	ADJ
fnp-3166	100	58	study	study	NOUN
fnp-3166	100	59	by	by	ADP
fnp-3166	100	60	junker	junker	PROPN
fnp-3166	100	61	et	et	PROPN
fnp-3166	100	62	al	al	PROPN
fnp-3166	100	63	.	.	PROPN
fnp-3166	101	1	(	(	PUNCT
fnp-3166	101	2	2020	2020	NUM
fnp-3166	101	3	)	)	PUNCT
fnp-3166	101	4	,	,	PUNCT
fnp-3166	101	5	in	in	ADP
fnp-3166	101	6	which	which	PRON
fnp-3166	101	7	nearly	nearly	ADV
fnp-3166	101	8	every	every	PRON
fnp-3166	101	9	thinkable	thinkable	ADJ
fnp-3166	101	10	neuropathological	neuropathological	ADJ
fnp-3166	101	11	condition	condition	NOUN
fnp-3166	101	12	has	have	AUX
fnp-3166	101	13	been	be	AUX
fnp-3166	101	14	investigated	investigate	VERB
fnp-3166	101	15	for	for	ADP
fnp-3166	101	16	cortical	cortical	ADJ
fnp-3166	101	17	demyelination	demyelination	NOUN
fnp-3166	101	18	.	.	PUNCT
fnp-3166	102	1	interestingly	interestingly	ADV
fnp-3166	102	2	,	,	PUNCT
fnp-3166	102	3	subpial	subpial	ADJ
fnp-3166	102	4	demyelination	demyelination	NOUN
fnp-3166	102	5	was	be	AUX
fnp-3166	102	6	exclusively	exclusively	ADV
fnp-3166	102	7	present	present	ADJ
fnp-3166	102	8	in	in	ADP
fnp-3166	102	9	ms	ms	NOUN
fnp-3166	102	10	and	and	CCONJ
fnp-3166	102	11	not	not	PART
fnp-3166	102	12	seen	see	VERB
fnp-3166	102	13	in	in	ADP
fnp-3166	102	14	any	any	PRON
fnp-3166	102	15	of	of	ADP
fnp-3166	102	16	the	the	DET
fnp-3166	102	17	other	other	ADJ
fnp-3166	102	18	conditions	condition	NOUN
fnp-3166	102	19	.	.	PUNCT
fnp-3166	103	1	the	the	DET
fnp-3166	103	2	only	only	ADJ
fnp-3166	103	3	key	key	ADJ
fnp-3166	103	4	diagnosis	diagnosis	NOUN
fnp-3166	103	5	missed	miss	VERB
fnp-3166	103	6	in	in	ADP
fnp-3166	103	7	this	this	DET
fnp-3166	103	8	case	case	NOUN
fnp-3166	103	9	series	series	NOUN
fnp-3166	103	10	was	be	AUX
fnp-3166	103	11	mogad	mogad	ADJ
fnp-3166	103	12	.	.	PUNCT
fnp-3166	104	1	however	however	ADV
fnp-3166	104	2	,	,	PUNCT
fnp-3166	104	3	this	this	PRON
fnp-3166	104	4	was	be	AUX
fnp-3166	104	5	also	also	ADV
fnp-3166	104	6	specifically	specifically	ADV
fnp-3166	104	7	addressed	address	VERB
fnp-3166	104	8	in	in	ADP
fnp-3166	104	9	the	the	DET
fnp-3166	104	10	systematic	systematic	ADJ
fnp-3166	104	11	studies	study	NOUN
fnp-3166	104	12	of	of	ADP
fnp-3166	104	13	mogad	mogad	PROPN
fnp-3166	104	14	pathology	pathology	NOUN
fnp-3166	104	15	outlined	outline	VERB
fnp-3166	104	16	above	above	ADV
fnp-3166	104	17	(	(	PUNCT
fnp-3166	104	18	höftberger	höftberger	NOUN
fnp-3166	104	19	et	et	PROPN
fnp-3166	104	20	al	al	PROPN
fnp-3166	104	21	.	.	PROPN
fnp-3166	104	22	2020	2020	NUM
fnp-3166	104	23	,	,	PUNCT
fnp-3166	104	24	takai	takai	PROPN
fnp-3166	104	25	et	et	PROPN
fnp-3166	104	26	al	al	PROPN
fnp-3166	104	27	.	.	PROPN
fnp-3166	104	28	2020	2020	NUM
fnp-3166	104	29	)	)	PUNCT
fnp-3166	104	30	,	,	PUNCT
fnp-3166	104	31	describing	describe	VERB
fnp-3166	104	32	intracortical	intracortical	ADJ
fnp-3166	104	33	and	and	CCONJ
fnp-3166	104	34	cortico	cortico	NOUN
fnp-3166	104	35	-	-	PUNCT
fnp-3166	104	36	subcortical	subcortical	ADJ
fnp-3166	104	37	lesions	lesion	NOUN
fnp-3166	104	38	but	but	CCONJ
fnp-3166	104	39	absent	absent	ADJ
fnp-3166	104	40	subpial	subpial	ADJ
fnp-3166	104	41	cortical	cortical	ADJ
fnp-3166	104	42	lesions	lesion	NOUN
fnp-3166	104	43	.	.	PUNCT
fnp-3166	105	1	in	in	ADP
fnp-3166	105	2	rare	rare	ADJ
fnp-3166	105	3	instances	instance	NOUN
fnp-3166	105	4	,	,	PUNCT
fnp-3166	105	5	these	these	DET
fnp-3166	105	6	intracortical	intracortical	ADJ
fnp-3166	105	7	lesions	lesion	NOUN
fnp-3166	105	8	can	can	AUX
fnp-3166	105	9	fuse	fuse	VERB
fnp-3166	105	10	and	and	CCONJ
fnp-3166	105	11	give	give	VERB
fnp-3166	105	12	rise	rise	NOUN
fnp-3166	105	13	to	to	ADP
fnp-3166	105	14	large	large	ADJ
fnp-3166	105	15	focal	focal	ADJ
fnp-3166	105	16	confluent	confluent	ADJ
fnp-3166	105	17	plaques	plaque	NOUN
fnp-3166	105	18	of	of	ADP
fnp-3166	105	19	demyelination	demyelination	NOUN
fnp-3166	105	20	.	.	PUNCT
fnp-3166	106	1	thus	thus	ADV
fnp-3166	106	2	,	,	PUNCT
fnp-3166	106	3	so	so	ADV
fnp-3166	106	4	far	far	ADV
fnp-3166	106	5	it	it	PRON
fnp-3166	106	6	seems	seem	VERB
fnp-3166	106	7	that	that	SCONJ
fnp-3166	106	8	subpial	subpial	ADJ
fnp-3166	106	9	cortical	cortical	ADJ
fnp-3166	106	10	demyelination	demyelination	NOUN
fnp-3166	106	11	is	be	AUX
fnp-3166	106	12	a	a	DET
fnp-3166	106	13	unique	unique	ADJ
fnp-3166	106	14	feature	feature	NOUN
fnp-3166	106	15	of	of	ADP
fnp-3166	106	16	ms	ms	PROPN
fnp-3166	106	17	pathology	pathology	NOUN
fnp-3166	106	18	,	,	PUNCT
fnp-3166	106	19	but	but	CCONJ
fnp-3166	106	20	the	the	DET
fnp-3166	106	21	evidence	evidence	NOUN
fnp-3166	106	22	for	for	ADP
fnp-3166	106	23	its	its	PRON
fnp-3166	106	24	absence	absence	NOUN
fnp-3166	106	25	in	in	ADP
fnp-3166	106	26	mogad	mogad	PROPN
fnp-3166	106	27	is	be	AUX
fnp-3166	106	28	thus	thus	ADV
fnp-3166	106	29	far	far	ADV
fnp-3166	106	30	based	base	VERB
fnp-3166	106	31	on	on	ADP
fnp-3166	106	32	a	a	DET
fnp-3166	106	33	rather	rather	ADV
fnp-3166	106	34	small	small	ADJ
fnp-3166	106	35	sample	sample	NOUN
fnp-3166	106	36	of	of	ADP
fnp-3166	106	37	cases	case	NOUN
fnp-3166	106	38	.	.	PUNCT
fnp-3166	107	1	nevertheless	nevertheless	ADV
fnp-3166	107	2	,	,	PUNCT
fnp-3166	107	3	the	the	DET
fnp-3166	107	4	presence	presence	NOUN
fnp-3166	107	5	of	of	ADP
fnp-3166	107	6	a	a	DET
fnp-3166	107	7	subpial	subpial	ADJ
fnp-3166	107	8	cortical	cortical	ADJ
fnp-3166	107	9	lesion	lesion	NOUN
fnp-3166	107	10	strongly	strongly	ADV
fnp-3166	107	11	supports	support	VERB
fnp-3166	107	12	a	a	DET
fnp-3166	107	13	neuropathological	neuropathological	ADJ
fnp-3166	107	14	diagnosis	diagnosis	NOUN
fnp-3166	107	15	of	of	ADP
fnp-3166	107	16	ms	ms	PROPN
fnp-3166	107	17	.	.	PROPN
fnp-3166	107	18	figure	figure	PROPN
fnp-3166	107	19	2	2	NUM
fnp-3166	107	20	:	:	PUNCT
fnp-3166	107	21	patterns	pattern	NOUN
fnp-3166	107	22	of	of	ADP
fnp-3166	107	23	cortical	cortical	ADJ
fnp-3166	107	24	demyelination	demyelination	NOUN
fnp-3166	107	25	in	in	ADP
fnp-3166	107	26	ms	ms	PROPN
fnp-3166	107	27	and	and	CCONJ
fnp-3166	107	28	mogad	mogad	PROPN
fnp-3166	107	29	:	:	PUNCT
fnp-3166	107	30	a	a	X
fnp-3166	107	31	)	)	PUNCT
fnp-3166	107	32	in	in	ADP
fnp-3166	107	33	ms	ms	PROPN
fnp-3166	107	34	,	,	PUNCT
fnp-3166	107	35	the	the	DET
fnp-3166	107	36	dominant	dominant	ADJ
fnp-3166	107	37	and	and	CCONJ
fnp-3166	107	38	most	most	ADV
fnp-3166	107	39	specific	specific	ADJ
fnp-3166	107	40	type	type	NOUN
fnp-3166	107	41	of	of	ADP
fnp-3166	107	42	cortical	cortical	ADJ
fnp-3166	107	43	demyelination	demyelination	NOUN
fnp-3166	107	44	is	be	AUX
fnp-3166	107	45	the	the	DET
fnp-3166	107	46	subpial	subpial	ADJ
fnp-3166	107	47	lesion	lesion	NOUN
fnp-3166	107	48	.	.	PUNCT
fnp-3166	108	1	it	it	PRON
fnp-3166	108	2	is	be	AUX
fnp-3166	108	3	characterized	characterize	VERB
fnp-3166	108	4	by	by	ADP
fnp-3166	108	5	a	a	DET
fnp-3166	108	6	band	band	NOUN
fnp-3166	108	7	of	of	ADP
fnp-3166	108	8	demyelination	demyelination	NOUN
fnp-3166	108	9	spanning	span	VERB
fnp-3166	108	10	over	over	ADP
fnp-3166	108	11	several	several	ADJ
fnp-3166	108	12	gyri	gyri	NOUN
fnp-3166	108	13	and	and	CCONJ
fnp-3166	108	14	sulci	sulci	NOUN
fnp-3166	108	15	(	(	PUNCT
fnp-3166	108	16	red	red	ADJ
fnp-3166	108	17	lesions	lesion	NOUN
fnp-3166	108	18	)	)	PUNCT
fnp-3166	108	19	.	.	PUNCT
fnp-3166	109	1	the	the	DET
fnp-3166	109	2	lesions	lesion	NOUN
fnp-3166	109	3	are	be	AUX
fnp-3166	109	4	more	more	ADV
fnp-3166	109	5	extensive	extensive	ADJ
fnp-3166	109	6	in	in	ADP
fnp-3166	109	7	the	the	DET
fnp-3166	109	8	invaginations	invagination	NOUN
fnp-3166	109	9	of	of	ADP
fnp-3166	109	10	the	the	DET
fnp-3166	109	11	cortex	cortex	NOUN
fnp-3166	109	12	.	.	PUNCT
fnp-3166	110	1	active	active	ADJ
fnp-3166	110	2	cortical	cortical	ADJ
fnp-3166	110	3	demyelination	demyelination	NOUN
fnp-3166	110	4	is	be	AUX
fnp-3166	110	5	associated	associate	VERB
fnp-3166	110	6	with	with	ADP
fnp-3166	110	7	meningeal	meningeal	ADJ
fnp-3166	110	8	inflammation	inflammation	NOUN
fnp-3166	110	9	by	by	ADP
fnp-3166	110	10	t	t	PROPN
fnp-3166	110	11	-	-	PUNCT
fnp-3166	110	12	cells	cell	NOUN
fnp-3166	110	13	(	(	PUNCT
fnp-3166	110	14	blue	blue	ADJ
fnp-3166	110	15	dots	dot	NOUN
fnp-3166	110	16	)	)	PUNCT
fnp-3166	110	17	and	and	CCONJ
fnp-3166	110	18	b	b	X
fnp-3166	110	19	-	-	PUNCT
fnp-3166	110	20	cells	cell	NOUN
fnp-3166	110	21	(	(	PUNCT
fnp-3166	110	22	red	red	ADJ
fnp-3166	110	23	dots	dot	NOUN
fnp-3166	110	24	)	)	PUNCT
fnp-3166	110	25	and	and	CCONJ
fnp-3166	110	26	is	be	AUX
fnp-3166	110	27	characterized	characterize	VERB
fnp-3166	110	28	by	by	ADP
fnp-3166	110	29	a	a	DET
fnp-3166	110	30	band	band	NOUN
fnp-3166	110	31	of	of	ADP
fnp-3166	110	32	activated	activate	VERB
fnp-3166	110	33	macrophages	macrophage	NOUN
fnp-3166	110	34	/	/	SYM
fnp-3166	110	35	microglia	microglia	NOUN
fnp-3166	110	36	at	at	ADP
fnp-3166	110	37	the	the	DET
fnp-3166	110	38	border	border	NOUN
fnp-3166	110	39	between	between	ADP
fnp-3166	110	40	the	the	DET
fnp-3166	110	41	cortical	cortical	ADJ
fnp-3166	110	42	lesion	lesion	NOUN
fnp-3166	110	43	and	and	CCONJ
fnp-3166	110	44	the	the	DET
fnp-3166	110	45	surrounding	surround	VERB
fnp-3166	110	46	normal	normal	ADJ
fnp-3166	110	47	appearing	appear	VERB
fnp-3166	110	48	cortex	cortex	NOUN
fnp-3166	110	49	(	(	PUNCT
fnp-3166	110	50	purple	purple	ADJ
fnp-3166	110	51	bands	band	NOUN
fnp-3166	110	52	)	)	PUNCT
fnp-3166	110	53	.	.	PUNCT
fnp-3166	111	1	b	b	X
fnp-3166	111	2	)	)	PUNCT
fnp-3166	111	3	in	in	ADP
fnp-3166	111	4	mogad	mogad	PROPN
fnp-3166	111	5	,	,	PUNCT
fnp-3166	111	6	the	the	DET
fnp-3166	111	7	dominant	dominant	ADJ
fnp-3166	111	8	cortical	cortical	ADJ
fnp-3166	111	9	pathology	pathology	NOUN
fnp-3166	111	10	is	be	AUX
fnp-3166	111	11	the	the	DET
fnp-3166	111	12	presence	presence	NOUN
fnp-3166	111	13	of	of	ADP
fnp-3166	111	14	small	small	ADJ
fnp-3166	111	15	perivenous	perivenous	ADJ
fnp-3166	111	16	intracortical	intracortical	ADJ
fnp-3166	111	17	demyelinated	demyelinate	VERB
fnp-3166	111	18	lesions	lesion	NOUN
fnp-3166	111	19	(	(	PUNCT
fnp-3166	111	20	red	red	ADJ
fnp-3166	111	21	circles	circle	NOUN
fnp-3166	111	22	)	)	PUNCT
fnp-3166	111	23	.	.	PUNCT
fnp-3166	112	1	they	they	PRON
fnp-3166	112	2	arise	arise	VERB
fnp-3166	112	3	around	around	ADP
fnp-3166	112	4	small	small	ADJ
fnp-3166	112	5	cortical	cortical	ADJ
fnp-3166	112	6	veins	vein	NOUN
fnp-3166	112	7	and	and	CCONJ
fnp-3166	112	8	venules	venule	NOUN
fnp-3166	112	9	with	with	ADP
fnp-3166	112	10	inflammatory	inflammatory	ADJ
fnp-3166	112	11	infiltrates	infiltrate	NOUN
fnp-3166	112	12	.	.	PUNCT
fnp-3166	113	1	on	on	ADP
fnp-3166	113	2	rare	rare	ADJ
fnp-3166	113	3	occasions	occasion	NOUN
fnp-3166	113	4	,	,	PUNCT
fnp-3166	113	5	such	such	ADJ
fnp-3166	113	6	intracortical	intracortical	ADJ
fnp-3166	113	7	perivenous	perivenous	ADJ
fnp-3166	113	8	lesions	lesion	NOUN
fnp-3166	113	9	may	may	AUX
fnp-3166	113	10	give	give	VERB
fnp-3166	113	11	rise	rise	NOUN
fnp-3166	113	12	to	to	ADP
fnp-3166	113	13	a	a	DET
fnp-3166	113	14	focal	focal	ADJ
fnp-3166	113	15	confluent	confluent	ADJ
fnp-3166	113	16	cortical	cortical	ADJ
fnp-3166	113	17	lesion	lesion	NOUN
fnp-3166	113	18	,	,	PUNCT
fnp-3166	113	19	which	which	PRON
fnp-3166	113	20	frequently	frequently	ADV
fnp-3166	113	21	also	also	ADV
fnp-3166	113	22	expands	expand	VERB
fnp-3166	113	23	into	into	ADP
fnp-3166	113	24	the	the	DET
fnp-3166	113	25	adjacent	adjacent	ADJ
fnp-3166	113	26	subcortical	subcortical	ADJ
fnp-3166	113	27	white	white	ADJ
fnp-3166	113	28	matter	matter	NOUN
fnp-3166	113	29	.	.	PUNCT
fnp-3166	114	1	5	5	X
fnp-3166	114	2	)	)	PUNCT
fnp-3166	114	3	what	what	PRON
fnp-3166	114	4	immune	immune	ADJ
fnp-3166	114	5	cells	cell	NOUN
fnp-3166	114	6	drive	drive	VERB
fnp-3166	114	7	inflammation	inflammation	NOUN
fnp-3166	114	8	in	in	ADP
fnp-3166	114	9	multiple	multiple	ADJ
fnp-3166	114	10	sclerosis	sclerosis	NOUN
fnp-3166	114	11	?	?	PUNCT
fnp-3166	115	1	our	our	PRON
fnp-3166	115	2	understanding	understanding	NOUN
fnp-3166	115	3	of	of	ADP
fnp-3166	115	4	the	the	DET
fnp-3166	115	5	immune	immune	ADJ
fnp-3166	115	6	mechanisms	mechanism	NOUN
fnp-3166	115	7	driving	drive	VERB
fnp-3166	115	8	inflammation	inflammation	NOUN
fnp-3166	115	9	in	in	ADP
fnp-3166	115	10	ms	ms	PROPN
fnp-3166	115	11	is	be	AUX
fnp-3166	115	12	largely	largely	ADV
fnp-3166	115	13	biased	bias	VERB
fnp-3166	115	14	by	by	ADP
fnp-3166	115	15	immunological	immunological	ADJ
fnp-3166	115	16	studies	study	NOUN
fnp-3166	115	17	of	of	ADP
fnp-3166	115	18	experimental	experimental	ADJ
fnp-3166	115	19	autoimmune	autoimmune	ADJ
fnp-3166	115	20	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	115	21	,	,	PUNCT
fnp-3166	115	22	which	which	PRON
fnp-3166	115	23	now	now	ADV
fnp-3166	115	24	turns	turn	VERB
fnp-3166	115	25	out	out	ADP
fnp-3166	115	26	to	to	PART
fnp-3166	115	27	have	have	VERB
fnp-3166	115	28	more	more	ADJ
fnp-3166	115	29	relevance	relevance	NOUN
fnp-3166	115	30	for	for	ADP
fnp-3166	115	31	mogad	mogad	NOUN
fnp-3166	115	32	than	than	ADP
fnp-3166	115	33	for	for	ADP
fnp-3166	115	34	ms	ms	PROPN
fnp-3166	115	35	.	.	PROPN
fnp-3166	115	36	key	key	ADJ
fnp-3166	115	37	mechanisms	mechanism	NOUN
fnp-3166	115	38	of	of	ADP
fnp-3166	115	39	inflammation	inflammation	NOUN
fnp-3166	115	40	,	,	PUNCT
fnp-3166	115	41	defined	define	VERB
fnp-3166	115	42	from	from	ADP
fnp-3166	115	43	such	such	ADJ
fnp-3166	115	44	eae	eae	PROPN
fnp-3166	115	45	studies	study	NOUN
fnp-3166	115	46	,	,	PUNCT
fnp-3166	115	47	such	such	ADJ
fnp-3166	115	48	as	as	ADP
fnp-3166	115	49	the	the	DET
fnp-3166	115	50	key	key	ADJ
fnp-3166	115	51	role	role	NOUN
fnp-3166	115	52	of	of	ADP
fnp-3166	115	53	mhc	mhc	PROPN
fnp-3166	115	54	class	class	PROPN
fnp-3166	115	55	ii	ii	PROPN
fnp-3166	115	56	restricted	restrict	VERB
fnp-3166	115	57	t	t	PROPN
fnp-3166	115	58	-	-	PUNCT
fnp-3166	115	59	cells	cell	NOUN
fnp-3166	115	60	responses	response	NOUN
fnp-3166	115	61	,	,	PUNCT
fnp-3166	115	62	the	the	DET
fnp-3166	115	63	involvement	involvement	NOUN
fnp-3166	115	64	of	of	ADP
fnp-3166	115	65	cd4	cd4	PROPN
fnp-3166	115	66	+	+	PROPN
fnp-3166	115	67	th17	th17	PROPN
fnp-3166	115	68	cells	cell	NOUN
fnp-3166	115	69	,	,	PUNCT
fnp-3166	115	70	or	or	CCONJ
fnp-3166	115	71	the	the	DET
fnp-3166	115	72	central	central	ADJ
fnp-3166	115	73	role	role	NOUN
fnp-3166	115	74	of	of	ADP
fnp-3166	115	75	gm	gm	PROPN
fnp-3166	115	76	-	-	PUNCT
fnp-3166	115	77	csf	csf	ADV
fnp-3166	115	78	driven	drive	VERB
fnp-3166	115	79	myeloid	myeloid	NOUN
fnp-3166	115	80	cell	cell	NOUN
fnp-3166	115	81	activation	activation	NOUN
fnp-3166	115	82	(	(	PUNCT
fnp-3166	115	83	schreiner	schreiner	NOUN
fnp-3166	115	84	and	and	CCONJ
fnp-3166	115	85	becher	becher	PROPN
fnp-3166	115	86	2015	2015	NUM
fnp-3166	115	87	)	)	PUNCT
fnp-3166	115	88	are	be	AUX
fnp-3166	115	89	not	not	PART
fnp-3166	115	90	convincingly	convincingly	ADV
fnp-3166	115	91	supported	support	VERB
fnp-3166	115	92	by	by	ADP
fnp-3166	115	93	recent	recent	ADJ
fnp-3166	115	94	therapeutic	therapeutic	ADJ
fnp-3166	115	95	trials	trial	NOUN
fnp-3166	115	96	targeting	target	VERB
fnp-3166	115	97	the	the	DET
fnp-3166	115	98	respective	respective	ADJ
fnp-3166	115	99	immunological	immunological	ADJ
fnp-3166	115	100	pathways	pathway	NOUN
fnp-3166	115	101	(	(	PUNCT
fnp-3166	115	102	baker	baker	PROPN
fnp-3166	115	103	et	et	PROPN
fnp-3166	115	104	al	al	PROPN
fnp-3166	115	105	.	.	PROPN
fnp-3166	115	106	2017	2017	NUM
fnp-3166	115	107	)	)	PUNCT
fnp-3166	115	108	.	.	PUNCT
fnp-3166	116	1	in	in	ADP
fnp-3166	116	2	contrast	contrast	NOUN
fnp-3166	116	3	,	,	PUNCT
fnp-3166	116	4	most	most	ADV
fnp-3166	116	5	effective	effective	ADJ
fnp-3166	116	6	therapeutic	therapeutic	ADJ
fnp-3166	116	7	success	success	NOUN
fnp-3166	116	8	is	be	AUX
fnp-3166	116	9	seen	see	VERB
fnp-3166	116	10	with	with	ADP
fnp-3166	116	11	drugs	drug	NOUN
fnp-3166	116	12	that	that	PRON
fnp-3166	116	13	target	target	VERB
fnp-3166	116	14	t	t	NOUN
fnp-3166	116	15	-	-	PUNCT
fnp-3166	116	16	cells	cell	NOUN
fnp-3166	116	17	and	and	CCONJ
fnp-3166	116	18	b	b	NOUN
fnp-3166	116	19	-	-	NOUN
fnp-3166	116	20	cells	cell	NOUN
fnp-3166	116	21	together	together	ADV
fnp-3166	116	22	or	or	CCONJ
fnp-3166	116	23	even	even	ADV
fnp-3166	116	24	b	b	NOUN
fnp-3166	116	25	-	-	PUNCT
fnp-3166	116	26	cells	cell	NOUN
fnp-3166	116	27	alone	alone	ADV
fnp-3166	116	28	.	.	PUNCT
fnp-3166	117	1	thus	thus	ADV
fnp-3166	117	2	,	,	PUNCT
fnp-3166	117	3	it	it	PRON
fnp-3166	117	4	is	be	AUX
fnp-3166	117	5	still	still	ADV
fnp-3166	117	6	an	an	DET
fnp-3166	117	7	unresolved	unresolved	ADJ
fnp-3166	117	8	question	question	NOUN
fnp-3166	117	9	,	,	PUNCT
fnp-3166	117	10	as	as	SCONJ
fnp-3166	117	11	to	to	ADP
fnp-3166	117	12	what	what	PRON
fnp-3166	117	13	cells	cell	NOUN
fnp-3166	117	14	and	and	CCONJ
fnp-3166	117	15	immune	immune	ADJ
fnp-3166	117	16	mechanisms	mechanism	NOUN
fnp-3166	117	17	trigger	trigger	NOUN
fnp-3166	117	18	or	or	CCONJ
fnp-3166	117	19	drive	drive	VERB
fnp-3166	117	20	inflammation	inflammation	NOUN
fnp-3166	117	21	in	in	ADP
fnp-3166	117	22	ms	ms	PROPN
fnp-3166	117	23	.	.	PROPN
fnp-3166	117	24	pathology	pathology	PROPN
fnp-3166	117	25	can	can	AUX
fnp-3166	117	26	help	help	AUX
fnp-3166	117	27	clarify	clarify	VERB
fnp-3166	117	28	this	this	DET
fnp-3166	117	29	issue	issue	NOUN
fnp-3166	117	30	by	by	ADP
fnp-3166	117	31	providing	provide	VERB
fnp-3166	117	32	a	a	DET
fnp-3166	117	33	concise	concise	ADJ
fnp-3166	117	34	account	account	NOUN
fnp-3166	117	35	of	of	ADP
fnp-3166	117	36	the	the	DET
fnp-3166	117	37	types	type	NOUN
fnp-3166	117	38	of	of	ADP
fnp-3166	117	39	inflammatory	inflammatory	ADJ
fnp-3166	117	40	cells	cell	NOUN
fnp-3166	117	41	seen	see	VERB
fnp-3166	117	42	in	in	ADP
fnp-3166	117	43	different	different	ADJ
fnp-3166	117	44	stages	stage	NOUN
fnp-3166	117	45	in	in	ADP
fnp-3166	117	46	the	the	DET
fnp-3166	117	47	evolution	evolution	NOUN
fnp-3166	117	48	of	of	ADP
fnp-3166	117	49	ms	ms	NOUN
fnp-3166	117	50	lesions	lesion	NOUN
fnp-3166	117	51	.	.	PUNCT
fnp-3166	118	1	until	until	SCONJ
fnp-3166	118	2	a	a	DET
fnp-3166	118	3	few	few	ADJ
fnp-3166	118	4	years	year	NOUN
fnp-3166	118	5	ago	ago	ADV
fnp-3166	118	6	,	,	PUNCT
fnp-3166	118	7	information	information	NOUN
fnp-3166	118	8	about	about	ADP
fnp-3166	118	9	the	the	DET
fnp-3166	118	10	composition	composition	NOUN
fnp-3166	118	11	of	of	ADP
fnp-3166	118	12	inflammatory	inflammatory	ADJ
fnp-3166	118	13	infiltrates	infiltrate	NOUN
fnp-3166	118	14	in	in	ADP
fnp-3166	118	15	ms	ms	PROPN
fnp-3166	118	16	was	be	AUX
fnp-3166	118	17	restricted	restrict	VERB
fnp-3166	118	18	to	to	ADP
fnp-3166	118	19	small	small	ADJ
fnp-3166	118	20	studies	study	NOUN
fnp-3166	118	21	performed	perform	VERB
fnp-3166	118	22	on	on	ADP
fnp-3166	118	23	a	a	DET
fnp-3166	118	24	limited	limited	ADJ
fnp-3166	118	25	number	number	NOUN
fnp-3166	118	26	of	of	ADP
fnp-3166	118	27	patients	patient	NOUN
fnp-3166	118	28	and	and	CCONJ
fnp-3166	118	29	lesions	lesion	NOUN
fnp-3166	118	30	.	.	PUNCT
fnp-3166	119	1	since	since	SCONJ
fnp-3166	119	2	2017	2017	NUM
fnp-3166	119	3	,	,	PUNCT
fnp-3166	119	4	however	however	ADV
fnp-3166	119	5	,	,	PUNCT
fnp-3166	119	6	there	there	PRON
fnp-3166	119	7	are	be	VERB
fnp-3166	119	8	now	now	ADV
fnp-3166	119	9	three	three	NUM
fnp-3166	119	10	large	large	ADJ
fnp-3166	119	11	studies	study	NOUN
fnp-3166	119	12	available	available	ADJ
fnp-3166	119	13	,	,	PUNCT
fnp-3166	119	14	which	which	PRON
fnp-3166	119	15	performed	perform	VERB
fnp-3166	119	16	a	a	DET
fnp-3166	119	17	phenotyping	phenotyping	NOUN
fnp-3166	119	18	of	of	ADP
fnp-3166	119	19	inflammatory	inflammatory	ADJ
fnp-3166	119	20	cells	cell	NOUN
fnp-3166	119	21	in	in	ADP
fnp-3166	119	22	an	an	DET
fnp-3166	119	23	overall	overall	ADJ
fnp-3166	119	24	sample	sample	NOUN
fnp-3166	119	25	of	of	ADP
fnp-3166	119	26	more	more	ADJ
fnp-3166	119	27	than	than	ADP
fnp-3166	119	28	200	200	NUM
fnp-3166	119	29	ms	ms	ADJ
fnp-3166	119	30	patients	patient	NOUN
fnp-3166	119	31	and	and	CCONJ
fnp-3166	119	32	which	which	PRON
fnp-3166	119	33	included	include	VERB
fnp-3166	119	34	all	all	DET
fnp-3166	119	35	stages	stage	NOUN
fnp-3166	119	36	of	of	ADP
fnp-3166	119	37	the	the	DET
fnp-3166	119	38	disease	disease	NOUN
fnp-3166	119	39	(	(	PUNCT
fnp-3166	119	40	van	van	PROPN
fnp-3166	119	41	nierop	nierop	PROPN
fnp-3166	119	42	et	et	PROPN
fnp-3166	119	43	al	al	PROPN
fnp-3166	119	44	.	.	PROPN
fnp-3166	119	45	2017	2017	NUM
fnp-3166	119	46	,	,	PUNCT
fnp-3166	119	47	machado	machado	PROPN
fnp-3166	119	48	santos	santos	PROPN
fnp-3166	119	49	et	et	PROPN
fnp-3166	119	50	al	al	PROPN
fnp-3166	119	51	.	.	PROPN
fnp-3166	119	52	2018	2018	NUM
fnp-3166	119	53	,	,	PUNCT
fnp-3166	119	54	fransen	fransen	VERB
fnp-3166	119	55	et	et	PROPN
fnp-3166	119	56	al	al	PROPN
fnp-3166	119	57	.	.	PROPN
fnp-3166	119	58	2020	2020	NUM
fnp-3166	119	59	)	)	PUNCT
fnp-3166	119	60	.	.	PUNCT
fnp-3166	120	1	all	all	DET
fnp-3166	120	2	studies	study	NOUN
fnp-3166	120	3	reached	reach	VERB
fnp-3166	120	4	a	a	DET
fnp-3166	120	5	similar	similar	ADJ
fnp-3166	120	6	conclusion	conclusion	NOUN
fnp-3166	120	7	that	that	SCONJ
fnp-3166	120	8	the	the	DET
fnp-3166	120	9	dominant	dominant	ADJ
fnp-3166	120	10	lymphocytes	lymphocyte	NOUN
fnp-3166	120	11	in	in	ADP
fnp-3166	120	12	the	the	DET
fnp-3166	120	13	ms	ms	PROPN
fnp-3166	120	14	lesions	lesion	NOUN
fnp-3166	120	15	are	be	AUX
fnp-3166	120	16	tissue	tissue	NOUN
fnp-3166	120	17	resident	resident	ADJ
fnp-3166	120	18	cd8	cd8	PROPN
fnp-3166	120	19	+	+	PROPN
fnp-3166	120	20	effector	effector	NOUN
fnp-3166	120	21	memory	memory	NOUN
fnp-3166	120	22	t	t	PROPN
fnp-3166	120	23	-	-	PUNCT
fnp-3166	120	24	cells	cell	NOUN
fnp-3166	120	25	(	(	PUNCT
fnp-3166	120	26	ttrm	ttrm	NOUN
fnp-3166	120	27	)	)	PUNCT
fnp-3166	120	28	,	,	PUNCT
fnp-3166	120	29	while	while	SCONJ
fnp-3166	120	30	infiltration	infiltration	NOUN
fnp-3166	120	31	with	with	ADP
fnp-3166	120	32	cd4	cd4	PROPN
fnp-3166	120	33	+	+	PROPN
fnp-3166	120	34	t	t	PROPN
fnp-3166	120	35	-	-	PUNCT
fnp-3166	120	36	cells	cell	NOUN
fnp-3166	120	37	is	be	AUX
fnp-3166	120	38	sparse	sparse	ADJ
fnp-3166	120	39	.	.	PUNCT
fnp-3166	121	1	this	this	PRON
fnp-3166	121	2	is	be	AUX
fnp-3166	121	3	the	the	DET
fnp-3166	121	4	case	case	NOUN
fnp-3166	121	5	in	in	ADP
fnp-3166	121	6	all	all	DET
fnp-3166	121	7	types	type	NOUN
fnp-3166	121	8	of	of	ADP
fnp-3166	121	9	ms	ms	NOUN
fnp-3166	121	10	,	,	PUNCT
fnp-3166	121	11	including	include	VERB
fnp-3166	121	12	fulminant	fulminant	ADJ
fnp-3166	121	13	acute	acute	PROPN
fnp-3166	121	14	ms	ms	PROPN
fnp-3166	121	15	,	,	PUNCT
fnp-3166	121	16	relapsing	relapse	VERB
fnp-3166	121	17	remitting	remit	VERB
fnp-3166	121	18	ms	ms	NOUN
fnp-3166	121	19	as	as	ADV
fnp-3166	121	20	well	well	ADV
fnp-3166	121	21	as	as	ADP
fnp-3166	121	22	primary	primary	ADJ
fnp-3166	121	23	or	or	CCONJ
fnp-3166	121	24	secondary	secondary	ADJ
fnp-3166	121	25	progressive	progressive	ADJ
fnp-3166	121	26	ms	ms	NOUN
fnp-3166	121	27	and	and	CCONJ
fnp-3166	121	28	is	be	AUX
fnp-3166	121	29	the	the	DET
fnp-3166	121	30	same	same	ADJ
fnp-3166	121	31	in	in	ADP
fnp-3166	121	32	all	all	DET
fnp-3166	121	33	activity	activity	NOUN
fnp-3166	121	34	stages	stage	NOUN
fnp-3166	121	35	of	of	ADP
fnp-3166	121	36	the	the	DET
fnp-3166	121	37	lesions	lesion	NOUN
fnp-3166	121	38	.	.	PUNCT
fnp-3166	122	1	in	in	ADP
fnp-3166	122	2	active	active	ADJ
fnp-3166	122	3	lesions	lesion	NOUN
fnp-3166	122	4	,	,	PUNCT
fnp-3166	122	5	a	a	DET
fnp-3166	122	6	subset	subset	NOUN
fnp-3166	122	7	of	of	ADP
fnp-3166	122	8	cd8	cd8	PROPN
fnp-3166	122	9	+	+	PROPN
fnp-3166	122	10	cells	cell	NOUN
fnp-3166	122	11	show	show	VERB
fnp-3166	122	12	focally	focally	ADV
fnp-3166	122	13	and	and	CCONJ
fnp-3166	122	14	temporally	temporally	ADV
fnp-3166	122	15	restricted	restricted	ADJ
fnp-3166	122	16	activation	activation	NOUN
fnp-3166	122	17	,	,	PUNCT
fnp-3166	122	18	and	and	CCONJ
fnp-3166	122	19	b	b	X
fnp-3166	122	20	-	-	PUNCT
fnp-3166	122	21	cells	cell	NOUN
fnp-3166	122	22	are	be	AUX
fnp-3166	122	23	much	much	ADV
fnp-3166	122	24	more	more	ADV
fnp-3166	122	25	numerous	numerous	ADJ
fnp-3166	122	26	in	in	ADP
fnp-3166	122	27	early	early	ADJ
fnp-3166	122	28	stages	stage	NOUN
fnp-3166	122	29	of	of	ADP
fnp-3166	122	30	the	the	DET
fnp-3166	122	31	disease	disease	NOUN
fnp-3166	122	32	and	and	CCONJ
fnp-3166	122	33	in	in	ADP
fnp-3166	122	34	active	active	ADJ
fnp-3166	122	35	lesions	lesion	NOUN
fnp-3166	122	36	than	than	ADP
fnp-3166	122	37	in	in	ADP
fnp-3166	122	38	inactive	inactive	ADJ
fnp-3166	122	39	lesions	lesion	NOUN
fnp-3166	122	40	at	at	ADP
fnp-3166	122	41	late	late	ADJ
fnp-3166	122	42	stages	stage	NOUN
fnp-3166	122	43	(	(	PUNCT
fnp-3166	122	44	machado	machado	PROPN
fnp-3166	122	45	santos	santos	PROPN
fnp-3166	122	46	et	et	PROPN
fnp-3166	122	47	al	al	PROPN
fnp-3166	122	48	.	.	PROPN
fnp-3166	122	49	2018	2018	NUM
fnp-3166	122	50	)	)	PUNCT
fnp-3166	122	51	.	.	PUNCT
fnp-3166	123	1	in	in	ADP
fnp-3166	123	2	a	a	DET
fnp-3166	123	3	recent	recent	ADJ
fnp-3166	123	4	study	study	NOUN
fnp-3166	123	5	,	,	PUNCT
fnp-3166	123	6	imaging	imaging	NOUN
fnp-3166	123	7	mass	mass	NOUN
fnp-3166	123	8	cytometry	cytometry	NOUN
fnp-3166	123	9	was	be	AUX
fnp-3166	123	10	applied	apply	VERB
fnp-3166	123	11	to	to	ADP
fnp-3166	123	12	the	the	DET
fnp-3166	123	13	biopsy	biopsy	NOUN
fnp-3166	123	14	tissue	tissue	NOUN
fnp-3166	123	15	of	of	ADP
fnp-3166	123	16	a	a	DET
fnp-3166	123	17	single	single	ADJ
fnp-3166	123	18	ms	ms	NOUN
fnp-3166	123	19	patient	patient	NOUN
fnp-3166	123	20	who	who	PRON
fnp-3166	123	21	suffered	suffer	VERB
fnp-3166	123	22	from	from	ADP
fnp-3166	123	23	a	a	DET
fnp-3166	123	24	rebound	rebound	NOUN
fnp-3166	123	25	exacerbation	exacerbation	NOUN
fnp-3166	123	26	after	after	ADP
fnp-3166	123	27	cessation	cessation	NOUN
fnp-3166	123	28	of	of	ADP
fnp-3166	123	29	natalizumab	natalizumab	NOUN
fnp-3166	123	30	treatment	treatment	NOUN
fnp-3166	123	31	(	(	PUNCT
fnp-3166	123	32	ramaglia	ramaglia	X
fnp-3166	123	33	et	et	PROPN
fnp-3166	123	34	al	al	PROPN
fnp-3166	123	35	.	.	PROPN
fnp-3166	123	36	2019	2019	NUM
fnp-3166	123	37	)	)	PUNCT
fnp-3166	123	38	.	.	PUNCT
fnp-3166	124	1	also	also	ADV
fnp-3166	124	2	,	,	PUNCT
fnp-3166	124	3	in	in	ADP
fnp-3166	124	4	this	this	DET
fnp-3166	124	5	study	study	NOUN
fnp-3166	124	6	,	,	PUNCT
fnp-3166	124	7	the	the	DET
fnp-3166	124	8	infiltrates	infiltrate	NOUN
fnp-3166	124	9	contained	contain	VERB
fnp-3166	124	10	t	t	NOUN
fnp-3166	124	11	-	-	PUNCT
fnp-3166	124	12	cells	cell	NOUN
fnp-3166	124	13	and	and	CCONJ
fnp-3166	124	14	b	b	NOUN
fnp-3166	124	15	-	-	PUNCT
fnp-3166	124	16	cells	cell	NOUN
fnp-3166	124	17	,	,	PUNCT
fnp-3166	124	18	but	but	CCONJ
fnp-3166	124	19	the	the	DET
fnp-3166	124	20	relative	relative	ADJ
fnp-3166	124	21	proportion	proportion	NOUN
fnp-3166	124	22	of	of	ADP
fnp-3166	124	23	cd4	cd4	PROPN
fnp-3166	124	24	+	+	PROPN
fnp-3166	124	25	t	t	PROPN
fnp-3166	124	26	-	-	PUNCT
fnp-3166	124	27	cells	cell	NOUN
fnp-3166	124	28	was	be	AUX
fnp-3166	124	29	higher	high	ADJ
fnp-3166	124	30	compared	compare	VERB
fnp-3166	124	31	to	to	ADP
fnp-3166	124	32	that	that	PRON
fnp-3166	124	33	seen	see	VERB
fnp-3166	124	34	in	in	ADP
fnp-3166	124	35	the	the	DET
fnp-3166	124	36	previous	previous	ADJ
fnp-3166	124	37	studies	study	NOUN
fnp-3166	124	38	.	.	PUNCT
fnp-3166	125	1	however	however	ADV
fnp-3166	125	2	,	,	PUNCT
fnp-3166	125	3	activation	activation	NOUN
fnp-3166	125	4	of	of	ADP
fnp-3166	125	5	t	t	PROPN
fnp-3166	125	6	-	-	PUNCT
fnp-3166	125	7	cells	cell	NOUN
fnp-3166	125	8	,	,	PUNCT
fnp-3166	125	9	visualized	visualize	VERB
fnp-3166	125	10	by	by	ADP
fnp-3166	125	11	the	the	DET
fnp-3166	125	12	expression	expression	NOUN
fnp-3166	125	13	of	of	ADP
fnp-3166	125	14	the	the	DET
fnp-3166	125	15	transcription	transcription	NOUN
fnp-3166	125	16	factor	factor	NOUN
fnp-3166	125	17	nfat	nfat	NOUN
fnp-3166	125	18	or	or	CCONJ
fnp-3166	125	19	proliferation	proliferation	NOUN
fnp-3166	125	20	markers	marker	NOUN
fnp-3166	125	21	,	,	PUNCT
fnp-3166	125	22	was	be	AUX
fnp-3166	125	23	seen	see	VERB
fnp-3166	125	24	only	only	ADV
fnp-3166	125	25	in	in	ADP
fnp-3166	125	26	cd8	cd8	PROPN
fnp-3166	125	27	+	+	PROPN
fnp-3166	125	28	t	t	PROPN
fnp-3166	125	29	-	-	PUNCT
fnp-3166	125	30	cells	cell	NOUN
fnp-3166	125	31	.	.	PUNCT
fnp-3166	126	1	besides	besides	SCONJ
fnp-3166	126	2	their	their	PRON
fnp-3166	126	3	absolute	absolute	ADJ
fnp-3166	126	4	numbers	number	NOUN
fnp-3166	126	5	,	,	PUNCT
fnp-3166	126	6	the	the	DET
fnp-3166	126	7	activation	activation	NOUN
fnp-3166	126	8	state	state	NOUN
fnp-3166	126	9	of	of	ADP
fnp-3166	126	10	leukocytes	leukocyte	NOUN
fnp-3166	126	11	is	be	AUX
fnp-3166	126	12	relevant	relevant	ADJ
fnp-3166	126	13	for	for	ADP
fnp-3166	126	14	driving	drive	VERB
fnp-3166	126	15	the	the	DET
fnp-3166	126	16	inflammatory	inflammatory	ADJ
fnp-3166	126	17	reaction	reaction	NOUN
fnp-3166	126	18	.	.	PUNCT
fnp-3166	127	1	similarly	similarly	ADV
fnp-3166	127	2	as	as	ADP
fnp-3166	127	3	before	before	ADV
fnp-3166	127	4	(	(	PUNCT
fnp-3166	127	5	machado	machado	PROPN
fnp-3166	127	6	santos	santos	PROPN
fnp-3166	127	7	et	et	PROPN
fnp-3166	127	8	al	al	PROPN
fnp-3166	127	9	.	.	PROPN
fnp-3166	127	10	2018	2018	NUM
fnp-3166	127	11	)	)	PUNCT
fnp-3166	127	12	,	,	PUNCT
fnp-3166	127	13	the	the	DET
fnp-3166	127	14	most	most	ADV
fnp-3166	127	15	frequent	frequent	ADJ
fnp-3166	127	16	b	b	NOUN
fnp-3166	127	17	-	-	PUNCT
fnp-3166	127	18	cell	cell	NOUN
fnp-3166	127	19	phenotypes	phenotype	NOUN
fnp-3166	127	20	were	be	AUX
fnp-3166	127	21	igg+	igg+	ADP
fnp-3166	127	22	cd38	cd38	PROPN
fnp-3166	127	23	+	+	PART
fnp-3166	127	24	plasmablasts	plasmablast	NOUN
fnp-3166	127	25	.	.	PUNCT
fnp-3166	128	1	thus	thus	ADV
fnp-3166	128	2	,	,	PUNCT
fnp-3166	128	3	overall	overall	ADV
fnp-3166	128	4	,	,	PUNCT
fnp-3166	128	5	the	the	DET
fnp-3166	128	6	pathological	pathological	ADJ
fnp-3166	128	7	data	datum	NOUN
fnp-3166	128	8	are	be	AUX
fnp-3166	128	9	in	in	ADP
fnp-3166	128	10	line	line	NOUN
fnp-3166	128	11	with	with	ADP
fnp-3166	128	12	the	the	DET
fnp-3166	128	13	observed	observe	VERB
fnp-3166	128	14	effects	effect	NOUN
fnp-3166	128	15	of	of	ADP
fnp-3166	128	16	anti	anti	ADJ
fnp-3166	128	17	-	-	ADJ
fnp-3166	128	18	inflammatory	inflammatory	ADJ
fnp-3166	128	19	treatments	treatment	NOUN
fnp-3166	128	20	in	in	ADP
fnp-3166	128	21	ms	ms	ADJ
fnp-3166	128	22	patients	patient	NOUN
fnp-3166	128	23	.	.	PUNCT
fnp-3166	129	1	6	6	X
fnp-3166	129	2	)	)	PUNCT
fnp-3166	129	3	what	what	PRON
fnp-3166	129	4	do	do	AUX
fnp-3166	129	5	the	the	DET
fnp-3166	129	6	inflammatory	inflammatory	ADJ
fnp-3166	129	7	cells	cell	NOUN
fnp-3166	129	8	in	in	ADP
fnp-3166	129	9	ms	ms	PROPN
fnp-3166	129	10	lesions	lesion	NOUN
fnp-3166	129	11	recognize	recognize	VERB
fnp-3166	129	12	?	?	PUNCT
fnp-3166	130	1	an	an	DET
fnp-3166	130	2	important	important	ADJ
fnp-3166	130	3	open	open	ADJ
fnp-3166	130	4	question	question	NOUN
fnp-3166	130	5	is	be	AUX
fnp-3166	130	6	what	what	PRON
fnp-3166	130	7	antigen	antigen	ADJ
fnp-3166	130	8	is	be	AUX
fnp-3166	130	9	recognized	recognize	VERB
fnp-3166	130	10	by	by	ADP
fnp-3166	130	11	the	the	DET
fnp-3166	130	12	cd8	cd8	PROPN
fnp-3166	130	13	+	+	CCONJ
fnp-3166	130	14	tissue	tissue	NOUN
fnp-3166	130	15	resident	resident	NOUN
fnp-3166	130	16	memory	memory	NOUN
fnp-3166	130	17	t	t	PROPN
fnp-3166	130	18	-	-	PUNCT
fnp-3166	130	19	cells	cell	NOUN
fnp-3166	130	20	.	.	PUNCT
fnp-3166	131	1	since	since	SCONJ
fnp-3166	131	2	such	such	ADJ
fnp-3166	131	3	t	t	NOUN
fnp-3166	131	4	-	-	PUNCT
fnp-3166	131	5	cells	cell	NOUN
fnp-3166	131	6	acquire	acquire	VERB
fnp-3166	131	7	their	their	PRON
fnp-3166	131	8	phenotype	phenotype	NOUN
fnp-3166	131	9	and	and	CCONJ
fnp-3166	131	10	persist	persist	VERB
fnp-3166	131	11	after	after	ADP
fnp-3166	131	12	effective	effective	ADJ
fnp-3166	131	13	clearance	clearance	NOUN
fnp-3166	131	14	of	of	ADP
fnp-3166	131	15	their	their	PRON
fnp-3166	131	16	cognate	cognate	NOUN
fnp-3166	131	17	antigen	antigen	NOUN
fnp-3166	131	18	and	and	CCONJ
fnp-3166	131	19	become	become	VERB
fnp-3166	131	20	reactivated	reactivate	VERB
fnp-3166	131	21	when	when	SCONJ
fnp-3166	131	22	the	the	DET
fnp-3166	131	23	antigen	antigen	NOUN
fnp-3166	131	24	re	re	VERB
fnp-3166	131	25	-	-	NOUN
fnp-3166	131	26	appears	appear	VERB
fnp-3166	131	27	,	,	PUNCT
fnp-3166	131	28	it	it	PRON
fnp-3166	131	29	is	be	AUX
fnp-3166	131	30	unlikely	unlikely	ADJ
fnp-3166	131	31	that	that	SCONJ
fnp-3166	131	32	these	these	DET
fnp-3166	131	33	cells	cell	NOUN
fnp-3166	131	34	recognize	recognize	VERB
fnp-3166	131	35	a	a	DET
fnp-3166	131	36	classical	classical	ADJ
fnp-3166	131	37	auto	auto	NOUN
fnp-3166	131	38	-	-	PUNCT
fnp-3166	131	39	antigen	antigen	NOUN
fnp-3166	131	40	,	,	PUNCT
fnp-3166	131	41	which	which	PRON
fnp-3166	131	42	is	be	AUX
fnp-3166	131	43	present	present	ADJ
fnp-3166	131	44	in	in	ADP
fnp-3166	131	45	the	the	DET
fnp-3166	131	46	cns	cns	NOUN
fnp-3166	131	47	in	in	ADP
fnp-3166	131	48	excess	excess	NOUN
fnp-3166	131	49	all	all	DET
fnp-3166	131	50	the	the	DET
fnp-3166	131	51	time	time	NOUN
fnp-3166	131	52	.	.	PUNCT
fnp-3166	132	1	in	in	ADP
fnp-3166	132	2	line	line	NOUN
fnp-3166	132	3	with	with	ADP
fnp-3166	132	4	this	this	DET
fnp-3166	132	5	view	view	NOUN
fnp-3166	132	6	,	,	PUNCT
fnp-3166	132	7	no	no	DET
fnp-3166	132	8	reactivity	reactivity	NOUN
fnp-3166	132	9	of	of	ADP
fnp-3166	132	10	cd8	cd8	PROPN
fnp-3166	132	11	+	+	PROPN
fnp-3166	132	12	t	t	PROPN
fnp-3166	132	13	-	-	PUNCT
fnp-3166	132	14	cells	cell	NOUN
fnp-3166	132	15	from	from	ADP
fnp-3166	132	16	ms	ms	ADJ
fnp-3166	132	17	brain	brain	NOUN
fnp-3166	132	18	lesions	lesion	NOUN
fnp-3166	132	19	has	have	AUX
fnp-3166	132	20	been	be	AUX
fnp-3166	132	21	seen	see	VERB
fnp-3166	132	22	against	against	ADP
fnp-3166	132	23	the	the	DET
fnp-3166	132	24	commonly	commonly	ADV
fnp-3166	132	25	tested	test	VERB
fnp-3166	132	26	myelin	myelin	NOUN
fnp-3166	132	27	antigens	antigen	NOUN
fnp-3166	132	28	(	(	PUNCT
fnp-3166	132	29	van	van	PROPN
fnp-3166	132	30	nierop	nierop	PROPN
fnp-3166	132	31	et	et	PROPN
fnp-3166	132	32	al	al	PROPN
fnp-3166	132	33	.	.	PROPN
fnp-3166	132	34	2017	2017	NUM
fnp-3166	132	35	)	)	PUNCT
fnp-3166	132	36	.	.	PUNCT
fnp-3166	133	1	several	several	ADJ
fnp-3166	133	2	potential	potential	ADJ
fnp-3166	133	3	candidate	candidate	NOUN
fnp-3166	133	4	antigens	antigen	NOUN
fnp-3166	133	5	have	have	AUX
fnp-3166	133	6	recently	recently	ADV
fnp-3166	133	7	been	be	AUX
fnp-3166	133	8	identified	identify	VERB
fnp-3166	133	9	.	.	PUNCT
fnp-3166	134	1	since	since	SCONJ
fnp-3166	134	2	accumulating	accumulate	VERB
fnp-3166	134	3	epidemiological	epidemiological	ADJ
fnp-3166	134	4	evidence	evidence	NOUN
fnp-3166	134	5	associates	associates	PROPN
fnp-3166	134	6	epstein	epstein	PROPN
fnp-3166	134	7	barr	barr	PROPN
fnp-3166	134	8	virus	virus	PROPN
fnp-3166	134	9	infection	infection	NOUN
fnp-3166	134	10	with	with	ADP
fnp-3166	134	11	ms	ms	PROPN
fnp-3166	134	12	(	(	PUNCT
fnp-3166	134	13	bar	bar	NOUN
fnp-3166	134	14	-	-	PUNCT
fnp-3166	134	15	or	or	CCONJ
fnp-3166	134	16	et	et	NOUN
fnp-3166	134	17	al	al	PROPN
fnp-3166	134	18	.	.	PROPN
fnp-3166	134	19	2020	2020	NUM
fnp-3166	134	20	,	,	PUNCT
fnp-3166	134	21	levin	levin	PROPN
fnp-3166	134	22	et	et	PROPN
fnp-3166	134	23	al	al	PROPN
fnp-3166	134	24	.	.	PROPN
fnp-3166	134	25	2010	2010	NUM
fnp-3166	134	26	)	)	PUNCT
fnp-3166	134	27	,	,	PUNCT
fnp-3166	134	28	one	one	NUM
fnp-3166	134	29	hypothesis	hypothesis	NOUN
fnp-3166	134	30	is	be	AUX
fnp-3166	134	31	that	that	PRON
fnp-3166	134	32	b	b	X
fnp-3166	134	33	-	-	PUNCT
fnp-3166	134	34	cells	cell	NOUN
fnp-3166	134	35	with	with	ADP
fnp-3166	134	36	latent	latent	NOUN
fnp-3166	134	37	ebv	ebv	NOUN
fnp-3166	134	38	infection	infection	NOUN
fnp-3166	134	39	are	be	AUX
fnp-3166	134	40	present	present	ADJ
fnp-3166	134	41	within	within	ADP
fnp-3166	134	42	the	the	DET
fnp-3166	134	43	cns	cns	NOUN
fnp-3166	134	44	of	of	ADP
fnp-3166	134	45	ms	ms	PROPN
fnp-3166	134	46	patients	patient	NOUN
fnp-3166	134	47	(	(	PUNCT
fnp-3166	134	48	serafini	serafini	NOUN
fnp-3166	134	49	et	et	PROPN
fnp-3166	134	50	al	al	PROPN
fnp-3166	134	51	.	.	PROPN
fnp-3166	134	52	2007	2007	NUM
fnp-3166	134	53	,	,	PUNCT
fnp-3166	134	54	veroni	veroni	NOUN
fnp-3166	134	55	et	et	PROPN
fnp-3166	134	56	al	al	PROPN
fnp-3166	134	57	.	.	PROPN
fnp-3166	134	58	2018	2018	NUM
fnp-3166	134	59	)	)	PUNCT
fnp-3166	134	60	together	together	ADV
fnp-3166	134	61	with	with	ADP
fnp-3166	134	62	ebv	ebv	NOUN
fnp-3166	134	63	-	-	PUNCT
fnp-3166	134	64	reactive	reactive	ADJ
fnp-3166	134	65	cd8	cd8	PROPN
fnp-3166	134	66	+	+	CCONJ
fnp-3166	134	67	tissue	tissue	NOUN
fnp-3166	134	68	resident	resident	NOUN
fnp-3166	134	69	effector	effector	NOUN
fnp-3166	134	70	memory	memory	NOUN
fnp-3166	134	71	t	t	PROPN
fnp-3166	134	72	-	-	PUNCT
fnp-3166	134	73	cells	cell	NOUN
fnp-3166	134	74	(	(	PUNCT
fnp-3166	134	75	serafini	serafini	NOUN
fnp-3166	134	76	et	et	PROPN
fnp-3166	134	77	al	al	PROPN
fnp-3166	134	78	.	.	PROPN
fnp-3166	134	79	2020	2020	NUM
fnp-3166	134	80	)	)	PUNCT
fnp-3166	134	81	.	.	PUNCT
fnp-3166	135	1	here	here	ADV
fnp-3166	135	2	,	,	PUNCT
fnp-3166	135	3	the	the	DET
fnp-3166	135	4	hypothesis	hypothesis	NOUN
fnp-3166	135	5	is	be	AUX
fnp-3166	135	6	that	that	PRON
fnp-3166	135	7	inflammatory	inflammatory	ADJ
fnp-3166	135	8	activity	activity	NOUN
fnp-3166	135	9	is	be	AUX
fnp-3166	135	10	triggered	trigger	VERB
fnp-3166	135	11	and	and	CCONJ
fnp-3166	135	12	propagated	propagate	VERB
fnp-3166	135	13	when	when	SCONJ
fnp-3166	135	14	the	the	DET
fnp-3166	135	15	virus	virus	NOUN
fnp-3166	135	16	is	be	AUX
fnp-3166	135	17	activated	activate	VERB
fnp-3166	135	18	in	in	ADP
fnp-3166	135	19	latently	latently	ADV
fnp-3166	135	20	infected	infect	VERB
fnp-3166	135	21	cells	cell	NOUN
fnp-3166	135	22	and	and	CCONJ
fnp-3166	135	23	recognized	recognize	VERB
fnp-3166	135	24	by	by	ADP
fnp-3166	135	25	the	the	DET
fnp-3166	135	26	specific	specific	ADJ
fnp-3166	135	27	t	t	PROPN
fnp-3166	135	28	-	-	PUNCT
fnp-3166	135	29	cells	cell	NOUN
fnp-3166	135	30	(	(	PUNCT
fnp-3166	135	31	serafini	serafini	NOUN
fnp-3166	135	32	et	et	PROPN
fnp-3166	135	33	al	al	PROPN
fnp-3166	135	34	.	.	PROPN
fnp-3166	135	35	2020	2020	NUM
fnp-3166	135	36	)	)	PUNCT
fnp-3166	135	37	.	.	PUNCT
fnp-3166	136	1	as	as	ADP
fnp-3166	136	2	a	a	DET
fnp-3166	136	3	note	note	NOUN
fnp-3166	136	4	of	of	ADP
fnp-3166	136	5	caution	caution	NOUN
fnp-3166	136	6	,	,	PUNCT
fnp-3166	136	7	several	several	ADJ
fnp-3166	136	8	other	other	ADJ
fnp-3166	136	9	groups	group	NOUN
fnp-3166	136	10	have	have	AUX
fnp-3166	136	11	tried	try	VERB
fnp-3166	136	12	to	to	PART
fnp-3166	136	13	confirm	confirm	VERB
fnp-3166	136	14	the	the	DET
fnp-3166	136	15	specific	specific	ADJ
fnp-3166	136	16	presence	presence	NOUN
fnp-3166	136	17	of	of	ADP
fnp-3166	136	18	ebv	ebv	NOUN
fnp-3166	136	19	infected	infect	VERB
fnp-3166	136	20	b	b	NOUN
fnp-3166	136	21	-	-	NOUN
fnp-3166	136	22	cells	cell	NOUN
fnp-3166	136	23	in	in	ADP
fnp-3166	136	24	the	the	DET
fnp-3166	136	25	ms	ms	PROPN
fnp-3166	136	26	brain	brain	NOUN
fnp-3166	136	27	and	and	CCONJ
fnp-3166	136	28	lesions	lesion	NOUN
fnp-3166	136	29	and	and	CCONJ
fnp-3166	136	30	have	have	AUX
fnp-3166	136	31	failed	fail	VERB
fnp-3166	136	32	(	(	PUNCT
fnp-3166	136	33	lassmann	lassmann	PROPN
fnp-3166	136	34	et	et	PROPN
fnp-3166	136	35	al	al	PROPN
fnp-3166	136	36	.	.	PROPN
fnp-3166	136	37	2010	2010	NUM
fnp-3166	136	38	,	,	PUNCT
fnp-3166	136	39	van	van	PROPN
fnp-3166	136	40	nierop	nierop	PROPN
fnp-3166	136	41	et	et	PROPN
fnp-3166	136	42	al	al	PROPN
fnp-3166	136	43	.	.	PROPN
fnp-3166	136	44	2017	2017	NUM
fnp-3166	136	45	)	)	PUNCT
fnp-3166	136	46	.	.	PUNCT
fnp-3166	137	1	the	the	DET
fnp-3166	137	2	reason	reason	NOUN
fnp-3166	137	3	for	for	ADP
fnp-3166	137	4	these	these	DET
fnp-3166	137	5	discrepancies	discrepancy	NOUN
fnp-3166	137	6	is	be	AUX
fnp-3166	137	7	still	still	ADV
fnp-3166	137	8	unresolved	unresolved	ADJ
fnp-3166	137	9	.	.	PUNCT
fnp-3166	138	1	in	in	ADP
fnp-3166	138	2	a	a	DET
fnp-3166	138	3	similar	similar	ADJ
fnp-3166	138	4	approach	approach	NOUN
fnp-3166	138	5	,	,	PUNCT
fnp-3166	138	6	an	an	DET
fnp-3166	138	7	interaction	interaction	NOUN
fnp-3166	138	8	between	between	ADP
fnp-3166	138	9	brain	brain	NOUN
fnp-3166	138	10	resident	resident	NOUN
fnp-3166	138	11	cd8	cd8	PROPN
fnp-3166	138	12	+	+	PROPN
fnp-3166	138	13	cells	cell	NOUN
fnp-3166	138	14	and	and	CCONJ
fnp-3166	138	15	b	b	X
fnp-3166	138	16	-	-	PUNCT
fnp-3166	138	17	cells	cell	NOUN
fnp-3166	138	18	has	have	AUX
fnp-3166	138	19	been	be	AUX
fnp-3166	138	20	described	describe	VERB
fnp-3166	138	21	,	,	PUNCT
fnp-3166	138	22	where	where	SCONJ
fnp-3166	138	23	the	the	DET
fnp-3166	138	24	b	b	NOUN
fnp-3166	138	25	-	-	PUNCT
fnp-3166	138	26	cells	cell	NOUN
fnp-3166	138	27	did	do	AUX
fnp-3166	138	28	not	not	PART
fnp-3166	138	29	express	express	VERB
fnp-3166	138	30	ebv	ebv	NOUN
fnp-3166	138	31	(	(	PUNCT
fnp-3166	138	32	van	van	PROPN
fnp-3166	138	33	nierop	nierop	PROPN
fnp-3166	138	34	et	et	PROPN
fnp-3166	138	35	al	al	PROPN
fnp-3166	138	36	.	.	PROPN
fnp-3166	138	37	2017	2017	NUM
fnp-3166	138	38	)	)	PUNCT
fnp-3166	138	39	.	.	PUNCT
fnp-3166	139	1	this	this	PRON
fnp-3166	139	2	suggests	suggest	VERB
fnp-3166	139	3	that	that	SCONJ
fnp-3166	139	4	the	the	DET
fnp-3166	139	5	cells	cell	NOUN
fnp-3166	139	6	recognize	recognize	VERB
fnp-3166	139	7	a	a	DET
fnp-3166	139	8	b	b	NOUN
fnp-3166	139	9	-	-	PUNCT
fnp-3166	139	10	cell	cell	NOUN
fnp-3166	139	11	autoantigen	autoantigen	NOUN
fnp-3166	139	12	.	.	PUNCT
fnp-3166	140	1	a	a	DET
fnp-3166	140	2	possible	possible	ADJ
fnp-3166	140	3	mechanism	mechanism	NOUN
fnp-3166	140	4	for	for	ADP
fnp-3166	140	5	how	how	SCONJ
fnp-3166	140	6	such	such	ADJ
fnp-3166	140	7	autoimmunity	autoimmunity	NOUN
fnp-3166	140	8	against	against	ADP
fnp-3166	140	9	b	b	NOUN
fnp-3166	140	10	-	-	PUNCT
fnp-3166	140	11	cells	cell	NOUN
fnp-3166	140	12	may	may	AUX
fnp-3166	140	13	be	be	AUX
fnp-3166	140	14	induced	induce	VERB
fnp-3166	140	15	is	be	AUX
fnp-3166	140	16	provided	provide	VERB
fnp-3166	140	17	by	by	ADP
fnp-3166	140	18	jelcic	jelcic	PROPN
fnp-3166	140	19	et	et	PROPN
fnp-3166	140	20	al	al	PROPN
fnp-3166	140	21	.	.	PROPN
fnp-3166	141	1	(	(	PUNCT
fnp-3166	141	2	2018	2018	NUM
fnp-3166	141	3	)	)	PUNCT
fnp-3166	141	4	.	.	PUNCT
fnp-3166	142	1	ms	ms	PROPN
fnp-3166	142	2	b	b	PROPN
fnp-3166	142	3	-	-	PUNCT
fnp-3166	142	4	cells	cell	NOUN
fnp-3166	142	5	,	,	PUNCT
fnp-3166	142	6	possibly	possibly	ADV
fnp-3166	142	7	in	in	ADP
fnp-3166	142	8	relation	relation	NOUN
fnp-3166	142	9	to	to	ADP
fnp-3166	142	10	their	their	PRON
fnp-3166	142	11	ebv	ebv	NOUN
fnp-3166	142	12	infection	infection	NOUN
fnp-3166	142	13	status	status	NOUN
fnp-3166	142	14	,	,	PUNCT
fnp-3166	142	15	expand	expand	VERB
fnp-3166	142	16	by	by	ADP
fnp-3166	142	17	auto	auto	NOUN
fnp-3166	142	18	-	-	PUNCT
fnp-3166	142	19	proliferation	proliferation	NOUN
fnp-3166	142	20	and	and	CCONJ
fnp-3166	142	21	present	present	VERB
fnp-3166	142	22	a	a	DET
fnp-3166	142	23	b	b	NOUN
fnp-3166	142	24	-	-	PUNCT
fnp-3166	142	25	cell	cell	NOUN
fnp-3166	142	26	specific	specific	ADJ
fnp-3166	142	27	auto	auto	NOUN
fnp-3166	142	28	-	-	PUNCT
fnp-3166	142	29	antigen	antigen	NOUN
fnp-3166	142	30	to	to	ADP
fnp-3166	142	31	cd4	cd4	PROPN
fnp-3166	142	32	+	+	PROPN
fnp-3166	142	33	t	t	PROPN
fnp-3166	142	34	-	-	PUNCT
fnp-3166	142	35	cells	cell	NOUN
fnp-3166	142	36	,	,	PUNCT
fnp-3166	142	37	which	which	PRON
fnp-3166	142	38	also	also	ADV
fnp-3166	142	39	expand	expand	VERB
fnp-3166	142	40	and	and	CCONJ
fnp-3166	142	41	infiltrate	infiltrate	VERB
fnp-3166	142	42	the	the	DET
fnp-3166	142	43	brain	brain	NOUN
fnp-3166	142	44	and	and	CCONJ
fnp-3166	142	45	spinal	spinal	ADJ
fnp-3166	142	46	cord	cord	NOUN
fnp-3166	142	47	.	.	PUNCT
fnp-3166	143	1	within	within	ADP
fnp-3166	143	2	the	the	DET
fnp-3166	143	3	cns	cns	NOUN
fnp-3166	143	4	,	,	PUNCT
fnp-3166	143	5	these	these	DET
fnp-3166	143	6	t	t	NOUN
fnp-3166	143	7	-	-	PUNCT
fnp-3166	143	8	cells	cell	NOUN
fnp-3166	143	9	are	be	AUX
fnp-3166	143	10	activated	activate	VERB
fnp-3166	143	11	by	by	ADP
fnp-3166	143	12	antigen	antigen	ADJ
fnp-3166	143	13	recognition	recognition	NOUN
fnp-3166	143	14	on	on	ADP
fnp-3166	143	15	infiltrating	infiltrate	VERB
fnp-3166	143	16	b	b	NOUN
fnp-3166	143	17	-	-	PUNCT
fnp-3166	143	18	cells	cell	NOUN
fnp-3166	143	19	.	.	PUNCT
fnp-3166	144	1	in	in	ADP
fnp-3166	144	2	addition	addition	NOUN
fnp-3166	144	3	,	,	PUNCT
fnp-3166	144	4	the	the	DET
fnp-3166	144	5	respective	respective	ADJ
fnp-3166	144	6	auto	auto	NOUN
fnp-3166	144	7	-	-	PUNCT
fnp-3166	144	8	antigen	antigen	NOUN
fnp-3166	144	9	(	(	PUNCT
fnp-3166	144	10	rasgrp2	rasgrp2	PROPN
fnp-3166	144	11	)	)	PUNCT
fnp-3166	144	12	is	be	AUX
fnp-3166	144	13	also	also	ADV
fnp-3166	144	14	expressed	express	VERB
fnp-3166	144	15	in	in	ADP
fnp-3166	144	16	neurons	neuron	NOUN
fnp-3166	144	17	,	,	PUNCT
fnp-3166	144	18	which	which	PRON
fnp-3166	144	19	may	may	AUX
fnp-3166	144	20	further	far	ADV
fnp-3166	144	21	propagate	propagate	VERB
fnp-3166	144	22	inflammation	inflammation	NOUN
fnp-3166	144	23	and	and	CCONJ
fnp-3166	144	24	tissue	tissue	NOUN
fnp-3166	144	25	injury	injury	NOUN
fnp-3166	144	26	.	.	PUNCT
fnp-3166	145	1	whether	whether	SCONJ
fnp-3166	145	2	this	this	DET
fnp-3166	145	3	mechanism	mechanism	NOUN
fnp-3166	145	4	also	also	ADV
fnp-3166	145	5	accounts	account	VERB
fnp-3166	145	6	for	for	ADP
fnp-3166	145	7	activation	activation	NOUN
fnp-3166	145	8	of	of	ADP
fnp-3166	145	9	cd8	cd8	PROPN
fnp-3166	145	10	+	+	PROPN
fnp-3166	145	11	t	t	PROPN
fnp-3166	145	12	-	-	PUNCT
fnp-3166	145	13	cells	cell	NOUN
fnp-3166	145	14	,	,	PUNCT
fnp-3166	145	15	the	the	DET
fnp-3166	145	16	dominant	dominant	ADJ
fnp-3166	145	17	inflammatory	inflammatory	ADJ
fnp-3166	145	18	cells	cell	NOUN
fnp-3166	145	19	in	in	ADP
fnp-3166	145	20	ms	ms	ADJ
fnp-3166	145	21	lesions	lesion	NOUN
fnp-3166	145	22	,	,	PUNCT
fnp-3166	145	23	is	be	AUX
fnp-3166	145	24	unknown	unknown	ADJ
fnp-3166	145	25	.	.	PUNCT
fnp-3166	146	1	a	a	DET
fnp-3166	146	2	different	different	ADJ
fnp-3166	146	3	approach	approach	NOUN
fnp-3166	146	4	has	have	AUX
fnp-3166	146	5	been	be	AUX
fnp-3166	146	6	followed	follow	VERB
fnp-3166	146	7	by	by	ADP
fnp-3166	146	8	konjevic	konjevic	ADJ
fnp-3166	146	9	sabolek	sabolek	PROPN
fnp-3166	146	10	et	et	PROPN
fnp-3166	146	11	al	al	PROPN
fnp-3166	146	12	.	.	PROPN
fnp-3166	147	1	(	(	PUNCT
fnp-3166	147	2	2019	2019	NUM
fnp-3166	147	3	)	)	PUNCT
fnp-3166	147	4	.	.	PUNCT
fnp-3166	148	1	in	in	ADP
fnp-3166	148	2	this	this	DET
fnp-3166	148	3	study	study	NOUN
fnp-3166	148	4	,	,	PUNCT
fnp-3166	148	5	the	the	DET
fnp-3166	148	6	interaction	interaction	NOUN
fnp-3166	148	7	of	of	ADP
fnp-3166	148	8	cd8	cd8	PROPN
fnp-3166	148	9	+	+	PROPN
fnp-3166	148	10	t	t	PROPN
fnp-3166	148	11	-	-	PUNCT
fnp-3166	148	12	cells	cell	NOUN
fnp-3166	148	13	with	with	ADP
fnp-3166	148	14	local	local	ADJ
fnp-3166	148	15	target	target	NOUN
fnp-3166	148	16	cells	cell	NOUN
fnp-3166	148	17	was	be	AUX
fnp-3166	148	18	identified	identify	VERB
fnp-3166	148	19	by	by	ADP
fnp-3166	148	20	the	the	DET
fnp-3166	148	21	polarized	polarize	VERB
fnp-3166	148	22	location	location	NOUN
fnp-3166	148	23	of	of	ADP
fnp-3166	148	24	cytotoxic	cytotoxic	ADJ
fnp-3166	148	25	granules	granule	NOUN
fnp-3166	148	26	at	at	ADP
fnp-3166	148	27	the	the	DET
fnp-3166	148	28	site	site	NOUN
fnp-3166	148	29	of	of	ADP
fnp-3166	148	30	contact	contact	NOUN
fnp-3166	148	31	.	.	PUNCT
fnp-3166	149	1	when	when	SCONJ
fnp-3166	149	2	this	this	PRON
fnp-3166	149	3	was	be	AUX
fnp-3166	149	4	seen	see	VERB
fnp-3166	149	5	,	,	PUNCT
fnp-3166	149	6	the	the	DET
fnp-3166	149	7	target	target	NOUN
fnp-3166	149	8	cell	cell	NOUN
fnp-3166	149	9	was	be	AUX
fnp-3166	149	10	isolated	isolate	VERB
fnp-3166	149	11	and	and	CCONJ
fnp-3166	149	12	its	its	PRON
fnp-3166	149	13	nature	nature	NOUN
fnp-3166	149	14	was	be	AUX
fnp-3166	149	15	determined	determine	VERB
fnp-3166	149	16	in	in	ADP
fnp-3166	149	17	gene	gene	NOUN
fnp-3166	149	18	expression	expression	NOUN
fnp-3166	149	19	studies	study	NOUN
fnp-3166	149	20	and	and	CCONJ
fnp-3166	149	21	by	by	ADP
fnp-3166	149	22	immunohistochemistry	immunohistochemistry	NOUN
fnp-3166	149	23	.	.	PUNCT
fnp-3166	150	1	in	in	ADP
fnp-3166	150	2	this	this	DET
fnp-3166	150	3	study	study	NOUN
fnp-3166	150	4	,	,	PUNCT
fnp-3166	150	5	the	the	DET
fnp-3166	150	6	only	only	ADJ
fnp-3166	150	7	cells	cell	NOUN
fnp-3166	150	8	which	which	PRON
fnp-3166	150	9	interacted	interact	VERB
fnp-3166	150	10	with	with	ADP
fnp-3166	150	11	cytotoxic	cytotoxic	ADJ
fnp-3166	150	12	cd8	cd8	PROPN
fnp-3166	150	13	+	+	PROPN
fnp-3166	150	14	t	t	PROPN
fnp-3166	150	15	-	-	PUNCT
fnp-3166	150	16	cells	cell	NOUN
fnp-3166	150	17	in	in	ADP
fnp-3166	150	18	ms	ms	ADJ
fnp-3166	150	19	lesions	lesion	NOUN
fnp-3166	150	20	were	be	AUX
fnp-3166	150	21	myeloid	myeloid	ADJ
fnp-3166	150	22	cells	cell	NOUN
fnp-3166	150	23	,	,	PUNCT
fnp-3166	150	24	expressing	express	VERB
fnp-3166	150	25	markers	marker	NOUN
fnp-3166	150	26	of	of	ADP
fnp-3166	150	27	macrophages	macrophage	NOUN
fnp-3166	150	28	and	and	CCONJ
fnp-3166	150	29	microglia	microglia	ADJ
fnp-3166	150	30	,	,	PUNCT
fnp-3166	150	31	suggesting	suggest	VERB
fnp-3166	150	32	these	these	PRON
fnp-3166	150	33	may	may	AUX
fnp-3166	150	34	harbor	harbor	VERB
fnp-3166	150	35	the	the	DET
fnp-3166	150	36	target	target	NOUN
fnp-3166	150	37	antigen(s	antigen(s	PROPN
fnp-3166	150	38	)	)	PUNCT
fnp-3166	150	39	.	.	PUNCT
fnp-3166	151	1	finally	finally	ADV
fnp-3166	151	2	,	,	PUNCT
fnp-3166	151	3	other	other	ADJ
fnp-3166	151	4	studies	study	NOUN
fnp-3166	151	5	suggest	suggest	VERB
fnp-3166	151	6	that	that	SCONJ
fnp-3166	151	7	the	the	DET
fnp-3166	151	8	target	target	NOUN
fnp-3166	151	9	antigen	antigen	NOUN
fnp-3166	151	10	recognized	recognize	VERB
fnp-3166	151	11	by	by	ADP
fnp-3166	151	12	t	t	PROPN
fnp-3166	151	13	-	-	PUNCT
fnp-3166	151	14	cells	cell	NOUN
fnp-3166	151	15	in	in	ADP
fnp-3166	151	16	ms	ms	ADJ
fnp-3166	151	17	lesions	lesion	NOUN
fnp-3166	151	18	may	may	AUX
fnp-3166	151	19	be	be	AUX
fnp-3166	151	20	the	the	DET
fnp-3166	151	21	stress	stress	NOUN
fnp-3166	151	22	protein	protein	NOUN
fnp-3166	151	23	alpha	alpha	NOUN
fnp-3166	151	24	b	b	PROPN
fnp-3166	151	25	crystallin	crystallin	PROPN
fnp-3166	151	26	,	,	PUNCT
fnp-3166	151	27	which	which	PRON
fnp-3166	151	28	is	be	AUX
fnp-3166	151	29	in	in	ADP
fnp-3166	151	30	ms	ms	ADJ
fnp-3166	151	31	lesions	lesion	NOUN
fnp-3166	151	32	most	most	ADV
fnp-3166	151	33	prominently	prominently	ADV
fnp-3166	151	34	expressed	express	VERB
fnp-3166	151	35	in	in	ADP
fnp-3166	151	36	active	active	ADJ
fnp-3166	151	37	lesions	lesion	NOUN
fnp-3166	151	38	(	(	PUNCT
fnp-3166	151	39	van	van	PROPN
fnp-3166	151	40	noort	noort	PROPN
fnp-3166	151	41	et	et	PROPN
fnp-3166	151	42	al	al	PROPN
fnp-3166	151	43	.	.	PROPN
fnp-3166	151	44	2010	2010	NUM
fnp-3166	151	45	)	)	PUNCT
fnp-3166	151	46	.	.	PUNCT
fnp-3166	152	1	in	in	ADP
fnp-3166	152	2	summary	summary	NOUN
fnp-3166	152	3	,	,	PUNCT
fnp-3166	152	4	the	the	DET
fnp-3166	152	5	new	new	ADJ
fnp-3166	152	6	data	datum	NOUN
fnp-3166	152	7	from	from	ADP
fnp-3166	152	8	systematic	systematic	ADJ
fnp-3166	152	9	phenotypical	phenotypical	ADJ
fnp-3166	152	10	and	and	CCONJ
fnp-3166	152	11	functional	functional	ADJ
fnp-3166	152	12	studies	study	NOUN
fnp-3166	152	13	on	on	ADP
fnp-3166	152	14	the	the	DET
fnp-3166	152	15	inflammatory	inflammatory	ADJ
fnp-3166	152	16	response	response	NOUN
fnp-3166	152	17	within	within	ADP
fnp-3166	152	18	ms	ms	ADJ
fnp-3166	152	19	lesions	lesion	NOUN
fnp-3166	152	20	provide	provide	VERB
fnp-3166	152	21	groundbreaking	groundbreake	VERB
fnp-3166	152	22	new	new	ADJ
fnp-3166	152	23	insights	insight	NOUN
fnp-3166	152	24	into	into	ADP
fnp-3166	152	25	the	the	DET
fnp-3166	152	26	pathophysiology	pathophysiology	NOUN
fnp-3166	152	27	of	of	ADP
fnp-3166	152	28	the	the	DET
fnp-3166	152	29	disease	disease	NOUN
fnp-3166	152	30	and	and	CCONJ
fnp-3166	152	31	question	question	VERB
fnp-3166	152	32	the	the	DET
fnp-3166	152	33	concept	concept	NOUN
fnp-3166	152	34	of	of	ADP
fnp-3166	152	35	ms	ms	PROPN
fnp-3166	152	36	being	be	AUX
fnp-3166	152	37	an	an	DET
fnp-3166	152	38	autoimmune	autoimmune	ADJ
fnp-3166	152	39	disease	disease	NOUN
fnp-3166	152	40	against	against	ADP
fnp-3166	152	41	myelin	myelin	NOUN
fnp-3166	152	42	.	.	PUNCT
fnp-3166	153	1	however	however	ADV
fnp-3166	153	2	,	,	PUNCT
fnp-3166	153	3	the	the	DET
fnp-3166	153	4	results	result	NOUN
fnp-3166	153	5	are	be	AUX
fnp-3166	153	6	in	in	ADP
fnp-3166	153	7	part	part	NOUN
fnp-3166	153	8	very	very	ADV
fnp-3166	153	9	divergent	divergent	ADJ
fnp-3166	153	10	and	and	CCONJ
fnp-3166	153	11	,	,	PUNCT
fnp-3166	153	12	to	to	ADP
fnp-3166	153	13	some	some	DET
fnp-3166	153	14	extent	extent	NOUN
fnp-3166	153	15	,	,	PUNCT
fnp-3166	153	16	contradicting	contradict	VERB
fnp-3166	153	17	.	.	PUNCT
fnp-3166	154	1	whether	whether	SCONJ
fnp-3166	154	2	this	this	PRON
fnp-3166	154	3	indicates	indicate	VERB
fnp-3166	154	4	heterogeneous	heterogeneous	ADJ
fnp-3166	154	5	disease	disease	NOUN
fnp-3166	154	6	mechanisms	mechanism	NOUN
fnp-3166	154	7	between	between	ADP
fnp-3166	154	8	individual	individual	ADJ
fnp-3166	154	9	patients	patient	NOUN
fnp-3166	154	10	or	or	CCONJ
fnp-3166	154	11	patient	patient	NOUN
fnp-3166	154	12	subgroups	subgroup	NOUN
fnp-3166	154	13	will	will	AUX
fnp-3166	154	14	be	be	AUX
fnp-3166	154	15	seen	see	VERB
fnp-3166	154	16	in	in	ADP
fnp-3166	154	17	the	the	DET
fnp-3166	154	18	future	future	NOUN
fnp-3166	154	19	.	.	PUNCT
fnp-3166	155	1	7	7	X
fnp-3166	155	2	)	)	PUNCT
fnp-3166	155	3	which	which	PRON
fnp-3166	155	4	microglia	microglia	ADJ
fnp-3166	155	5	or	or	CCONJ
fnp-3166	155	6	macrophage	macrophage	ADJ
fnp-3166	155	7	phenotypes	phenotype	NOUN
fnp-3166	155	8	are	be	AUX
fnp-3166	155	9	associated	associate	VERB
fnp-3166	155	10	with	with	ADP
fnp-3166	155	11	tissue	tissue	NOUN
fnp-3166	155	12	damage	damage	NOUN
fnp-3166	155	13	in	in	ADP
fnp-3166	155	14	the	the	DET
fnp-3166	155	15	brain	brain	NOUN
fnp-3166	155	16	?	?	PUNCT
fnp-3166	156	1	microglia	microglia	ADJ
fnp-3166	156	2	and	and	CCONJ
fnp-3166	156	3	recruited	recruit	VERB
fnp-3166	156	4	macrophages	macrophage	NOUN
fnp-3166	156	5	play	play	VERB
fnp-3166	156	6	a	a	DET
fnp-3166	156	7	major	major	ADJ
fnp-3166	156	8	role	role	NOUN
fnp-3166	156	9	in	in	ADP
fnp-3166	156	10	the	the	DET
fnp-3166	156	11	induction	induction	NOUN
fnp-3166	156	12	of	of	ADP
fnp-3166	156	13	tissue	tissue	NOUN
fnp-3166	156	14	injury	injury	NOUN
fnp-3166	156	15	,	,	PUNCT
fnp-3166	156	16	not	not	PART
fnp-3166	156	17	only	only	ADV
fnp-3166	156	18	in	in	ADP
fnp-3166	156	19	inflammatory	inflammatory	ADJ
fnp-3166	156	20	brain	brain	NOUN
fnp-3166	156	21	lesions	lesion	NOUN
fnp-3166	156	22	but	but	CCONJ
fnp-3166	156	23	also	also	ADV
fnp-3166	156	24	in	in	ADP
fnp-3166	156	25	neurodegenerative	neurodegenerative	ADJ
fnp-3166	156	26	diseases	disease	NOUN
fnp-3166	156	27	.	.	PUNCT
fnp-3166	157	1	for	for	ADP
fnp-3166	157	2	a	a	DET
fnp-3166	157	3	long	long	ADJ
fnp-3166	157	4	time	time	NOUN
fnp-3166	157	5	,	,	PUNCT
fnp-3166	157	6	it	it	PRON
fnp-3166	157	7	was	be	AUX
fnp-3166	157	8	difficult	difficult	ADJ
fnp-3166	157	9	to	to	PART
fnp-3166	157	10	distinguish	distinguish	VERB
fnp-3166	157	11	between	between	ADP
fnp-3166	157	12	activated	activate	VERB
fnp-3166	157	13	microglia	microglia	NOUN
fnp-3166	157	14	and	and	CCONJ
fnp-3166	157	15	recruited	recruit	VERB
fnp-3166	157	16	macrophages	macrophage	NOUN
fnp-3166	157	17	within	within	ADP
fnp-3166	157	18	brain	brain	NOUN
fnp-3166	157	19	lesions	lesion	NOUN
fnp-3166	157	20	.	.	PUNCT
fnp-3166	158	1	this	this	PRON
fnp-3166	158	2	has	have	AUX
fnp-3166	158	3	changed	change	VERB
fnp-3166	158	4	with	with	ADP
fnp-3166	158	5	the	the	DET
fnp-3166	158	6	introduction	introduction	NOUN
fnp-3166	158	7	of	of	ADP
fnp-3166	158	8	markers	marker	NOUN
fnp-3166	158	9	,	,	PUNCT
fnp-3166	158	10	which	which	PRON
fnp-3166	158	11	are	be	AUX
fnp-3166	158	12	selectively	selectively	ADV
fnp-3166	158	13	expressed	express	VERB
fnp-3166	158	14	on	on	ADP
fnp-3166	158	15	microglia	microglia	NOUN
fnp-3166	158	16	,	,	PUNCT
fnp-3166	158	17	such	such	ADJ
fnp-3166	158	18	as	as	ADP
fnp-3166	158	19	the	the	DET
fnp-3166	158	20	membrane	membrane	NOUN
fnp-3166	158	21	protein	protein	NOUN
fnp-3166	158	22	tmem	tmem	VERB
fnp-3166	158	23	119	119	NUM
fnp-3166	158	24	and	and	CCONJ
fnp-3166	158	25	the	the	DET
fnp-3166	158	26	marker	marker	NOUN
fnp-3166	158	27	for	for	ADP
fnp-3166	158	28	homeostatic	homeostatic	ADJ
fnp-3166	158	29	microglia	microglia	NOUN
fnp-3166	158	30	p2ry12	p2ry12	PROPN
fnp-3166	158	31	.	.	PUNCT
fnp-3166	159	1	these	these	DET
fnp-3166	159	2	markers	marker	NOUN
fnp-3166	159	3	have	have	AUX
fnp-3166	159	4	been	be	AUX
fnp-3166	159	5	used	use	VERB
fnp-3166	159	6	in	in	ADP
fnp-3166	159	7	a	a	DET
fnp-3166	159	8	number	number	NOUN
fnp-3166	159	9	of	of	ADP
fnp-3166	159	10	studies	study	NOUN
fnp-3166	159	11	on	on	ADP
fnp-3166	159	12	various	various	ADJ
fnp-3166	159	13	different	different	ADJ
fnp-3166	159	14	inflammatory	inflammatory	ADJ
fnp-3166	159	15	and	and	CCONJ
fnp-3166	159	16	neurodegenerative	neurodegenerative	ADJ
fnp-3166	159	17	conditions	condition	NOUN
fnp-3166	159	18	and	and	CCONJ
fnp-3166	159	19	revealed	reveal	VERB
fnp-3166	159	20	a	a	DET
fnp-3166	159	21	surprisingly	surprisingly	ADV
fnp-3166	159	22	uniform	uniform	ADJ
fnp-3166	159	23	reaction	reaction	NOUN
fnp-3166	159	24	pattern	pattern	NOUN
fnp-3166	159	25	of	of	ADP
fnp-3166	159	26	myeloid	myeloid	ADJ
fnp-3166	159	27	cells	cell	NOUN
fnp-3166	159	28	in	in	ADP
fnp-3166	159	29	human	human	ADJ
fnp-3166	159	30	diseases	disease	NOUN
fnp-3166	159	31	(	(	PUNCT
fnp-3166	159	32	zrzavy	zrzavy	NOUN
fnp-3166	159	33	et	et	PROPN
fnp-3166	159	34	al	al	PROPN
fnp-3166	159	35	.	.	PROPN
fnp-3166	159	36	2017	2017	NUM
fnp-3166	159	37	,	,	PUNCT
fnp-3166	159	38	2018	2018	NUM
fnp-3166	159	39	,	,	PUNCT
fnp-3166	159	40	hayashida	hayashida	ADV
fnp-3166	159	41	et	et	PROPN
fnp-3166	159	42	al	al	PROPN
fnp-3166	159	43	.	.	PROPN
fnp-3166	159	44	2020	2020	NUM
fnp-3166	159	45	,	,	PUNCT
fnp-3166	159	46	jäckle	jäckle	NOUN
fnp-3166	159	47	et	et	PROPN
fnp-3166	159	48	al	al	PROPN
fnp-3166	159	49	.	.	PROPN
fnp-3166	159	50	2020	2020	NUM
fnp-3166	159	51	)	)	PUNCT
fnp-3166	159	52	.	.	PUNCT
fnp-3166	160	1	in	in	ADP
fnp-3166	160	2	essence	essence	NOUN
fnp-3166	160	3	,	,	PUNCT
fnp-3166	160	4	at	at	ADP
fnp-3166	160	5	sites	site	NOUN
fnp-3166	160	6	of	of	ADP
fnp-3166	160	7	initial	initial	ADJ
fnp-3166	160	8	tissue	tissue	NOUN
fnp-3166	160	9	injury	injury	NOUN
fnp-3166	160	10	,	,	PUNCT
fnp-3166	160	11	resident	resident	ADJ
fnp-3166	160	12	microglia	microglia	NOUN
fnp-3166	160	13	become	become	VERB
fnp-3166	160	14	activated	activate	VERB
fnp-3166	160	15	in	in	ADP
fnp-3166	160	16	a	a	DET
fnp-3166	160	17	pro	pro	ADJ
fnp-3166	160	18	-	-	ADJ
fnp-3166	160	19	inflammatory	inflammatory	ADJ
fnp-3166	160	20	pattern	pattern	NOUN
fnp-3166	160	21	.	.	PUNCT
fnp-3166	161	1	this	this	DET
fnp-3166	161	2	initial	initial	ADJ
fnp-3166	161	3	step	step	NOUN
fnp-3166	161	4	is	be	AUX
fnp-3166	161	5	followed	follow	VERB
fnp-3166	161	6	by	by	ADP
fnp-3166	161	7	recruitment	recruitment	NOUN
fnp-3166	161	8	of	of	ADP
fnp-3166	161	9	myeloid	myeloid	ADJ
fnp-3166	161	10	cells	cell	NOUN
fnp-3166	161	11	from	from	ADP
fnp-3166	161	12	the	the	DET
fnp-3166	161	13	circulation	circulation	NOUN
fnp-3166	161	14	,	,	PUNCT
fnp-3166	161	15	and	and	CCONJ
fnp-3166	161	16	the	the	DET
fnp-3166	161	17	recruited	recruit	VERB
fnp-3166	161	18	cells	cell	NOUN
fnp-3166	161	19	also	also	ADV
fnp-3166	161	20	show	show	VERB
fnp-3166	161	21	pro	pro	ADJ
fnp-3166	161	22	-	-	ADJ
fnp-3166	161	23	inflammatory	inflammatory	ADJ
fnp-3166	161	24	activation	activation	NOUN
fnp-3166	161	25	or	or	CCONJ
fnp-3166	161	26	,	,	PUNCT
fnp-3166	161	27	at	at	ADP
fnp-3166	161	28	later	later	ADJ
fnp-3166	161	29	stages	stage	NOUN
fnp-3166	161	30	of	of	ADP
fnp-3166	161	31	lesion	lesion	NOUN
fnp-3166	161	32	maturation	maturation	NOUN
fnp-3166	161	33	,	,	PUNCT
fnp-3166	161	34	an	an	DET
fnp-3166	161	35	intermediate	intermediate	ADJ
fnp-3166	161	36	phenotype	phenotype	NOUN
fnp-3166	161	37	.	.	PUNCT
fnp-3166	162	1	the	the	DET
fnp-3166	162	2	distinction	distinction	NOUN
fnp-3166	162	3	of	of	ADP
fnp-3166	162	4	proversus	proversus	NOUN
fnp-3166	162	5	anti	anti	ADJ
fnp-3166	162	6	-	-	ADJ
fnp-3166	162	7	inflammatory	inflammatory	ADJ
fnp-3166	162	8	phenotypes	phenotype	NOUN
fnp-3166	162	9	is	be	AUX
fnp-3166	162	10	now	now	ADV
fnp-3166	162	11	seen	see	VERB
fnp-3166	162	12	in	in	ADP
fnp-3166	162	13	a	a	DET
fnp-3166	162	14	much	much	ADV
fnp-3166	162	15	more	more	ADV
fnp-3166	162	16	critical	critical	ADJ
fnp-3166	162	17	way	way	NOUN
fnp-3166	162	18	,	,	PUNCT
fnp-3166	162	19	since	since	SCONJ
fnp-3166	162	20	some	some	DET
fnp-3166	162	21	pro	pro	ADJ
fnp-3166	162	22	-	-	ADJ
fnp-3166	162	23	inflammatory	inflammatory	ADJ
fnp-3166	162	24	actions	action	NOUN
fnp-3166	162	25	,	,	PUNCT
fnp-3166	162	26	such	such	ADJ
fnp-3166	162	27	as	as	ADP
fnp-3166	162	28	the	the	DET
fnp-3166	162	29	interaction	interaction	NOUN
fnp-3166	162	30	of	of	ADP
fnp-3166	162	31	macrophages	macrophage	NOUN
fnp-3166	162	32	with	with	ADP
fnp-3166	162	33	target	target	NOUN
fnp-3166	162	34	cells	cell	NOUN
fnp-3166	162	35	may	may	AUX
fnp-3166	162	36	contribute	contribute	VERB
fnp-3166	162	37	to	to	ADP
fnp-3166	162	38	tissue	tissue	NOUN
fnp-3166	162	39	damage	damage	NOUN
fnp-3166	162	40	but	but	CCONJ
fnp-3166	162	41	may	may	AUX
fnp-3166	162	42	also	also	ADV
fnp-3166	162	43	be	be	AUX
fnp-3166	162	44	essential	essential	ADJ
fnp-3166	162	45	for	for	ADP
fnp-3166	162	46	neuroprotection	neuroprotection	NOUN
fnp-3166	162	47	and	and	CCONJ
fnp-3166	162	48	regeneration	regeneration	NOUN
fnp-3166	162	49	through	through	ADP
fnp-3166	162	50	the	the	DET
fnp-3166	162	51	clearance	clearance	NOUN
fnp-3166	162	52	of	of	ADP
fnp-3166	162	53	debris	debris	NOUN
fnp-3166	162	54	(	(	PUNCT
fnp-3166	162	55	cignarella	cignarella	X
fnp-3166	162	56	et	et	PROPN
fnp-3166	162	57	al	al	PROPN
fnp-3166	162	58	.	.	PROPN
fnp-3166	162	59	2020	2020	NUM
fnp-3166	162	60	)	)	PUNCT
fnp-3166	162	61	.	.	PUNCT
fnp-3166	163	1	an	an	DET
fnp-3166	163	2	important	important	ADJ
fnp-3166	163	3	pro	pro	ADJ
fnp-3166	163	4	-	-	ADJ
fnp-3166	163	5	inflammatory	inflammatory	ADJ
fnp-3166	163	6	type	type	NOUN
fnp-3166	163	7	of	of	ADP
fnp-3166	163	8	activation	activation	NOUN
fnp-3166	163	9	,	,	PUNCT
fnp-3166	163	10	which	which	PRON
fnp-3166	163	11	seems	seem	VERB
fnp-3166	163	12	to	to	PART
fnp-3166	163	13	play	play	VERB
fnp-3166	163	14	a	a	DET
fnp-3166	163	15	major	major	ADJ
fnp-3166	163	16	role	role	NOUN
fnp-3166	163	17	in	in	ADP
fnp-3166	163	18	the	the	DET
fnp-3166	163	19	induction	induction	NOUN
fnp-3166	163	20	of	of	ADP
fnp-3166	163	21	tissue	tissue	NOUN
fnp-3166	163	22	injury	injury	NOUN
fnp-3166	163	23	,	,	PUNCT
fnp-3166	163	24	is	be	AUX
fnp-3166	163	25	the	the	DET
fnp-3166	163	26	expression	expression	NOUN
fnp-3166	163	27	of	of	ADP
fnp-3166	163	28	proteins	protein	NOUN
fnp-3166	163	29	involved	involve	VERB
fnp-3166	163	30	in	in	ADP
fnp-3166	163	31	oxidative	oxidative	ADJ
fnp-3166	163	32	stress	stress	NOUN
fnp-3166	163	33	,	,	PUNCT
fnp-3166	163	34	such	such	ADJ
fnp-3166	163	35	as	as	ADP
fnp-3166	163	36	the	the	DET
fnp-3166	163	37	expression	expression	NOUN
fnp-3166	163	38	of	of	ADP
fnp-3166	163	39	the	the	DET
fnp-3166	163	40	nox2	nox2	PROPN
fnp-3166	163	41	complex	complex	NOUN
fnp-3166	163	42	(	(	PUNCT
fnp-3166	163	43	nadph	nadph	ADJ
fnp-3166	163	44	oxidase	oxidase	NOUN
fnp-3166	163	45	complex	complex	NOUN
fnp-3166	163	46	2	2	NUM
fnp-3166	163	47	)	)	PUNCT
fnp-3166	163	48	,	,	PUNCT
fnp-3166	163	49	a	a	DET
fnp-3166	163	50	prominent	prominent	ADJ
fnp-3166	163	51	marker	marker	NOUN
fnp-3166	163	52	of	of	ADP
fnp-3166	163	53	microglia	microglia	NOUN
fnp-3166	163	54	expressed	express	VERB
fnp-3166	163	55	in	in	ADP
fnp-3166	163	56	active	active	ADJ
fnp-3166	163	57	lesions	lesion	NOUN
fnp-3166	163	58	in	in	ADP
fnp-3166	163	59	different	different	ADJ
fnp-3166	163	60	inflammatory	inflammatory	ADJ
fnp-3166	163	61	conditions	condition	NOUN
fnp-3166	163	62	as	as	ADV
fnp-3166	163	63	well	well	ADV
fnp-3166	163	64	as	as	ADP
fnp-3166	163	65	vascular	vascular	ADJ
fnp-3166	163	66	or	or	CCONJ
fnp-3166	163	67	neurodegenerative	neurodegenerative	ADJ
fnp-3166	163	68	diseases	disease	NOUN
fnp-3166	163	69	in	in	ADP
fnp-3166	163	70	humans	human	NOUN
fnp-3166	163	71	(	(	PUNCT
fnp-3166	163	72	zrzavy	zrzavy	X
fnp-3166	163	73	et	et	PROPN
fnp-3166	163	74	al	al	PROPN
fnp-3166	163	75	.	.	PROPN
fnp-3166	163	76	2017	2017	NUM
fnp-3166	163	77	,	,	PUNCT
fnp-3166	163	78	fischer	fischer	PROPN
fnp-3166	163	79	et	et	PROPN
fnp-3166	163	80	al	al	PROPN
fnp-3166	163	81	.	.	PROPN
fnp-3166	163	82	2013	2013	NUM
fnp-3166	163	83	)	)	PUNCT
fnp-3166	163	84	.	.	PUNCT
fnp-3166	164	1	to	to	PART
fnp-3166	164	2	define	define	VERB
fnp-3166	164	3	the	the	DET
fnp-3166	164	4	patterns	pattern	NOUN
fnp-3166	164	5	of	of	ADP
fnp-3166	164	6	microglia	microglia	ADJ
fnp-3166	164	7	activation	activation	NOUN
fnp-3166	164	8	in	in	ADP
fnp-3166	164	9	such	such	ADJ
fnp-3166	164	10	diseases	disease	NOUN
fnp-3166	164	11	may	may	AUX
fnp-3166	164	12	finally	finally	ADV
fnp-3166	164	13	result	result	VERB
fnp-3166	164	14	in	in	ADP
fnp-3166	164	15	more	more	ADV
fnp-3166	164	16	selective	selective	ADJ
fnp-3166	164	17	and	and	CCONJ
fnp-3166	164	18	efficient	efficient	ADJ
fnp-3166	164	19	neuroprotective	neuroprotective	ADJ
fnp-3166	164	20	treatments	treatment	NOUN
fnp-3166	164	21	.	.	PUNCT
fnp-3166	165	1	this	this	PRON
fnp-3166	165	2	is	be	AUX
fnp-3166	165	3	now	now	ADV
fnp-3166	165	4	possible	possible	ADJ
fnp-3166	165	5	with	with	ADP
fnp-3166	165	6	new	new	ADJ
fnp-3166	165	7	technologies	technology	NOUN
fnp-3166	165	8	,	,	PUNCT
fnp-3166	165	9	such	such	ADJ
fnp-3166	165	10	as	as	ADP
fnp-3166	165	11	single	single	ADJ
fnp-3166	165	12	-	-	PUNCT
fnp-3166	165	13	cell	cell	NOUN
fnp-3166	165	14	rna	rna	NOUN
fnp-3166	165	15	sequencing	sequencing	NOUN
fnp-3166	165	16	or	or	CCONJ
fnp-3166	165	17	immunocytochemical	immunocytochemical	ADJ
fnp-3166	165	18	methods	method	NOUN
fnp-3166	165	19	,	,	PUNCT
fnp-3166	165	20	which	which	PRON
fnp-3166	165	21	allow	allow	VERB
fnp-3166	165	22	the	the	DET
fnp-3166	165	23	simultaneous	simultaneous	ADJ
fnp-3166	165	24	detection	detection	NOUN
fnp-3166	165	25	of	of	ADP
fnp-3166	165	26	multiple	multiple	ADJ
fnp-3166	165	27	protein	protein	NOUN
fnp-3166	165	28	antigens	antigen	NOUN
fnp-3166	165	29	within	within	ADP
fnp-3166	165	30	the	the	DET
fnp-3166	165	31	same	same	ADJ
fnp-3166	165	32	section	section	NOUN
fnp-3166	165	33	,	,	PUNCT
fnp-3166	165	34	such	such	ADJ
fnp-3166	165	35	as	as	ADP
fnp-3166	165	36	imaging	image	VERB
fnp-3166	165	37	mass	mass	NOUN
fnp-3166	165	38	cytometry	cytometry	NOUN
fnp-3166	165	39	.	.	PUNCT
fnp-3166	166	1	in	in	ADP
fnp-3166	166	2	some	some	DET
fnp-3166	166	3	studies	study	NOUN
fnp-3166	166	4	of	of	ADP
fnp-3166	166	5	models	model	NOUN
fnp-3166	166	6	of	of	ADP
fnp-3166	166	7	autoimmune	autoimmune	ADJ
fnp-3166	166	8	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	166	9	and	and	CCONJ
fnp-3166	166	10	ms	ms	NOUN
fnp-3166	166	11	,	,	PUNCT
fnp-3166	166	12	these	these	DET
fnp-3166	166	13	techniques	technique	NOUN
fnp-3166	166	14	have	have	AUX
fnp-3166	166	15	been	be	AUX
fnp-3166	166	16	used	use	VERB
fnp-3166	166	17	and	and	CCONJ
fnp-3166	166	18	confirmed	confirm	VERB
fnp-3166	166	19	in	in	ADP
fnp-3166	166	20	an	an	DET
fnp-3166	166	21	elegant	elegant	ADJ
fnp-3166	166	22	way	way	NOUN
fnp-3166	166	23	the	the	DET
fnp-3166	166	24	patterns	pattern	NOUN
fnp-3166	166	25	of	of	ADP
fnp-3166	166	26	microglia	microglia	ADJ
fnp-3166	166	27	activation	activation	NOUN
fnp-3166	166	28	and	and	CCONJ
fnp-3166	166	29	macrophage	macrophage	ADJ
fnp-3166	166	30	recruitment	recruitment	NOUN
fnp-3166	166	31	,	,	PUNCT
fnp-3166	166	32	which	which	PRON
fnp-3166	166	33	have	have	AUX
fnp-3166	166	34	been	be	AUX
fnp-3166	166	35	described	describe	VERB
fnp-3166	166	36	before	before	ADV
fnp-3166	166	37	with	with	ADP
fnp-3166	166	38	more	more	ADJ
fnp-3166	166	39	conventional	conventional	ADJ
fnp-3166	166	40	techniques	technique	NOUN
fnp-3166	166	41	as	as	SCONJ
fnp-3166	166	42	summarized	summarize	VERB
fnp-3166	166	43	above	above	ADV
fnp-3166	166	44	(	(	PUNCT
fnp-3166	166	45	masuda	masuda	PROPN
fnp-3166	166	46	et	et	PROPN
fnp-3166	166	47	al	al	PROPN
fnp-3166	166	48	.	.	PROPN
fnp-3166	166	49	2019	2019	NUM
fnp-3166	166	50	,	,	PUNCT
fnp-3166	166	51	ramaglia	ramaglia	PROPN
fnp-3166	166	52	et	et	PROPN
fnp-3166	166	53	al	al	PROPN
fnp-3166	166	54	.	.	PROPN
fnp-3166	166	55	2020	2020	NUM
fnp-3166	166	56	)	)	PUNCT
fnp-3166	166	57	.	.	PUNCT
fnp-3166	167	1	however	however	ADV
fnp-3166	167	2	,	,	PUNCT
fnp-3166	167	3	they	they	PRON
fnp-3166	167	4	additionally	additionally	ADV
fnp-3166	167	5	showed	show	VERB
fnp-3166	167	6	that	that	SCONJ
fnp-3166	167	7	microglia	microglia	NOUN
fnp-3166	167	8	and	and	CCONJ
fnp-3166	167	9	macrophages	macrophage	NOUN
fnp-3166	167	10	with	with	ADP
fnp-3166	167	11	different	different	ADJ
fnp-3166	167	12	phenotypes	phenotype	NOUN
fnp-3166	167	13	are	be	AUX
fnp-3166	167	14	present	present	ADJ
fnp-3166	167	15	side	side	NOUN
fnp-3166	167	16	-	-	PUNCT
fnp-3166	167	17	by	by	ADP
fnp-3166	167	18	-	-	PUNCT
fnp-3166	167	19	side	side	NOUN
fnp-3166	167	20	in	in	ADP
fnp-3166	167	21	the	the	DET
fnp-3166	167	22	same	same	ADJ
fnp-3166	167	23	lesion	lesion	NOUN
fnp-3166	167	24	.	.	PUNCT
fnp-3166	168	1	this	this	PRON
fnp-3166	168	2	may	may	AUX
fnp-3166	168	3	indicate	indicate	VERB
fnp-3166	168	4	selective	selective	ADJ
fnp-3166	168	5	activation	activation	NOUN
fnp-3166	168	6	signals	signal	NOUN
fnp-3166	168	7	in	in	ADP
fnp-3166	168	8	specific	specific	ADJ
fnp-3166	168	9	subpopulations	subpopulation	NOUN
fnp-3166	168	10	of	of	ADP
fnp-3166	168	11	cells	cell	NOUN
fnp-3166	168	12	.	.	PUNCT
fnp-3166	169	1	not	not	PART
fnp-3166	169	2	surprisingly	surprisingly	ADV
fnp-3166	169	3	,	,	PUNCT
fnp-3166	169	4	the	the	DET
fnp-3166	169	5	data	datum	NOUN
fnp-3166	169	6	showed	show	VERB
fnp-3166	169	7	that	that	SCONJ
fnp-3166	169	8	different	different	ADJ
fnp-3166	169	9	ms	ms	NOUN
fnp-3166	169	10	lesions	lesion	NOUN
fnp-3166	169	11	,	,	PUNCT
fnp-3166	169	12	which	which	PRON
fnp-3166	169	13	were	be	AUX
fnp-3166	169	14	in	in	ADP
fnp-3166	169	15	the	the	DET
fnp-3166	169	16	same	same	ADJ
fnp-3166	169	17	activity	activity	NOUN
fnp-3166	169	18	stage	stage	NOUN
fnp-3166	169	19	but	but	CCONJ
fnp-3166	169	20	still	still	ADV
fnp-3166	169	21	displayed	display	VERB
fnp-3166	169	22	some	some	DET
fnp-3166	169	23	distinct	distinct	ADJ
fnp-3166	169	24	morphological	morphological	ADJ
fnp-3166	169	25	features	feature	NOUN
fnp-3166	169	26	,	,	PUNCT
fnp-3166	169	27	were	be	AUX
fnp-3166	169	28	infiltrated	infiltrate	VERB
fnp-3166	169	29	by	by	ADP
fnp-3166	169	30	different	different	ADJ
fnp-3166	169	31	subsets	subset	NOUN
fnp-3166	169	32	of	of	ADP
fnp-3166	169	33	myeloid	myeloid	ADJ
fnp-3166	169	34	cells	cell	NOUN
fnp-3166	169	35	(	(	PUNCT
fnp-3166	169	36	masuda	masuda	PROPN
fnp-3166	169	37	et	et	PROPN
fnp-3166	169	38	al	al	PROPN
fnp-3166	169	39	.	.	PROPN
fnp-3166	169	40	2019	2019	NUM
fnp-3166	169	41	)	)	PUNCT
fnp-3166	169	42	.	.	PUNCT
fnp-3166	170	1	however	however	ADV
fnp-3166	170	2	,	,	PUNCT
fnp-3166	170	3	these	these	DET
fnp-3166	170	4	studies	study	NOUN
fnp-3166	170	5	did	do	AUX
fnp-3166	170	6	not	not	PART
fnp-3166	170	7	reveal	reveal	VERB
fnp-3166	170	8	the	the	DET
fnp-3166	170	9	high	high	ADJ
fnp-3166	170	10	expression	expression	NOUN
fnp-3166	170	11	of	of	ADP
fnp-3166	170	12	molecules	molecule	NOUN
fnp-3166	170	13	involved	involve	VERB
fnp-3166	170	14	in	in	ADP
fnp-3166	170	15	oxidative	oxidative	ADJ
fnp-3166	170	16	injury	injury	NOUN
fnp-3166	170	17	,	,	PUNCT
fnp-3166	170	18	which	which	PRON
fnp-3166	170	19	had	have	AUX
fnp-3166	170	20	been	be	AUX
fnp-3166	170	21	prominent	prominent	ADJ
fnp-3166	170	22	in	in	ADP
fnp-3166	170	23	earlier	early	ADV
fnp-3166	170	24	more	more	ADJ
fnp-3166	170	25	conventional	conventional	ADJ
fnp-3166	170	26	neuropathological	neuropathological	ADJ
fnp-3166	170	27	studies	study	NOUN
fnp-3166	170	28	.	.	PUNCT
fnp-3166	171	1	a	a	DET
fnp-3166	171	2	possible	possible	ADJ
fnp-3166	171	3	explanation	explanation	NOUN
fnp-3166	171	4	for	for	ADP
fnp-3166	171	5	these	these	DET
fnp-3166	171	6	discrepancies	discrepancy	NOUN
fnp-3166	171	7	is	be	AUX
fnp-3166	171	8	provided	provide	VERB
fnp-3166	171	9	by	by	ADP
fnp-3166	171	10	an	an	DET
fnp-3166	171	11	elegant	elegant	ADJ
fnp-3166	171	12	study	study	NOUN
fnp-3166	171	13	,	,	PUNCT
fnp-3166	171	14	which	which	PRON
fnp-3166	171	15	specifically	specifically	ADV
fnp-3166	171	16	focused	focus	VERB
fnp-3166	171	17	on	on	ADP
fnp-3166	171	18	microglia	microglia	ADJ
fnp-3166	171	19	activation	activation	NOUN
fnp-3166	171	20	and	and	CCONJ
fnp-3166	171	21	oxidative	oxidative	ADJ
fnp-3166	171	22	injury	injury	NOUN
fnp-3166	171	23	in	in	ADP
fnp-3166	171	24	autoimmune	autoimmune	ADJ
fnp-3166	171	25	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	171	26	(	(	PUNCT
fnp-3166	171	27	mendiola	mendiola	PROPN
fnp-3166	171	28	et	et	PROPN
fnp-3166	171	29	al	al	PROPN
fnp-3166	171	30	.	.	PROPN
fnp-3166	171	31	2020	2020	NUM
fnp-3166	171	32	)	)	PUNCT
fnp-3166	171	33	.	.	PUNCT
fnp-3166	172	1	the	the	DET
fnp-3166	172	2	authors	author	NOUN
fnp-3166	172	3	first	first	ADV
fnp-3166	172	4	defined	define	VERB
fnp-3166	172	5	the	the	DET
fnp-3166	172	6	molecular	molecular	ADJ
fnp-3166	172	7	phenotype	phenotype	NOUN
fnp-3166	172	8	of	of	ADP
fnp-3166	172	9	microglia	microglia	NOUN
fnp-3166	172	10	specifically	specifically	ADV
fnp-3166	172	11	selected	select	VERB
fnp-3166	172	12	from	from	ADP
fnp-3166	172	13	areas	area	NOUN
fnp-3166	172	14	of	of	ADP
fnp-3166	172	15	oxidative	oxidative	ADJ
fnp-3166	172	16	injury	injury	NOUN
fnp-3166	172	17	.	.	PUNCT
fnp-3166	173	1	incorporating	incorporate	VERB
fnp-3166	173	2	this	this	DET
fnp-3166	173	3	profile	profile	NOUN
fnp-3166	173	4	in	in	ADP
fnp-3166	173	5	the	the	DET
fnp-3166	173	6	analysis	analysis	NOUN
fnp-3166	173	7	of	of	ADP
fnp-3166	173	8	single	single	ADJ
fnp-3166	173	9	-	-	PUNCT
fnp-3166	173	10	cell	cell	NOUN
fnp-3166	173	11	rna	rna	NOUN
fnp-3166	173	12	sequencing	sequencing	NOUN
fnp-3166	173	13	data	datum	NOUN
fnp-3166	173	14	and	and	CCONJ
fnp-3166	173	15	immunocytochemistry	immunocytochemistry	NOUN
fnp-3166	173	16	,	,	PUNCT
fnp-3166	173	17	they	they	PRON
fnp-3166	173	18	identified	identify	VERB
fnp-3166	173	19	specific	specific	ADJ
fnp-3166	173	20	microglia	microglia	ADJ
fnp-3166	173	21	and	and	CCONJ
fnp-3166	173	22	macrophage	macrophage	ADJ
fnp-3166	173	23	subpopulations	subpopulation	NOUN
fnp-3166	173	24	,	,	PUNCT
fnp-3166	173	25	which	which	PRON
fnp-3166	173	26	trigger	trigger	NOUN
fnp-3166	173	27	oxidative	oxidative	ADJ
fnp-3166	173	28	stress	stress	NOUN
fnp-3166	173	29	,	,	PUNCT
fnp-3166	173	30	and	and	CCONJ
fnp-3166	173	31	showed	show	VERB
fnp-3166	173	32	that	that	SCONJ
fnp-3166	173	33	these	these	PRON
fnp-3166	173	34	are	be	AUX
fnp-3166	173	35	selective	selective	ADJ
fnp-3166	173	36	subtypes	subtype	NOUN
fnp-3166	173	37	of	of	ADP
fnp-3166	173	38	cells	cell	NOUN
fnp-3166	173	39	within	within	ADP
fnp-3166	173	40	the	the	DET
fnp-3166	173	41	population	population	NOUN
fnp-3166	173	42	of	of	ADP
fnp-3166	173	43	activated	activated	ADJ
fnp-3166	173	44	myeloid	myeloid	ADJ
fnp-3166	173	45	cells	cell	NOUN
fnp-3166	173	46	.	.	PUNCT
fnp-3166	174	1	these	these	DET
fnp-3166	174	2	particular	particular	ADJ
fnp-3166	174	3	cell	cell	NOUN
fnp-3166	174	4	types	type	NOUN
fnp-3166	174	5	also	also	ADV
fnp-3166	174	6	express	express	VERB
fnp-3166	174	7	molecules	molecule	NOUN
fnp-3166	174	8	that	that	PRON
fnp-3166	174	9	are	be	AUX
fnp-3166	174	10	important	important	ADJ
fnp-3166	174	11	in	in	ADP
fnp-3166	174	12	the	the	DET
fnp-3166	174	13	coagulation	coagulation	NOUN
fnp-3166	174	14	cascade	cascade	NOUN
fnp-3166	174	15	and	and	CCONJ
fnp-3166	174	16	in	in	ADP
fnp-3166	174	17	glutathione	glutathione	NOUN
fnp-3166	174	18	metabolism	metabolism	NOUN
fnp-3166	174	19	.	.	PUNCT
fnp-3166	175	1	in	in	ADP
fnp-3166	175	2	addition	addition	NOUN
fnp-3166	175	3	,	,	PUNCT
fnp-3166	175	4	they	they	PRON
fnp-3166	175	5	produce	produce	VERB
fnp-3166	175	6	molecules	molecule	NOUN
fnp-3166	175	7	,	,	PUNCT
fnp-3166	175	8	which	which	PRON
fnp-3166	175	9	counteract	counteract	VERB
fnp-3166	175	10	oxidative	oxidative	ADJ
fnp-3166	175	11	stress	stress	NOUN
fnp-3166	175	12	.	.	PUNCT
fnp-3166	176	1	one	one	NUM
fnp-3166	176	2	of	of	ADP
fnp-3166	176	3	these	these	DET
fnp-3166	176	4	molecules	molecule	NOUN
fnp-3166	176	5	acivivin	acivivin	NOUN
fnp-3166	176	6	,	,	PUNCT
fnp-3166	176	7	a	a	DET
fnp-3166	176	8	glutathione	glutathione	NOUN
fnp-3166	176	9	regulating	regulate	VERB
fnp-3166	176	10	compound	compound	NOUN
fnp-3166	176	11	,	,	PUNCT
fnp-3166	176	12	suppresses	suppress	VERB
fnp-3166	176	13	the	the	DET
fnp-3166	176	14	inflammatory	inflammatory	ADJ
fnp-3166	176	15	tissue	tissue	NOUN
fnp-3166	176	16	damage	damage	NOUN
fnp-3166	176	17	in	in	ADP
fnp-3166	176	18	a	a	DET
fnp-3166	176	19	model	model	NOUN
fnp-3166	176	20	of	of	ADP
fnp-3166	176	21	autoimmune	autoimmune	ADJ
fnp-3166	176	22	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	176	23	.	.	PUNCT
fnp-3166	177	1	it	it	PRON
fnp-3166	177	2	will	will	AUX
fnp-3166	177	3	be	be	AUX
fnp-3166	177	4	instrumental	instrumental	ADJ
fnp-3166	177	5	in	in	ADP
fnp-3166	177	6	the	the	DET
fnp-3166	177	7	future	future	NOUN
fnp-3166	177	8	to	to	PART
fnp-3166	177	9	validate	validate	VERB
fnp-3166	177	10	directly	directly	ADV
fnp-3166	177	11	the	the	DET
fnp-3166	177	12	relevance	relevance	NOUN
fnp-3166	177	13	of	of	ADP
fnp-3166	177	14	these	these	DET
fnp-3166	177	15	findings	finding	NOUN
fnp-3166	177	16	in	in	ADP
fnp-3166	177	17	ms	ms	ADJ
fnp-3166	177	18	lesions	lesion	NOUN
fnp-3166	177	19	and	and	CCONJ
fnp-3166	177	20	also	also	ADV
fnp-3166	177	21	in	in	ADP
fnp-3166	177	22	vascular	vascular	ADJ
fnp-3166	177	23	or	or	CCONJ
fnp-3166	177	24	neurodegenerative	neurodegenerative	ADJ
fnp-3166	177	25	diseases	disease	NOUN
fnp-3166	177	26	of	of	ADP
fnp-3166	177	27	the	the	DET
fnp-3166	177	28	central	central	ADJ
fnp-3166	177	29	nervous	nervous	ADJ
fnp-3166	177	30	system	system	NOUN
fnp-3166	177	31	.	.	PUNCT
fnp-3166	178	1	the	the	DET
fnp-3166	178	2	presence	presence	NOUN
fnp-3166	178	3	of	of	ADP
fnp-3166	178	4	a	a	DET
fnp-3166	178	5	subtype	subtype	NOUN
fnp-3166	178	6	of	of	ADP
fnp-3166	178	7	myeloid	myeloid	ADJ
fnp-3166	178	8	cells	cell	NOUN
fnp-3166	178	9	triggering	trigger	VERB
fnp-3166	178	10	and	and	CCONJ
fnp-3166	178	11	resolving	resolve	VERB
fnp-3166	178	12	oxidative	oxidative	ADJ
fnp-3166	178	13	stress	stress	NOUN
fnp-3166	178	14	could	could	AUX
fnp-3166	178	15	reconcile	reconcile	VERB
fnp-3166	178	16	the	the	DET
fnp-3166	178	17	above	above	ADJ
fnp-3166	178	18	discrepancies	discrepancy	NOUN
fnp-3166	178	19	and	and	CCONJ
fnp-3166	178	20	provide	provide	VERB
fnp-3166	178	21	a	a	DET
fnp-3166	178	22	mechanism	mechanism	NOUN
fnp-3166	178	23	for	for	ADP
fnp-3166	178	24	the	the	DET
fnp-3166	178	25	excessive	excessive	ADJ
fnp-3166	178	26	oxidative	oxidative	ADJ
fnp-3166	178	27	injury	injury	NOUN
fnp-3166	178	28	in	in	ADP
fnp-3166	178	29	the	the	DET
fnp-3166	178	30	lesions	lesion	NOUN
fnp-3166	178	31	and	and	CCONJ
fnp-3166	178	32	the	the	DET
fnp-3166	178	33	associations	association	NOUN
fnp-3166	178	34	of	of	ADP
fnp-3166	178	35	markers	marker	NOUN
fnp-3166	178	36	for	for	ADP
fnp-3166	178	37	oxidative	oxidative	ADJ
fnp-3166	178	38	injury	injury	NOUN
fnp-3166	178	39	with	with	ADP
fnp-3166	178	40	markers	marker	NOUN
fnp-3166	178	41	for	for	ADP
fnp-3166	178	42	disturbed	disturbed	ADJ
fnp-3166	178	43	blood	blood	NOUN
fnp-3166	178	44	coagulation	coagulation	NOUN
fnp-3166	178	45	in	in	ADP
fnp-3166	178	46	the	the	DET
fnp-3166	178	47	lesions	lesion	NOUN
fnp-3166	178	48	.	.	PUNCT
fnp-3166	179	1	in	in	ADP
fnp-3166	179	2	the	the	DET
fnp-3166	179	3	long	long	ADJ
fnp-3166	179	4	run	run	NOUN
fnp-3166	179	5	,	,	PUNCT
fnp-3166	179	6	these	these	DET
fnp-3166	179	7	data	datum	NOUN
fnp-3166	179	8	may	may	AUX
fnp-3166	179	9	lead	lead	VERB
fnp-3166	179	10	to	to	ADP
fnp-3166	179	11	tools	tool	NOUN
fnp-3166	179	12	for	for	ADP
fnp-3166	179	13	the	the	DET
fnp-3166	179	14	therapeutic	therapeutic	ADJ
fnp-3166	179	15	blockade	blockade	NOUN
fnp-3166	179	16	of	of	ADP
fnp-3166	179	17	one	one	NUM
fnp-3166	179	18	of	of	ADP
fnp-3166	179	19	the	the	DET
fnp-3166	179	20	most	most	ADV
fnp-3166	179	21	detrimental	detrimental	ADJ
fnp-3166	179	22	aspects	aspect	NOUN
fnp-3166	179	23	of	of	ADP
fnp-3166	179	24	microglia	microglia	ADJ
fnp-3166	179	25	activation	activation	NOUN
fnp-3166	179	26	in	in	ADP
fnp-3166	179	27	human	human	ADJ
fnp-3166	179	28	brain	brain	NOUN
fnp-3166	179	29	disease	disease	NOUN
fnp-3166	179	30	.	.	PUNCT
fnp-3166	180	1	8)	8)	NUM
fnp-3166	180	2	how	how	SCONJ
fnp-3166	180	3	do	do	AUX
fnp-3166	180	4	vascular	vascular	ADJ
fnp-3166	180	5	comorbidities	comorbiditie	NOUN
fnp-3166	180	6	influence	influence	VERB
fnp-3166	180	7	multiple	multiple	ADJ
fnp-3166	180	8	sclerosis	sclerosis	NOUN
fnp-3166	180	9	patients	patient	NOUN
fnp-3166	180	10	?	?	PUNCT
fnp-3166	181	1	clinical	clinical	ADJ
fnp-3166	181	2	epidemiology	epidemiology	NOUN
fnp-3166	181	3	of	of	ADP
fnp-3166	181	4	ms	ms	PROPN
fnp-3166	181	5	has	have	AUX
fnp-3166	181	6	shown	show	VERB
fnp-3166	181	7	that	that	SCONJ
fnp-3166	181	8	patients	patient	NOUN
fnp-3166	181	9	with	with	ADP
fnp-3166	181	10	vascular	vascular	ADJ
fnp-3166	181	11	risk	risk	NOUN
fnp-3166	181	12	factors	factor	NOUN
fnp-3166	181	13	,	,	PUNCT
fnp-3166	181	14	such	such	ADJ
fnp-3166	181	15	as	as	ADP
fnp-3166	181	16	diabetes	diabetes	NOUN
fnp-3166	181	17	,	,	PUNCT
fnp-3166	181	18	hypercholesterolaemia	hypercholesterolaemia	NOUN
fnp-3166	181	19	,	,	PUNCT
fnp-3166	181	20	hypertension	hypertension	NOUN
fnp-3166	181	21	,	,	PUNCT
fnp-3166	181	22	or	or	CCONJ
fnp-3166	181	23	heart	heart	NOUN
fnp-3166	181	24	disease	disease	NOUN
fnp-3166	181	25	have	have	VERB
fnp-3166	181	26	a	a	DET
fnp-3166	181	27	more	more	ADV
fnp-3166	181	28	aggressive	aggressive	ADJ
fnp-3166	181	29	disability	disability	NOUN
fnp-3166	181	30	progression	progression	NOUN
fnp-3166	181	31	in	in	ADP
fnp-3166	181	32	comparison	comparison	NOUN
fnp-3166	181	33	to	to	ADP
fnp-3166	181	34	patients	patient	NOUN
fnp-3166	181	35	lacking	lack	VERB
fnp-3166	181	36	these	these	DET
fnp-3166	181	37	co	co	NOUN
fnp-3166	181	38	-	-	NOUN
fnp-3166	181	39	morbidities	morbidity	NOUN
fnp-3166	181	40	(	(	PUNCT
fnp-3166	181	41	marrie	marrie	PROPN
fnp-3166	181	42	et	et	PROPN
fnp-3166	181	43	al	al	PROPN
fnp-3166	181	44	.	.	PROPN
fnp-3166	181	45	2010	2010	NUM
fnp-3166	181	46	)	)	PUNCT
fnp-3166	181	47	.	.	PUNCT
fnp-3166	182	1	this	this	PRON
fnp-3166	182	2	is	be	AUX
fnp-3166	182	3	also	also	ADV
fnp-3166	182	4	reflected	reflect	VERB
fnp-3166	182	5	by	by	ADP
fnp-3166	182	6	lower	low	ADJ
fnp-3166	182	7	brain	brain	NOUN
fnp-3166	182	8	volumes	volume	NOUN
fnp-3166	182	9	(	(	PUNCT
fnp-3166	182	10	pichler	pichler	NOUN
fnp-3166	182	11	et	et	PROPN
fnp-3166	182	12	al	al	PROPN
fnp-3166	182	13	.	.	PROPN
fnp-3166	182	14	2019	2019	NUM
fnp-3166	182	15	)	)	PUNCT
fnp-3166	182	16	.	.	PUNCT
fnp-3166	183	1	furthermore	furthermore	ADV
fnp-3166	183	2	,	,	PUNCT
fnp-3166	183	3	persistence	persistence	NOUN
fnp-3166	183	4	of	of	ADP
fnp-3166	183	5	inflammatory	inflammatory	ADJ
fnp-3166	183	6	demyelinating	demyelinate	VERB
fnp-3166	183	7	lesions	lesion	NOUN
fnp-3166	183	8	and	and	CCONJ
fnp-3166	183	9	higher	high	ADJ
fnp-3166	183	10	lesion	lesion	NOUN
fnp-3166	183	11	volumes	volume	NOUN
fnp-3166	183	12	are	be	AUX
fnp-3166	183	13	present	present	ADJ
fnp-3166	183	14	in	in	ADP
fnp-3166	183	15	brain	brain	NOUN
fnp-3166	183	16	areas	area	NOUN
fnp-3166	183	17	with	with	ADP
fnp-3166	183	18	a	a	DET
fnp-3166	183	19	blood	blood	NOUN
fnp-3166	183	20	perfusion	perfusion	NOUN
fnp-3166	183	21	that	that	PRON
fnp-3166	183	22	is	be	AUX
fnp-3166	183	23	lower	low	ADJ
fnp-3166	183	24	than	than	ADP
fnp-3166	183	25	in	in	ADP
fnp-3166	183	26	other	other	ADJ
fnp-3166	183	27	brain	brain	NOUN
fnp-3166	183	28	areas	area	NOUN
fnp-3166	183	29	(	(	PUNCT
fnp-3166	183	30	haider	haider	PROPN
fnp-3166	183	31	et	et	NOUN
fnp-3166	183	32	al	al	PROPN
fnp-3166	183	33	.	.	PROPN
fnp-3166	183	34	2016	2016	NUM
fnp-3166	183	35	)	)	PUNCT
fnp-3166	183	36	.	.	PUNCT
fnp-3166	184	1	such	such	DET
fnp-3166	184	2	a	a	DET
fnp-3166	184	3	synergism	synergism	NOUN
fnp-3166	184	4	in	in	ADP
fnp-3166	184	5	neurodegeneration	neurodegeneration	NOUN
fnp-3166	184	6	may	may	AUX
fnp-3166	184	7	in	in	ADP
fnp-3166	184	8	part	part	NOUN
fnp-3166	184	9	be	be	AUX
fnp-3166	184	10	explained	explain	VERB
fnp-3166	184	11	by	by	ADP
fnp-3166	184	12	shared	share	VERB
fnp-3166	184	13	effector	effector	NOUN
fnp-3166	184	14	mechanisms	mechanism	NOUN
fnp-3166	184	15	of	of	ADP
fnp-3166	184	16	tissue	tissue	NOUN
fnp-3166	184	17	injury	injury	NOUN
fnp-3166	184	18	between	between	ADP
fnp-3166	184	19	vascular	vascular	ADJ
fnp-3166	184	20	and	and	CCONJ
fnp-3166	184	21	inflammatory	inflammatory	ADJ
fnp-3166	184	22	diseases	disease	NOUN
fnp-3166	184	23	,	,	PUNCT
fnp-3166	184	24	including	include	VERB
fnp-3166	184	25	microglia	microglia	ADJ
fnp-3166	184	26	activation	activation	NOUN
fnp-3166	184	27	,	,	PUNCT
fnp-3166	184	28	oxidative	oxidative	ADJ
fnp-3166	184	29	injury	injury	NOUN
fnp-3166	184	30	,	,	PUNCT
fnp-3166	184	31	and	and	CCONJ
fnp-3166	184	32	mitochondrial	mitochondrial	ADJ
fnp-3166	184	33	damage	damage	NOUN
fnp-3166	184	34	(	(	PUNCT
fnp-3166	184	35	zrzavy	zrzavy	NOUN
fnp-3166	184	36	et	et	PROPN
fnp-3166	184	37	al	al	PROPN
fnp-3166	184	38	.	.	PROPN
fnp-3166	184	39	2017	2017	NUM
fnp-3166	184	40	,	,	PUNCT
fnp-3166	184	41	2018	2018	NUM
fnp-3166	184	42	,	,	PUNCT
fnp-3166	184	43	mahad	mahad	PROPN
fnp-3166	184	44	et	et	PROPN
fnp-3166	184	45	al	al	PROPN
fnp-3166	184	46	.	.	PROPN
fnp-3166	184	47	2015	2015	NUM
fnp-3166	184	48	)	)	PUNCT
fnp-3166	184	49	.	.	PUNCT
fnp-3166	185	1	a	a	DET
fnp-3166	185	2	strategically	strategically	ADV
fnp-3166	185	3	important	important	ADJ
fnp-3166	185	4	piece	piece	NOUN
fnp-3166	185	5	in	in	ADP
fnp-3166	185	6	the	the	DET
fnp-3166	185	7	puzzle	puzzle	NOUN
fnp-3166	185	8	of	of	ADP
fnp-3166	185	9	vascular	vascular	ADJ
fnp-3166	185	10	comorbidities	comorbiditie	NOUN
fnp-3166	185	11	and	and	CCONJ
fnp-3166	185	12	ms	ms	NOUN
fnp-3166	185	13	,	,	PUNCT
fnp-3166	185	14	which	which	PRON
fnp-3166	185	15	was	be	AUX
fnp-3166	185	16	missing	miss	VERB
fnp-3166	185	17	so	so	ADV
fnp-3166	185	18	far	far	ADV
fnp-3166	185	19	,	,	PUNCT
fnp-3166	185	20	was	be	AUX
fnp-3166	185	21	the	the	DET
fnp-3166	185	22	lack	lack	NOUN
fnp-3166	185	23	of	of	ADP
fnp-3166	185	24	a	a	DET
fnp-3166	185	25	comprehensive	comprehensive	ADJ
fnp-3166	185	26	neuropathological	neuropathological	ADJ
fnp-3166	185	27	description	description	NOUN
fnp-3166	185	28	of	of	ADP
fnp-3166	185	29	systemic	systemic	ADJ
fnp-3166	185	30	and	and	CCONJ
fnp-3166	185	31	intracranial	intracranial	ADJ
fnp-3166	185	32	vascular	vascular	ADJ
fnp-3166	185	33	pathology	pathology	NOUN
fnp-3166	185	34	in	in	ADP
fnp-3166	185	35	patients	patient	NOUN
fnp-3166	185	36	versus	versus	ADP
fnp-3166	185	37	controls	control	NOUN
fnp-3166	185	38	.	.	PUNCT
fnp-3166	186	1	this	this	DET
fnp-3166	186	2	information	information	NOUN
fnp-3166	186	3	has	have	AUX
fnp-3166	186	4	now	now	ADV
fnp-3166	186	5	been	be	AUX
fnp-3166	186	6	provided	provide	VERB
fnp-3166	186	7	by	by	ADP
fnp-3166	186	8	a	a	DET
fnp-3166	186	9	study	study	NOUN
fnp-3166	186	10	,	,	PUNCT
fnp-3166	186	11	which	which	PRON
fnp-3166	186	12	is	be	AUX
fnp-3166	186	13	based	base	VERB
fnp-3166	186	14	on	on	ADP
fnp-3166	186	15	a	a	DET
fnp-3166	186	16	unique	unique	ADJ
fnp-3166	186	17	archival	archival	NOUN
fnp-3166	186	18	collection	collection	NOUN
fnp-3166	186	19	of	of	ADP
fnp-3166	186	20	ms	ms	NOUN
fnp-3166	186	21	and	and	CCONJ
fnp-3166	186	22	control	control	VERB
fnp-3166	186	23	autopsy	autopsy	ADJ
fnp-3166	186	24	cases	case	NOUN
fnp-3166	186	25	,	,	PUNCT
fnp-3166	186	26	where	where	SCONJ
fnp-3166	186	27	detailed	detailed	ADJ
fnp-3166	186	28	information	information	NOUN
fnp-3166	186	29	regarding	regard	VERB
fnp-3166	186	30	systemic	systemic	ADJ
fnp-3166	186	31	vascular	vascular	ADJ
fnp-3166	186	32	diseases	disease	NOUN
fnp-3166	186	33	was	be	AUX
fnp-3166	186	34	recorded	record	VERB
fnp-3166	186	35	,	,	PUNCT
fnp-3166	186	36	and	and	CCONJ
fnp-3166	186	37	which	which	PRON
fnp-3166	186	38	was	be	AUX
fnp-3166	186	39	collected	collect	VERB
fnp-3166	186	40	prior	prior	ADV
fnp-3166	186	41	to	to	ADP
fnp-3166	186	42	the	the	DET
fnp-3166	186	43	availability	availability	NOUN
fnp-3166	186	44	of	of	ADP
fnp-3166	186	45	disease	disease	NOUN
fnp-3166	186	46	modifying	modify	VERB
fnp-3166	186	47	treatments	treatment	NOUN
fnp-3166	186	48	(	(	PUNCT
fnp-3166	186	49	geraldes	geralde	NOUN
fnp-3166	186	50	et	et	PROPN
fnp-3166	186	51	al	al	PROPN
fnp-3166	186	52	.	.	PROPN
fnp-3166	186	53	2020	2020	NUM
fnp-3166	186	54	)	)	PUNCT
fnp-3166	186	55	.	.	PUNCT
fnp-3166	187	1	the	the	DET
fnp-3166	187	2	study	study	NOUN
fnp-3166	187	3	shows	show	VERB
fnp-3166	187	4	,	,	PUNCT
fnp-3166	187	5	as	as	SCONJ
fnp-3166	187	6	expected	expect	VERB
fnp-3166	187	7	,	,	PUNCT
fnp-3166	187	8	that	that	SCONJ
fnp-3166	187	9	systemic	systemic	ADJ
fnp-3166	187	10	and	and	CCONJ
fnp-3166	187	11	intracranial	intracranial	ADJ
fnp-3166	187	12	vascular	vascular	ADJ
fnp-3166	187	13	abnormalities	abnormality	NOUN
fnp-3166	187	14	increase	increase	VERB
fnp-3166	187	15	with	with	ADP
fnp-3166	187	16	age	age	NOUN
fnp-3166	187	17	in	in	ADP
fnp-3166	187	18	both	both	CCONJ
fnp-3166	187	19	the	the	DET
fnp-3166	187	20	ms	ms	NOUN
fnp-3166	187	21	and	and	CCONJ
fnp-3166	187	22	the	the	DET
fnp-3166	187	23	control	control	NOUN
fnp-3166	187	24	group	group	NOUN
fnp-3166	187	25	.	.	PUNCT
fnp-3166	188	1	young	young	ADJ
fnp-3166	188	2	ms	ms	PROPN
fnp-3166	188	3	patients	patient	NOUN
fnp-3166	188	4	appear	appear	VERB
fnp-3166	188	5	to	to	PART
fnp-3166	188	6	have	have	VERB
fnp-3166	188	7	a	a	DET
fnp-3166	188	8	moderate	moderate	ADJ
fnp-3166	188	9	reduction	reduction	NOUN
fnp-3166	188	10	of	of	ADP
fnp-3166	188	11	systemic	systemic	ADJ
fnp-3166	188	12	vascular	vascular	ADJ
fnp-3166	188	13	co	co	NOUN
fnp-3166	188	14	-	-	NOUN
fnp-3166	188	15	morbidities	morbidity	NOUN
fnp-3166	188	16	compared	compare	VERB
fnp-3166	188	17	to	to	ADP
fnp-3166	188	18	controls	control	NOUN
fnp-3166	188	19	,	,	PUNCT
fnp-3166	188	20	but	but	CCONJ
fnp-3166	188	21	this	this	DET
fnp-3166	188	22	difference	difference	NOUN
fnp-3166	188	23	disappears	disappear	VERB
fnp-3166	188	24	with	with	ADP
fnp-3166	188	25	aging	aging	NOUN
fnp-3166	188	26	.	.	PUNCT
fnp-3166	189	1	within	within	ADP
fnp-3166	189	2	the	the	DET
fnp-3166	189	3	central	central	ADJ
fnp-3166	189	4	nervous	nervous	ADJ
fnp-3166	189	5	system	system	NOUN
fnp-3166	189	6	,	,	PUNCT
fnp-3166	189	7	ms	ms	PROPN
fnp-3166	189	8	patients	patient	NOUN
fnp-3166	189	9	showed	show	VERB
fnp-3166	189	10	a	a	DET
fnp-3166	189	11	profound	profound	ADJ
fnp-3166	189	12	increase	increase	NOUN
fnp-3166	189	13	in	in	ADP
fnp-3166	189	14	small	small	ADJ
fnp-3166	189	15	arteries	artery	NOUN
fnp-3166	189	16	with	with	ADP
fnp-3166	189	17	increased	increase	VERB
fnp-3166	189	18	perivascular	perivascular	ADJ
fnp-3166	189	19	space	space	NOUN
fnp-3166	189	20	,	,	PUNCT
fnp-3166	189	21	perivascular	perivascular	ADJ
fnp-3166	189	22	hemosiderin	hemosiderin	NOUN
fnp-3166	189	23	depositions	deposition	NOUN
fnp-3166	189	24	and	and	CCONJ
fnp-3166	189	25	periarteriolar	periarteriolar	ADJ
fnp-3166	189	26	accumulation	accumulation	NOUN
fnp-3166	189	27	of	of	ADP
fnp-3166	189	28	inflammatory	inflammatory	ADJ
fnp-3166	189	29	cells	cell	NOUN
fnp-3166	189	30	,	,	PUNCT
fnp-3166	189	31	a	a	DET
fnp-3166	189	32	type	type	NOUN
fnp-3166	189	33	of	of	ADP
fnp-3166	189	34	pathology	pathology	NOUN
fnp-3166	189	35	which	which	PRON
fnp-3166	189	36	correlated	correlate	VERB
fnp-3166	189	37	in	in	ADP
fnp-3166	189	38	its	its	PRON
fnp-3166	189	39	extent	extent	NOUN
fnp-3166	189	40	with	with	ADP
fnp-3166	189	41	the	the	DET
fnp-3166	189	42	degree	degree	NOUN
fnp-3166	189	43	of	of	ADP
fnp-3166	189	44	ms	ms	NOUN
fnp-3166	189	45	-	-	PUNCT
fnp-3166	189	46	related	relate	VERB
fnp-3166	189	47	pathology	pathology	NOUN
fnp-3166	189	48	.	.	PUNCT
fnp-3166	190	1	these	these	DET
fnp-3166	190	2	results	result	NOUN
fnp-3166	190	3	underline	underline	VERB
fnp-3166	190	4	the	the	DET
fnp-3166	190	5	presence	presence	NOUN
fnp-3166	190	6	of	of	ADP
fnp-3166	190	7	age	age	NOUN
fnp-3166	190	8	-	-	PUNCT
fnp-3166	190	9	related	relate	VERB
fnp-3166	190	10	vascular	vascular	ADJ
fnp-3166	190	11	co	co	NOUN
fnp-3166	190	12	-	-	NOUN
fnp-3166	190	13	morbidities	morbidity	NOUN
fnp-3166	190	14	in	in	ADP
fnp-3166	190	15	the	the	DET
fnp-3166	190	16	brain	brain	NOUN
fnp-3166	190	17	of	of	ADP
fnp-3166	190	18	ms	ms	NOUN
fnp-3166	190	19	patients	patient	NOUN
fnp-3166	190	20	,	,	PUNCT
fnp-3166	190	21	which	which	PRON
fnp-3166	190	22	may	may	AUX
fnp-3166	190	23	be	be	AUX
fnp-3166	190	24	an	an	DET
fnp-3166	190	25	amplification	amplification	NOUN
fnp-3166	190	26	factor	factor	NOUN
fnp-3166	190	27	for	for	ADP
fnp-3166	190	28	neurodegeneration	neurodegeneration	NOUN
fnp-3166	190	29	and	and	CCONJ
fnp-3166	190	30	disease	disease	NOUN
fnp-3166	190	31	progression	progression	NOUN
fnp-3166	190	32	in	in	ADP
fnp-3166	190	33	aging	age	VERB
fnp-3166	190	34	patients	patient	NOUN
fnp-3166	190	35	.	.	PUNCT
fnp-3166	191	1	additionally	additionally	ADV
fnp-3166	191	2	,	,	PUNCT
fnp-3166	191	3	they	they	PRON
fnp-3166	191	4	indicate	indicate	VERB
fnp-3166	191	5	that	that	SCONJ
fnp-3166	191	6	,	,	PUNCT
fnp-3166	191	7	in	in	ADP
fnp-3166	191	8	contrast	contrast	NOUN
fnp-3166	191	9	to	to	ADP
fnp-3166	191	10	the	the	DET
fnp-3166	191	11	current	current	ADJ
fnp-3166	191	12	view	view	NOUN
fnp-3166	191	13	,	,	PUNCT
fnp-3166	191	14	vascular	vascular	ADJ
fnp-3166	191	15	pathology	pathology	NOUN
fnp-3166	191	16	is	be	AUX
fnp-3166	191	17	not	not	PART
fnp-3166	191	18	restricted	restrict	VERB
fnp-3166	191	19	to	to	ADP
fnp-3166	191	20	veins	vein	NOUN
fnp-3166	191	21	but	but	CCONJ
fnp-3166	191	22	also	also	ADV
fnp-3166	191	23	affects	affect	VERB
fnp-3166	191	24	small	small	ADJ
fnp-3166	191	25	arteries	artery	NOUN
fnp-3166	191	26	,	,	PUNCT
fnp-3166	191	27	and	and	CCONJ
fnp-3166	191	28	this	this	DET
fnp-3166	191	29	arterial	arterial	ADJ
fnp-3166	191	30	pathology	pathology	NOUN
fnp-3166	191	31	develops	develop	VERB
fnp-3166	191	32	at	at	ADP
fnp-3166	191	33	least	least	ADJ
fnp-3166	191	34	in	in	ADP
fnp-3166	191	35	part	part	NOUN
fnp-3166	191	36	independently	independently	ADV
fnp-3166	191	37	from	from	ADP
fnp-3166	191	38	systemic	systemic	ADJ
fnp-3166	191	39	vascular	vascular	ADJ
fnp-3166	191	40	risk	risk	NOUN
fnp-3166	191	41	factors	factor	NOUN
fnp-3166	191	42	.	.	PUNCT
fnp-3166	192	1	in	in	ADP
fnp-3166	192	2	particular	particular	ADJ
fnp-3166	192	3	,	,	PUNCT
fnp-3166	192	4	the	the	DET
fnp-3166	192	5	mechanisms	mechanism	NOUN
fnp-3166	192	6	how	how	SCONJ
fnp-3166	192	7	inflammatory	inflammatory	ADJ
fnp-3166	192	8	infiltrates	infiltrate	NOUN
fnp-3166	192	9	accumulate	accumulate	VERB
fnp-3166	192	10	around	around	ADP
fnp-3166	192	11	arteries	artery	NOUN
fnp-3166	192	12	in	in	ADP
fnp-3166	192	13	the	the	DET
fnp-3166	192	14	ms	ms	PROPN
fnp-3166	192	15	brain	brain	NOUN
fnp-3166	192	16	requires	require	VERB
fnp-3166	192	17	further	further	ADJ
fnp-3166	192	18	attention	attention	NOUN
fnp-3166	192	19	.	.	PUNCT
fnp-3166	193	1	9	9	X
fnp-3166	193	2	)	)	PUNCT
fnp-3166	193	3	what	what	PRON
fnp-3166	193	4	is	be	AUX
fnp-3166	193	5	wrong	wrong	ADJ
fnp-3166	193	6	with	with	ADP
fnp-3166	193	7	remyelination	remyelination	NOUN
fnp-3166	193	8	in	in	ADP
fnp-3166	193	9	multiple	multiple	ADJ
fnp-3166	193	10	sclerosis	sclerosis	NOUN
fnp-3166	193	11	?	?	PUNCT
fnp-3166	194	1	primary	primary	ADJ
fnp-3166	194	2	demyelination	demyelination	NOUN
fnp-3166	194	3	with	with	ADP
fnp-3166	194	4	preservation	preservation	NOUN
fnp-3166	194	5	of	of	ADP
fnp-3166	194	6	axons	axon	NOUN
fnp-3166	194	7	is	be	AUX
fnp-3166	194	8	the	the	DET
fnp-3166	194	9	pathological	pathological	ADJ
fnp-3166	194	10	hallmark	hallmark	NOUN
fnp-3166	194	11	of	of	ADP
fnp-3166	194	12	inflammatory	inflammatory	ADJ
fnp-3166	194	13	demyelinating	demyelinate	VERB
fnp-3166	194	14	diseases	disease	NOUN
fnp-3166	194	15	,	,	PUNCT
fnp-3166	194	16	such	such	ADJ
fnp-3166	194	17	as	as	ADP
fnp-3166	194	18	ms	ms	PROPN
fnp-3166	194	19	.	.	PROPN
fnp-3166	194	20	myelin	myelin	PROPN
fnp-3166	194	21	allows	allow	VERB
fnp-3166	194	22	saltatory	saltatory	ADJ
fnp-3166	194	23	conduction	conduction	NOUN
fnp-3166	194	24	in	in	ADP
fnp-3166	194	25	axons	axon	NOUN
fnp-3166	194	26	and	and	CCONJ
fnp-3166	194	27	also	also	ADV
fnp-3166	194	28	protects	protect	VERB
fnp-3166	194	29	the	the	DET
fnp-3166	194	30	axons	axon	NOUN
fnp-3166	194	31	from	from	ADP
fnp-3166	194	32	neurodegeneration	neurodegeneration	NOUN
fnp-3166	194	33	.	.	PUNCT
fnp-3166	195	1	thus	thus	ADV
fnp-3166	195	2	,	,	PUNCT
fnp-3166	195	3	major	major	ADJ
fnp-3166	195	4	efforts	effort	NOUN
fnp-3166	195	5	in	in	ADP
fnp-3166	195	6	ms	ms	PROPN
fnp-3166	195	7	research	research	NOUN
fnp-3166	195	8	have	have	AUX
fnp-3166	195	9	been	be	AUX
fnp-3166	195	10	devoted	devote	VERB
fnp-3166	195	11	to	to	PART
fnp-3166	195	12	develop	develop	VERB
fnp-3166	195	13	treatments	treatment	NOUN
fnp-3166	195	14	which	which	PRON
fnp-3166	195	15	prevent	prevent	VERB
fnp-3166	195	16	demyelination	demyelination	NOUN
fnp-3166	195	17	or	or	CCONJ
fnp-3166	195	18	stimulate	stimulate	VERB
fnp-3166	195	19	myelin	myelin	NOUN
fnp-3166	195	20	repair	repair	NOUN
fnp-3166	195	21	(	(	PUNCT
fnp-3166	195	22	lubetzki	lubetzki	PROPN
fnp-3166	195	23	et	et	PROPN
fnp-3166	195	24	al	al	PROPN
fnp-3166	195	25	.	.	PROPN
fnp-3166	195	26	2020	2020	NUM
fnp-3166	195	27	)	)	PUNCT
fnp-3166	195	28	.	.	PUNCT
fnp-3166	196	1	these	these	DET
fnp-3166	196	2	repair	repair	NOUN
fnp-3166	196	3	strategies	strategy	NOUN
fnp-3166	196	4	,	,	PUNCT
fnp-3166	196	5	mainly	mainly	ADV
fnp-3166	196	6	designed	design	VERB
fnp-3166	196	7	to	to	PART
fnp-3166	196	8	provide	provide	VERB
fnp-3166	196	9	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	196	10	progenitor	progenitor	NOUN
fnp-3166	196	11	cells	cell	NOUN
fnp-3166	196	12	in	in	ADP
fnp-3166	196	13	the	the	DET
fnp-3166	196	14	lesions	lesion	NOUN
fnp-3166	196	15	and	and	CCONJ
fnp-3166	196	16	to	to	PART
fnp-3166	196	17	stimulate	stimulate	VERB
fnp-3166	196	18	their	their	PRON
fnp-3166	196	19	differentiation	differentiation	NOUN
fnp-3166	196	20	into	into	ADP
fnp-3166	196	21	myelinating	myelinate	VERB
fnp-3166	196	22	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	196	23	,	,	PUNCT
fnp-3166	196	24	have	have	AUX
fnp-3166	196	25	been	be	AUX
fnp-3166	196	26	developed	develop	VERB
fnp-3166	196	27	and	and	CCONJ
fnp-3166	196	28	tested	test	VERB
fnp-3166	196	29	in	in	ADP
fnp-3166	196	30	experimental	experimental	ADJ
fnp-3166	196	31	models	model	NOUN
fnp-3166	196	32	of	of	ADP
fnp-3166	196	33	demyelinating	demyelinate	VERB
fnp-3166	196	34	disease	disease	NOUN
fnp-3166	196	35	and	and	CCONJ
fnp-3166	196	36	found	find	VERB
fnp-3166	196	37	to	to	PART
fnp-3166	196	38	be	be	AUX
fnp-3166	196	39	quite	quite	ADV
fnp-3166	196	40	effective	effective	ADJ
fnp-3166	196	41	.	.	PUNCT
fnp-3166	197	1	however	however	ADV
fnp-3166	197	2	,	,	PUNCT
fnp-3166	197	3	none	none	NOUN
fnp-3166	197	4	of	of	ADP
fnp-3166	197	5	the	the	DET
fnp-3166	197	6	strategies	strategy	NOUN
fnp-3166	197	7	have	have	AUX
fnp-3166	197	8	yet	yet	ADV
fnp-3166	197	9	resulted	result	VERB
fnp-3166	197	10	in	in	ADP
fnp-3166	197	11	clinically	clinically	ADV
fnp-3166	197	12	meaningful	meaningful	ADJ
fnp-3166	197	13	myelin	myelin	ADJ
fnp-3166	197	14	repair	repair	NOUN
fnp-3166	197	15	in	in	ADP
fnp-3166	197	16	controlled	control	VERB
fnp-3166	197	17	clinical	clinical	ADJ
fnp-3166	197	18	trials	trial	NOUN
fnp-3166	197	19	in	in	ADP
fnp-3166	197	20	ms	ms	ADJ
fnp-3166	197	21	patients	patient	NOUN
fnp-3166	197	22	.	.	PUNCT
fnp-3166	198	1	in	in	ADP
fnp-3166	198	2	experimental	experimental	ADJ
fnp-3166	198	3	models	model	NOUN
fnp-3166	198	4	of	of	ADP
fnp-3166	198	5	demyelinating	demyelinate	VERB
fnp-3166	198	6	disease	disease	NOUN
fnp-3166	198	7	,	,	PUNCT
fnp-3166	198	8	profound	profound	ADJ
fnp-3166	198	9	spontaneous	spontaneous	ADJ
fnp-3166	198	10	remyelination	remyelination	NOUN
fnp-3166	198	11	is	be	AUX
fnp-3166	198	12	the	the	DET
fnp-3166	198	13	rule	rule	NOUN
fnp-3166	198	14	,	,	PUNCT
fnp-3166	198	15	and	and	CCONJ
fnp-3166	198	16	remyelination	remyelination	NOUN
fnp-3166	198	17	stimulating	stimulate	VERB
fnp-3166	198	18	therapies	therapy	NOUN
fnp-3166	198	19	in	in	ADP
fnp-3166	198	20	essence	essence	NOUN
fnp-3166	198	21	accelerate	accelerate	NOUN
fnp-3166	198	22	myelin	myelin	ADJ
fnp-3166	198	23	repair	repair	NOUN
fnp-3166	198	24	.	.	PUNCT
fnp-3166	199	1	although	although	SCONJ
fnp-3166	199	2	spontaneous	spontaneous	ADJ
fnp-3166	199	3	remyelination	remyelination	NOUN
fnp-3166	199	4	may	may	AUX
fnp-3166	199	5	also	also	ADV
fnp-3166	199	6	occur	occur	VERB
fnp-3166	199	7	in	in	ADP
fnp-3166	199	8	ms	ms	ADJ
fnp-3166	199	9	patients	patient	NOUN
fnp-3166	199	10	,	,	PUNCT
fnp-3166	199	11	in	in	ADP
fnp-3166	199	12	particular	particular	ADJ
fnp-3166	199	13	in	in	ADP
fnp-3166	199	14	fresh	fresh	ADJ
fnp-3166	199	15	lesions	lesion	NOUN
fnp-3166	199	16	at	at	ADP
fnp-3166	199	17	early	early	ADJ
fnp-3166	199	18	disease	disease	NOUN
fnp-3166	199	19	stages	stage	NOUN
fnp-3166	199	20	,	,	PUNCT
fnp-3166	199	21	remyelination	remyelination	NOUN
fnp-3166	199	22	is	be	AUX
fnp-3166	199	23	,	,	PUNCT
fnp-3166	199	24	in	in	ADP
fnp-3166	199	25	general	general	ADJ
fnp-3166	199	26	,	,	PUNCT
fnp-3166	199	27	sparse	sparse	ADJ
fnp-3166	199	28	or	or	CCONJ
fnp-3166	199	29	absent	absent	ADJ
fnp-3166	199	30	.	.	PUNCT
fnp-3166	200	1	several	several	ADJ
fnp-3166	200	2	different	different	ADJ
fnp-3166	200	3	mechanisms	mechanism	NOUN
fnp-3166	200	4	have	have	AUX
fnp-3166	200	5	been	be	AUX
fnp-3166	200	6	suggested	suggest	VERB
fnp-3166	200	7	to	to	PART
fnp-3166	200	8	be	be	AUX
fnp-3166	200	9	responsible	responsible	ADJ
fnp-3166	200	10	for	for	ADP
fnp-3166	200	11	this	this	DET
fnp-3166	200	12	remyelination	remyelination	NOUN
fnp-3166	200	13	failure	failure	NOUN
fnp-3166	200	14	in	in	ADP
fnp-3166	200	15	ms	ms	ADJ
fnp-3166	200	16	lesions	lesion	NOUN
fnp-3166	200	17	.	.	PUNCT
fnp-3166	201	1	it	it	PRON
fnp-3166	201	2	may	may	AUX
fnp-3166	201	3	be	be	AUX
fnp-3166	201	4	due	due	ADJ
fnp-3166	201	5	to	to	ADP
fnp-3166	201	6	a	a	DET
fnp-3166	201	7	genuine	genuine	ADJ
fnp-3166	201	8	defect	defect	NOUN
fnp-3166	201	9	in	in	ADP
fnp-3166	201	10	oligodendrocyte	oligodendrocyte	NOUN
fnp-3166	201	11	(	(	PUNCT
fnp-3166	201	12	progenitor	progenitor	NOUN
fnp-3166	201	13	)	)	PUNCT
fnp-3166	201	14	biology	biology	NOUN
fnp-3166	201	15	.	.	PUNCT
fnp-3166	202	1	in	in	ADP
fnp-3166	202	2	an	an	DET
fnp-3166	202	3	elegant	elegant	ADJ
fnp-3166	202	4	study	study	NOUN
fnp-3166	202	5	,	,	PUNCT
fnp-3166	202	6	starost	starost	NOUN
fnp-3166	202	7	et	et	PROPN
fnp-3166	202	8	al	al	PROPN
fnp-3166	202	9	.	.	PROPN
fnp-3166	203	1	(	(	PUNCT
fnp-3166	203	2	2020	2020	NUM
fnp-3166	203	3	)	)	PUNCT
fnp-3166	203	4	approached	approach	VERB
fnp-3166	203	5	this	this	DET
fnp-3166	203	6	question	question	NOUN
fnp-3166	203	7	by	by	ADP
fnp-3166	203	8	studying	study	VERB
fnp-3166	203	9	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	203	10	,	,	PUNCT
fnp-3166	203	11	induced	induce	VERB
fnp-3166	203	12	from	from	ADP
fnp-3166	203	13	pluripotent	pluripotent	ADJ
fnp-3166	203	14	stem	stem	NOUN
fnp-3166	203	15	cells	cell	NOUN
fnp-3166	203	16	from	from	ADP
fnp-3166	203	17	ms	ms	PROPN
fnp-3166	203	18	patients	patient	NOUN
fnp-3166	203	19	and	and	CCONJ
fnp-3166	203	20	controls	control	NOUN
fnp-3166	203	21	.	.	PUNCT
fnp-3166	204	1	they	they	PRON
fnp-3166	204	2	show	show	VERB
fnp-3166	204	3	that	that	SCONJ
fnp-3166	204	4	there	there	PRON
fnp-3166	204	5	is	be	VERB
fnp-3166	204	6	no	no	DET
fnp-3166	204	7	difference	difference	NOUN
fnp-3166	204	8	in	in	ADP
fnp-3166	204	9	the	the	DET
fnp-3166	204	10	proliferation	proliferation	NOUN
fnp-3166	204	11	,	,	PUNCT
fnp-3166	204	12	differentiation	differentiation	NOUN
fnp-3166	204	13	and	and	CCONJ
fnp-3166	204	14	myelin	myelin	NOUN
fnp-3166	204	15	production	production	NOUN
fnp-3166	204	16	between	between	ADP
fnp-3166	204	17	such	such	ADJ
fnp-3166	204	18	cells	cell	NOUN
fnp-3166	204	19	derived	derive	VERB
fnp-3166	204	20	from	from	ADP
fnp-3166	204	21	ms	ms	PROPN
fnp-3166	204	22	patients	patient	NOUN
fnp-3166	204	23	and	and	CCONJ
fnp-3166	204	24	from	from	ADP
fnp-3166	204	25	controls	control	NOUN
fnp-3166	204	26	,	,	PUNCT
fnp-3166	204	27	thus	thus	ADV
fnp-3166	204	28	strongly	strongly	ADV
fnp-3166	204	29	suggesting	suggest	VERB
fnp-3166	204	30	that	that	SCONJ
fnp-3166	204	31	there	there	PRON
fnp-3166	204	32	is	be	VERB
fnp-3166	204	33	no	no	DET
fnp-3166	204	34	genuine	genuine	ADJ
fnp-3166	204	35	defect	defect	NOUN
fnp-3166	204	36	of	of	ADP
fnp-3166	204	37	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	204	38	in	in	ADP
fnp-3166	204	39	ms	ms	ADJ
fnp-3166	204	40	patients	patient	NOUN
fnp-3166	204	41	,	,	PUNCT
fnp-3166	204	42	though	though	SCONJ
fnp-3166	204	43	with	with	ADP
fnp-3166	204	44	the	the	DET
fnp-3166	204	45	caveat	caveat	NOUN
fnp-3166	204	46	that	that	SCONJ
fnp-3166	204	47	this	this	PRON
fnp-3166	204	48	was	be	AUX
fnp-3166	204	49	only	only	ADV
fnp-3166	204	50	performed	perform	VERB
fnp-3166	204	51	in	in	ADP
fnp-3166	204	52	cells	cell	NOUN
fnp-3166	204	53	induced	induce	VERB
fnp-3166	204	54	to	to	PART
fnp-3166	204	55	form	form	VERB
fnp-3166	204	56	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	204	57	with	with	ADP
fnp-3166	204	58	expression	expression	NOUN
fnp-3166	204	59	of	of	ADP
fnp-3166	204	60	transcriptional	transcriptional	ADJ
fnp-3166	204	61	factors	factor	NOUN
fnp-3166	204	62	from	from	ADP
fnp-3166	204	63	three	three	NUM
fnp-3166	204	64	ms	ms	ADJ
fnp-3166	204	65	patients	patient	NOUN
fnp-3166	204	66	and	and	CCONJ
fnp-3166	204	67	three	three	NUM
fnp-3166	204	68	controls	control	NOUN
fnp-3166	204	69	.	.	PUNCT
fnp-3166	205	1	in	in	ADP
fnp-3166	205	2	a	a	DET
fnp-3166	205	3	parallel	parallel	ADJ
fnp-3166	205	4	neuropathological	neuropathological	ADJ
fnp-3166	205	5	approach	approach	NOUN
fnp-3166	205	6	,	,	PUNCT
fnp-3166	205	7	the	the	DET
fnp-3166	205	8	same	same	ADJ
fnp-3166	205	9	group	group	NOUN
fnp-3166	205	10	analyzed	analyze	VERB
fnp-3166	205	11	the	the	DET
fnp-3166	205	12	patterns	pattern	NOUN
fnp-3166	205	13	or	or	CCONJ
fnp-3166	205	14	remyelination	remyelination	NOUN
fnp-3166	205	15	in	in	ADP
fnp-3166	205	16	different	different	ADJ
fnp-3166	205	17	disease	disease	NOUN
fnp-3166	205	18	stages	stage	NOUN
fnp-3166	205	19	of	of	ADP
fnp-3166	205	20	ms	ms	NOUN
fnp-3166	205	21	and	and	CCONJ
fnp-3166	205	22	in	in	ADP
fnp-3166	205	23	different	different	ADJ
fnp-3166	205	24	stages	stage	NOUN
fnp-3166	205	25	of	of	ADP
fnp-3166	205	26	lesion	lesion	NOUN
fnp-3166	205	27	formation	formation	NOUN
fnp-3166	205	28	(	(	PUNCT
fnp-3166	205	29	heß	heß	NOUN
fnp-3166	205	30	et	et	PROPN
fnp-3166	205	31	al	al	PROPN
fnp-3166	205	32	.	.	PROPN
fnp-3166	205	33	2020	2020	NUM
fnp-3166	205	34	)	)	PUNCT
fnp-3166	205	35	.	.	PUNCT
fnp-3166	206	1	they	they	PRON
fnp-3166	206	2	found	find	VERB
fnp-3166	206	3	that	that	SCONJ
fnp-3166	206	4	remyelination	remyelination	NOUN
fnp-3166	206	5	is	be	AUX
fnp-3166	206	6	highly	highly	ADV
fnp-3166	206	7	efficient	efficient	ADJ
fnp-3166	206	8	in	in	ADP
fnp-3166	206	9	a	a	DET
fnp-3166	206	10	subset	subset	NOUN
fnp-3166	206	11	of	of	ADP
fnp-3166	206	12	active	active	ADJ
fnp-3166	206	13	lesions	lesion	NOUN
fnp-3166	206	14	in	in	ADP
fnp-3166	206	15	the	the	DET
fnp-3166	206	16	early	early	ADJ
fnp-3166	206	17	stage	stage	NOUN
fnp-3166	206	18	of	of	ADP
fnp-3166	206	19	the	the	DET
fnp-3166	206	20	disease	disease	NOUN
fnp-3166	206	21	,	,	PUNCT
fnp-3166	206	22	and	and	CCONJ
fnp-3166	206	23	their	their	PRON
fnp-3166	206	24	data	datum	NOUN
fnp-3166	206	25	suggest	suggest	VERB
fnp-3166	206	26	that	that	SCONJ
fnp-3166	206	27	the	the	DET
fnp-3166	206	28	remyelinating	remyelinate	VERB
fnp-3166	206	29	cells	cell	NOUN
fnp-3166	206	30	may	may	AUX
fnp-3166	206	31	be	be	AUX
fnp-3166	206	32	derived	derive	VERB
fnp-3166	206	33	from	from	ADP
fnp-3166	206	34	mature	mature	ADJ
fnp-3166	206	35	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	206	36	that	that	PRON
fnp-3166	206	37	had	have	AUX
fnp-3166	206	38	survived	survive	VERB
fnp-3166	206	39	active	active	ADJ
fnp-3166	206	40	myelin	myelin	ADJ
fnp-3166	206	41	destruction	destruction	NOUN
fnp-3166	206	42	.	.	PUNCT
fnp-3166	207	1	this	this	PRON
fnp-3166	207	2	has	have	AUX
fnp-3166	207	3	also	also	ADV
fnp-3166	207	4	been	be	AUX
fnp-3166	207	5	suggested	suggest	VERB
fnp-3166	207	6	in	in	ADP
fnp-3166	207	7	recent	recent	ADJ
fnp-3166	207	8	studies	study	NOUN
fnp-3166	207	9	,	,	PUNCT
fnp-3166	207	10	using	use	VERB
fnp-3166	207	11	radiocarbon	radiocarbon	NOUN
fnp-3166	207	12	methods	method	NOUN
fnp-3166	207	13	to	to	PART
fnp-3166	207	14	determine	determine	VERB
fnp-3166	207	15	the	the	DET
fnp-3166	207	16	time	time	NOUN
fnp-3166	207	17	of	of	ADP
fnp-3166	207	18	birth	birth	NOUN
fnp-3166	207	19	of	of	ADP
fnp-3166	207	20	new	new	ADJ
fnp-3166	207	21	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	207	22	in	in	ADP
fnp-3166	207	23	ms	ms	ADJ
fnp-3166	207	24	lesions	lesion	NOUN
fnp-3166	207	25	(	(	PUNCT
fnp-3166	207	26	yeung	yeung	PROPN
fnp-3166	207	27	et	et	PROPN
fnp-3166	207	28	al	al	PROPN
fnp-3166	207	29	.	.	PROPN
fnp-3166	207	30	2019	2019	NUM
fnp-3166	207	31	)	)	PUNCT
fnp-3166	207	32	.	.	PUNCT
fnp-3166	208	1	in	in	ADP
fnp-3166	208	2	contrast	contrast	NOUN
fnp-3166	208	3	,	,	PUNCT
fnp-3166	208	4	in	in	ADP
fnp-3166	208	5	chronic	chronic	ADJ
fnp-3166	208	6	active	active	ADJ
fnp-3166	208	7	lesions	lesion	NOUN
fnp-3166	208	8	at	at	ADP
fnp-3166	208	9	later	later	ADJ
fnp-3166	208	10	stages	stage	NOUN
fnp-3166	208	11	of	of	ADP
fnp-3166	208	12	ms	ms	NOUN
fnp-3166	208	13	,	,	PUNCT
fnp-3166	208	14	very	very	ADV
fnp-3166	208	15	little	little	ADJ
fnp-3166	208	16	remyelination	remyelination	NOUN
fnp-3166	208	17	was	be	AUX
fnp-3166	208	18	seen	see	VERB
fnp-3166	208	19	and	and	CCONJ
fnp-3166	208	20	the	the	DET
fnp-3166	208	21	lack	lack	NOUN
fnp-3166	208	22	of	of	ADP
fnp-3166	208	23	remyelination	remyelination	NOUN
fnp-3166	208	24	was	be	AUX
fnp-3166	208	25	associated	associate	VERB
fnp-3166	208	26	with	with	ADP
fnp-3166	208	27	pro	pro	ADJ
fnp-3166	208	28	-	-	ADJ
fnp-3166	208	29	inflammatory	inflammatory	ADJ
fnp-3166	208	30	activity	activity	NOUN
fnp-3166	208	31	of	of	ADP
fnp-3166	208	32	the	the	DET
fnp-3166	208	33	local	local	ADJ
fnp-3166	208	34	microglia	microglia	ADJ
fnp-3166	208	35	population	population	NOUN
fnp-3166	208	36	(	(	PUNCT
fnp-3166	208	37	heß	heß	NOUN
fnp-3166	208	38	et	et	PROPN
fnp-3166	208	39	al	al	PROPN
fnp-3166	208	40	.	.	PROPN
fnp-3166	208	41	2020	2020	NUM
fnp-3166	208	42	)	)	PUNCT
fnp-3166	208	43	.	.	PUNCT
fnp-3166	209	1	these	these	DET
fnp-3166	209	2	data	datum	NOUN
fnp-3166	209	3	suggest	suggest	VERB
fnp-3166	209	4	that	that	SCONJ
fnp-3166	209	5	products	product	NOUN
fnp-3166	209	6	of	of	ADP
fnp-3166	209	7	activated	activate	VERB
fnp-3166	209	8	inflammatory	inflammatory	ADJ
fnp-3166	209	9	cells	cell	NOUN
fnp-3166	209	10	in	in	ADP
fnp-3166	209	11	chronic	chronic	ADJ
fnp-3166	209	12	ms	ms	PROPN
fnp-3166	209	13	lesions	lesion	NOUN
fnp-3166	209	14	may	may	AUX
fnp-3166	209	15	not	not	PART
fnp-3166	209	16	only	only	ADV
fnp-3166	209	17	lead	lead	VERB
fnp-3166	209	18	to	to	ADP
fnp-3166	209	19	their	their	PRON
fnp-3166	209	20	slow	slow	ADJ
fnp-3166	209	21	expansion	expansion	NOUN
fnp-3166	209	22	but	but	CCONJ
fnp-3166	209	23	also	also	ADV
fnp-3166	209	24	inhibit	inhibit	VERB
fnp-3166	209	25	the	the	DET
fnp-3166	209	26	repair	repair	NOUN
fnp-3166	209	27	of	of	ADP
fnp-3166	209	28	myelin	myelin	NOUN
fnp-3166	209	29	.	.	PUNCT
fnp-3166	210	1	this	this	DET
fnp-3166	210	2	finding	finding	NOUN
fnp-3166	210	3	is	be	AUX
fnp-3166	210	4	also	also	ADV
fnp-3166	210	5	supported	support	VERB
fnp-3166	210	6	by	by	ADP
fnp-3166	210	7	the	the	DET
fnp-3166	210	8	other	other	ADJ
fnp-3166	210	9	study	study	NOUN
fnp-3166	210	10	(	(	PUNCT
fnp-3166	210	11	starost	starost	X
fnp-3166	210	12	et	et	PROPN
fnp-3166	210	13	al	al	PROPN
fnp-3166	210	14	.	.	PROPN
fnp-3166	210	15	2020	2020	NUM
fnp-3166	210	16	)	)	PUNCT
fnp-3166	210	17	,	,	PUNCT
fnp-3166	210	18	which	which	PRON
fnp-3166	210	19	provides	provide	VERB
fnp-3166	210	20	convincing	convincing	ADJ
fnp-3166	210	21	evidence	evidence	NOUN
fnp-3166	210	22	that	that	SCONJ
fnp-3166	210	23	pro	pro	ADJ
fnp-3166	210	24	-	-	ADJ
fnp-3166	210	25	inflammatory	inflammatory	ADJ
fnp-3166	210	26	mediators	mediator	NOUN
fnp-3166	210	27	,	,	PUNCT
fnp-3166	210	28	in	in	ADP
fnp-3166	210	29	particular	particular	ADJ
fnp-3166	210	30	gamma	gamma	NOUN
fnp-3166	210	31	-	-	PUNCT
fnp-3166	210	32	interferon	interferon	NOUN
fnp-3166	210	33	,	,	PUNCT
fnp-3166	210	34	blocks	block	VERB
fnp-3166	210	35	the	the	DET
fnp-3166	210	36	differentiation	differentiation	NOUN
fnp-3166	210	37	of	of	ADP
fnp-3166	210	38	inducible	inducible	ADJ
fnp-3166	210	39	pluripotent	pluripotent	ADJ
fnp-3166	210	40	stem	stem	NOUN
fnp-3166	210	41	cells	cell	NOUN
fnp-3166	210	42	into	into	ADP
fnp-3166	210	43	myelinating	myelinate	VERB
fnp-3166	210	44	oligodendrocytes	oligodendrocyte	NOUN
fnp-3166	210	45	.	.	PUNCT
fnp-3166	211	1	the	the	DET
fnp-3166	211	2	key	key	ADJ
fnp-3166	211	3	importance	importance	NOUN
fnp-3166	211	4	of	of	ADP
fnp-3166	211	5	these	these	DET
fnp-3166	211	6	studies	study	NOUN
fnp-3166	211	7	is	be	AUX
fnp-3166	211	8	that	that	SCONJ
fnp-3166	211	9	they	they	PRON
fnp-3166	211	10	document	document	VERB
fnp-3166	211	11	that	that	SCONJ
fnp-3166	211	12	the	the	DET
fnp-3166	211	13	process	process	NOUN
fnp-3166	211	14	of	of	ADP
fnp-3166	211	15	remyelination	remyelination	NOUN
fnp-3166	211	16	failure	failure	NOUN
fnp-3166	211	17	in	in	ADP
fnp-3166	211	18	ms	ms	PROPN
fnp-3166	211	19	is	be	AUX
fnp-3166	211	20	complex	complex	ADJ
fnp-3166	211	21	and	and	CCONJ
fnp-3166	211	22	not	not	PART
fnp-3166	211	23	fully	fully	ADV
fnp-3166	211	24	reflected	reflect	VERB
fnp-3166	211	25	in	in	ADP
fnp-3166	211	26	the	the	DET
fnp-3166	211	27	current	current	ADJ
fnp-3166	211	28	experimental	experimental	ADJ
fnp-3166	211	29	models	model	NOUN
fnp-3166	211	30	of	of	ADP
fnp-3166	211	31	inflammatory	inflammatory	ADJ
fnp-3166	211	32	demyelinating	demyelinate	VERB
fnp-3166	211	33	disease	disease	NOUN
fnp-3166	211	34	.	.	PUNCT
fnp-3166	212	1	thus	thus	ADV
fnp-3166	212	2	,	,	PUNCT
fnp-3166	212	3	for	for	ADP
fnp-3166	212	4	test	test	NOUN
fnp-3166	212	5	screening	screening	NOUN
fnp-3166	212	6	of	of	ADP
fnp-3166	212	7	remyelination	remyelination	NOUN
fnp-3166	212	8	-	-	PUNCT
fnp-3166	212	9	promoting	promote	VERB
fnp-3166	212	10	therapies	therapy	NOUN
fnp-3166	212	11	different	different	ADJ
fnp-3166	212	12	systems	system	NOUN
fnp-3166	212	13	have	have	VERB
fnp-3166	212	14	to	to	PART
fnp-3166	212	15	be	be	AUX
fnp-3166	212	16	used	use	VERB
fnp-3166	212	17	,	,	PUNCT
fnp-3166	212	18	which	which	PRON
fnp-3166	212	19	reproduce	reproduce	VERB
fnp-3166	212	20	the	the	DET
fnp-3166	212	21	inflammation	inflammation	NOUN
fnp-3166	212	22	-	-	PUNCT
fnp-3166	212	23	associated	associate	VERB
fnp-3166	212	24	remyelination	remyelination	NOUN
fnp-3166	212	25	failure	failure	NOUN
fnp-3166	212	26	.	.	PUNCT
fnp-3166	213	1	10	10	NUM
fnp-3166	213	2	)	)	PUNCT
fnp-3166	213	3	what	what	PRON
fnp-3166	213	4	can	can	AUX
fnp-3166	213	5	we	we	PRON
fnp-3166	213	6	learn	learn	VERB
fnp-3166	213	7	from	from	ADP
fnp-3166	213	8	down	down	ADP
fnp-3166	213	9	syndrome	syndrome	NOUN
fnp-3166	213	10	about	about	ADP
fnp-3166	213	11	inflammation	inflammation	NOUN
fnp-3166	213	12	and	and	CCONJ
fnp-3166	213	13	neurodegeneration	neurodegeneration	NOUN
fnp-3166	213	14	in	in	ADP
fnp-3166	213	15	alzheimer	alzheimer	PROPN
fnp-3166	213	16	’s	’s	PART
fnp-3166	213	17	disease	disease	NOUN
fnp-3166	213	18	?	?	PUNCT
fnp-3166	214	1	a	a	DET
fnp-3166	214	2	large	large	ADJ
fnp-3166	214	3	spectrum	spectrum	NOUN
fnp-3166	214	4	of	of	ADP
fnp-3166	214	5	data	datum	NOUN
fnp-3166	214	6	coming	come	VERB
fnp-3166	214	7	from	from	ADP
fnp-3166	214	8	experimental	experimental	ADJ
fnp-3166	214	9	studies	study	NOUN
fnp-3166	214	10	as	as	ADV
fnp-3166	214	11	well	well	ADV
fnp-3166	214	12	as	as	ADP
fnp-3166	214	13	from	from	ADP
fnp-3166	214	14	neuropathological	neuropathological	ADJ
fnp-3166	214	15	and	and	CCONJ
fnp-3166	214	16	genetic	genetic	ADJ
fnp-3166	214	17	investigations	investigation	NOUN
fnp-3166	214	18	suggest	suggest	VERB
fnp-3166	214	19	an	an	DET
fnp-3166	214	20	important	important	ADJ
fnp-3166	214	21	role	role	NOUN
fnp-3166	214	22	of	of	ADP
fnp-3166	214	23	innate	innate	ADJ
fnp-3166	214	24	immune	immune	ADJ
fnp-3166	214	25	mechanisms	mechanism	NOUN
fnp-3166	214	26	in	in	ADP
fnp-3166	214	27	the	the	DET
fnp-3166	214	28	pathogenesis	pathogenesis	NOUN
fnp-3166	214	29	of	of	ADP
fnp-3166	214	30	alzheimer	alzheimer	PROPN
fnp-3166	214	31	’s	’s	PART
fnp-3166	214	32	disease	disease	NOUN
fnp-3166	214	33	(	(	PUNCT
fnp-3166	214	34	akiyama	akiyama	PROPN
fnp-3166	214	35	et	et	PROPN
fnp-3166	214	36	al	al	PROPN
fnp-3166	214	37	.	.	PROPN
fnp-3166	214	38	2000	2000	NUM
fnp-3166	214	39	)	)	PUNCT
fnp-3166	214	40	.	.	PUNCT
fnp-3166	215	1	in	in	ADP
fnp-3166	215	2	particular	particular	ADJ
fnp-3166	215	3	,	,	PUNCT
fnp-3166	215	4	microglia	microglia	ADJ
fnp-3166	215	5	phenotype	phenotype	NOUN
fnp-3166	215	6	and	and	CCONJ
fnp-3166	215	7	function	function	NOUN
fnp-3166	215	8	are	be	AUX
fnp-3166	215	9	associated	associate	VERB
fnp-3166	215	10	with	with	ADP
fnp-3166	215	11	progression	progression	NOUN
fnp-3166	215	12	of	of	ADP
fnp-3166	215	13	cognitive	cognitive	ADJ
fnp-3166	215	14	decline	decline	NOUN
fnp-3166	215	15	.	.	PUNCT
fnp-3166	216	1	however	however	ADV
fnp-3166	216	2	,	,	PUNCT
fnp-3166	216	3	information	information	NOUN
fnp-3166	216	4	regarding	regard	VERB
fnp-3166	216	5	the	the	DET
fnp-3166	216	6	time	time	NOUN
fnp-3166	216	7	course	course	NOUN
fnp-3166	216	8	and	and	CCONJ
fnp-3166	216	9	type	type	NOUN
fnp-3166	216	10	of	of	ADP
fnp-3166	216	11	microglia	microglia	ADJ
fnp-3166	216	12	pathology	pathology	NOUN
fnp-3166	216	13	especially	especially	ADV
fnp-3166	216	14	in	in	ADP
fnp-3166	216	15	the	the	DET
fnp-3166	216	16	pre	pre	ADJ
fnp-3166	216	17	-	-	ADJ
fnp-3166	216	18	symptomatic	symptomatic	ADJ
fnp-3166	216	19	phases	phase	NOUN
fnp-3166	216	20	of	of	ADP
fnp-3166	216	21	the	the	DET
fnp-3166	216	22	disease	disease	NOUN
fnp-3166	216	23	is	be	AUX
fnp-3166	216	24	limited	limit	VERB
fnp-3166	216	25	.	.	PUNCT
fnp-3166	217	1	analyzing	analyze	VERB
fnp-3166	217	2	down	down	ADP
fnp-3166	217	3	syndrome	syndrome	NOUN
fnp-3166	217	4	brain	brain	NOUN
fnp-3166	217	5	pathology	pathology	NOUN
fnp-3166	217	6	of	of	ADP
fnp-3166	217	7	patients	patient	NOUN
fnp-3166	217	8	may	may	AUX
fnp-3166	217	9	provide	provide	VERB
fnp-3166	217	10	some	some	DET
fnp-3166	217	11	answers	answer	NOUN
fnp-3166	217	12	to	to	ADP
fnp-3166	217	13	these	these	DET
fnp-3166	217	14	questions	question	NOUN
fnp-3166	217	15	,	,	PUNCT
fnp-3166	217	16	since	since	SCONJ
fnp-3166	217	17	a	a	DET
fnp-3166	217	18	gene	gene	NOUN
fnp-3166	217	19	dosage	dosage	NOUN
fnp-3166	217	20	effect	effect	NOUN
fnp-3166	217	21	on	on	ADP
fnp-3166	217	22	amyloid	amyloid	NOUN
fnp-3166	217	23	precursor	precursor	NOUN
fnp-3166	217	24	protein	protein	NOUN
fnp-3166	217	25	production	production	NOUN
fnp-3166	217	26	predictably	predictably	ADV
fnp-3166	217	27	results	result	VERB
fnp-3166	217	28	in	in	ADP
fnp-3166	217	29	early	early	ADJ
fnp-3166	217	30	onset	onset	ADJ
fnp-3166	217	31	alzheimer	alzheimer	PROPN
fnp-3166	217	32	’s	’s	PART
fnp-3166	217	33	disease	disease	NOUN
fnp-3166	217	34	(	(	PUNCT
fnp-3166	217	35	wisniewski	wisniewski	PROPN
fnp-3166	217	36	et	et	PROPN
fnp-3166	217	37	al	al	PROPN
fnp-3166	217	38	.	.	PROPN
fnp-3166	217	39	1985	1985	NUM
fnp-3166	217	40	,	,	PUNCT
fnp-3166	217	41	ballard	ballard	PROPN
fnp-3166	217	42	et	et	PROPN
fnp-3166	217	43	al	al	PROPN
fnp-3166	217	44	.	.	PROPN
fnp-3166	217	45	2016	2016	NUM
fnp-3166	217	46	)	)	PUNCT
fnp-3166	217	47	.	.	PUNCT
fnp-3166	218	1	this	this	DET
fnp-3166	218	2	approach	approach	NOUN
fnp-3166	218	3	was	be	AUX
fnp-3166	218	4	followed	follow	VERB
fnp-3166	218	5	in	in	ADP
fnp-3166	218	6	a	a	DET
fnp-3166	218	7	recent	recent	ADJ
fnp-3166	218	8	study	study	NOUN
fnp-3166	218	9	,	,	PUNCT
fnp-3166	218	10	in	in	ADP
fnp-3166	218	11	which	which	PRON
fnp-3166	218	12	the	the	DET
fnp-3166	218	13	patterns	pattern	NOUN
fnp-3166	218	14	of	of	ADP
fnp-3166	218	15	microglia	microglia	ADJ
fnp-3166	218	16	activation	activation	NOUN
fnp-3166	218	17	and	and	CCONJ
fnp-3166	218	18	the	the	DET
fnp-3166	218	19	expression	expression	NOUN
fnp-3166	218	20	of	of	ADP
fnp-3166	218	21	proand	proand	NOUN
fnp-3166	218	22	anti	anti	ADJ
fnp-3166	218	23	-	-	ADJ
fnp-3166	218	24	inflammatory	inflammatory	ADJ
fnp-3166	218	25	cytokines	cytokine	NOUN
fnp-3166	218	26	was	be	AUX
fnp-3166	218	27	analyzed	analyze	VERB
fnp-3166	218	28	in	in	ADP
fnp-3166	218	29	a	a	DET
fnp-3166	218	30	large	large	ADJ
fnp-3166	218	31	sample	sample	NOUN
fnp-3166	218	32	of	of	ADP
fnp-3166	218	33	brain	brain	NOUN
fnp-3166	218	34	tissue	tissue	NOUN
fnp-3166	218	35	of	of	ADP
fnp-3166	218	36	patients	patient	NOUN
fnp-3166	218	37	with	with	ADP
fnp-3166	218	38	trisomy	trisomy	NOUN
fnp-3166	218	39	21	21	NUM
fnp-3166	218	40	who	who	PRON
fnp-3166	218	41	had	have	AUX
fnp-3166	218	42	died	die	VERB
fnp-3166	218	43	at	at	ADP
fnp-3166	218	44	different	different	ADJ
fnp-3166	218	45	ages	age	NOUN
fnp-3166	218	46	(	(	PUNCT
fnp-3166	218	47	flores	flores	PROPN
fnp-3166	218	48	aguilar	aguilar	PROPN
fnp-3166	218	49	et	et	PROPN
fnp-3166	218	50	al	al	PROPN
fnp-3166	218	51	.	.	PROPN
fnp-3166	218	52	2020	2020	NUM
fnp-3166	218	53	)	)	PUNCT
fnp-3166	218	54	.	.	PUNCT
fnp-3166	219	1	already	already	ADV
fnp-3166	219	2	,	,	PUNCT
fnp-3166	219	3	in	in	ADP
fnp-3166	219	4	juvenile	juvenile	ADJ
fnp-3166	219	5	patients	patient	NOUN
fnp-3166	219	6	,	,	PUNCT
fnp-3166	219	7	a	a	DET
fnp-3166	219	8	long	long	ADJ
fnp-3166	219	9	time	time	NOUN
fnp-3166	219	10	before	before	ADP
fnp-3166	219	11	the	the	DET
fnp-3166	219	12	first	first	ADJ
fnp-3166	219	13	accumulation	accumulation	NOUN
fnp-3166	219	14	of	of	ADP
fnp-3166	219	15	soluble	soluble	ADJ
fnp-3166	219	16	aß	aß	ADP
fnp-3166	219	17	or	or	CCONJ
fnp-3166	219	18	the	the	DET
fnp-3166	219	19	first	first	ADJ
fnp-3166	219	20	deposition	deposition	NOUN
fnp-3166	219	21	of	of	ADP
fnp-3166	219	22	aß	aß	NOUN
fnp-3166	219	23	-	-	PUNCT
fnp-3166	219	24	plaques	plaque	NOUN
fnp-3166	219	25	,	,	PUNCT
fnp-3166	219	26	microglia	microglia	ADJ
fnp-3166	219	27	activation	activation	NOUN
fnp-3166	219	28	and	and	CCONJ
fnp-3166	219	29	the	the	DET
fnp-3166	219	30	production	production	NOUN
fnp-3166	219	31	of	of	ADP
fnp-3166	219	32	proinflammatory	proinflammatory	ADJ
fnp-3166	219	33	cytokines	cytokine	NOUN
fnp-3166	219	34	was	be	AUX
fnp-3166	219	35	elevated	elevate	VERB
fnp-3166	219	36	in	in	ADP
fnp-3166	219	37	comparison	comparison	NOUN
fnp-3166	219	38	to	to	ADP
fnp-3166	219	39	age	age	NOUN
fnp-3166	219	40	matched	match	VERB
fnp-3166	219	41	controls	control	NOUN
fnp-3166	219	42	.	.	PUNCT
fnp-3166	220	1	in	in	ADP
fnp-3166	220	2	contrast	contrast	NOUN
fnp-3166	220	3	,	,	PUNCT
fnp-3166	220	4	in	in	ADP
fnp-3166	220	5	older	old	ADJ
fnp-3166	220	6	patients	patient	NOUN
fnp-3166	220	7	,	,	PUNCT
fnp-3166	220	8	when	when	SCONJ
fnp-3166	220	9	initial	initial	ADJ
fnp-3166	220	10	alzheimer	alzheimer	PROPN
fnp-3166	220	11	’s	’s	PART
fnp-3166	220	12	disease	disease	NOUN
fnp-3166	220	13	pathology	pathology	NOUN
fnp-3166	220	14	became	become	VERB
fnp-3166	220	15	apparent	apparent	ADJ
fnp-3166	220	16	,	,	PUNCT
fnp-3166	220	17	microglia	microglia	ADJ
fnp-3166	220	18	activation	activation	NOUN
fnp-3166	220	19	decreased	decrease	VERB
fnp-3166	220	20	and	and	CCONJ
fnp-3166	220	21	was	be	AUX
fnp-3166	220	22	replaced	replace	VERB
fnp-3166	220	23	by	by	ADP
fnp-3166	220	24	senescent	senescent	ADJ
fnp-3166	220	25	microglia	microglia	ADJ
fnp-3166	220	26	phenotypes	phenotype	NOUN
fnp-3166	220	27	as	as	ADV
fnp-3166	220	28	well	well	ADV
fnp-3166	220	29	as	as	ADP
fnp-3166	220	30	a	a	DET
fnp-3166	220	31	reduction	reduction	NOUN
fnp-3166	220	32	of	of	ADP
fnp-3166	220	33	the	the	DET
fnp-3166	220	34	production	production	NOUN
fnp-3166	220	35	of	of	ADP
fnp-3166	220	36	pro	pro	ADJ
fnp-3166	220	37	-	-	ADJ
fnp-3166	220	38	inflammatory	inflammatory	ADJ
fnp-3166	220	39	cytokines	cytokine	NOUN
fnp-3166	220	40	.	.	PUNCT
fnp-3166	221	1	these	these	DET
fnp-3166	221	2	results	result	NOUN
fnp-3166	221	3	further	far	ADV
fnp-3166	221	4	support	support	VERB
fnp-3166	221	5	the	the	DET
fnp-3166	221	6	view	view	NOUN
fnp-3166	221	7	that	that	SCONJ
fnp-3166	221	8	anti	anti	ADJ
fnp-3166	221	9	-	-	ADJ
fnp-3166	221	10	inflammatory	inflammatory	ADJ
fnp-3166	221	11	treatment	treatment	NOUN
fnp-3166	221	12	strategies	strategy	NOUN
fnp-3166	221	13	in	in	ADP
fnp-3166	221	14	alzheimer	alzheimer	PROPN
fnp-3166	221	15	’s	’s	PART
fnp-3166	221	16	disease	disease	NOUN
fnp-3166	221	17	may	may	AUX
fnp-3166	221	18	be	be	AUX
fnp-3166	221	19	most	most	ADV
fnp-3166	221	20	beneficial	beneficial	ADJ
fnp-3166	221	21	when	when	SCONJ
fnp-3166	221	22	applied	apply	VERB
fnp-3166	221	23	in	in	ADP
fnp-3166	221	24	very	very	ADV
fnp-3166	221	25	early	early	ADV
fnp-3166	221	26	(	(	PUNCT
fnp-3166	221	27	pre	pre	ADJ
fnp-3166	221	28	-	-	ADJ
fnp-3166	221	29	symptomatic	symptomatic	ADJ
fnp-3166	221	30	)	)	PUNCT
fnp-3166	221	31	stages	stage	NOUN
fnp-3166	221	32	of	of	ADP
fnp-3166	221	33	disease	disease	NOUN
fnp-3166	221	34	evolution	evolution	NOUN
fnp-3166	221	35	.	.	PUNCT
fnp-3166	222	1	the	the	DET
fnp-3166	222	2	data	datum	NOUN
fnp-3166	222	3	further	far	ADV
fnp-3166	222	4	suggest	suggest	VERB
fnp-3166	222	5	that	that	SCONJ
fnp-3166	222	6	the	the	DET
fnp-3166	222	7	inclusion	inclusion	NOUN
fnp-3166	222	8	of	of	ADP
fnp-3166	222	9	patients	patient	NOUN
fnp-3166	222	10	with	with	ADP
fnp-3166	222	11	trisomy	trisomy	NOUN
fnp-3166	222	12	21	21	NUM
fnp-3166	222	13	in	in	ADP
fnp-3166	222	14	future	future	ADJ
fnp-3166	222	15	clinical	clinical	ADJ
fnp-3166	222	16	trials	trial	NOUN
fnp-3166	222	17	could	could	AUX
fnp-3166	222	18	provide	provide	VERB
fnp-3166	222	19	a	a	DET
fnp-3166	222	20	valuable	valuable	ADJ
fnp-3166	222	21	contribution	contribution	NOUN
fnp-3166	222	22	to	to	PART
fnp-3166	222	23	improve	improve	VERB
fnp-3166	222	24	treatment	treatment	NOUN
fnp-3166	222	25	options	option	NOUN
fnp-3166	222	26	in	in	ADP
fnp-3166	222	27	patients	patient	NOUN
fnp-3166	222	28	with	with	ADP
fnp-3166	222	29	alzheimer	alzheimer	PROPN
fnp-3166	222	30	’s	’s	PART
fnp-3166	222	31	disease	disease	NOUN
fnp-3166	222	32	.	.	PUNCT
fnp-3166	223	1	conclusions	conclusion	NOUN
fnp-3166	223	2	neuroimmunology	neuroimmunology	NOUN
fnp-3166	223	3	is	be	AUX
fnp-3166	223	4	a	a	DET
fnp-3166	223	5	highly	highly	ADV
fnp-3166	223	6	dynamic	dynamic	ADJ
fnp-3166	223	7	field	field	NOUN
fnp-3166	223	8	providing	provide	VERB
fnp-3166	223	9	fascinating	fascinating	ADJ
fnp-3166	223	10	new	new	ADJ
fnp-3166	223	11	insights	insight	NOUN
fnp-3166	223	12	into	into	ADP
fnp-3166	223	13	the	the	DET
fnp-3166	223	14	pathogenesis	pathogenesis	NOUN
fnp-3166	223	15	of	of	ADP
fnp-3166	223	16	brain	brain	NOUN
fnp-3166	223	17	inflammation	inflammation	NOUN
fnp-3166	223	18	and	and	CCONJ
fnp-3166	223	19	neurodegeneration	neurodegeneration	NOUN
fnp-3166	223	20	.	.	PUNCT
fnp-3166	224	1	the	the	DET
fnp-3166	224	2	bulk	bulk	NOUN
fnp-3166	224	3	of	of	ADP
fnp-3166	224	4	data	datum	NOUN
fnp-3166	224	5	,	,	PUNCT
fnp-3166	224	6	however	however	ADV
fnp-3166	224	7	,	,	PUNCT
fnp-3166	224	8	describe	describe	VERB
fnp-3166	224	9	experimental	experimental	ADJ
fnp-3166	224	10	models	model	NOUN
fnp-3166	224	11	and	and	CCONJ
fnp-3166	224	12	,	,	PUNCT
fnp-3166	224	13	thus	thus	ADV
fnp-3166	224	14	,	,	PUNCT
fnp-3166	224	15	an	an	DET
fnp-3166	224	16	additional	additional	ADJ
fnp-3166	224	17	step	step	NOUN
fnp-3166	224	18	is	be	AUX
fnp-3166	224	19	necessary	necessary	ADJ
fnp-3166	224	20	,	,	PUNCT
fnp-3166	224	21	which	which	PRON
fnp-3166	224	22	defines	define	VERB
fnp-3166	224	23	the	the	DET
fnp-3166	224	24	relevance	relevance	NOUN
fnp-3166	224	25	of	of	ADP
fnp-3166	224	26	the	the	DET
fnp-3166	224	27	data	datum	NOUN
fnp-3166	224	28	for	for	ADP
fnp-3166	224	29	human	human	ADJ
fnp-3166	224	30	disease	disease	NOUN
fnp-3166	224	31	.	.	PUNCT
fnp-3166	225	1	for	for	ADP
fnp-3166	225	2	this	this	PRON
fnp-3166	225	3	,	,	PUNCT
fnp-3166	225	4	neuropathological	neuropathological	ADJ
fnp-3166	225	5	studies	study	NOUN
fnp-3166	225	6	are	be	AUX
fnp-3166	225	7	essential	essential	ADJ
fnp-3166	225	8	,	,	PUNCT
fnp-3166	225	9	but	but	CCONJ
fnp-3166	225	10	they	they	PRON
fnp-3166	225	11	have	have	VERB
fnp-3166	225	12	to	to	PART
fnp-3166	225	13	be	be	AUX
fnp-3166	225	14	based	base	VERB
fnp-3166	225	15	on	on	ADP
fnp-3166	225	16	systematic	systematic	ADJ
fnp-3166	225	17	analysis	analysis	NOUN
fnp-3166	225	18	of	of	ADP
fnp-3166	225	19	a	a	DET
fnp-3166	225	20	broad	broad	ADJ
fnp-3166	225	21	spectrum	spectrum	NOUN
fnp-3166	225	22	of	of	ADP
fnp-3166	225	23	cases	case	NOUN
fnp-3166	225	24	and	and	CCONJ
fnp-3166	225	25	controls	control	NOUN
fnp-3166	225	26	and	and	CCONJ
fnp-3166	225	27	have	have	VERB
fnp-3166	225	28	to	to	PART
fnp-3166	225	29	be	be	AUX
fnp-3166	225	30	performed	perform	VERB
fnp-3166	225	31	with	with	ADP
fnp-3166	225	32	the	the	DET
fnp-3166	225	33	most	most	ADV
fnp-3166	225	34	suitable	suitable	ADJ
fnp-3166	225	35	molecular	molecular	ADJ
fnp-3166	225	36	or	or	CCONJ
fnp-3166	225	37	immunological	immunological	ADJ
fnp-3166	225	38	technology	technology	NOUN
fnp-3166	225	39	.	.	PUNCT
fnp-3166	226	1	in	in	ADP
fnp-3166	226	2	this	this	DET
fnp-3166	226	3	short	short	ADJ
fnp-3166	226	4	review	review	NOUN
fnp-3166	226	5	the	the	DET
fnp-3166	226	6	prime	prime	ADJ
fnp-3166	226	7	focus	focus	NOUN
fnp-3166	226	8	was	be	AUX
fnp-3166	226	9	laid	lay	VERB
fnp-3166	226	10	on	on	ADP
fnp-3166	226	11	such	such	ADJ
fnp-3166	226	12	studies	study	NOUN
fnp-3166	226	13	of	of	ADP
fnp-3166	226	14	human	human	ADJ
fnp-3166	226	15	disease	disease	NOUN
fnp-3166	226	16	,	,	PUNCT
fnp-3166	226	17	which	which	PRON
fnp-3166	226	18	were	be	AUX
fnp-3166	226	19	sufficiently	sufficiently	ADV
fnp-3166	226	20	powered	power	VERB
fnp-3166	226	21	to	to	PART
fnp-3166	226	22	provide	provide	VERB
fnp-3166	226	23	definite	definite	ADJ
fnp-3166	226	24	answers	answer	NOUN
fnp-3166	226	25	to	to	ADP
fnp-3166	226	26	burning	burn	VERB
fnp-3166	226	27	questions	question	NOUN
fnp-3166	226	28	of	of	ADP
fnp-3166	226	29	neuroinflammation	neuroinflammation	NOUN
fnp-3166	226	30	and	and	CCONJ
fnp-3166	226	31	inflammatory	inflammatory	ADJ
fnp-3166	226	32	brain	brain	NOUN
fnp-3166	226	33	diseases	disease	NOUN
fnp-3166	226	34	.	.	PUNCT
fnp-3166	227	1	references	reference	NOUN
fnp-3166	227	2	akiyama	akiyama	PROPN
fnp-3166	227	3	h	h	PROPN
fnp-3166	227	4	,	,	PUNCT
fnp-3166	227	5	barger	barger	PROPN
fnp-3166	227	6	s	s	PROPN
fnp-3166	227	7	,	,	PUNCT
fnp-3166	227	8	barnum	barnum	PROPN
fnp-3166	227	9	s	s	PROPN
fnp-3166	227	10	,	,	PUNCT
fnp-3166	227	11	bradt	bradt	PROPN
fnp-3166	227	12	b	b	PROPN
fnp-3166	227	13	,	,	PUNCT
fnp-3166	227	14	bauer	bauer	PROPN
fnp-3166	227	15	j	j	PROPN
fnp-3166	227	16	,	,	PUNCT
fnp-3166	227	17	cole	cole	PROPN
fnp-3166	227	18	gm	gm	PROPN
fnp-3166	227	19	,	,	PUNCT
fnp-3166	227	20	et	et	PROPN
fnp-3166	227	21	al	al	PROPN
fnp-3166	227	22	..	..	PUNCT
fnp-3166	227	23	inflammation	inflammation	NOUN
fnp-3166	227	24	and	and	CCONJ
fnp-3166	227	25	alzheimer	alzheimer	PROPN
fnp-3166	227	26	’s	’s	PART
fnp-3166	227	27	disease	disease	NOUN
fnp-3166	227	28	.	.	PUNCT
fnp-3166	228	1	neurobiol	neurobiol	PROPN
fnp-3166	228	2	aging	age	VERB
fnp-3166	228	3	2000	2000	NUM
fnp-3166	228	4	;	;	PUNCT
fnp-3166	229	1	21	21	NUM
fnp-3166	229	2	:	:	PUNCT
fnp-3166	229	3	383–421	383–421	NUM
fnp-3166	229	4	.	.	PUNCT
fnp-3166	229	5	doi	doi	NOUN
fnp-3166	229	6	:	:	PUNCT
fnp-3166	229	7	10.1016	10.1016	NUM
fnp-3166	229	8	/	/	SYM
fnp-3166	229	9	s0197	s0197	PROPN
fnp-3166	229	10	-	-	PUNCT
fnp-3166	229	11	4580(00)00124	4580(00)00124	NUM
fnp-3166	229	12	-	-	PUNCT
fnp-3166	229	13	x.	x.	NOUN
fnp-3166	229	14	baker	baker	PROPN
fnp-3166	229	15	d	d	PROPN
fnp-3166	229	16	,	,	PUNCT
fnp-3166	229	17	marta	marta	PROPN
fnp-3166	229	18	m	m	PROPN
fnp-3166	229	19	,	,	PUNCT
fnp-3166	229	20	pryce	pryce	PROPN
fnp-3166	229	21	g	g	PROPN
fnp-3166	229	22	,	,	PUNCT
fnp-3166	229	23	giovannoni	giovannoni	NOUN
fnp-3166	229	24	g	g	PROPN
fnp-3166	229	25	,	,	PUNCT
fnp-3166	229	26	schmierer	schmierer	PROPN
fnp-3166	229	27	k.	k.	PROPN
fnp-3166	229	28	memory	memory	PROPN
fnp-3166	229	29	b	b	PROPN
fnp-3166	229	30	cells	cell	NOUN
fnp-3166	229	31	are	be	AUX
fnp-3166	229	32	major	major	ADJ
fnp-3166	229	33	targets	target	NOUN
fnp-3166	229	34	for	for	ADP
fnp-3166	229	35	effective	effective	ADJ
fnp-3166	229	36	immunotherapy	immunotherapy	NOUN
fnp-3166	229	37	in	in	ADP
fnp-3166	229	38	relapsing	relapse	VERB
fnp-3166	229	39	multiple	multiple	ADJ
fnp-3166	229	40	sclerosis	sclerosis	NOUN
fnp-3166	229	41	.	.	PUNCT
fnp-3166	230	1	ebiomedicine	ebiomedicine	PROPN
fnp-3166	230	2	.	.	PUNCT
fnp-3166	231	1	2017	2017	NUM
fnp-3166	231	2	feb;16:41	feb;16:41	PROPN
fnp-3166	231	3	-	-	PUNCT
fnp-3166	231	4	50	50	NUM
fnp-3166	231	5	.	.	PUNCT
fnp-3166	232	1	doi	doi	NOUN
fnp-3166	232	2	:	:	PUNCT
fnp-3166	232	3	10.1016	10.1016	NUM
fnp-3166	232	4	/	/	SYM
fnp-3166	232	5	j.ebiom.2017.01.042	j.ebiom.2017.01.042	PROPN
fnp-3166	232	6	.	.	PUNCT
fnp-3166	233	1	epub	epub	PROPN
fnp-3166	233	2	2017	2017	NUM
fnp-3166	233	3	jan	jan	PROPN
fnp-3166	233	4	31	31	NUM
fnp-3166	233	5	.	.	PUNCT
fnp-3166	234	1	pmid	pmid	NOUN
fnp-3166	234	2	:	:	PUNCT
fnp-3166	234	3	28161400	28161400	NUM
fnp-3166	234	4	;	;	PUNCT
fnp-3166	234	5	pmcid	pmcid	ADJ
fnp-3166	234	6	:	:	PUNCT
fnp-3166	234	7	pmc5474520	pmc5474520	PROPN
fnp-3166	234	8	.	.	PUNCT
fnp-3166	235	1	ballard	ballard	PROPN
fnp-3166	235	2	c	c	PROPN
fnp-3166	235	3	,	,	PUNCT
fnp-3166	235	4	mobley	mobley	PROPN
fnp-3166	235	5	w	w	PROPN
fnp-3166	235	6	,	,	PUNCT
fnp-3166	235	7	hardy	hardy	PROPN
fnp-3166	235	8	j	j	PROPN
fnp-3166	235	9	,	,	PUNCT
fnp-3166	235	10	williams	williams	PROPN
fnp-3166	235	11	g	g	PROPN
fnp-3166	235	12	,	,	PUNCT
fnp-3166	235	13	corbett	corbett	NOUN
fnp-3166	235	14	a.	a.	NOUN
fnp-3166	235	15	dementia	dementia	NOUN
fnp-3166	235	16	in	in	ADP
fnp-3166	235	17	down	down	ADP
fnp-3166	235	18	’s	’s	PART
fnp-3166	235	19	syndrome	syndrome	NOUN
fnp-3166	235	20	.	.	PUNCT
fnp-3166	236	1	lancet	lancet	PROPN
fnp-3166	236	2	neurol	neurol	PROPN
fnp-3166	236	3	2016	2016	NUM
fnp-3166	236	4	;	;	PUNCT
fnp-3166	236	5	15	15	NUM
fnp-3166	236	6	:	:	PUNCT
fnp-3166	236	7	622–36	622–36	NUM
fnp-3166	236	8	.	.	PUNCT
fnp-3166	237	1	doi	doi	NOUN
fnp-3166	237	2	:	:	PUNCT
fnp-3166	237	3	10.1016	10.1016	NUM
fnp-3166	237	4	/	/	SYM
fnp-3166	237	5	s1474	s1474	NOUN
fnp-3166	237	6	-	-	PUNCT
fnp-3166	237	7	4422(16)00063	4422(16)00063	NUM
fnp-3166	237	8	-	-	PUNCT
fnp-3166	237	9	6	6	NUM
fnp-3166	237	10	.	.	PUNCT
fnp-3166	238	1	epub	epub	NOUN
fnp-3166	238	2	2016	2016	NUM
fnp-3166	238	3	apr	apr	NOUN
fnp-3166	238	4	11	11	NUM
fnp-3166	238	5	.	.	PUNCT
fnp-3166	239	1	bar	bar	NOUN
fnp-3166	239	2	-	-	PUNCT
fnp-3166	239	3	or	or	CCONJ
fnp-3166	239	4	a	a	PRON
fnp-3166	239	5	,	,	PUNCT
fnp-3166	239	6	pender	pender	PROPN
fnp-3166	239	7	mp	mp	PROPN
fnp-3166	239	8	,	,	PUNCT
fnp-3166	239	9	khanna	khanna	PROPN
fnp-3166	239	10	r	r	PROPN
fnp-3166	239	11	,	,	PUNCT
fnp-3166	239	12	steinman	steinman	PROPN
fnp-3166	239	13	l	l	PROPN
fnp-3166	239	14	,	,	PUNCT
fnp-3166	239	15	hartung	hartung	PROPN
fnp-3166	239	16	hp	hp	PROPN
fnp-3166	239	17	,	,	PUNCT
fnp-3166	239	18	maniar	maniar	NOUN
fnp-3166	239	19	t	t	PROPN
fnp-3166	239	20	,	,	PUNCT
fnp-3166	239	21	croze	croze	NOUN
fnp-3166	239	22	e	e	NOUN
fnp-3166	239	23	,	,	PUNCT
fnp-3166	239	24	aftab	aftab	PROPN
fnp-3166	239	25	bt	bt	PROPN
fnp-3166	239	26	,	,	PUNCT
fnp-3166	239	27	giovannoni	giovannoni	NOUN
fnp-3166	239	28	g	g	PROPN
fnp-3166	239	29	,	,	PUNCT
fnp-3166	239	30	joshi	joshi	PROPN
fnp-3166	239	31	ma	ma	PROPN
fnp-3166	239	32	.	.	PROPN
fnp-3166	239	33	epstein	epstein	PROPN
fnp-3166	239	34	-	-	PUNCT
fnp-3166	239	35	barr	barr	PROPN
fnp-3166	239	36	virus	virus	PROPN
fnp-3166	239	37	in	in	ADP
fnp-3166	239	38	multiple	multiple	ADJ
fnp-3166	239	39	sclerosis	sclerosis	NOUN
fnp-3166	239	40	:	:	PUNCT
fnp-3166	239	41	theory	theory	NOUN
fnp-3166	239	42	and	and	CCONJ
fnp-3166	239	43	emerging	emerge	VERB
fnp-3166	239	44	immunotherapies	immunotherapy	NOUN
fnp-3166	239	45	.	.	PUNCT
fnp-3166	240	1	trends	trend	NOUN
fnp-3166	240	2	mol	mol	ADP
fnp-3166	240	3	med	med	PROPN
fnp-3166	240	4	.	.	PUNCT
fnp-3166	240	5	2020	2020	NUM
fnp-3166	240	6	mar;26(3):296	mar;26(3):296	SYM
fnp-3166	240	7	-	-	SYM
fnp-3166	240	8	310	310	NUM
fnp-3166	240	9	.	.	PUNCT
fnp-3166	241	1	doi	doi	NOUN
fnp-3166	241	2	:	:	PUNCT
fnp-3166	241	3	10.1016	10.1016	NUM
fnp-3166	241	4	/	/	SYM
fnp-3166	241	5	j.molmed.2019.11.003	j.molmed.2019.11.003	PROPN
fnp-3166	241	6	.	.	PROPN
fnp-3166	242	1	epub	epub	PROPN
fnp-3166	242	2	2019	2019	NUM
fnp-3166	242	3	dec	dec	PROPN
fnp-3166	242	4	17	17	NUM
fnp-3166	242	5	.	.	PUNCT
fnp-3166	243	1	pmid	pmid	NOUN
fnp-3166	243	2	:	:	PUNCT
fnp-3166	243	3	31862243	31862243	NUM
fnp-3166	243	4	;	;	PUNCT
fnp-3166	243	5	pmcid	pmcid	ADJ
fnp-3166	243	6	:	:	PUNCT
fnp-3166	243	7	pmc7106557	pmc7106557	NOUN
fnp-3166	243	8	.	.	PUNCT
fnp-3166	244	1	beltrán	beltrán	NOUN
fnp-3166	244	2	e	e	NOUN
fnp-3166	244	3	,	,	PUNCT
fnp-3166	244	4	paunovic	paunovic	ADJ
fnp-3166	244	5	m	m	PRON
fnp-3166	244	6	,	,	PUNCT
fnp-3166	244	7	gebert	gebert	PROPN
fnp-3166	244	8	d	d	PROPN
fnp-3166	244	9	,	,	PUNCT
fnp-3166	244	10	cesur	cesur	PROPN
fnp-3166	244	11	e	e	NOUN
fnp-3166	244	12	,	,	PUNCT
fnp-3166	244	13	jeitler	jeitler	PROPN
fnp-3166	244	14	m	m	PROPN
fnp-3166	244	15	,	,	PUNCT
fnp-3166	244	16	höftberger	höftberger	ADJ
fnp-3166	244	17	r	r	NOUN
fnp-3166	244	18	,	,	PUNCT
fnp-3166	244	19	malotka	malotka	PROPN
fnp-3166	244	20	j	j	PROPN
fnp-3166	244	21	,	,	PUNCT
fnp-3166	244	22	mader	mader	PROPN
fnp-3166	244	23	s	s	PROPN
fnp-3166	244	24	,	,	PUNCT
fnp-3166	244	25	kawakami	kawakami	PROPN
fnp-3166	244	26	n	n	CCONJ
fnp-3166	244	27	,	,	PUNCT
fnp-3166	244	28	meinl	meinl	NOUN
fnp-3166	244	29	e	e	NOUN
fnp-3166	244	30	,	,	PUNCT
fnp-3166	244	31	bradl	bradl	NOUN
fnp-3166	244	32	m	m	PROPN
fnp-3166	244	33	,	,	PUNCT
fnp-3166	244	34	dornmair	dornmair	VERB
fnp-3166	244	35	k	k	PROPN
fnp-3166	244	36	,	,	PUNCT
fnp-3166	244	37	lassmann	lassmann	PROPN
fnp-3166	244	38	h.	h.	PROPN
fnp-3166	244	39	archeological	archeological	PROPN
fnp-3166	244	40	neuroimmunology	neuroimmunology	PROPN
fnp-3166	244	41	:	:	PUNCT
fnp-3166	244	42	resurrection	resurrection	NOUN
fnp-3166	244	43	of	of	ADP
fnp-3166	244	44	a	a	DET
fnp-3166	244	45	pathogenic	pathogenic	ADJ
fnp-3166	244	46	immune	immune	ADJ
fnp-3166	244	47	response	response	NOUN
fnp-3166	244	48	from	from	ADP
fnp-3166	244	49	a	a	DET
fnp-3166	244	50	historical	historical	ADJ
fnp-3166	244	51	case	case	NOUN
fnp-3166	244	52	sheds	shed	VERB
fnp-3166	244	53	light	light	NOUN
fnp-3166	244	54	on	on	ADP
fnp-3166	244	55	human	human	ADJ
fnp-3166	244	56	autoimmune	autoimmune	ADJ
fnp-3166	244	57	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	244	58	and	and	CCONJ
fnp-3166	244	59	multiple	multiple	ADJ
fnp-3166	244	60	sclerosis	sclerosis	NOUN
fnp-3166	244	61	.	.	PUNCT
fnp-3166	245	1	acta	acta	PROPN
fnp-3166	245	2	neuropathol	neuropathol	PROPN
fnp-3166	245	3	.	.	PUNCT
fnp-3166	246	1	2020	2020	NUM
fnp-3166	246	2	oct	oct	PROPN
fnp-3166	246	3	29	29	NUM
fnp-3166	246	4	.	.	PUNCT
fnp-3166	247	1	doi	doi	NOUN
fnp-3166	247	2	:	:	PUNCT
fnp-3166	247	3	10.1007	10.1007	NUM
fnp-3166	247	4	/	/	SYM
fnp-3166	247	5	s00401	s00401	NOUN
fnp-3166	247	6	-	-	PUNCT
fnp-3166	247	7	020	020	NUM
fnp-3166	247	8	-	-	PUNCT
fnp-3166	247	9	02239	02239	NUM
fnp-3166	247	10	-	-	PUNCT
fnp-3166	247	11	2	2	NUM
fnp-3166	247	12	.	.	PUNCT
fnp-3166	248	1	epub	epub	NOUN
fnp-3166	248	2	ahead	ahead	ADV
fnp-3166	248	3	of	of	ADP
fnp-3166	248	4	print	print	NOUN
fnp-3166	248	5	.	.	PUNCT
fnp-3166	249	1	pmid	pmid	NOUN
fnp-3166	249	2	:	:	PUNCT
fnp-3166	249	3	33242149	33242149	NUM
fnp-3166	249	4	.	.	PUNCT
fnp-3166	250	1	bø	bø	PROPN
fnp-3166	250	2	l	l	PROPN
fnp-3166	250	3	,	,	PUNCT
fnp-3166	250	4	vedeler	vedeler	PROPN
fnp-3166	250	5	ca	can	AUX
fnp-3166	250	6	,	,	PUNCT
fnp-3166	250	7	nyland	nyland	PROPN
fnp-3166	250	8	hi	hi	INTJ
fnp-3166	250	9	,	,	PUNCT
fnp-3166	250	10	trapp	trapp	PROPN
fnp-3166	250	11	bd	bd	PROPN
fnp-3166	250	12	,	,	PUNCT
fnp-3166	250	13	mørk	mørk	NOUN
fnp-3166	250	14	sj	sj	PROPN
fnp-3166	250	15	.	.	PROPN
fnp-3166	250	16	subpial	subpial	PROPN
fnp-3166	250	17	demyelination	demyelination	NOUN
fnp-3166	250	18	in	in	ADP
fnp-3166	250	19	the	the	DET
fnp-3166	250	20	cerebral	cerebral	ADJ
fnp-3166	250	21	cortex	cortex	NOUN
fnp-3166	250	22	of	of	ADP
fnp-3166	250	23	multiple	multiple	ADJ
fnp-3166	250	24	sclerosis	sclerosis	NOUN
fnp-3166	250	25	patients	patient	NOUN
fnp-3166	250	26	.	.	PUNCT
fnp-3166	251	1	j	j	PROPN
fnp-3166	251	2	neuropathol	neuropathol	PROPN
fnp-3166	251	3	exp	exp	PROPN
fnp-3166	251	4	neurol	neurol	NOUN
fnp-3166	251	5	.	.	PUNCT
fnp-3166	252	1	2003	2003	NUM
fnp-3166	252	2	jul;62(7):723	jul;62(7):723	PROPN
fnp-3166	252	3	-	-	PUNCT
fnp-3166	252	4	32	32	NUM
fnp-3166	252	5	.	.	PUNCT
fnp-3166	253	1	doi	doi	NOUN
fnp-3166	253	2	:	:	PUNCT
fnp-3166	253	3	10.1093	10.1093	NUM
fnp-3166	253	4	/	/	SYM
fnp-3166	253	5	jnen/62.7.723	jnen/62.7.723	PROPN
fnp-3166	253	6	.	.	PUNCT
fnp-3166	254	1	pmid	pmid	NOUN
fnp-3166	254	2	:	:	PUNCT
fnp-3166	254	3	12901699	12901699	NUM
fnp-3166	254	4	.	.	PUNCT
fnp-3166	255	1	cantuti	cantuti	PROPN
fnp-3166	255	2	-	-	PUNCT
fnp-3166	255	3	castelvetri	castelvetri	NOUN
fnp-3166	255	4	l	l	NOUN
fnp-3166	255	5	,	,	PUNCT
fnp-3166	255	6	ojha	ojha	PROPN
fnp-3166	255	7	r	r	PROPN
fnp-3166	255	8	,	,	PUNCT
fnp-3166	255	9	pedro	pedro	PROPN
fnp-3166	255	10	ld	ld	PROPN
fnp-3166	255	11	,	,	PUNCT
fnp-3166	255	12	djannatian	djannatian	PROPN
fnp-3166	255	13	m	m	PROPN
fnp-3166	255	14	,	,	PUNCT
fnp-3166	255	15	franz	franz	PROPN
fnp-3166	255	16	j	j	PROPN
fnp-3166	255	17	,	,	PUNCT
fnp-3166	255	18	kuivanen	kuivanen	PROPN
fnp-3166	255	19	s	s	PROPN
fnp-3166	255	20	,	,	PUNCT
fnp-3166	255	21	van	van	PROPN
fnp-3166	255	22	der	der	PROPN
fnp-3166	255	23	meer	meer	PROPN
fnp-3166	255	24	f	f	PROPN
fnp-3166	255	25	,	,	PUNCT
fnp-3166	255	26	kallio	kallio	PROPN
fnp-3166	255	27	k	k	PROPN
fnp-3166	255	28	,	,	PUNCT
fnp-3166	255	29	kaya	kaya	PROPN
fnp-3166	255	30	t	t	PROPN
fnp-3166	255	31	,	,	PUNCT
fnp-3166	255	32	anastasina	anastasina	NOUN
fnp-3166	255	33	m	m	PROPN
fnp-3166	255	34	,	,	PUNCT
fnp-3166	255	35	smura	smura	PROPN
fnp-3166	255	36	t	t	PROPN
fnp-3166	255	37	,	,	PUNCT
fnp-3166	255	38	levanov	levanov	PROPN
fnp-3166	255	39	l	l	PROPN
fnp-3166	255	40	,	,	PUNCT
fnp-3166	255	41	szirovicza	szirovicza	PROPN
fnp-3166	255	42	l	l	PROPN
fnp-3166	255	43	,	,	PUNCT
fnp-3166	255	44	tobi	tobi	PROPN
fnp-3166	255	45	a	a	PRON
fnp-3166	255	46	,	,	PUNCT
fnp-3166	255	47	kallio	kallio	NOUN
fnp-3166	255	48	-	-	PUNCT
fnp-3166	255	49	kokko	kokko	PROPN
fnp-3166	255	50	h	h	NOUN
fnp-3166	255	51	,	,	PUNCT
fnp-3166	255	52	österlund	österlund	VERB
fnp-3166	255	53	p	p	NOUN
fnp-3166	255	54	,	,	PUNCT
fnp-3166	255	55	joensuu	joensuu	PROPN
fnp-3166	255	56	m	m	PROPN
fnp-3166	255	57	,	,	PUNCT
fnp-3166	255	58	meunier	meunier	PROPN
fnp-3166	255	59	fa	fa	PROPN
fnp-3166	255	60	,	,	PUNCT
fnp-3166	255	61	butcher	butcher	NOUN
fnp-3166	255	62	sj	sj	PROPN
fnp-3166	255	63	,	,	PUNCT
fnp-3166	255	64	winkler	winkler	PROPN
fnp-3166	255	65	ms	ms	PROPN
fnp-3166	255	66	,	,	PUNCT
fnp-3166	255	67	mollenhauer	mollenhauer	NOUN
fnp-3166	255	68	b	b	NUM
fnp-3166	255	69	,	,	PUNCT
fnp-3166	255	70	helenius	helenius	PROPN
fnp-3166	255	71	a	a	NOUN
fnp-3166	255	72	,	,	PUNCT
fnp-3166	255	73	gokce	gokce	ADJ
fnp-3166	255	74	o	o	PROPN
fnp-3166	255	75	,	,	PUNCT
fnp-3166	255	76	teesalu	teesalu	PROPN
fnp-3166	255	77	t	t	PROPN
fnp-3166	255	78	,	,	PUNCT
fnp-3166	255	79	hepojoki	hepojoki	PROPN
fnp-3166	255	80	j	j	PROPN
fnp-3166	255	81	,	,	PUNCT
fnp-3166	255	82	vapalahti	vapalahti	ADJ
fnp-3166	255	83	o	o	NOUN
fnp-3166	255	84	,	,	PUNCT
fnp-3166	255	85	stadelmann	stadelmann	PROPN
fnp-3166	255	86	c	c	PROPN
fnp-3166	255	87	,	,	PUNCT
fnp-3166	255	88	balistreri	balistreri	PROPN
fnp-3166	255	89	g	g	PROPN
fnp-3166	255	90	,	,	PUNCT
fnp-3166	255	91	simons	simons	PROPN
fnp-3166	255	92	m.	m.	NOUN
fnp-3166	255	93	neuropilin-1	neuropilin-1	PROPN
fnp-3166	255	94	facilitates	facilitate	VERB
fnp-3166	255	95	sars	sar	NOUN
fnp-3166	255	96	-	-	PUNCT
fnp-3166	255	97	cov-2	cov-2	NOUN
fnp-3166	255	98	cell	cell	NOUN
fnp-3166	255	99	entry	entry	NOUN
fnp-3166	255	100	and	and	CCONJ
fnp-3166	255	101	infectivity	infectivity	NOUN
fnp-3166	255	102	.	.	PUNCT
fnp-3166	256	1	science	science	NOUN
fnp-3166	256	2	.	.	PUNCT
fnp-3166	257	1	2020	2020	NUM
fnp-3166	258	1	nov	nov	PROPN
fnp-3166	258	2	13;370(6518):856	13;370(6518):856	NUM
fnp-3166	258	3	-	-	SYM
fnp-3166	258	4	860	860	NUM
fnp-3166	258	5	.	.	PUNCT
fnp-3166	258	6	doi	doi	NOUN
fnp-3166	258	7	:	:	PUNCT
fnp-3166	258	8	10.1126	10.1126	NUM
fnp-3166	258	9	/	/	SYM
fnp-3166	258	10	science.abd2985	science.abd2985	NOUN
fnp-3166	258	11	.	.	PUNCT
fnp-3166	259	1	epub	epub	PROPN
fnp-3166	259	2	2020	2020	NUM
fnp-3166	259	3	oct	oct	PROPN
fnp-3166	259	4	20	20	NUM
fnp-3166	259	5	.	.	PUNCT
fnp-3166	260	1	pmid	pmid	NOUN
fnp-3166	260	2	:	:	PUNCT
fnp-3166	260	3	33082293	33082293	NUM
fnp-3166	260	4	.	.	PUNCT
fnp-3166	261	1	carceles	carcele	NOUN
fnp-3166	261	2	-	-	PUNCT
fnp-3166	261	3	cordon	cordon	NOUN
fnp-3166	261	4	m	m	NOUN
fnp-3166	261	5	,	,	PUNCT
fnp-3166	261	6	mannara	mannara	PROPN
fnp-3166	261	7	f	f	PROPN
fnp-3166	261	8	,	,	PUNCT
fnp-3166	261	9	aguilar	aguilar	PROPN
fnp-3166	261	10	e	e	PROPN
fnp-3166	261	11	,	,	PUNCT
fnp-3166	261	12	castellanos	castellanos	PROPN
fnp-3166	261	13	a	a	PROPN
fnp-3166	261	14	,	,	PUNCT
fnp-3166	261	15	planagumà	planagumà	PROPN
fnp-3166	261	16	j	j	PROPN
fnp-3166	261	17	,	,	PUNCT
fnp-3166	261	18	dalmau	dalmau	PROPN
fnp-3166	261	19	j.	j.	PROPN
fnp-3166	261	20	nmdar	nmdar	PROPN
fnp-3166	261	21	antibodies	antibodie	VERB
fnp-3166	261	22	alter	alter	VERB
fnp-3166	261	23	dopamine	dopamine	NOUN
fnp-3166	261	24	receptors	receptor	NOUN
fnp-3166	261	25	and	and	CCONJ
fnp-3166	261	26	cause	cause	VERB
fnp-3166	261	27	psychotic	psychotic	ADJ
fnp-3166	261	28	behavior	behavior	NOUN
fnp-3166	261	29	in	in	ADP
fnp-3166	261	30	mice	mouse	NOUN
fnp-3166	261	31	.	.	PUNCT
fnp-3166	262	1	ann	ann	PROPN
fnp-3166	262	2	neurol	neurol	PROPN
fnp-3166	262	3	.	.	PUNCT
fnp-3166	263	1	2020	2020	NUM
fnp-3166	263	2	sep;88(3):603	sep;88(3):603	PROPN
fnp-3166	263	3	-	-	SYM
fnp-3166	263	4	613	613	PROPN
fnp-3166	263	5	.	.	PUNCT
fnp-3166	263	6	doi	doi	NOUN
fnp-3166	263	7	:	:	PUNCT
fnp-3166	263	8	10.1002	10.1002	NUM
fnp-3166	263	9	/	/	SYM
fnp-3166	263	10	ana.25829	ana.25829	PROPN
fnp-3166	263	11	.	.	PUNCT
fnp-3166	264	1	epub	epub	PROPN
fnp-3166	264	2	2020	2020	NUM
fnp-3166	264	3	jul	jul	PROPN
fnp-3166	264	4	11	11	NUM
fnp-3166	264	5	.	.	PUNCT
fnp-3166	265	1	pmid	pmid	NOUN
fnp-3166	265	2	:	:	PUNCT
fnp-3166	265	3	32583480	32583480	NUM
fnp-3166	265	4	.	.	PUNCT
fnp-3166	266	1	cignarella	cignarella	PROPN
fnp-3166	266	2	f	f	PROPN
fnp-3166	266	3	,	,	PUNCT
fnp-3166	266	4	filipello	filipello	PROPN
fnp-3166	266	5	f	f	PROPN
fnp-3166	266	6	,	,	PUNCT
fnp-3166	266	7	bollman	bollman	NOUN
fnp-3166	266	8	b	b	NUM
fnp-3166	266	9	,	,	PUNCT
fnp-3166	266	10	cantoni	cantoni	PROPN
fnp-3166	266	11	c	c	NOUN
fnp-3166	266	12	,	,	PUNCT
fnp-3166	266	13	locca	locca	VERB
fnp-3166	266	14	a	a	DET
fnp-3166	266	15	,	,	PUNCT
fnp-3166	266	16	mikesell	mikesell	NOUN
fnp-3166	266	17	r	r	NOUN
fnp-3166	266	18	,	,	PUNCT
fnp-3166	266	19	manis	manis	PROPN
fnp-3166	266	20	m	m	PROPN
fnp-3166	266	21	,	,	PUNCT
fnp-3166	266	22	ibrahim	ibrahim	PROPN
fnp-3166	266	23	a	a	PROPN
fnp-3166	266	24	,	,	PUNCT
fnp-3166	266	25	deng	deng	PROPN
fnp-3166	266	26	l	l	PROPN
fnp-3166	266	27	,	,	PUNCT
fnp-3166	266	28	benitez	benitez	PROPN
fnp-3166	266	29	ba	ba	PROPN
fnp-3166	266	30	,	,	PUNCT
fnp-3166	266	31	cruchaga	cruchaga	NOUN
fnp-3166	266	32	c	c	NOUN
fnp-3166	266	33	,	,	PUNCT
fnp-3166	266	34	licastro	licastro	PROPN
fnp-3166	266	35	d	d	PROPN
fnp-3166	266	36	,	,	PUNCT
fnp-3166	266	37	mihindukulasuriya	mihindukulasuriya	PROPN
fnp-3166	267	1	k	k	NOUN
fnp-3166	267	2	,	,	PUNCT
fnp-3166	267	3	harari	harari	PROPN
fnp-3166	267	4	o	o	NOUN
fnp-3166	267	5	,	,	PUNCT
fnp-3166	267	6	buckland	buckland	PROPN
fnp-3166	267	7	m	m	PROPN
fnp-3166	267	8	,	,	PUNCT
fnp-3166	267	9	holtzman	holtzman	ADJ
fnp-3166	267	10	dm	dm	PROPN
fnp-3166	267	11	,	,	PUNCT
fnp-3166	267	12	rosenthal	rosenthal	PROPN
fnp-3166	267	13	a	a	PRON
fnp-3166	267	14	,	,	PUNCT
fnp-3166	267	15	schwabe	schwabe	PROPN
fnp-3166	267	16	t	t	PROPN
fnp-3166	267	17	,	,	PUNCT
fnp-3166	267	18	tassi	tassi	PROPN
fnp-3166	267	19	i	i	PROPN
fnp-3166	267	20	,	,	PUNCT
fnp-3166	267	21	piccio	piccio	PROPN
fnp-3166	267	22	l.	l.	PROPN
fnp-3166	267	23	trem2	trem2	PROPN
fnp-3166	267	24	activation	activation	NOUN
fnp-3166	267	25	on	on	ADP
fnp-3166	267	26	microglia	microglia	ADJ
fnp-3166	267	27	promotes	promote	VERB
fnp-3166	267	28	myelin	myelin	ADJ
fnp-3166	267	29	debris	debris	NOUN
fnp-3166	267	30	clearance	clearance	NOUN
fnp-3166	267	31	and	and	CCONJ
fnp-3166	267	32	remyelination	remyelination	NOUN
fnp-3166	267	33	in	in	ADP
fnp-3166	267	34	a	a	DET
fnp-3166	267	35	model	model	NOUN
fnp-3166	267	36	of	of	ADP
fnp-3166	267	37	multiple	multiple	ADJ
fnp-3166	267	38	sclerosis	sclerosis	NOUN
fnp-3166	267	39	.	.	PUNCT
fnp-3166	268	1	acta	acta	PROPN
fnp-3166	268	2	neuropathol	neuropathol	PROPN
fnp-3166	268	3	.	.	PUNCT
fnp-3166	269	1	2020	2020	NUM
fnp-3166	269	2	oct;140(4):513	oct;140(4):513	NOUN
fnp-3166	269	3	-	-	PUNCT
fnp-3166	269	4	534	534	NUM
fnp-3166	269	5	.	.	PUNCT
fnp-3166	270	1	doi	doi	NOUN
fnp-3166	270	2	:	:	PUNCT
fnp-3166	270	3	10.1007	10.1007	NUM
fnp-3166	270	4	/	/	SYM
fnp-3166	270	5	s00401	s00401	NOUN
fnp-3166	270	6	-	-	PUNCT
fnp-3166	270	7	020	020	NUM
fnp-3166	270	8	-	-	PUNCT
fnp-3166	270	9	02193	02193	NUM
fnp-3166	270	10	-	-	PUNCT
fnp-3166	270	11	z.	z.	PROPN
fnp-3166	270	12	epub	epub	PROPN
fnp-3166	270	13	2020	2020	NUM
fnp-3166	270	14	aug	aug	PROPN
fnp-3166	270	15	9	9	NUM
fnp-3166	270	16	.	.	PUNCT
fnp-3166	271	1	pmid	pmid	NOUN
fnp-3166	271	2	:	:	PUNCT
fnp-3166	271	3	32772264	32772264	NUM
fnp-3166	271	4	;	;	PUNCT
fnp-3166	271	5	pmcid	pmcid	ADJ
fnp-3166	271	6	:	:	PUNCT
fnp-3166	271	7	pmc7498497	pmc7498497	ADJ
fnp-3166	271	8	.	.	PUNCT
fnp-3166	272	1	deigendesch	deigendesch	PROPN
fnp-3166	272	2	n	n	CCONJ
fnp-3166	272	3	,	,	PUNCT
fnp-3166	272	4	sironi	sironi	PROPN
fnp-3166	272	5	l	l	NOUN
fnp-3166	272	6	,	,	PUNCT
fnp-3166	272	7	kutza	kutza	PROPN
fnp-3166	272	8	m	m	PROPN
fnp-3166	272	9	,	,	PUNCT
fnp-3166	272	10	wischnewski	wischnewski	PROPN
fnp-3166	272	11	s	s	NOUN
fnp-3166	272	12	,	,	PUNCT
fnp-3166	272	13	fuchs	fuchs	PROPN
fnp-3166	272	14	v	v	ADP
fnp-3166	272	15	,	,	PUNCT
fnp-3166	272	16	hench	hench	PROPN
fnp-3166	272	17	j	j	PROPN
fnp-3166	272	18	,	,	PUNCT
fnp-3166	272	19	frank	frank	PROPN
fnp-3166	272	20	a	a	PRON
fnp-3166	272	21	,	,	PUNCT
fnp-3166	272	22	nienhold	nienhold	NOUN
fnp-3166	272	23	r	r	NOUN
fnp-3166	272	24	,	,	PUNCT
fnp-3166	272	25	mertz	mertz	PROPN
fnp-3166	272	26	kd	kd	PROPN
fnp-3166	272	27	,	,	PUNCT
fnp-3166	272	28	cathomas	cathoma	VERB
fnp-3166	272	29	g	g	NOUN
fnp-3166	272	30	,	,	PUNCT
fnp-3166	272	31	matter	matter	NOUN
fnp-3166	272	32	ms	ms	PROPN
fnp-3166	272	33	,	,	PUNCT
fnp-3166	272	34	siegemund	siegemund	PROPN
fnp-3166	272	35	m	m	PROPN
fnp-3166	272	36	,	,	PUNCT
fnp-3166	272	37	tolnay	tolnay	PROPN
fnp-3166	272	38	m	m	PROPN
fnp-3166	272	39	,	,	PUNCT
fnp-3166	272	40	schirmer	schirmer	PROPN
fnp-3166	272	41	l	l	PROPN
fnp-3166	272	42	,	,	PUNCT
fnp-3166	272	43	pröbstel	pröbstel	PROPN
fnp-3166	272	44	ak	ak	PROPN
fnp-3166	272	45	,	,	PUNCT
fnp-3166	272	46	tzankov	tzankov	VERB
fnp-3166	272	47	a	a	NOUN
fnp-3166	272	48	,	,	PUNCT
fnp-3166	272	49	frank	frank	PROPN
fnp-3166	272	50	s.	s.	PROPN
fnp-3166	272	51	correlates	correlate	VERB
fnp-3166	272	52	of	of	ADP
fnp-3166	272	53	critical	critical	ADJ
fnp-3166	272	54	illness	illness	NOUN
fnp-3166	272	55	-	-	PUNCT
fnp-3166	272	56	related	relate	VERB
fnp-3166	272	57	encephalopathy	encephalopathy	NOUN
fnp-3166	272	58	predominate	predominate	ADJ
fnp-3166	272	59	postmortem	postmortem	NOUN
fnp-3166	272	60	covid-19	covid-19	PROPN
fnp-3166	272	61	neuropathology	neuropathology	NOUN
fnp-3166	272	62	.	.	PUNCT
fnp-3166	273	1	acta	acta	PROPN
fnp-3166	273	2	neuropathol	neuropathol	PROPN
fnp-3166	273	3	.	.	PUNCT
fnp-3166	274	1	2020	2020	NUM
fnp-3166	274	2	oct;140(4):583	oct;140(4):583	NOUN
fnp-3166	274	3	-	-	PUNCT
fnp-3166	274	4	586	586	NUM
fnp-3166	274	5	.	.	PUNCT
fnp-3166	275	1	doi	doi	NOUN
fnp-3166	275	2	:	:	PUNCT
fnp-3166	275	3	10.1007	10.1007	NUM
fnp-3166	275	4	/	/	SYM
fnp-3166	275	5	s00401	s00401	NOUN
fnp-3166	275	6	-	-	PUNCT
fnp-3166	275	7	020	020	NUM
fnp-3166	275	8	-	-	PUNCT
fnp-3166	275	9	02213	02213	NUM
fnp-3166	275	10	-	-	PUNCT
fnp-3166	275	11	y.	y.	PROPN
fnp-3166	275	12	epub	epub	NOUN
fnp-3166	275	13	2020	2020	NUM
fnp-3166	275	14	aug	aug	PROPN
fnp-3166	275	15	26	26	NUM
fnp-3166	275	16	.	.	PUNCT
fnp-3166	276	1	pmid	pmid	NOUN
fnp-3166	276	2	:	:	PUNCT
fnp-3166	276	3	32851506	32851506	NUM
fnp-3166	276	4	;	;	PUNCT
fnp-3166	276	5	pmcid	pmcid	ADJ
fnp-3166	276	6	:	:	PUNCT
fnp-3166	276	7	pmc7449525	pmc7449525	NOUN
fnp-3166	276	8	.	.	PUNCT
fnp-3166	277	1	fischer	fischer	PROPN
fnp-3166	277	2	mt	mt	PROPN
fnp-3166	277	3	,	,	PUNCT
fnp-3166	277	4	wimmer	wimmer	PROPN
fnp-3166	278	1	i	i	PROPN
fnp-3166	278	2	,	,	PUNCT
fnp-3166	278	3	höftberger	höftberger	ADJ
fnp-3166	278	4	r	r	NOUN
fnp-3166	278	5	,	,	PUNCT
fnp-3166	278	6	gerlach	gerlach	PROPN
fnp-3166	278	7	s	s	PROPN
fnp-3166	278	8	,	,	PUNCT
fnp-3166	278	9	haider	haider	PROPN
fnp-3166	278	10	l	l	PROPN
fnp-3166	278	11	,	,	PUNCT
fnp-3166	278	12	zrzavy	zrzavy	PROPN
fnp-3166	278	13	t	t	PROPN
fnp-3166	278	14	,	,	PUNCT
fnp-3166	278	15	hametner	hametner	X
fnp-3166	278	16	s	s	PROPN
fnp-3166	278	17	,	,	PUNCT
fnp-3166	278	18	mahad	mahad	PROPN
fnp-3166	278	19	d	d	PROPN
fnp-3166	278	20	,	,	PUNCT
fnp-3166	278	21	binder	binder	NOUN
fnp-3166	278	22	cj	cj	PROPN
fnp-3166	278	23	,	,	PUNCT
fnp-3166	278	24	krumbholz	krumbholz	PROPN
fnp-3166	278	25	m	m	PROPN
fnp-3166	278	26	,	,	PUNCT
fnp-3166	278	27	bauer	bauer	PROPN
fnp-3166	278	28	j	j	PROPN
fnp-3166	278	29	,	,	PUNCT
fnp-3166	278	30	bradl	bradl	NOUN
fnp-3166	278	31	m	m	PROPN
fnp-3166	278	32	,	,	PUNCT
fnp-3166	278	33	lassmann	lassmann	PROPN
fnp-3166	278	34	h.	h.	PROPN
fnp-3166	278	35	disease	disease	PROPN
fnp-3166	278	36	-	-	PUNCT
fnp-3166	278	37	specific	specific	ADJ
fnp-3166	278	38	molecular	molecular	ADJ
fnp-3166	278	39	events	event	NOUN
fnp-3166	278	40	in	in	ADP
fnp-3166	278	41	cortical	cortical	ADJ
fnp-3166	278	42	multiple	multiple	ADJ
fnp-3166	278	43	sclerosis	sclerosis	NOUN
fnp-3166	278	44	lesions	lesion	NOUN
fnp-3166	278	45	.	.	PUNCT
fnp-3166	279	1	brain	brain	NOUN
fnp-3166	279	2	.	.	PUNCT
fnp-3166	280	1	2013	2013	NUM
fnp-3166	280	2	jun;136(pt	jun;136(pt	PROPN
fnp-3166	280	3	6):1799	6):1799	NUM
fnp-3166	280	4	-	-	PUNCT
fnp-3166	280	5	815	815	NUM
fnp-3166	280	6	.	.	PUNCT
fnp-3166	281	1	doi	doi	NOUN
fnp-3166	281	2	:	:	PUNCT
fnp-3166	281	3	10.1093	10.1093	NUM
fnp-3166	281	4	/	/	SYM
fnp-3166	281	5	brain	brain	NOUN
fnp-3166	281	6	/	/	SYM
fnp-3166	281	7	awt110	awt110	PROPN
fnp-3166	281	8	.	.	PUNCT
fnp-3166	282	1	epub	epub	PROPN
fnp-3166	282	2	2013	2013	NUM
fnp-3166	282	3	may	may	PROPN
fnp-3166	282	4	17	17	NUM
fnp-3166	282	5	.	.	PUNCT
fnp-3166	283	1	pmid	pmid	NOUN
fnp-3166	283	2	:	:	PUNCT
fnp-3166	283	3	23687122	23687122	NUM
fnp-3166	283	4	;	;	PUNCT
fnp-3166	283	5	pmcid	pmcid	PROPN
fnp-3166	283	6	:	:	PUNCT
fnp-3166	283	7	pmc3673462	pmc3673462	PROPN
fnp-3166	283	8	.	.	PUNCT
fnp-3166	284	1	flores	flores	PROPN
fnp-3166	284	2	-	-	PUNCT
fnp-3166	284	3	aguilar	aguilar	PROPN
fnp-3166	284	4	l	l	PROPN
fnp-3166	284	5	,	,	PUNCT
fnp-3166	284	6	iulita	iulita	PROPN
fnp-3166	284	7	mf	mf	NOUN
fnp-3166	284	8	,	,	PUNCT
fnp-3166	284	9	kovecses	kovecse	VERB
fnp-3166	284	10	o	o	PROPN
fnp-3166	284	11	,	,	PUNCT
fnp-3166	284	12	torres	torre	VERB
fnp-3166	284	13	md	md	PROPN
fnp-3166	284	14	,	,	PUNCT
fnp-3166	284	15	levi	levi	PROPN
fnp-3166	284	16	sm	sm	PROPN
fnp-3166	284	17	,	,	PUNCT
fnp-3166	284	18	zhang	zhang	PROPN
fnp-3166	284	19	y	y	PROPN
fnp-3166	284	20	,	,	PUNCT
fnp-3166	284	21	askenazi	askenazi	PROPN
fnp-3166	284	22	m	m	PROPN
fnp-3166	284	23	,	,	PUNCT
fnp-3166	284	24	wisniewski	wisniewski	PROPN
fnp-3166	284	25	t	t	PROPN
fnp-3166	284	26	,	,	PUNCT
fnp-3166	284	27	busciglio	busciglio	PROPN
fnp-3166	284	28	j	j	PROPN
fnp-3166	284	29	,	,	PUNCT
fnp-3166	284	30	cuello	cuello	PROPN
fnp-3166	284	31	ac	ac	PROPN
fnp-3166	284	32	.	.	PUNCT
fnp-3166	285	1	evolution	evolution	NOUN
fnp-3166	285	2	of	of	ADP
fnp-3166	285	3	neuroinflammation	neuroinflammation	NOUN
fnp-3166	285	4	across	across	ADP
fnp-3166	285	5	the	the	DET
fnp-3166	285	6	lifespan	lifespan	NOUN
fnp-3166	285	7	of	of	ADP
fnp-3166	285	8	individuals	individual	NOUN
fnp-3166	285	9	with	with	ADP
fnp-3166	285	10	down	down	ADP
fnp-3166	285	11	syndrome	syndrome	NOUN
fnp-3166	285	12	.	.	PUNCT
fnp-3166	286	1	brain	brain	NOUN
fnp-3166	286	2	.	.	PUNCT
fnp-3166	287	1	2020	2020	NUM
fnp-3166	287	2	nov	nov	PROPN
fnp-3166	287	3	18	18	NUM
fnp-3166	287	4	:	:	PUNCT
fnp-3166	287	5	awaa326	awaa326	PROPN
fnp-3166	287	6	.	.	PUNCT
fnp-3166	288	1	doi	doi	PROPN
fnp-3166	288	2	:	:	PUNCT
fnp-3166	288	3	10.1093	10.1093	NUM
fnp-3166	288	4	/	/	SYM
fnp-3166	288	5	brain	brain	NOUN
fnp-3166	288	6	/	/	SYM
fnp-3166	288	7	awaa326	awaa326	PROPN
fnp-3166	288	8	.	.	PUNCT
fnp-3166	289	1	epub	epub	NOUN
fnp-3166	289	2	ahead	ahead	ADV
fnp-3166	289	3	of	of	ADP
fnp-3166	289	4	print	print	NOUN
fnp-3166	289	5	.	.	PUNCT
fnp-3166	290	1	pmid	pmid	NOUN
fnp-3166	290	2	:	:	PUNCT
fnp-3166	290	3	33206953	33206953	NUM
fnp-3166	290	4	.	.	PUNCT
fnp-3166	291	1	fransen	fransen	PROPN
fnp-3166	291	2	nl	nl	PROPN
fnp-3166	291	3	,	,	PUNCT
fnp-3166	291	4	hsiao	hsiao	PROPN
fnp-3166	291	5	cc	cc	PROPN
fnp-3166	291	6	,	,	PUNCT
fnp-3166	291	7	van	van	PROPN
fnp-3166	291	8	der	der	PROPN
fnp-3166	291	9	poel	poel	PROPN
fnp-3166	291	10	m	m	PROPN
fnp-3166	291	11	,	,	PUNCT
fnp-3166	291	12	engelenburg	engelenburg	PROPN
fnp-3166	291	13	hj	hj	PROPN
fnp-3166	291	14	,	,	PUNCT
fnp-3166	291	15	verdaasdonk	verdaasdonk	PROPN
fnp-3166	291	16	k	k	PROPN
fnp-3166	291	17	,	,	PUNCT
fnp-3166	291	18	vincenten	vincenten	VERB
fnp-3166	291	19	mcj	mcj	NOUN
fnp-3166	291	20	,	,	PUNCT
fnp-3166	291	21	remmerswaal	remmerswaal	NOUN
fnp-3166	291	22	ebm	ebm	PROPN
fnp-3166	291	23	,	,	PUNCT
fnp-3166	291	24	kuhlmann	kuhlmann	PROPN
fnp-3166	291	25	t	t	PROPN
fnp-3166	291	26	,	,	PUNCT
fnp-3166	291	27	mason	mason	PROPN
fnp-3166	291	28	mrj	mrj	PROPN
fnp-3166	291	29	,	,	PUNCT
fnp-3166	291	30	hamann	hamann	PROPN
fnp-3166	291	31	j	j	PROPN
fnp-3166	291	32	,	,	PUNCT
fnp-3166	291	33	smolders	smolder	VERB
fnp-3166	291	34	j	j	PROPN
fnp-3166	291	35	,	,	PUNCT
fnp-3166	291	36	huitinga	huitinga	PROPN
fnp-3166	291	37	i.	i.	NOUN
fnp-3166	291	38	tissue	tissue	PROPN
fnp-3166	291	39	-	-	PUNCT
fnp-3166	291	40	resident	resident	NOUN
fnp-3166	291	41	memory	memory	NOUN
fnp-3166	291	42	t	t	PROPN
fnp-3166	291	43	cells	cell	NOUN
fnp-3166	291	44	invade	invade	VERB
fnp-3166	291	45	the	the	DET
fnp-3166	291	46	brain	brain	NOUN
fnp-3166	291	47	parenchyma	parenchyma	NOUN
fnp-3166	291	48	in	in	ADP
fnp-3166	291	49	multiple	multiple	ADJ
fnp-3166	291	50	sclerosis	sclerosis	NOUN
fnp-3166	291	51	white	white	ADJ
fnp-3166	291	52	matter	matter	NOUN
fnp-3166	291	53	lesions	lesion	NOUN
fnp-3166	291	54	.	.	PUNCT
fnp-3166	292	1	brain	brain	NOUN
fnp-3166	292	2	.	.	PUNCT
fnp-3166	293	1	2020	2020	NUM
fnp-3166	293	2	jun	jun	PROPN
fnp-3166	293	3	1;143(6):1714	1;143(6):1714	PROPN
fnp-3166	293	4	-	-	PUNCT
fnp-3166	293	5	1730	1730	NUM
fnp-3166	293	6	.	.	PUNCT
fnp-3166	294	1	doi	doi	NOUN
fnp-3166	294	2	:	:	PUNCT
fnp-3166	294	3	10.1093	10.1093	NUM
fnp-3166	294	4	/	/	SYM
fnp-3166	294	5	brain	brain	NOUN
fnp-3166	294	6	/	/	SYM
fnp-3166	294	7	awaa117	awaa117	PROPN
fnp-3166	294	8	.	.	PUNCT
fnp-3166	295	1	pmid	pmid	PROPN
fnp-3166	295	2	:	:	PUNCT
fnp-3166	295	3	32400866	32400866	NUM
fnp-3166	295	4	.	.	PUNCT
fnp-3166	296	1	fujihara	fujihara	PROPN
fnp-3166	296	2	k	k	PROPN
fnp-3166	296	3	,	,	PUNCT
fnp-3166	296	4	cook	cook	VERB
fnp-3166	296	5	lj	lj	PROPN
fnp-3166	296	6	.	.	PUNCT
fnp-3166	297	1	neuromyelitis	neuromyelitis	PROPN
fnp-3166	297	2	optica	optica	PROPN
fnp-3166	297	3	spectrum	spectrum	NOUN
fnp-3166	297	4	disorders	disorder	NOUN
fnp-3166	297	5	and	and	CCONJ
fnp-3166	297	6	myelin	myelin	ADJ
fnp-3166	297	7	oligodendrocyte	oligodendrocyte	NOUN
fnp-3166	297	8	glycoprotein	glycoprotein	NOUN
fnp-3166	297	9	antibody	antibody	NOUN
fnp-3166	297	10	-	-	PUNCT
fnp-3166	297	11	associated	associate	VERB
fnp-3166	297	12	disease	disease	NOUN
fnp-3166	297	13	:	:	PUNCT
fnp-3166	297	14	current	current	ADJ
fnp-3166	297	15	topics	topic	NOUN
fnp-3166	297	16	.	.	PUNCT
fnp-3166	298	1	curr	curr	PROPN
fnp-3166	298	2	opin	opin	NOUN
fnp-3166	298	3	neurol	neurol	NOUN
fnp-3166	298	4	.	.	PUNCT
fnp-3166	299	1	2020	2020	NUM
fnp-3166	300	1	jun;33(3):300	jun;33(3):300	NOUN
fnp-3166	300	2	-	-	SYM
fnp-3166	300	3	308	308	NUM
fnp-3166	300	4	.	.	PUNCT
fnp-3166	301	1	doi	doi	NOUN
fnp-3166	301	2	:	:	PUNCT
fnp-3166	301	3	10.1097	10.1097	NUM
fnp-3166	301	4	/	/	SYM
fnp-3166	301	5	wco.0000000000000828	wco.0000000000000828	ADV
fnp-3166	301	6	.	.	PUNCT
fnp-3166	302	1	pmid	pmid	NOUN
fnp-3166	302	2	:	:	PUNCT
fnp-3166	302	3	32374571	32374571	NUM
fnp-3166	302	4	.	.	PUNCT
fnp-3166	303	1	geraldes	geralde	NOUN
fnp-3166	303	2	r	r	NOUN
fnp-3166	303	3	,	,	PUNCT
fnp-3166	303	4	esiri	esiri	PROPN
fnp-3166	303	5	mm	mm	PROPN
fnp-3166	303	6	,	,	PUNCT
fnp-3166	303	7	perera	perera	PROPN
fnp-3166	303	8	r	r	PROPN
fnp-3166	303	9	,	,	PUNCT
fnp-3166	303	10	yee	yee	PROPN
fnp-3166	303	11	sa	sa	PROPN
fnp-3166	303	12	,	,	PUNCT
fnp-3166	303	13	jenkins	jenkins	PROPN
fnp-3166	303	14	d	d	PROPN
fnp-3166	303	15	,	,	PUNCT
fnp-3166	303	16	palace	palace	PROPN
fnp-3166	303	17	j	j	PROPN
fnp-3166	303	18	,	,	PUNCT
fnp-3166	303	19	deluca	deluca	PROPN
fnp-3166	303	20	gc	gc	PROPN
fnp-3166	303	21	.	.	PROPN
fnp-3166	303	22	vascular	vascular	ADJ
fnp-3166	303	23	disease	disease	NOUN
fnp-3166	303	24	and	and	CCONJ
fnp-3166	303	25	multiple	multiple	ADJ
fnp-3166	303	26	sclerosis	sclerosis	NOUN
fnp-3166	303	27	:	:	PUNCT
fnp-3166	303	28	a	a	DET
fnp-3166	303	29	post	post	ADJ
fnp-3166	303	30	-	-	ADJ
fnp-3166	303	31	mortem	mortem	ADJ
fnp-3166	303	32	study	study	NOUN
fnp-3166	303	33	exploring	explore	VERB
fnp-3166	303	34	their	their	PRON
fnp-3166	303	35	relationships	relationship	NOUN
fnp-3166	303	36	.	.	PUNCT
fnp-3166	304	1	brain	brain	NOUN
fnp-3166	304	2	.	.	PUNCT
fnp-3166	305	1	2020	2020	NUM
fnp-3166	305	2	oct	oct	NOUN
fnp-3166	305	3	1;143(10):2998	1;143(10):2998	NUM
fnp-3166	305	4	-	-	PUNCT
fnp-3166	305	5	3012	3012	NUM
fnp-3166	305	6	.	.	PUNCT
fnp-3166	306	1	doi	doi	NOUN
fnp-3166	306	2	:	:	PUNCT
fnp-3166	306	3	10.1093	10.1093	NUM
fnp-3166	306	4	/	/	SYM
fnp-3166	306	5	brain	brain	NOUN
fnp-3166	306	6	/	/	SYM
fnp-3166	306	7	awaa255	awaa255	PROPN
fnp-3166	306	8	.	.	PUNCT
fnp-3166	307	1	pmid	pmid	NOUN
fnp-3166	307	2	:	:	PUNCT
fnp-3166	307	3	32875311	32875311	NUM
fnp-3166	307	4	.	.	PUNCT
fnp-3166	308	1	haider	haider	PROPN
fnp-3166	308	2	l	l	PROPN
fnp-3166	308	3	,	,	PUNCT
fnp-3166	308	4	zrzavy	zrzavy	PROPN
fnp-3166	308	5	t	t	PROPN
fnp-3166	308	6	,	,	PUNCT
fnp-3166	308	7	hametner	hametner	PROPN
fnp-3166	308	8	s	s	PART
fnp-3166	308	9	,	,	PUNCT
fnp-3166	308	10	höftberger	höftberger	ADJ
fnp-3166	308	11	r	r	NOUN
fnp-3166	308	12	,	,	PUNCT
fnp-3166	308	13	bagnato	bagnato	NOUN
fnp-3166	308	14	f	f	PROPN
fnp-3166	308	15	,	,	PUNCT
fnp-3166	308	16	grabner	grabner	NOUN
fnp-3166	308	17	g	g	NOUN
fnp-3166	308	18	,	,	PUNCT
fnp-3166	308	19	trattnig	trattnig	NOUN
fnp-3166	308	20	s	s	PART
fnp-3166	308	21	,	,	PUNCT
fnp-3166	308	22	pfeifenbring	pfeifenbring	ADJ
fnp-3166	308	23	s	s	PROPN
fnp-3166	308	24	,	,	PUNCT
fnp-3166	308	25	brück	brück	PROPN
fnp-3166	308	26	w	w	PROPN
fnp-3166	308	27	,	,	PUNCT
fnp-3166	308	28	lassmann	lassmann	PROPN
fnp-3166	308	29	h.	h.	PROPN
fnp-3166	308	30	the	the	DET
fnp-3166	308	31	topograpy	topograpy	NOUN
fnp-3166	308	32	of	of	ADP
fnp-3166	308	33	demyelination	demyelination	NOUN
fnp-3166	308	34	and	and	CCONJ
fnp-3166	308	35	neurodegeneration	neurodegeneration	NOUN
fnp-3166	308	36	in	in	ADP
fnp-3166	308	37	the	the	DET
fnp-3166	308	38	multiple	multiple	ADJ
fnp-3166	308	39	sclerosis	sclerosis	NOUN
fnp-3166	308	40	brain	brain	NOUN
fnp-3166	308	41	.	.	PUNCT
fnp-3166	309	1	brain	brain	NOUN
fnp-3166	309	2	.	.	PUNCT
fnp-3166	310	1	2016	2016	NUM
fnp-3166	310	2	mar;139(pt	mar;139(pt	NOUN
fnp-3166	310	3	3):807	3):807	NUM
fnp-3166	310	4	-	-	SYM
fnp-3166	310	5	15	15	NUM
fnp-3166	310	6	.	.	PUNCT
fnp-3166	311	1	doi	doi	NOUN
fnp-3166	311	2	:	:	PUNCT
fnp-3166	311	3	10.1093	10.1093	NUM
fnp-3166	311	4	/	/	SYM
fnp-3166	311	5	brain	brain	NOUN
fnp-3166	311	6	/	/	SYM
fnp-3166	311	7	awv398	awv398	PROPN
fnp-3166	311	8	.	.	PUNCT
fnp-3166	312	1	epub	epub	PROPN
fnp-3166	312	2	2016	2016	NUM
fnp-3166	312	3	feb	feb	NOUN
fnp-3166	312	4	8	8	NUM
fnp-3166	312	5	.	.	PUNCT
fnp-3166	313	1	pmid	pmid	NOUN
fnp-3166	313	2	:	:	PUNCT
fnp-3166	313	3	26912645	26912645	NUM
fnp-3166	313	4	;	;	PUNCT
fnp-3166	313	5	pmcid	pmcid	ADJ
fnp-3166	313	6	:	:	PUNCT
fnp-3166	313	7	pmc4766379	pmc4766379	NOUN
fnp-3166	313	8	.	.	PUNCT
fnp-3166	314	1	hayashida	hayashida	PROPN
fnp-3166	314	2	s	s	PROPN
fnp-3166	314	3	,	,	PUNCT
fnp-3166	314	4	masaki	masaki	PROPN
fnp-3166	314	5	k	k	PROPN
fnp-3166	314	6	,	,	PUNCT
fnp-3166	314	7	suzuki	suzuki	PROPN
fnp-3166	314	8	so	so	ADV
fnp-3166	314	9	,	,	PUNCT
fnp-3166	314	10	yamasaki	yamasaki	PROPN
fnp-3166	314	11	r	r	PROPN
fnp-3166	314	12	,	,	PUNCT
fnp-3166	314	13	watanabe	watanabe	PROPN
fnp-3166	314	14	m	m	PROPN
fnp-3166	314	15	,	,	PUNCT
fnp-3166	314	16	koyama	koyama	PROPN
fnp-3166	314	17	s	s	PROPN
fnp-3166	314	18	,	,	PUNCT
fnp-3166	314	19	isobe	isobe	PROPN
fnp-3166	314	20	n	n	CCONJ
fnp-3166	314	21	,	,	PUNCT
fnp-3166	314	22	matsushita	matsushita	PROPN
fnp-3166	314	23	t	t	PROPN
fnp-3166	314	24	,	,	PUNCT
fnp-3166	314	25	takahashi	takahashi	PROPN
fnp-3166	314	26	k	k	PROPN
fnp-3166	314	27	,	,	PUNCT
fnp-3166	314	28	tabira	tabira	PROPN
fnp-3166	314	29	t	t	PROPN
fnp-3166	314	30	,	,	PUNCT
fnp-3166	314	31	iwaki	iwaki	NOUN
fnp-3166	314	32	t	t	PROPN
fnp-3166	314	33	,	,	PUNCT
fnp-3166	314	34	kira	kira	PROPN
fnp-3166	314	35	ji	ji	PROPN
fnp-3166	314	36	.	.	PROPN
fnp-3166	314	37	distinct	distinct	ADJ
fnp-3166	314	38	microglial	microglial	ADJ
fnp-3166	314	39	and	and	CCONJ
fnp-3166	314	40	macrophage	macrophage	ADJ
fnp-3166	314	41	distribution	distribution	NOUN
fnp-3166	314	42	patterns	pattern	NOUN
fnp-3166	314	43	in	in	ADP
fnp-3166	314	44	the	the	DET
fnp-3166	314	45	concentric	concentric	ADJ
fnp-3166	314	46	and	and	CCONJ
fnp-3166	314	47	lamellar	lamellar	ADJ
fnp-3166	314	48	lesions	lesion	NOUN
fnp-3166	314	49	in	in	ADP
fnp-3166	314	50	baló	baló	PROPN
fnp-3166	314	51	's	's	PART
fnp-3166	314	52	disease	disease	NOUN
fnp-3166	314	53	and	and	CCONJ
fnp-3166	314	54	neuromyelitis	neuromyelitis	PROPN
fnp-3166	314	55	optica	optica	PROPN
fnp-3166	314	56	spectrum	spectrum	NOUN
fnp-3166	314	57	disorders	disorder	NOUN
fnp-3166	314	58	.	.	PUNCT
fnp-3166	315	1	brain	brain	NOUN
fnp-3166	315	2	pathol	pathol	NOUN
fnp-3166	315	3	.	.	PUNCT
fnp-3166	316	1	2020	2020	NUM
fnp-3166	316	2	sep	sep	PROPN
fnp-3166	316	3	9	9	NUM
fnp-3166	316	4	.	.	PUNCT
fnp-3166	316	5	doi	doi	NOUN
fnp-3166	316	6	:	:	PUNCT
fnp-3166	316	7	10.1111	10.1111	NUM
fnp-3166	316	8	/	/	SYM
fnp-3166	316	9	bpa.12898	bpa.12898	PROPN
fnp-3166	316	10	.	.	PUNCT
fnp-3166	317	1	epub	epub	PROPN
fnp-3166	317	2	ahead	ahead	ADV
fnp-3166	317	3	of	of	ADP
fnp-3166	317	4	print	print	NOUN
fnp-3166	317	5	.	.	PUNCT
fnp-3166	318	1	pmid	pmid	NOUN
fnp-3166	318	2	:	:	PUNCT
fnp-3166	318	3	32902014	32902014	NUM
fnp-3166	318	4	.	.	PUNCT
fnp-3166	319	1	hernández	hernández	PROPN
fnp-3166	319	2	-	-	PUNCT
fnp-3166	319	3	fernández	fernández	PROPN
fnp-3166	319	4	f	f	X
fnp-3166	319	5	,	,	PUNCT
fnp-3166	319	6	sandoval	sandoval	PROPN
fnp-3166	319	7	valencia	valencia	PROPN
fnp-3166	319	8	h	h	NOUN
fnp-3166	319	9	,	,	PUNCT
fnp-3166	319	10	barbella	barbella	NOUN
fnp-3166	319	11	-	-	PUNCT
fnp-3166	319	12	aponte	aponte	PROPN
fnp-3166	319	13	ra	ra	PROPN
fnp-3166	319	14	,	,	PUNCT
fnp-3166	319	15	collado	collado	PROPN
fnp-3166	319	16	-	-	PUNCT
fnp-3166	319	17	jiménez	jiménez	PROPN
fnp-3166	319	18	r	r	NOUN
fnp-3166	319	19	,	,	PUNCT
fnp-3166	319	20	ayo	ayo	PROPN
fnp-3166	319	21	-	-	PUNCT
fnp-3166	319	22	martín	martín	NOUN
fnp-3166	319	23	ó	ó	PROPN
fnp-3166	319	24	,	,	PUNCT
fnp-3166	319	25	barrena	barrena	PROPN
fnp-3166	319	26	c	c	NOUN
fnp-3166	319	27	,	,	PUNCT
fnp-3166	319	28	molina	molina	PROPN
fnp-3166	319	29	-	-	PUNCT
fnp-3166	319	30	nuevo	nuevo	PROPN
fnp-3166	319	31	jd	jd	PROPN
fnp-3166	319	32	,	,	PUNCT
fnp-3166	319	33	garcía	garcía	ADJ
fnp-3166	319	34	-	-	PUNCT
fnp-3166	319	35	garcía	garcía	ADJ
fnp-3166	319	36	j	j	PROPN
fnp-3166	319	37	,	,	PUNCT
fnp-3166	319	38	lozano	lozano	PROPN
fnp-3166	319	39	-	-	PUNCT
fnp-3166	319	40	setién	setién	PROPN
fnp-3166	319	41	e	e	NOUN
fnp-3166	319	42	,	,	PUNCT
fnp-3166	319	43	alcahut	alcahut	NOUN
fnp-3166	319	44	-	-	PUNCT
fnp-3166	319	45	rodriguez	rodriguez	NOUN
fnp-3166	319	46	c	c	PROPN
fnp-3166	319	47	,	,	PUNCT
fnp-3166	319	48	martínez	martínez	NOUN
fnp-3166	319	49	-	-	PUNCT
fnp-3166	319	50	martín	martín	PROPN
fnp-3166	319	51	á	á	PROPN
fnp-3166	319	52	,	,	PUNCT
fnp-3166	319	53	sánchez	sánchez	NOUN
fnp-3166	319	54	-	-	PUNCT
fnp-3166	319	55	lópez	lópez	PROPN
fnp-3166	319	56	a	a	NOUN
fnp-3166	319	57	,	,	PUNCT
fnp-3166	319	58	segura	segura	ADJ
fnp-3166	319	59	t.	t.	ADJ
fnp-3166	319	60	cerebrovascular	cerebrovascular	ADJ
fnp-3166	319	61	disease	disease	NOUN
fnp-3166	319	62	in	in	ADP
fnp-3166	319	63	patients	patient	NOUN
fnp-3166	319	64	with	with	ADP
fnp-3166	319	65	covid-19	covid-19	PROPN
fnp-3166	319	66	:	:	PUNCT
fnp-3166	319	67	neuroimaging	neuroimaging	ADJ
fnp-3166	319	68	,	,	PUNCT
fnp-3166	319	69	histological	histological	ADJ
fnp-3166	319	70	and	and	CCONJ
fnp-3166	319	71	clinical	clinical	ADJ
fnp-3166	319	72	description	description	NOUN
fnp-3166	319	73	.	.	PUNCT
fnp-3166	320	1	brain	brain	NOUN
fnp-3166	320	2	.	.	PUNCT
fnp-3166	321	1	2020	2020	NUM
fnp-3166	321	2	oct	oct	PROPN
fnp-3166	321	3	1;143(10):3089	1;143(10):3089	PROPN
fnp-3166	321	4	-	-	PUNCT
fnp-3166	321	5	3103	3103	NUM
fnp-3166	321	6	.	.	PUNCT
fnp-3166	322	1	doi	doi	NOUN
fnp-3166	322	2	:	:	PUNCT
fnp-3166	322	3	10.1093	10.1093	NUM
fnp-3166	322	4	/	/	SYM
fnp-3166	322	5	brain	brain	NOUN
fnp-3166	322	6	/	/	SYM
fnp-3166	322	7	awaa239	awaa239	PROPN
fnp-3166	322	8	.	.	PUNCT
fnp-3166	322	9	pmid	pmid	PROPN
fnp-3166	322	10	:	:	PUNCT
fnp-3166	322	11	32645151	32645151	NUM
fnp-3166	322	12	;	;	PUNCT
fnp-3166	322	13	pmcid	pmcid	ADJ
fnp-3166	322	14	:	:	PUNCT
fnp-3166	322	15	pmc7454411	pmc7454411	NOUN
fnp-3166	322	16	.	.	PUNCT
fnp-3166	323	1	heß	heß	PROPN
fnp-3166	324	1	k	k	NOUN
fnp-3166	324	2	,	,	PUNCT
fnp-3166	324	3	starost	starost	ADJ
fnp-3166	324	4	l	l	NOUN
fnp-3166	324	5	,	,	PUNCT
fnp-3166	324	6	kieran	kieran	PROPN
fnp-3166	324	7	nw	nw	PROPN
fnp-3166	324	8	,	,	PUNCT
fnp-3166	324	9	thomas	thomas	PROPN
fnp-3166	324	10	c	c	PROPN
fnp-3166	324	11	,	,	PUNCT
fnp-3166	324	12	vincenten	vincenten	ADJ
fnp-3166	324	13	mcj	mcj	NOUN
fnp-3166	324	14	,	,	PUNCT
fnp-3166	324	15	antel	antel	PROPN
fnp-3166	324	16	j	j	PROPN
fnp-3166	324	17	,	,	PUNCT
fnp-3166	324	18	martino	martino	PROPN
fnp-3166	324	19	g	g	PROPN
fnp-3166	324	20	,	,	PUNCT
fnp-3166	324	21	huitinga	huitinga	PROPN
fnp-3166	324	22	i	i	PRON
fnp-3166	324	23	,	,	PUNCT
fnp-3166	324	24	healy	healy	PROPN
fnp-3166	324	25	l	l	PROPN
fnp-3166	324	26	,	,	PUNCT
fnp-3166	324	27	kuhlmann	kuhlmann	PROPN
fnp-3166	324	28	t.	t.	NOUN
fnp-3166	324	29	lesion	lesion	NOUN
fnp-3166	324	30	stage	stage	NOUN
fnp-3166	324	31	-	-	PUNCT
fnp-3166	324	32	dependent	dependent	ADJ
fnp-3166	324	33	causes	cause	NOUN
fnp-3166	324	34	for	for	ADP
fnp-3166	324	35	impaired	impaired	ADJ
fnp-3166	324	36	remyelination	remyelination	NOUN
fnp-3166	324	37	in	in	ADP
fnp-3166	324	38	ms	ms	PROPN
fnp-3166	324	39	.	.	PROPN
fnp-3166	324	40	acta	acta	PROPN
fnp-3166	324	41	neuropathol	neuropathol	PROPN
fnp-3166	324	42	.	.	PUNCT
fnp-3166	325	1	2020	2020	NUM
fnp-3166	325	2	sep;140(3):359	sep;140(3):359	NOUN
fnp-3166	325	3	-	-	PUNCT
fnp-3166	325	4	375	375	NUM
fnp-3166	325	5	.	.	PUNCT
fnp-3166	326	1	doi	doi	NOUN
fnp-3166	326	2	:	:	PUNCT
fnp-3166	326	3	10.1007	10.1007	NUM
fnp-3166	326	4	/	/	SYM
fnp-3166	326	5	s00401	s00401	NOUN
fnp-3166	326	6	-	-	PUNCT
fnp-3166	326	7	020	020	NUM
fnp-3166	326	8	-	-	PUNCT
fnp-3166	326	9	02189	02189	NUM
fnp-3166	326	10	-	-	SYM
fnp-3166	326	11	9	9	NUM
fnp-3166	326	12	.	.	PUNCT
fnp-3166	327	1	epub	epub	NOUN
fnp-3166	327	2	2020	2020	NUM
fnp-3166	327	3	jul	jul	PROPN
fnp-3166	327	4	24	24	NUM
fnp-3166	327	5	.	.	PUNCT
fnp-3166	328	1	pmid	pmid	NOUN
fnp-3166	328	2	:	:	PUNCT
fnp-3166	328	3	32710244	32710244	NUM
fnp-3166	328	4	;	;	PUNCT
fnp-3166	328	5	pmcid	pmcid	ADJ
fnp-3166	328	6	:	:	PUNCT
fnp-3166	328	7	pmc7424408	pmc7424408	NOUN
fnp-3166	328	8	.	.	PUNCT
fnp-3166	329	1	höftberger	höftberger	ADJ
fnp-3166	329	2	r	r	NOUN
fnp-3166	329	3	,	,	PUNCT
fnp-3166	329	4	guo	guo	PROPN
fnp-3166	329	5	y	y	PROPN
fnp-3166	329	6	,	,	PUNCT
fnp-3166	329	7	flanagan	flanagan	PROPN
fnp-3166	329	8	ep	ep	PROPN
fnp-3166	329	9	,	,	PUNCT
fnp-3166	329	10	lopez	lopez	NOUN
fnp-3166	329	11	-	-	PUNCT
fnp-3166	329	12	chiriboga	chiriboga	NOUN
fnp-3166	329	13	as	as	ADP
fnp-3166	329	14	,	,	PUNCT
fnp-3166	329	15	endmayr	endmayr	NOUN
fnp-3166	329	16	v	v	NOUN
fnp-3166	329	17	,	,	PUNCT
fnp-3166	329	18	hochmeister	hochmeister	PROPN
fnp-3166	329	19	s	s	PROPN
fnp-3166	329	20	,	,	PUNCT
fnp-3166	329	21	joldic	joldic	PROPN
fnp-3166	329	22	d	d	PROPN
fnp-3166	329	23	,	,	PUNCT
fnp-3166	329	24	pittock	pittock	PROPN
fnp-3166	329	25	sj	sj	PROPN
fnp-3166	329	26	,	,	PUNCT
fnp-3166	329	27	tillema	tillema	X
fnp-3166	329	28	jm	jm	PROPN
fnp-3166	329	29	,	,	PUNCT
fnp-3166	329	30	gorman	gorman	PROPN
fnp-3166	329	31	m	m	PROPN
fnp-3166	329	32	,	,	PUNCT
fnp-3166	329	33	lassmann	lassmann	PROPN
fnp-3166	329	34	h	h	NOUN
fnp-3166	329	35	,	,	PUNCT
fnp-3166	329	36	lucchinetti	lucchinetti	PROPN
fnp-3166	329	37	cf	cf	NOUN
fnp-3166	329	38	.	.	PUNCT
fnp-3166	330	1	the	the	DET
fnp-3166	330	2	pathology	pathology	NOUN
fnp-3166	330	3	of	of	ADP
fnp-3166	330	4	central	central	ADJ
fnp-3166	330	5	nervous	nervous	ADJ
fnp-3166	330	6	system	system	NOUN
fnp-3166	330	7	inflammatory	inflammatory	ADJ
fnp-3166	330	8	demyelinating	demyelinate	VERB
fnp-3166	330	9	disease	disease	NOUN
fnp-3166	330	10	accompanying	accompany	VERB
fnp-3166	330	11	myelin	myelin	NOUN
fnp-3166	330	12	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	330	13	glycoprotein	glycoprotein	NOUN
fnp-3166	330	14	autoantibody	autoantibody	NOUN
fnp-3166	330	15	.	.	PUNCT
fnp-3166	331	1	acta	acta	PROPN
fnp-3166	331	2	neuropathol	neuropathol	PROPN
fnp-3166	331	3	.	.	PUNCT
fnp-3166	332	1	2020	2020	NUM
fnp-3166	332	2	may;139(5):875	may;139(5):875	NOUN
fnp-3166	332	3	-	-	PUNCT
fnp-3166	332	4	892	892	NUM
fnp-3166	332	5	.	.	PUNCT
fnp-3166	333	1	doi	doi	NOUN
fnp-3166	333	2	:	:	PUNCT
fnp-3166	333	3	10.1007	10.1007	NUM
fnp-3166	333	4	/	/	SYM
fnp-3166	333	5	s00401	s00401	NOUN
fnp-3166	333	6	-	-	PUNCT
fnp-3166	333	7	020	020	NUM
fnp-3166	333	8	-	-	PUNCT
fnp-3166	333	9	02132	02132	NUM
fnp-3166	333	10	-	-	PUNCT
fnp-3166	333	11	y.	y.	PROPN
fnp-3166	333	12	epub	epub	PROPN
fnp-3166	333	13	2020	2020	NUM
fnp-3166	333	14	feb	feb	PROPN
fnp-3166	333	15	11	11	NUM
fnp-3166	333	16	.	.	PUNCT
fnp-3166	334	1	pmid	pmid	NOUN
fnp-3166	334	2	:	:	PUNCT
fnp-3166	334	3	32048003	32048003	NUM
fnp-3166	334	4	;	;	PUNCT
fnp-3166	334	5	pmcid	pmcid	ADJ
fnp-3166	334	6	:	:	PUNCT
fnp-3166	334	7	pmc7181560	pmc7181560	ADJ
fnp-3166	334	8	.	.	PUNCT
fnp-3166	335	1	höftberger	höftberger	ADJ
fnp-3166	335	2	r	r	NOUN
fnp-3166	335	3	,	,	PUNCT
fnp-3166	335	4	lassmann	lassmann	PROPN
fnp-3166	335	5	h.	h.	PROPN
fnp-3166	335	6	immune	immune	PROPN
fnp-3166	335	7	-	-	PUNCT
fnp-3166	335	8	mediated	mediate	VERB
fnp-3166	335	9	disorders	disorder	NOUN
fnp-3166	335	10	.	.	PUNCT
fnp-3166	336	1	handb	handb	PROPN
fnp-3166	336	2	clin	clin	PROPN
fnp-3166	336	3	neurol	neurol	PROPN
fnp-3166	336	4	.	.	PUNCT
fnp-3166	337	1	2017;145:285	2017;145:285	NUM
fnp-3166	337	2	-	-	SYM
fnp-3166	337	3	299	299	NUM
fnp-3166	337	4	.	.	PUNCT
fnp-3166	338	1	doi	doi	NOUN
fnp-3166	338	2	:	:	PUNCT
fnp-3166	338	3	10.1016	10.1016	NUM
fnp-3166	338	4	/	/	SYM
fnp-3166	338	5	b978	b978	NUM
fnp-3166	338	6	-	-	PUNCT
fnp-3166	338	7	0	0	NUM
fnp-3166	338	8	-	-	PUNCT
fnp-3166	338	9	12	12	NUM
fnp-3166	338	10	-	-	PUNCT
fnp-3166	338	11	802395	802395	NUM
fnp-3166	338	12	-	-	PUNCT
fnp-3166	338	13	2.00020	2.00020	NUM
fnp-3166	338	14	-	-	PUNCT
fnp-3166	338	15	1	1	NUM
fnp-3166	338	16	.	.	PUNCT
fnp-3166	339	1	pmid	pmid	NOUN
fnp-3166	339	2	:	:	PUNCT
fnp-3166	339	3	28987176	28987176	NUM
fnp-3166	339	4	.	.	PUNCT
fnp-3166	340	1	höftberger	höftberger	ADJ
fnp-3166	340	2	r	r	NOUN
fnp-3166	340	3	,	,	PUNCT
fnp-3166	340	4	leisser	leisser	NOUN
fnp-3166	340	5	m	m	PROPN
fnp-3166	340	6	,	,	PUNCT
fnp-3166	340	7	bauer	bauer	PROPN
fnp-3166	340	8	j	j	PROPN
fnp-3166	340	9	,	,	PUNCT
fnp-3166	340	10	lassmann	lassmann	PROPN
fnp-3166	340	11	h.	h.	PROPN
fnp-3166	340	12	autoimmune	autoimmune	PROPN
fnp-3166	340	13	encephalitis	encephalitis	NOUN
fnp-3166	340	14	in	in	ADP
fnp-3166	340	15	humans	human	NOUN
fnp-3166	340	16	:	:	PUNCT
fnp-3166	340	17	how	how	SCONJ
fnp-3166	340	18	closely	closely	ADV
fnp-3166	340	19	does	do	AUX
fnp-3166	340	20	it	it	PRON
fnp-3166	340	21	reflect	reflect	VERB
fnp-3166	340	22	multiple	multiple	ADJ
fnp-3166	340	23	sclerosis	sclerosis	NOUN
fnp-3166	340	24	?	?	PUNCT
fnp-3166	341	1	acta	acta	PROPN
fnp-3166	341	2	neuropathol	neuropathol	PROPN
fnp-3166	341	3	commun	commun	PROPN
fnp-3166	341	4	.	.	PUNCT
fnp-3166	342	1	2015	2015	NUM
fnp-3166	342	2	dec	dec	PROPN
fnp-3166	342	3	4;3:80	4;3:80	PROPN
fnp-3166	342	4	.	.	PUNCT
fnp-3166	343	1	doi	doi	NOUN
fnp-3166	343	2	:	:	PUNCT
fnp-3166	343	3	10.1186	10.1186	NUM
fnp-3166	343	4	/	/	SYM
fnp-3166	343	5	s40478	s40478	PROPN
fnp-3166	343	6	-	-	PUNCT
fnp-3166	343	7	015	015	NUM
fnp-3166	343	8	-	-	PUNCT
fnp-3166	343	9	0260	0260	NUM
fnp-3166	343	10	-	-	SYM
fnp-3166	343	11	9	9	NUM
fnp-3166	343	12	.	.	PUNCT
fnp-3166	344	1	pmid	pmid	NOUN
fnp-3166	344	2	:	:	PUNCT
fnp-3166	344	3	26637427	26637427	NUM
fnp-3166	344	4	;	;	PUNCT
fnp-3166	344	5	pmcid	pmcid	NOUN
fnp-3166	344	6	:	:	PUNCT
fnp-3166	344	7	pmc4670499	pmc4670499	NOUN
fnp-3166	344	8	.	.	PUNCT
fnp-3166	345	1	jäckle	jäckle	PROPN
fnp-3166	345	2	k	k	PROPN
fnp-3166	345	3	,	,	PUNCT
fnp-3166	345	4	zeis	zeis	PROPN
fnp-3166	345	5	t	t	PROPN
fnp-3166	345	6	,	,	PUNCT
fnp-3166	345	7	schaeren	schaeren	NOUN
fnp-3166	345	8	-	-	PUNCT
fnp-3166	345	9	wiemers	wiemer	NOUN
fnp-3166	345	10	n	n	CCONJ
fnp-3166	345	11	,	,	PUNCT
fnp-3166	345	12	junker	junker	PROPN
fnp-3166	345	13	a	a	NOUN
fnp-3166	345	14	,	,	PUNCT
fnp-3166	345	15	van	van	PROPN
fnp-3166	345	16	der	der	PROPN
fnp-3166	345	17	meer	meer	PROPN
fnp-3166	345	18	f	f	PROPN
fnp-3166	345	19	,	,	PUNCT
fnp-3166	345	20	kramann	kramann	PROPN
fnp-3166	345	21	n	n	CCONJ
fnp-3166	345	22	,	,	PUNCT
fnp-3166	345	23	stadelmann	stadelmann	PROPN
fnp-3166	345	24	c	c	NOUN
fnp-3166	345	25	,	,	PUNCT
fnp-3166	345	26	brück	brück	ADJ
fnp-3166	345	27	w.	w.	PROPN
fnp-3166	345	28	molecular	molecular	ADJ
fnp-3166	345	29	signature	signature	NOUN
fnp-3166	345	30	of	of	ADP
fnp-3166	345	31	slowly	slowly	ADV
fnp-3166	345	32	expanding	expand	VERB
fnp-3166	345	33	lesions	lesion	NOUN
fnp-3166	345	34	in	in	ADP
fnp-3166	345	35	progressive	progressive	ADJ
fnp-3166	345	36	multiple	multiple	ADJ
fnp-3166	345	37	sclerosis	sclerosis	NOUN
fnp-3166	345	38	.	.	PUNCT
fnp-3166	346	1	brain	brain	NOUN
fnp-3166	346	2	.	.	PUNCT
fnp-3166	347	1	2020	2020	NUM
fnp-3166	347	2	jul	jul	PROPN
fnp-3166	347	3	1;143(7):2073	1;143(7):2073	PROPN
fnp-3166	347	4	-	-	SYM
fnp-3166	347	5	2088	2088	NUM
fnp-3166	347	6	.	.	PUNCT
fnp-3166	348	1	doi	doi	NOUN
fnp-3166	348	2	:	:	PUNCT
fnp-3166	348	3	10.1093	10.1093	NUM
fnp-3166	348	4	/	/	SYM
fnp-3166	348	5	brain	brain	NOUN
fnp-3166	348	6	/	/	SYM
fnp-3166	348	7	awaa158	awaa158	PROPN
fnp-3166	348	8	.	.	PUNCT
fnp-3166	349	1	pmid	pmid	NOUN
fnp-3166	349	2	:	:	PUNCT
fnp-3166	349	3	32577755	32577755	NUM
fnp-3166	349	4	.	.	PUNCT
fnp-3166	350	1	jelcic	jelcic	PROPN
fnp-3166	350	2	i	i	PRON
fnp-3166	350	3	,	,	PUNCT
fnp-3166	350	4	al	al	PROPN
fnp-3166	350	5	nimer	nimer	PROPN
fnp-3166	350	6	f	f	PROPN
fnp-3166	350	7	,	,	PUNCT
fnp-3166	350	8	wang	wang	PROPN
fnp-3166	350	9	j	j	PROPN
fnp-3166	350	10	,	,	PUNCT
fnp-3166	350	11	lentsch	lentsch	PROPN
fnp-3166	350	12	v	v	NOUN
fnp-3166	350	13	,	,	PUNCT
fnp-3166	350	14	planas	planas	PROPN
fnp-3166	350	15	r	r	PROPN
fnp-3166	350	16	,	,	PUNCT
fnp-3166	350	17	jelcic	jelcic	PROPN
fnp-3166	350	18	i	i	PRON
fnp-3166	350	19	,	,	PUNCT
fnp-3166	350	20	madjovski	madjovski	VERB
fnp-3166	350	21	a	a	PRON
fnp-3166	350	22	,	,	PUNCT
fnp-3166	350	23	ruhrmann	ruhrmann	PROPN
fnp-3166	350	24	s	s	PROPN
fnp-3166	350	25	,	,	PUNCT
fnp-3166	350	26	faigle	faigle	PROPN
fnp-3166	350	27	w	w	NOUN
fnp-3166	350	28	,	,	PUNCT
fnp-3166	350	29	frauenknecht	frauenknecht	PROPN
fnp-3166	350	30	k	k	PROPN
fnp-3166	350	31	,	,	PUNCT
fnp-3166	350	32	pinilla	pinilla	NOUN
fnp-3166	350	33	c	c	NOUN
fnp-3166	350	34	,	,	PUNCT
fnp-3166	350	35	santos	santos	PROPN
fnp-3166	350	36	r	r	NOUN
fnp-3166	350	37	,	,	PUNCT
fnp-3166	350	38	hammer	hammer	NOUN
fnp-3166	350	39	c	c	NOUN
fnp-3166	350	40	,	,	PUNCT
fnp-3166	350	41	ortiz	ortiz	PROPN
fnp-3166	350	42	y	y	PROPN
fnp-3166	350	43	,	,	PUNCT
fnp-3166	350	44	opitz	opitz	PROPN
fnp-3166	350	45	l	l	PROPN
fnp-3166	350	46	,	,	PUNCT
fnp-3166	350	47	grönlund	grönlund	NOUN
fnp-3166	350	48	h	h	NOUN
fnp-3166	350	49	,	,	PUNCT
fnp-3166	350	50	rogler	rogler	NOUN
fnp-3166	350	51	g	g	NOUN
fnp-3166	350	52	,	,	PUNCT
fnp-3166	350	53	boyman	boyman	NOUN
fnp-3166	350	54	o	o	PROPN
fnp-3166	350	55	,	,	PUNCT
fnp-3166	350	56	reynolds	reynolds	PROPN
fnp-3166	350	57	r	r	PROPN
fnp-3166	350	58	,	,	PUNCT
fnp-3166	350	59	lutterotti	lutterotti	PROPN
fnp-3166	350	60	a	a	PRON
fnp-3166	350	61	,	,	PUNCT
fnp-3166	350	62	khademi	khademi	PROPN
fnp-3166	350	63	m	m	PROPN
fnp-3166	350	64	,	,	PUNCT
fnp-3166	350	65	olsson	olsson	PROPN
fnp-3166	350	66	t	t	PROPN
fnp-3166	350	67	,	,	PUNCT
fnp-3166	350	68	piehl	piehl	PROPN
fnp-3166	350	69	f	f	PROPN
fnp-3166	350	70	,	,	PUNCT
fnp-3166	350	71	sospedra	sospedra	PROPN
fnp-3166	350	72	m	m	PROPN
fnp-3166	350	73	,	,	PUNCT
fnp-3166	350	74	martin	martin	PROPN
fnp-3166	350	75	r.	r.	PROPN
fnp-3166	350	76	memory	memory	PROPN
fnp-3166	350	77	b	b	PROPN
fnp-3166	350	78	cells	cell	NOUN
fnp-3166	350	79	activate	activate	VERB
fnp-3166	350	80	brain	brain	NOUN
fnp-3166	350	81	-	-	PUNCT
fnp-3166	350	82	homing	homing	NOUN
fnp-3166	350	83	,	,	PUNCT
fnp-3166	350	84	autoreactive	autoreactive	ADJ
fnp-3166	350	85	cd4	cd4	PROPN
fnp-3166	350	86	+	+	PROPN
fnp-3166	350	87	t	t	NOUN
fnp-3166	350	88	cells	cell	NOUN
fnp-3166	350	89	in	in	ADP
fnp-3166	350	90	multiple	multiple	ADJ
fnp-3166	350	91	sclerosis	sclerosis	NOUN
fnp-3166	350	92	.	.	PUNCT
fnp-3166	351	1	cell	cell	NOUN
fnp-3166	351	2	.	.	PUNCT
fnp-3166	352	1	2018	2018	NUM
fnp-3166	352	2	sep	sep	NOUN
fnp-3166	352	3	20;175(1):85	20;175(1):85	PROPN
fnp-3166	352	4	-	-	PUNCT
fnp-3166	352	5	100.e23	100.e23	PROPN
fnp-3166	352	6	.	.	PUNCT
fnp-3166	352	7	doi	doi	NOUN
fnp-3166	352	8	:	:	PUNCT
fnp-3166	352	9	10.1016	10.1016	NUM
fnp-3166	352	10	/	/	SYM
fnp-3166	352	11	j.cell.2018.08.011	j.cell.2018.08.011	PROPN
fnp-3166	352	12	.	.	PUNCT
fnp-3166	353	1	epub	epub	PROPN
fnp-3166	353	2	2018	2018	NUM
fnp-3166	353	3	aug	aug	PROPN
fnp-3166	353	4	30	30	NUM
fnp-3166	353	5	.	.	PUNCT
fnp-3166	354	1	pmid	pmid	NOUN
fnp-3166	354	2	:	:	PUNCT
fnp-3166	354	3	30173916	30173916	NUM
fnp-3166	354	4	;	;	PUNCT
fnp-3166	354	5	pmcid	pmcid	NOUN
fnp-3166	354	6	:	:	PUNCT
fnp-3166	354	7	pmc6191934	pmc6191934	X
fnp-3166	354	8	.	.	PUNCT
fnp-3166	355	1	jensen	jensen	PROPN
fnp-3166	355	2	mp	mp	PROPN
fnp-3166	355	3	,	,	PUNCT
fnp-3166	355	4	le	le	X
fnp-3166	355	5	quesne	quesne	PROPN
fnp-3166	355	6	j	j	PROPN
fnp-3166	355	7	,	,	PUNCT
fnp-3166	355	8	officer	officer	NOUN
fnp-3166	355	9	-	-	PUNCT
fnp-3166	355	10	jones	jones	PROPN
fnp-3166	355	11	l	l	PROPN
fnp-3166	355	12	,	,	PUNCT
fnp-3166	355	13	teodòsio	teodòsio	ADV
fnp-3166	355	14	a	a	PRON
fnp-3166	355	15	,	,	PUNCT
fnp-3166	355	16	thaventhiran	thaventhiran	ADJ
fnp-3166	355	17	j	j	PROPN
fnp-3166	355	18	,	,	PUNCT
fnp-3166	355	19	ficken	ficken	ADJ
fnp-3166	355	20	c	c	NOUN
fnp-3166	355	21	,	,	PUNCT
fnp-3166	355	22	goddard	goddard	PROPN
fnp-3166	355	23	m	m	PROPN
fnp-3166	355	24	,	,	PUNCT
fnp-3166	355	25	smith	smith	PROPN
fnp-3166	355	26	c	c	PROPN
fnp-3166	355	27	,	,	PUNCT
fnp-3166	355	28	menon	menon	PROPN
fnp-3166	355	29	d	d	PROPN
fnp-3166	355	30	,	,	PUNCT
fnp-3166	355	31	allinson	allinson	NOUN
fnp-3166	355	32	ksj	ksj	ADJ
fnp-3166	355	33	.	.	PUNCT
fnp-3166	356	1	neuropathological	neuropathological	ADJ
fnp-3166	356	2	findings	finding	NOUN
fnp-3166	356	3	in	in	ADP
fnp-3166	356	4	two	two	NUM
fnp-3166	356	5	patients	patient	NOUN
fnp-3166	356	6	with	with	ADP
fnp-3166	356	7	fatal	fatal	ADJ
fnp-3166	356	8	covid-19	covid-19	PROPN
fnp-3166	356	9	.	.	PUNCT
fnp-3166	356	10	neuropathol	neuropathol	PROPN
fnp-3166	356	11	appl	appl	PROPN
fnp-3166	356	12	neurobiol	neurobiol	PROPN
fnp-3166	356	13	.	.	PUNCT
fnp-3166	357	1	2020	2020	NUM
fnp-3166	357	2	sep	sep	PROPN
fnp-3166	357	3	8	8	NUM
fnp-3166	357	4	.	.	PUNCT
fnp-3166	357	5	doi	doi	NOUN
fnp-3166	357	6	:	:	PUNCT
fnp-3166	357	7	10.1111	10.1111	NUM
fnp-3166	357	8	/	/	SYM
fnp-3166	357	9	nan.12662	nan.12662	PROPN
fnp-3166	357	10	.	.	PUNCT
fnp-3166	358	1	epub	epub	NOUN
fnp-3166	358	2	ahead	ahead	ADV
fnp-3166	358	3	of	of	ADP
fnp-3166	358	4	print	print	NOUN
fnp-3166	358	5	.	.	PUNCT
fnp-3166	359	1	pmid	pmid	NOUN
fnp-3166	359	2	:	:	PUNCT
fnp-3166	359	3	32895961	32895961	NUM
fnp-3166	359	4	.	.	PUNCT
fnp-3166	360	1	junker	junker	PROPN
fnp-3166	360	2	a	a	PROPN
fnp-3166	360	3	,	,	PUNCT
fnp-3166	360	4	wozniak	wozniak	PROPN
fnp-3166	360	5	j	j	PROPN
fnp-3166	360	6	,	,	PUNCT
fnp-3166	360	7	voigt	voigt	PROPN
fnp-3166	360	8	d	d	PROPN
fnp-3166	360	9	,	,	PUNCT
fnp-3166	360	10	scheidt	scheidt	PROPN
fnp-3166	360	11	u	u	PROPN
fnp-3166	360	12	,	,	PUNCT
fnp-3166	360	13	antel	antel	PROPN
fnp-3166	360	14	j	j	PROPN
fnp-3166	360	15	,	,	PUNCT
fnp-3166	360	16	wegner	wegner	PROPN
fnp-3166	360	17	c	c	PROPN
fnp-3166	360	18	,	,	PUNCT
fnp-3166	360	19	brück	brück	PROPN
fnp-3166	360	20	w	w	PROPN
fnp-3166	360	21	,	,	PUNCT
fnp-3166	360	22	stadelmann	stadelmann	PROPN
fnp-3166	360	23	c.	c.	PROPN
fnp-3166	360	24	extensive	extensive	ADJ
fnp-3166	360	25	subpial	subpial	ADJ
fnp-3166	360	26	cortical	cortical	ADJ
fnp-3166	360	27	demyelination	demyelination	NOUN
fnp-3166	360	28	is	be	AUX
fnp-3166	360	29	specific	specific	ADJ
fnp-3166	360	30	to	to	ADP
fnp-3166	360	31	multiple	multiple	ADJ
fnp-3166	360	32	sclerosis	sclerosis	NOUN
fnp-3166	360	33	.	.	PUNCT
fnp-3166	361	1	brain	brain	NOUN
fnp-3166	361	2	pathol	pathol	NOUN
fnp-3166	361	3	.	.	PUNCT
fnp-3166	362	1	2020	2020	NUM
fnp-3166	362	2	may;30(3):641	may;30(3):641	NOUN
fnp-3166	362	3	-	-	PUNCT
fnp-3166	362	4	652	652	NUM
fnp-3166	362	5	.	.	PUNCT
fnp-3166	363	1	doi	doi	NOUN
fnp-3166	363	2	:	:	PUNCT
fnp-3166	363	3	10.1111	10.1111	NUM
fnp-3166	363	4	/	/	SYM
fnp-3166	363	5	bpa.12813	bpa.12813	NUM
fnp-3166	363	6	.	.	PUNCT
fnp-3166	364	1	epub	epub	PROPN
fnp-3166	364	2	2020	2020	NUM
fnp-3166	364	3	feb	feb	NOUN
fnp-3166	364	4	3	3	NUM
fnp-3166	364	5	.	.	PUNCT
fnp-3166	364	6	pmid	pmid	NOUN
fnp-3166	364	7	:	:	PUNCT
fnp-3166	364	8	31916298	31916298	NUM
fnp-3166	364	9	.	.	PUNCT
fnp-3166	365	1	kabbani	kabbani	PROPN
fnp-3166	365	2	n	n	CCONJ
fnp-3166	365	3	,	,	PUNCT
fnp-3166	365	4	olds	old	NOUN
fnp-3166	365	5	jl	jl	PROPN
fnp-3166	365	6	.	.	PUNCT
fnp-3166	366	1	does	do	AUX
fnp-3166	366	2	covid19	covid19	NOUN
fnp-3166	366	3	infect	infect	VERB
fnp-3166	366	4	the	the	DET
fnp-3166	366	5	brain	brain	NOUN
fnp-3166	366	6	?	?	PUNCT
fnp-3166	367	1	if	if	SCONJ
fnp-3166	367	2	so	so	ADV
fnp-3166	367	3	,	,	PUNCT
fnp-3166	367	4	smokers	smoker	NOUN
fnp-3166	367	5	might	might	AUX
fnp-3166	367	6	be	be	AUX
fnp-3166	367	7	at	at	ADP
fnp-3166	367	8	a	a	DET
fnp-3166	367	9	higher	high	ADJ
fnp-3166	367	10	risk	risk	NOUN
fnp-3166	367	11	.	.	PUNCT
fnp-3166	368	1	mol	mol	ADP
fnp-3166	368	2	pharmacol	pharmacol	PROPN
fnp-3166	368	3	.	.	PUNCT
fnp-3166	369	1	2020	2020	NUM
fnp-3166	370	1	may;97(5):351	may;97(5):351	NOUN
fnp-3166	370	2	-	-	PUNCT
fnp-3166	370	3	353	353	NUM
fnp-3166	370	4	.	.	PUNCT
fnp-3166	371	1	doi	doi	NOUN
fnp-3166	371	2	:	:	PUNCT
fnp-3166	371	3	10.1124	10.1124	NUM
fnp-3166	371	4	/	/	SYM
fnp-3166	371	5	molpharm.120.000014	molpharm.120.000014	NOUN
fnp-3166	371	6	.	.	PUNCT
fnp-3166	372	1	epub	epub	NOUN
fnp-3166	372	2	2020	2020	NUM
fnp-3166	372	3	apr	apr	NOUN
fnp-3166	372	4	1	1	NUM
fnp-3166	372	5	.	.	PUNCT
fnp-3166	373	1	pmid	pmid	NOUN
fnp-3166	373	2	:	:	PUNCT
fnp-3166	373	3	32238438	32238438	NUM
fnp-3166	373	4	;	;	PUNCT
fnp-3166	373	5	pmcid	pmcid	NOUN
fnp-3166	373	6	:	:	PUNCT
fnp-3166	373	7	pmc7237865	pmc7237865	PROPN
fnp-3166	373	8	.	.	PUNCT
fnp-3166	374	1	kantonen	kantonen	PROPN
fnp-3166	374	2	j	j	PROPN
fnp-3166	374	3	,	,	PUNCT
fnp-3166	374	4	mahzabin	mahzabin	PROPN
fnp-3166	374	5	s	s	PROPN
fnp-3166	374	6	,	,	PUNCT
fnp-3166	374	7	mäyränpää	mäyränpää	PROPN
fnp-3166	374	8	mi	mi	PROPN
fnp-3166	374	9	,	,	PUNCT
fnp-3166	374	10	tynninen	tynninen	NOUN
fnp-3166	374	11	o	o	NOUN
fnp-3166	374	12	,	,	PUNCT
fnp-3166	374	13	paetau	paetau	VERB
fnp-3166	374	14	a	a	PRON
fnp-3166	374	15	,	,	PUNCT
fnp-3166	374	16	andersson	andersson	PROPN
fnp-3166	374	17	n	n	PRON
fnp-3166	374	18	,	,	PUNCT
fnp-3166	374	19	sajantila	sajantila	PROPN
fnp-3166	374	20	a	a	PRON
fnp-3166	374	21	,	,	PUNCT
fnp-3166	374	22	vapalahti	vapalahti	ADJ
fnp-3166	374	23	o	o	NOUN
fnp-3166	374	24	,	,	PUNCT
fnp-3166	374	25	carpén	carpén	PROPN
fnp-3166	374	26	o	o	NOUN
fnp-3166	374	27	,	,	PUNCT
fnp-3166	374	28	kekäläinen	kekäläinen	PROPN
fnp-3166	374	29	e	e	PROPN
fnp-3166	374	30	,	,	PUNCT
fnp-3166	374	31	kantele	kantele	PROPN
fnp-3166	374	32	a	a	PROPN
fnp-3166	374	33	,	,	PUNCT
fnp-3166	374	34	myllykangas	myllykangas	PROPN
fnp-3166	374	35	l.	l.	PROPN
fnp-3166	374	36	neuropathologic	neuropathologic	PROPN
fnp-3166	374	37	features	feature	NOUN
fnp-3166	374	38	of	of	ADP
fnp-3166	374	39	four	four	NUM
fnp-3166	374	40	autopsied	autopsie	VERB
fnp-3166	374	41	covid-19	covid-19	PROPN
fnp-3166	374	42	patients	patient	NOUN
fnp-3166	374	43	.	.	PUNCT
fnp-3166	375	1	brain	brain	NOUN
fnp-3166	375	2	pathol	pathol	NOUN
fnp-3166	375	3	.	.	PUNCT
fnp-3166	376	1	2020	2020	NUM
fnp-3166	376	2	aug	aug	PROPN
fnp-3166	376	3	6:10.1111	6:10.1111	NUM
fnp-3166	376	4	/	/	SYM
fnp-3166	376	5	bpa.12889	bpa.12889	NOUN
fnp-3166	376	6	.	.	PUNCT
fnp-3166	376	7	doi	doi	NOUN
fnp-3166	376	8	:	:	PUNCT
fnp-3166	376	9	10.1111	10.1111	NUM
fnp-3166	376	10	/	/	SYM
fnp-3166	376	11	bpa.12889	bpa.12889	X
fnp-3166	376	12	.	.	PUNCT
fnp-3166	377	1	epub	epub	NOUN
fnp-3166	377	2	ahead	ahead	ADV
fnp-3166	377	3	of	of	ADP
fnp-3166	377	4	print	print	NOUN
fnp-3166	377	5	.	.	PUNCT
fnp-3166	378	1	pmid	pmid	NOUN
fnp-3166	378	2	:	:	PUNCT
fnp-3166	378	3	32762083	32762083	NUM
fnp-3166	378	4	;	;	PUNCT
fnp-3166	378	5	pmcid	pmcid	PROPN
fnp-3166	378	6	:	:	PUNCT
fnp-3166	378	7	pmc7436498	pmc7436498	NOUN
fnp-3166	378	8	.	.	PUNCT
fnp-3166	379	1	kanwar	kanwar	PROPN
fnp-3166	379	2	d	d	PROPN
fnp-3166	379	3	,	,	PUNCT
fnp-3166	379	4	baig	baig	PROPN
fnp-3166	379	5	am	be	AUX
fnp-3166	379	6	,	,	PUNCT
fnp-3166	379	7	wasay	wasay	VERB
fnp-3166	379	8	m.	m.	NOUN
fnp-3166	379	9	neurological	neurological	ADJ
fnp-3166	379	10	manifestations	manifestation	NOUN
fnp-3166	379	11	of	of	ADP
fnp-3166	379	12	covid-19	covid-19	PROPN
fnp-3166	379	13	.	.	PUNCT
fnp-3166	380	1	j	j	PROPN
fnp-3166	380	2	pak	pak	PROPN
fnp-3166	380	3	med	med	PROPN
fnp-3166	380	4	assoc	assoc	PROPN
fnp-3166	380	5	.	.	PUNCT
fnp-3166	380	6	2020	2020	NUM
fnp-3166	381	1	may;70(suppl	may;70(suppl	PROPN
fnp-3166	381	2	3)(5):s101	3)(5):s101	NUM
fnp-3166	381	3	-	-	PUNCT
fnp-3166	381	4	s103	s103	PROPN
fnp-3166	381	5	.	.	PUNCT
fnp-3166	382	1	doi	doi	NOUN
fnp-3166	382	2	:	:	PUNCT
fnp-3166	382	3	10.5455	10.5455	NUM
fnp-3166	382	4	/	/	SYM
fnp-3166	382	5	jpma.20	jpma.20	PROPN
fnp-3166	382	6	.	.	PUNCT
fnp-3166	383	1	pmid	pmid	NOUN
fnp-3166	383	2	:	:	PUNCT
fnp-3166	383	3	32515379	32515379	NUM
fnp-3166	383	4	.	.	PUNCT
fnp-3166	384	1	konjevic	konjevic	PROPN
fnp-3166	384	2	sabolek	sabolek	PROPN
fnp-3166	384	3	m	m	PROPN
fnp-3166	384	4	,	,	PUNCT
fnp-3166	384	5	held	hold	VERB
fnp-3166	384	6	k	k	NOUN
fnp-3166	384	7	,	,	PUNCT
fnp-3166	384	8	beltrán	beltrán	NOUN
fnp-3166	384	9	e	e	NOUN
fnp-3166	384	10	,	,	PUNCT
fnp-3166	384	11	niedl	niedl	PROPN
fnp-3166	384	12	ag	ag	PROPN
fnp-3166	384	13	,	,	PUNCT
fnp-3166	384	14	meinl	meinl	NOUN
fnp-3166	384	15	e	e	NOUN
fnp-3166	384	16	,	,	PUNCT
fnp-3166	384	17	hohlfeld	hohlfeld	ADJ
fnp-3166	384	18	r	r	NOUN
fnp-3166	384	19	,	,	PUNCT
fnp-3166	384	20	lassmann	lassmann	PROPN
fnp-3166	384	21	h	h	NOUN
fnp-3166	384	22	,	,	PUNCT
fnp-3166	384	23	dornmair	dornmair	NOUN
fnp-3166	384	24	k.	k.	PROPN
fnp-3166	384	25	communication	communication	NOUN
fnp-3166	384	26	of	of	ADP
fnp-3166	384	27	cd8	cd8	PROPN
fnp-3166	384	28	+	+	PROPN
fnp-3166	384	29	t	t	PROPN
fnp-3166	384	30	cells	cell	NOUN
fnp-3166	384	31	with	with	ADP
fnp-3166	384	32	mononuclear	mononuclear	ADJ
fnp-3166	384	33	phagocytes	phagocyte	NOUN
fnp-3166	384	34	in	in	ADP
fnp-3166	384	35	multiple	multiple	ADJ
fnp-3166	384	36	sclerosis	sclerosis	NOUN
fnp-3166	384	37	.	.	PUNCT
fnp-3166	385	1	ann	ann	PROPN
fnp-3166	385	2	clin	clin	PROPN
fnp-3166	385	3	transl	transl	PROPN
fnp-3166	385	4	neurol	neurol	PROPN
fnp-3166	385	5	.	.	PUNCT
fnp-3166	386	1	2019	2019	NUM
fnp-3166	386	2	jul;6(7):1151	jul;6(7):1151	NOUN
fnp-3166	386	3	-	-	PUNCT
fnp-3166	386	4	1164	1164	NUM
fnp-3166	386	5	.	.	PUNCT
fnp-3166	387	1	doi	doi	NOUN
fnp-3166	387	2	:	:	PUNCT
fnp-3166	387	3	10.1002	10.1002	NUM
fnp-3166	387	4	/	/	SYM
fnp-3166	387	5	acn3.783	acn3.783	NOUN
fnp-3166	387	6	.	.	PUNCT
fnp-3166	388	1	epub	epub	PROPN
fnp-3166	388	2	2019	2019	NUM
fnp-3166	388	3	jun	jun	PROPN
fnp-3166	388	4	14	14	NUM
fnp-3166	388	5	.	.	PUNCT
fnp-3166	389	1	pmid	pmid	NOUN
fnp-3166	389	2	:	:	PUNCT
fnp-3166	389	3	31353869	31353869	NUM
fnp-3166	389	4	;	;	PUNCT
fnp-3166	389	5	pmcid	pmcid	NOUN
fnp-3166	389	6	:	:	PUNCT
fnp-3166	389	7	pmc6649540	pmc6649540	PROPN
fnp-3166	389	8	.	.	PUNCT
fnp-3166	390	1	kutzelnigg	kutzelnigg	PROPN
fnp-3166	390	2	a	a	PROPN
fnp-3166	390	3	,	,	PUNCT
fnp-3166	390	4	lucchinetti	lucchinetti	PROPN
fnp-3166	390	5	cf	cf	NOUN
fnp-3166	390	6	,	,	PUNCT
fnp-3166	390	7	stadelmann	stadelmann	PROPN
fnp-3166	390	8	c	c	NOUN
fnp-3166	390	9	,	,	PUNCT
fnp-3166	390	10	brück	brück	PROPN
fnp-3166	390	11	w	w	PROPN
fnp-3166	390	12	,	,	PUNCT
fnp-3166	390	13	rauschka	rauschka	PROPN
fnp-3166	390	14	h	h	NOUN
fnp-3166	390	15	,	,	PUNCT
fnp-3166	390	16	bergmann	bergmann	PROPN
fnp-3166	390	17	m	m	PROPN
fnp-3166	390	18	,	,	PUNCT
fnp-3166	390	19	schmidbauer	schmidbauer	PROPN
fnp-3166	390	20	m	m	PROPN
fnp-3166	390	21	,	,	PUNCT
fnp-3166	390	22	parisi	parisi	PROPN
fnp-3166	390	23	je	je	PROPN
fnp-3166	390	24	,	,	PUNCT
fnp-3166	390	25	lassmann	lassmann	PROPN
fnp-3166	390	26	h.	h.	PROPN
fnp-3166	390	27	cortical	cortical	ADJ
fnp-3166	390	28	demyelination	demyelination	NOUN
fnp-3166	390	29	and	and	CCONJ
fnp-3166	390	30	diffuse	diffuse	VERB
fnp-3166	390	31	white	white	ADJ
fnp-3166	390	32	matter	matter	NOUN
fnp-3166	390	33	injury	injury	NOUN
fnp-3166	390	34	in	in	ADP
fnp-3166	390	35	multiple	multiple	ADJ
fnp-3166	390	36	sclerosis	sclerosis	NOUN
fnp-3166	390	37	.	.	PUNCT
fnp-3166	391	1	brain	brain	NOUN
fnp-3166	391	2	.	.	PUNCT
fnp-3166	392	1	2005	2005	NUM
fnp-3166	392	2	nov;128(pt	nov;128(pt	NOUN
fnp-3166	392	3	11):2705	11):2705	NUM
fnp-3166	392	4	-	-	SYM
fnp-3166	392	5	12	12	NUM
fnp-3166	392	6	.	.	PUNCT
fnp-3166	393	1	doi	doi	NOUN
fnp-3166	393	2	:	:	PUNCT
fnp-3166	393	3	10.1093	10.1093	NUM
fnp-3166	393	4	/	/	SYM
fnp-3166	393	5	brain	brain	NOUN
fnp-3166	393	6	/	/	SYM
fnp-3166	393	7	awh641	awh641	PROPN
fnp-3166	393	8	.	.	PROPN
fnp-3166	394	1	epub	epub	PROPN
fnp-3166	394	2	2005	2005	NUM
fnp-3166	394	3	oct	oct	NOUN
fnp-3166	394	4	17	17	NUM
fnp-3166	394	5	.	.	PUNCT
fnp-3166	395	1	pmid	pmid	NOUN
fnp-3166	395	2	:	:	PUNCT
fnp-3166	395	3	16230320	16230320	NUM
fnp-3166	395	4	.	.	PUNCT
fnp-3166	396	1	landa	landa	PROPN
fnp-3166	396	2	j	j	PROPN
fnp-3166	396	3	,	,	PUNCT
fnp-3166	396	4	gaig	gaig	PROPN
fnp-3166	396	5	c	c	NOUN
fnp-3166	396	6	,	,	PUNCT
fnp-3166	396	7	plagumà	plagumà	PROPN
fnp-3166	396	8	j	j	PROPN
fnp-3166	396	9	,	,	PUNCT
fnp-3166	396	10	saiz	saiz	PROPN
fnp-3166	396	11	a	a	PROPN
fnp-3166	396	12	,	,	PUNCT
fnp-3166	396	13	antonell	antonell	PROPN
fnp-3166	396	14	a	a	PRON
fnp-3166	396	15	,	,	PUNCT
fnp-3166	396	16	sanchez	sanchez	NOUN
fnp-3166	396	17	-	-	PUNCT
fnp-3166	396	18	valle	valle	PROPN
fnp-3166	396	19	r	r	NOUN
fnp-3166	396	20	,	,	PUNCT
fnp-3166	396	21	dalmau	dalmau	PROPN
fnp-3166	396	22	j	j	PROPN
fnp-3166	396	23	,	,	PUNCT
fnp-3166	396	24	graus	graus	PROPN
fnp-3166	396	25	f	f	PROPN
fnp-3166	396	26	,	,	PUNCT
fnp-3166	396	27	sabater	sabater	PROPN
fnp-3166	396	28	l.	l.	PROPN
fnp-3166	396	29	effects	effect	NOUN
fnp-3166	396	30	of	of	ADP
fnp-3166	396	31	iglon5	iglon5	PROPN
fnp-3166	396	32	antibodies	antibody	NOUN
fnp-3166	396	33	on	on	ADP
fnp-3166	396	34	neuronal	neuronal	ADJ
fnp-3166	396	35	cytoskeleton	cytoskeleton	NOUN
fnp-3166	396	36	:	:	PUNCT
fnp-3166	396	37	a	a	DET
fnp-3166	396	38	link	link	NOUN
fnp-3166	396	39	between	between	ADP
fnp-3166	396	40	autoimmunity	autoimmunity	NOUN
fnp-3166	396	41	and	and	CCONJ
fnp-3166	396	42	neurodegeneration	neurodegeneration	NOUN
fnp-3166	396	43	.	.	PUNCT
fnp-3166	397	1	ann	ann	PROPN
fnp-3166	397	2	neurol	neurol	PROPN
fnp-3166	397	3	.	.	PUNCT
fnp-3166	398	1	2020	2020	NUM
fnp-3166	399	1	nov;88(5):1023	nov;88(5):1023	PROPN
fnp-3166	399	2	-	-	PUNCT
fnp-3166	399	3	1027	1027	NUM
fnp-3166	399	4	.	.	PUNCT
fnp-3166	400	1	doi	doi	NOUN
fnp-3166	400	2	:	:	PUNCT
fnp-3166	400	3	10.1002	10.1002	NUM
fnp-3166	400	4	/	/	SYM
fnp-3166	400	5	ana.25857	ana.25857	PROPN
fnp-3166	400	6	.	.	PUNCT
fnp-3166	401	1	epub	epub	PROPN
fnp-3166	401	2	2020	2020	NUM
fnp-3166	401	3	aug	aug	PROPN
fnp-3166	401	4	27	27	NUM
fnp-3166	401	5	.	.	PUNCT
fnp-3166	402	1	pmid	pmid	NOUN
fnp-3166	402	2	:	:	PUNCT
fnp-3166	402	3	32740999	32740999	NUM
fnp-3166	402	4	.	.	PUNCT
fnp-3166	403	1	lassmann	lassmann	PROPN
fnp-3166	403	2	h	h	PROPN
fnp-3166	403	3	,	,	PUNCT
fnp-3166	403	4	niedobitek	niedobitek	INTJ
fnp-3166	403	5	g	g	NOUN
fnp-3166	403	6	,	,	PUNCT
fnp-3166	403	7	aloisi	aloisi	ADJ
fnp-3166	403	8	f	f	PROPN
fnp-3166	403	9	,	,	PUNCT
fnp-3166	403	10	middeldorp	middeldorp	PROPN
fnp-3166	403	11	jm	jm	PROPN
fnp-3166	403	12	;	;	PUNCT
fnp-3166	403	13	neuropromise	neuropromise	PROPN
fnp-3166	403	14	ebv	ebv	NOUN
fnp-3166	403	15	working	working	NOUN
fnp-3166	403	16	group	group	NOUN
fnp-3166	403	17	.	.	PUNCT
fnp-3166	404	1	epstein	epstein	PROPN
fnp-3166	404	2	-	-	PUNCT
fnp-3166	404	3	barr	barr	PROPN
fnp-3166	404	4	virus	virus	PROPN
fnp-3166	404	5	in	in	ADP
fnp-3166	404	6	the	the	DET
fnp-3166	404	7	multiple	multiple	ADJ
fnp-3166	404	8	sclerosis	sclerosis	NOUN
fnp-3166	404	9	brain	brain	NOUN
fnp-3166	404	10	:	:	PUNCT
fnp-3166	404	11	a	a	DET
fnp-3166	404	12	controversial	controversial	ADJ
fnp-3166	404	13	issue	issue	NOUN
fnp-3166	404	14	--	--	PUNCT
fnp-3166	404	15	report	report	NOUN
fnp-3166	404	16	on	on	ADP
fnp-3166	404	17	a	a	DET
fnp-3166	404	18	focused	focus	VERB
fnp-3166	404	19	workshop	workshop	NOUN
fnp-3166	404	20	held	hold	VERB
fnp-3166	404	21	in	in	ADP
fnp-3166	404	22	the	the	DET
fnp-3166	404	23	centre	centre	NOUN
fnp-3166	404	24	for	for	ADP
fnp-3166	404	25	brain	brain	NOUN
fnp-3166	404	26	research	research	NOUN
fnp-3166	404	27	of	of	ADP
fnp-3166	404	28	the	the	DET
fnp-3166	404	29	medical	medical	ADJ
fnp-3166	404	30	university	university	PROPN
fnp-3166	404	31	of	of	ADP
fnp-3166	404	32	vienna	vienna	PROPN
fnp-3166	404	33	,	,	PUNCT
fnp-3166	404	34	austria	austria	PROPN
fnp-3166	404	35	.	.	PUNCT
fnp-3166	405	1	brain	brain	PROPN
fnp-3166	405	2	.	.	PUNCT
fnp-3166	406	1	2011	2011	NUM
fnp-3166	407	1	sep;134(pt	sep;134(pt	ADJ
fnp-3166	407	2	9):2772	9):2772	NOUN
fnp-3166	407	3	-	-	SYM
fnp-3166	407	4	86	86	NUM
fnp-3166	407	5	.	.	PUNCT
fnp-3166	408	1	doi	doi	NOUN
fnp-3166	408	2	:	:	PUNCT
fnp-3166	408	3	10.1093	10.1093	NUM
fnp-3166	408	4	/	/	SYM
fnp-3166	408	5	brain	brain	NOUN
fnp-3166	408	6	/	/	SYM
fnp-3166	408	7	awr197	awr197	PROPN
fnp-3166	408	8	.	.	PUNCT
fnp-3166	409	1	epub	epub	PROPN
fnp-3166	409	2	2011	2011	NUM
fnp-3166	409	3	aug	aug	PROPN
fnp-3166	409	4	16	16	NUM
fnp-3166	409	5	.	.	PUNCT
fnp-3166	410	1	pmid	pmid	NOUN
fnp-3166	410	2	:	:	PUNCT
fnp-3166	410	3	21846731	21846731	NUM
fnp-3166	410	4	;	;	PUNCT
fnp-3166	410	5	pmcid	pmcid	NOUN
fnp-3166	410	6	:	:	PUNCT
fnp-3166	410	7	pmc3170536	pmc3170536	NOUN
fnp-3166	410	8	.	.	PUNCT
fnp-3166	411	1	levin	levin	PROPN
fnp-3166	411	2	li	li	PROPN
fnp-3166	411	3	,	,	PUNCT
fnp-3166	411	4	munger	munger	PROPN
fnp-3166	411	5	kl	kl	PROPN
fnp-3166	411	6	,	,	PUNCT
fnp-3166	411	7	o'reilly	o'reilly	PROPN
fnp-3166	411	8	ej	ej	X
fnp-3166	411	9	,	,	PUNCT
fnp-3166	411	10	falk	falk	NOUN
fnp-3166	411	11	ki	ki	PROPN
fnp-3166	411	12	,	,	PUNCT
fnp-3166	411	13	ascherio	ascherio	NOUN
fnp-3166	411	14	a.	a.	PROPN
fnp-3166	411	15	primary	primary	ADJ
fnp-3166	411	16	infection	infection	NOUN
fnp-3166	411	17	with	with	ADP
fnp-3166	411	18	the	the	DET
fnp-3166	411	19	epstein	epstein	PROPN
fnp-3166	411	20	-	-	PUNCT
fnp-3166	411	21	barr	barr	PROPN
fnp-3166	411	22	virus	virus	NOUN
fnp-3166	411	23	and	and	CCONJ
fnp-3166	411	24	risk	risk	NOUN
fnp-3166	411	25	of	of	ADP
fnp-3166	411	26	multiple	multiple	ADJ
fnp-3166	411	27	sclerosis	sclerosis	NOUN
fnp-3166	411	28	.	.	PUNCT
fnp-3166	412	1	ann	ann	PROPN
fnp-3166	412	2	neurol	neurol	PROPN
fnp-3166	412	3	.	.	PUNCT
fnp-3166	413	1	2010	2010	NUM
fnp-3166	413	2	jun;67(6):824	jun;67(6):824	NOUN
fnp-3166	413	3	-	-	SYM
fnp-3166	413	4	30	30	NUM
fnp-3166	413	5	.	.	PUNCT
fnp-3166	414	1	doi	doi	NOUN
fnp-3166	414	2	:	:	PUNCT
fnp-3166	414	3	10.1002	10.1002	NUM
fnp-3166	414	4	/	/	SYM
fnp-3166	414	5	ana.21978	ana.21978	NOUN
fnp-3166	414	6	.	.	PUNCT
fnp-3166	415	1	pmid	pmid	NOUN
fnp-3166	415	2	:	:	PUNCT
fnp-3166	415	3	20517945	20517945	NUM
fnp-3166	415	4	;	;	PUNCT
fnp-3166	415	5	pmcid	pmcid	ADJ
fnp-3166	415	6	:	:	PUNCT
fnp-3166	415	7	pmc3089959	pmc3089959	NOUN
fnp-3166	415	8	.	.	PUNCT
fnp-3166	416	1	li	li	PROPN
fnp-3166	416	2	yc	yc	PROPN
fnp-3166	416	3	,	,	PUNCT
fnp-3166	416	4	bai	bai	PROPN
fnp-3166	416	5	wz	wz	PROPN
fnp-3166	416	6	,	,	PUNCT
fnp-3166	416	7	hashikawa	hashikawa	PROPN
fnp-3166	416	8	t.	t.	PROPN
fnp-3166	416	9	the	the	DET
fnp-3166	416	10	neuroinvasive	neuroinvasive	ADJ
fnp-3166	416	11	potential	potential	NOUN
fnp-3166	416	12	of	of	ADP
fnp-3166	416	13	sars	sar	NOUN
fnp-3166	416	14	-	-	PUNCT
fnp-3166	416	15	cov2	cov2	PROPN
fnp-3166	416	16	may	may	AUX
fnp-3166	416	17	play	play	VERB
fnp-3166	416	18	a	a	DET
fnp-3166	416	19	role	role	NOUN
fnp-3166	416	20	in	in	ADP
fnp-3166	416	21	the	the	DET
fnp-3166	416	22	respiratory	respiratory	ADJ
fnp-3166	416	23	failure	failure	NOUN
fnp-3166	416	24	of	of	ADP
fnp-3166	416	25	covid-19	covid-19	PROPN
fnp-3166	416	26	patients	patient	NOUN
fnp-3166	416	27	.	.	PUNCT
fnp-3166	417	1	j	j	PROPN
fnp-3166	417	2	med	med	PROPN
fnp-3166	417	3	virol	virol	NOUN
fnp-3166	417	4	.	.	PUNCT
fnp-3166	418	1	2020	2020	NUM
fnp-3166	418	2	jun;92(6):552	jun;92(6):552	NOUN
fnp-3166	418	3	-	-	PUNCT
fnp-3166	418	4	555	555	NUM
fnp-3166	418	5	.	.	PUNCT
fnp-3166	419	1	doi	doi	NOUN
fnp-3166	419	2	:	:	PUNCT
fnp-3166	419	3	10.1002	10.1002	NUM
fnp-3166	419	4	/	/	SYM
fnp-3166	419	5	jmv.25728	jmv.25728	NOUN
fnp-3166	419	6	.	.	PUNCT
fnp-3166	420	1	epub	epub	PROPN
fnp-3166	420	2	2020	2020	NUM
fnp-3166	420	3	mar	mar	PROPN
fnp-3166	420	4	11	11	NUM
fnp-3166	420	5	.	.	PUNCT
fnp-3166	421	1	pmid	pmid	NOUN
fnp-3166	421	2	:	:	PUNCT
fnp-3166	421	3	32104915	32104915	NUM
fnp-3166	421	4	;	;	PUNCT
fnp-3166	421	5	pmcid	pmcid	NOUN
fnp-3166	421	6	:	:	PUNCT
fnp-3166	421	7	pmc7228394	pmc7228394	NOUN
fnp-3166	421	8	.	.	PUNCT
fnp-3166	422	1	liu	liu	PROPN
fnp-3166	422	2	jm	jm	PROPN
fnp-3166	422	3	,	,	PUNCT
fnp-3166	422	4	tan	tan	PROPN
fnp-3166	422	5	bh	bh	PROPN
fnp-3166	422	6	,	,	PUNCT
fnp-3166	422	7	wu	wu	PROPN
fnp-3166	422	8	s	s	PROPN
fnp-3166	422	9	,	,	PUNCT
fnp-3166	422	10	gui	gui	PROPN
fnp-3166	422	11	y	y	PROPN
fnp-3166	422	12	,	,	PUNCT
fnp-3166	422	13	suo	suo	PROPN
fnp-3166	422	14	jl	jl	PROPN
fnp-3166	422	15	,	,	PUNCT
fnp-3166	422	16	li	li	PROPN
fnp-3166	422	17	yc	yc	PROPN
fnp-3166	422	18	.	.	PUNCT
fnp-3166	422	19	evidence	evidence	NOUN
fnp-3166	422	20	of	of	ADP
fnp-3166	422	21	central	central	ADJ
fnp-3166	422	22	nervous	nervous	ADJ
fnp-3166	422	23	system	system	NOUN
fnp-3166	422	24	infection	infection	NOUN
fnp-3166	422	25	and	and	CCONJ
fnp-3166	422	26	neuroinvasive	neuroinvasive	ADJ
fnp-3166	422	27	routes	route	NOUN
fnp-3166	422	28	,	,	PUNCT
fnp-3166	422	29	as	as	ADV
fnp-3166	422	30	well	well	ADV
fnp-3166	422	31	as	as	ADP
fnp-3166	422	32	neurological	neurological	ADJ
fnp-3166	422	33	involvement	involvement	NOUN
fnp-3166	422	34	,	,	PUNCT
fnp-3166	422	35	in	in	ADP
fnp-3166	422	36	the	the	DET
fnp-3166	422	37	lethality	lethality	NOUN
fnp-3166	422	38	of	of	ADP
fnp-3166	422	39	sars	sar	NOUN
fnp-3166	422	40	-	-	PUNCT
fnp-3166	422	41	cov-2	cov-2	NOUN
fnp-3166	422	42	infection	infection	NOUN
fnp-3166	422	43	.	.	PUNCT
fnp-3166	423	1	j	j	PROPN
fnp-3166	423	2	med	med	PROPN
fnp-3166	423	3	virol	virol	NOUN
fnp-3166	423	4	.	.	PUNCT
fnp-3166	424	1	2020	2020	NUM
fnp-3166	424	2	oct	oct	PROPN
fnp-3166	424	3	1:10.1002	1:10.1002	NUM
fnp-3166	424	4	/	/	SYM
fnp-3166	425	1	jmv.26570	jmv.26570	PROPN
fnp-3166	425	2	.	.	PUNCT
fnp-3166	425	3	doi	doi	PROPN
fnp-3166	425	4	:	:	PUNCT
fnp-3166	425	5	10.1002	10.1002	NUM
fnp-3166	425	6	/	/	SYM
fnp-3166	425	7	jmv.26570	jmv.26570	NOUN
fnp-3166	425	8	.	.	PUNCT
fnp-3166	426	1	epub	epub	PROPN
fnp-3166	426	2	ahead	ahead	ADV
fnp-3166	426	3	of	of	ADP
fnp-3166	426	4	print	print	NOUN
fnp-3166	426	5	.	.	PUNCT
fnp-3166	427	1	pmid	pmid	NOUN
fnp-3166	427	2	:	:	PUNCT
fnp-3166	427	3	33002209	33002209	NUM
fnp-3166	427	4	;	;	PUNCT
fnp-3166	427	5	pmcid	pmcid	ADJ
fnp-3166	427	6	:	:	PUNCT
fnp-3166	427	7	pmc7537172	pmc7537172	NOUN
fnp-3166	427	8	.	.	PUNCT
fnp-3166	428	1	lubetzki	lubetzki	PROPN
fnp-3166	428	2	c	c	PROPN
fnp-3166	428	3	,	,	PUNCT
fnp-3166	428	4	zalc	zalc	PROPN
fnp-3166	428	5	b	b	PROPN
fnp-3166	428	6	,	,	PUNCT
fnp-3166	428	7	williams	williams	PROPN
fnp-3166	428	8	a	a	PROPN
fnp-3166	428	9	,	,	PUNCT
fnp-3166	428	10	stadelmann	stadelmann	PROPN
fnp-3166	428	11	c	c	NOUN
fnp-3166	428	12	,	,	PUNCT
fnp-3166	428	13	stankoff	stankoff	PROPN
fnp-3166	428	14	b.	b.	PROPN
fnp-3166	428	15	remyelination	remyelination	NOUN
fnp-3166	428	16	in	in	ADP
fnp-3166	428	17	multiple	multiple	ADJ
fnp-3166	428	18	sclerosis	sclerosis	NOUN
fnp-3166	428	19	:	:	PUNCT
fnp-3166	428	20	from	from	ADP
fnp-3166	428	21	basic	basic	ADJ
fnp-3166	428	22	science	science	NOUN
fnp-3166	428	23	to	to	ADP
fnp-3166	428	24	clinical	clinical	ADJ
fnp-3166	428	25	translation	translation	NOUN
fnp-3166	428	26	.	.	PUNCT
fnp-3166	429	1	lancet	lancet	PROPN
fnp-3166	429	2	neurol	neurol	PROPN
fnp-3166	429	3	.	.	PUNCT
fnp-3166	430	1	2020	2020	NUM
fnp-3166	430	2	aug;19(8):678	aug;19(8):678	VERB
fnp-3166	430	3	-	-	PUNCT
fnp-3166	430	4	688	688	NUM
fnp-3166	430	5	.	.	PUNCT
fnp-3166	431	1	doi	doi	NOUN
fnp-3166	431	2	:	:	PUNCT
fnp-3166	431	3	10.1016	10.1016	NUM
fnp-3166	431	4	/	/	SYM
fnp-3166	431	5	s1474	s1474	PROPN
fnp-3166	431	6	-	-	PUNCT
fnp-3166	431	7	4422(20)30140	4422(20)30140	NUM
fnp-3166	431	8	-	-	PUNCT
fnp-3166	431	9	x.	x.	NOUN
fnp-3166	431	10	pmid	pmid	PROPN
fnp-3166	431	11	:	:	PUNCT
fnp-3166	431	12	32702337	32702337	NUM
fnp-3166	431	13	.	.	PUNCT
fnp-3166	432	1	machado	machado	PROPN
fnp-3166	432	2	-	-	PUNCT
fnp-3166	432	3	santos	santos	PROPN
fnp-3166	432	4	j	j	PROPN
fnp-3166	432	5	,	,	PUNCT
fnp-3166	432	6	saji	saji	PROPN
fnp-3166	432	7	e	e	PROPN
fnp-3166	432	8	,	,	PUNCT
fnp-3166	432	9	tröscher	tröscher	PROPN
fnp-3166	432	10	ar	ar	PROPN
fnp-3166	432	11	,	,	PUNCT
fnp-3166	432	12	paunovic	paunovic	PROPN
fnp-3166	432	13	m	m	PROPN
fnp-3166	432	14	,	,	PUNCT
fnp-3166	432	15	liblau	liblau	ADJ
fnp-3166	432	16	r	r	NOUN
fnp-3166	432	17	,	,	PUNCT
fnp-3166	432	18	gabriely	gabriely	ADV
fnp-3166	432	19	g	g	NOUN
fnp-3166	432	20	,	,	PUNCT
fnp-3166	432	21	bien	bien	PROPN
fnp-3166	432	22	cg	cg	PROPN
fnp-3166	432	23	,	,	PUNCT
fnp-3166	432	24	bauer	bauer	PROPN
fnp-3166	432	25	j	j	PROPN
fnp-3166	432	26	,	,	PUNCT
fnp-3166	432	27	lassmann	lassmann	PROPN
fnp-3166	432	28	h.	h.	PROPN
fnp-3166	433	1	the	the	DET
fnp-3166	433	2	compartmentalized	compartmentalized	ADJ
fnp-3166	433	3	inflammatory	inflammatory	ADJ
fnp-3166	433	4	response	response	NOUN
fnp-3166	433	5	in	in	ADP
fnp-3166	433	6	the	the	DET
fnp-3166	433	7	multiple	multiple	ADJ
fnp-3166	433	8	sclerosis	sclerosis	NOUN
fnp-3166	433	9	brain	brain	NOUN
fnp-3166	433	10	is	be	AUX
fnp-3166	433	11	composed	compose	VERB
fnp-3166	433	12	of	of	ADP
fnp-3166	433	13	tissue	tissue	NOUN
fnp-3166	433	14	-	-	PUNCT
fnp-3166	433	15	resident	resident	NOUN
fnp-3166	433	16	cd8	cd8	PROPN
fnp-3166	433	17	+	+	PROPN
fnp-3166	433	18	t	t	PROPN
fnp-3166	433	19	lymphocytes	lymphocyte	NOUN
fnp-3166	433	20	and	and	CCONJ
fnp-3166	433	21	b	b	NOUN
fnp-3166	433	22	cells	cell	NOUN
fnp-3166	433	23	.	.	PUNCT
fnp-3166	434	1	brain	brain	NOUN
fnp-3166	434	2	.	.	PUNCT
fnp-3166	435	1	2018	2018	NUM
fnp-3166	435	2	jul	jul	PROPN
fnp-3166	435	3	1;141(7):2066	1;141(7):2066	NUM
fnp-3166	435	4	-	-	SYM
fnp-3166	435	5	2082	2082	NUM
fnp-3166	435	6	.	.	PUNCT
fnp-3166	436	1	doi	doi	NOUN
fnp-3166	436	2	:	:	PUNCT
fnp-3166	436	3	10.1093	10.1093	NUM
fnp-3166	436	4	/	/	SYM
fnp-3166	436	5	brain	brain	NOUN
fnp-3166	436	6	/	/	SYM
fnp-3166	436	7	awy151	awy151	PROPN
fnp-3166	436	8	.	.	PUNCT
fnp-3166	437	1	pmid	pmid	NOUN
fnp-3166	437	2	:	:	PUNCT
fnp-3166	437	3	29873694	29873694	NUM
fnp-3166	437	4	;	;	PUNCT
fnp-3166	437	5	pmcid	pmcid	PROPN
fnp-3166	437	6	:	:	PUNCT
fnp-3166	437	7	pmc6022681	pmc6022681	VERB
fnp-3166	437	8	.	.	PUNCT
fnp-3166	438	1	magliozzi	magliozzi	NOUN
fnp-3166	438	2	r	r	NOUN
fnp-3166	438	3	,	,	PUNCT
fnp-3166	438	4	howell	howell	PROPN
fnp-3166	438	5	ow	ow	PROPN
fnp-3166	438	6	,	,	PUNCT
fnp-3166	438	7	reeves	reeves	PROPN
fnp-3166	438	8	c	c	PROPN
fnp-3166	438	9	,	,	PUNCT
fnp-3166	438	10	roncaroli	roncaroli	PROPN
fnp-3166	438	11	f	f	PROPN
fnp-3166	438	12	,	,	PUNCT
fnp-3166	438	13	nicholas	nicholas	PROPN
fnp-3166	438	14	r	r	PROPN
fnp-3166	438	15	,	,	PUNCT
fnp-3166	438	16	serafini	serafini	NOUN
fnp-3166	438	17	b	b	NOUN
fnp-3166	438	18	,	,	PUNCT
fnp-3166	438	19	aloisi	aloisi	ADJ
fnp-3166	438	20	f	f	PROPN
fnp-3166	438	21	,	,	PUNCT
fnp-3166	438	22	reynolds	reynolds	PROPN
fnp-3166	438	23	r.	r.	PROPN
fnp-3166	438	24	a	a	DET
fnp-3166	438	25	gradient	gradient	NOUN
fnp-3166	438	26	of	of	ADP
fnp-3166	438	27	neuronal	neuronal	ADJ
fnp-3166	438	28	loss	loss	NOUN
fnp-3166	438	29	and	and	CCONJ
fnp-3166	438	30	meningeal	meningeal	ADJ
fnp-3166	438	31	inflammation	inflammation	NOUN
fnp-3166	438	32	in	in	ADP
fnp-3166	438	33	multiple	multiple	ADJ
fnp-3166	438	34	sclerosis	sclerosis	NOUN
fnp-3166	438	35	.	.	PUNCT
fnp-3166	439	1	ann	ann	PROPN
fnp-3166	439	2	neurol	neurol	PROPN
fnp-3166	439	3	.	.	PUNCT
fnp-3166	440	1	2010	2010	NUM
fnp-3166	440	2	oct;68(4):477	oct;68(4):477	NOUN
fnp-3166	440	3	-	-	PUNCT
fnp-3166	440	4	93	93	NUM
fnp-3166	440	5	.	.	PUNCT
fnp-3166	441	1	doi	doi	NOUN
fnp-3166	441	2	:	:	PUNCT
fnp-3166	441	3	10.1002	10.1002	NUM
fnp-3166	441	4	/	/	SYM
fnp-3166	441	5	ana.22230	ana.22230	NOUN
fnp-3166	441	6	.	.	PUNCT
fnp-3166	442	1	pmid	pmid	NOUN
fnp-3166	442	2	:	:	PUNCT
fnp-3166	442	3	20976767	20976767	NUM
fnp-3166	442	4	.	.	PUNCT
fnp-3166	443	1	mahad	mahad	PROPN
fnp-3166	443	2	dh	dh	PROPN
fnp-3166	443	3	,	,	PUNCT
fnp-3166	443	4	trapp	trapp	PROPN
fnp-3166	443	5	bd	bd	PROPN
fnp-3166	443	6	,	,	PUNCT
fnp-3166	443	7	lassmann	lassmann	PROPN
fnp-3166	443	8	h.	h.	PROPN
fnp-3166	443	9	pathological	pathological	ADJ
fnp-3166	443	10	mechanisms	mechanism	NOUN
fnp-3166	443	11	in	in	ADP
fnp-3166	443	12	progressive	progressive	ADJ
fnp-3166	443	13	multiple	multiple	ADJ
fnp-3166	443	14	sclerosis	sclerosis	NOUN
fnp-3166	443	15	.	.	PUNCT
fnp-3166	444	1	lancet	lancet	PROPN
fnp-3166	444	2	neurol	neurol	PROPN
fnp-3166	444	3	.	.	PUNCT
fnp-3166	445	1	2015	2015	NUM
fnp-3166	445	2	feb;14(2):183	feb;14(2):183	NOUN
fnp-3166	445	3	-	-	SYM
fnp-3166	445	4	93	93	NUM
fnp-3166	445	5	.	.	PUNCT
fnp-3166	446	1	doi	doi	NOUN
fnp-3166	446	2	:	:	PUNCT
fnp-3166	446	3	10.1016	10.1016	NUM
fnp-3166	446	4	/	/	SYM
fnp-3166	446	5	s1474	s1474	PROPN
fnp-3166	446	6	-	-	PUNCT
fnp-3166	446	7	4422(14)70256	4422(14)70256	PROPN
fnp-3166	446	8	-	-	PUNCT
fnp-3166	446	9	x.	x.	NOUN
fnp-3166	446	10	pmid	pmid	PROPN
fnp-3166	446	11	:	:	PUNCT
fnp-3166	446	12	25772897	25772897	NUM
fnp-3166	446	13	.	.	PUNCT
fnp-3166	447	1	marrie	marrie	PROPN
fnp-3166	447	2	ra	ra	PROPN
fnp-3166	447	3	,	,	PUNCT
fnp-3166	447	4	rudick	rudick	VERB
fnp-3166	447	5	r	r	NOUN
fnp-3166	447	6	,	,	PUNCT
fnp-3166	447	7	horwitz	horwitz	PROPN
fnp-3166	447	8	r	r	PROPN
fnp-3166	447	9	,	,	PUNCT
fnp-3166	447	10	cutter	cutter	NOUN
fnp-3166	447	11	g	g	NOUN
fnp-3166	447	12	,	,	PUNCT
fnp-3166	447	13	tyry	tyry	PROPN
fnp-3166	447	14	t	t	PROPN
fnp-3166	447	15	,	,	PUNCT
fnp-3166	447	16	campagnolo	campagnolo	PROPN
fnp-3166	447	17	d	d	PROPN
fnp-3166	447	18	,	,	PUNCT
fnp-3166	447	19	vollmer	vollmer	PROPN
fnp-3166	447	20	t.	t.	NOUN
fnp-3166	447	21	vascular	vascular	ADJ
fnp-3166	447	22	comorbidity	comorbidity	NOUN
fnp-3166	447	23	is	be	AUX
fnp-3166	447	24	associated	associate	VERB
fnp-3166	447	25	with	with	ADP
fnp-3166	447	26	more	more	ADV
fnp-3166	447	27	rapid	rapid	ADJ
fnp-3166	447	28	disability	disability	NOUN
fnp-3166	447	29	progression	progression	NOUN
fnp-3166	447	30	in	in	ADP
fnp-3166	447	31	multiple	multiple	ADJ
fnp-3166	447	32	sclerosis	sclerosis	NOUN
fnp-3166	447	33	.	.	PUNCT
fnp-3166	448	1	neurology	neurology	NOUN
fnp-3166	448	2	.	.	PUNCT
fnp-3166	449	1	2010	2010	NUM
fnp-3166	449	2	mar	mar	PROPN
fnp-3166	449	3	30;74(13):1041	30;74(13):1041	PROPN
fnp-3166	449	4	-	-	SYM
fnp-3166	449	5	7	7	NUM
fnp-3166	449	6	.	.	PUNCT
fnp-3166	449	7	doi	doi	NOUN
fnp-3166	449	8	:	:	PUNCT
fnp-3166	449	9	10.1212	10.1212	NUM
fnp-3166	449	10	/	/	SYM
fnp-3166	449	11	wnl.0b013e3181d6b125	wnl.0b013e3181d6b125	PROPN
fnp-3166	449	12	.	.	PUNCT
fnp-3166	450	1	pmid	pmid	NOUN
fnp-3166	450	2	:	:	PUNCT
fnp-3166	450	3	20350978	20350978	NUM
fnp-3166	450	4	;	;	PUNCT
fnp-3166	450	5	pmcid	pmcid	PROPN
fnp-3166	450	6	:	:	PUNCT
fnp-3166	450	7	pmc2848107	pmc2848107	PROPN
fnp-3166	450	8	.	.	PUNCT
fnp-3166	451	1	masuda	masuda	PROPN
fnp-3166	451	2	t	t	PROPN
fnp-3166	451	3	,	,	PUNCT
fnp-3166	451	4	sankowski	sankowski	NOUN
fnp-3166	451	5	r	r	NOUN
fnp-3166	451	6	,	,	PUNCT
fnp-3166	451	7	staszewski	staszewski	NOUN
fnp-3166	451	8	o	o	NOUN
fnp-3166	451	9	,	,	PUNCT
fnp-3166	451	10	böttcher	böttcher	PROPN
fnp-3166	451	11	c	c	PROPN
fnp-3166	451	12	,	,	PUNCT
fnp-3166	451	13	amann	amann	PROPN
fnp-3166	451	14	l	l	PROPN
fnp-3166	451	15	,	,	PUNCT
fnp-3166	451	16	sagar	sagar	PROPN
fnp-3166	451	17	,	,	PUNCT
fnp-3166	451	18	scheiwe	scheiwe	NOUN
fnp-3166	451	19	c	c	PROPN
fnp-3166	451	20	,	,	PUNCT
fnp-3166	451	21	nessler	nessler	NOUN
fnp-3166	451	22	s	s	PROPN
fnp-3166	451	23	,	,	PUNCT
fnp-3166	451	24	kunz	kunz	PROPN
fnp-3166	451	25	p	p	PROPN
fnp-3166	451	26	,	,	PUNCT
fnp-3166	451	27	van	van	PROPN
fnp-3166	451	28	loo	loo	NOUN
fnp-3166	451	29	g	g	NOUN
fnp-3166	451	30	,	,	PUNCT
fnp-3166	451	31	coenen	coenen	PROPN
fnp-3166	451	32	va	va	PROPN
fnp-3166	451	33	,	,	PUNCT
fnp-3166	451	34	reinacher	reinacher	ADJ
fnp-3166	451	35	pc	pc	NOUN
fnp-3166	451	36	,	,	PUNCT
fnp-3166	451	37	michel	michel	PROPN
fnp-3166	451	38	a	a	PROPN
fnp-3166	451	39	,	,	PUNCT
fnp-3166	451	40	sure	sure	ADJ
fnp-3166	451	41	u	u	NOUN
fnp-3166	451	42	,	,	PUNCT
fnp-3166	451	43	gold	gold	NOUN
fnp-3166	451	44	r	r	NOUN
fnp-3166	451	45	,	,	PUNCT
fnp-3166	451	46	grün	grün	PROPN
fnp-3166	451	47	d	d	PROPN
fnp-3166	451	48	,	,	PUNCT
fnp-3166	451	49	priller	priller	NOUN
fnp-3166	451	50	j	j	PROPN
fnp-3166	451	51	,	,	PUNCT
fnp-3166	451	52	stadelmann	stadelmann	PROPN
fnp-3166	451	53	c	c	AUX
fnp-3166	451	54	,	,	PUNCT
fnp-3166	451	55	prinz	prinz	PROPN
fnp-3166	451	56	m.	m.	NOUN
fnp-3166	451	57	spatial	spatial	ADJ
fnp-3166	451	58	and	and	CCONJ
fnp-3166	451	59	temporal	temporal	ADJ
fnp-3166	451	60	heterogeneity	heterogeneity	NOUN
fnp-3166	451	61	of	of	ADP
fnp-3166	451	62	mouse	mouse	NOUN
fnp-3166	451	63	and	and	CCONJ
fnp-3166	451	64	human	human	ADJ
fnp-3166	451	65	microglia	microglia	NOUN
fnp-3166	451	66	at	at	ADP
fnp-3166	451	67	single	single	ADJ
fnp-3166	451	68	-	-	PUNCT
fnp-3166	451	69	cell	cell	NOUN
fnp-3166	451	70	resolution	resolution	NOUN
fnp-3166	451	71	.	.	PUNCT
fnp-3166	452	1	nature	nature	NOUN
fnp-3166	452	2	.	.	PUNCT
fnp-3166	453	1	2019	2019	NUM
fnp-3166	453	2	feb;566(7744):388	feb;566(7744):388	NOUN
fnp-3166	453	3	-	-	PUNCT
fnp-3166	453	4	392	392	NUM
fnp-3166	453	5	.	.	PUNCT
fnp-3166	453	6	doi	doi	NOUN
fnp-3166	453	7	:	:	PUNCT
fnp-3166	453	8	10.1038	10.1038	NUM
fnp-3166	453	9	/	/	SYM
fnp-3166	453	10	s41586	s41586	PROPN
fnp-3166	453	11	-	-	PUNCT
fnp-3166	453	12	019	019	NUM
fnp-3166	453	13	-	-	PUNCT
fnp-3166	453	14	0924	0924	NUM
fnp-3166	453	15	-	-	PUNCT
fnp-3166	453	16	x.	x.	NOUN
fnp-3166	453	17	epub	epub	PROPN
fnp-3166	453	18	2019	2019	NUM
fnp-3166	453	19	feb	feb	NOUN
fnp-3166	453	20	13	13	NUM
fnp-3166	453	21	.	.	PUNCT
fnp-3166	454	1	erratum	erratum	PROPN
fnp-3166	454	2	in	in	ADP
fnp-3166	454	3	:	:	PUNCT
fnp-3166	454	4	nature	nature	NOUN
fnp-3166	454	5	.	.	PUNCT
fnp-3166	455	1	2019	2019	NUM
fnp-3166	455	2	apr;568(7751):e4	apr;568(7751):e4	PROPN
fnp-3166	455	3	.	.	PUNCT
fnp-3166	456	1	pmid	pmid	NOUN
fnp-3166	456	2	:	:	PUNCT
fnp-3166	456	3	30760929	30760929	NUM
fnp-3166	456	4	.	.	PUNCT
fnp-3166	457	1	matschke	matschke	PROPN
fnp-3166	457	2	j	j	PROPN
fnp-3166	457	3	,	,	PUNCT
fnp-3166	457	4	lütgehetmann	lütgehetmann	PROPN
fnp-3166	457	5	m	m	PROPN
fnp-3166	457	6	,	,	PUNCT
fnp-3166	457	7	hagel	hagel	PROPN
fnp-3166	457	8	c	c	NOUN
fnp-3166	457	9	,	,	PUNCT
fnp-3166	457	10	sperhake	sperhake	NOUN
fnp-3166	457	11	jp	jp	PROPN
fnp-3166	457	12	,	,	PUNCT
fnp-3166	457	13	schröder	schröder	NOUN
fnp-3166	457	14	as	as	SCONJ
fnp-3166	457	15	,	,	PUNCT
fnp-3166	457	16	edler	edler	PROPN
fnp-3166	457	17	c	c	PROPN
fnp-3166	457	18	,	,	PUNCT
fnp-3166	457	19	mushumba	mushumba	PROPN
fnp-3166	457	20	h	h	PROPN
fnp-3166	457	21	,	,	PUNCT
fnp-3166	457	22	fitzek	fitzek	VERB
fnp-3166	457	23	a	a	DET
fnp-3166	457	24	,	,	PUNCT
fnp-3166	457	25	allweiss	allweiss	ADJ
fnp-3166	457	26	l	l	NOUN
fnp-3166	457	27	,	,	PUNCT
fnp-3166	457	28	dandri	dandri	PROPN
fnp-3166	457	29	m	m	PROPN
fnp-3166	457	30	,	,	PUNCT
fnp-3166	457	31	dottermusch	dottermusch	PROPN
fnp-3166	457	32	m	m	PROPN
fnp-3166	457	33	,	,	PUNCT
fnp-3166	457	34	heinemann	heinemann	PROPN
fnp-3166	457	35	a	a	X
fnp-3166	457	36	,	,	PUNCT
fnp-3166	457	37	pfefferle	pfefferle	PROPN
fnp-3166	457	38	s	s	PART
fnp-3166	457	39	,	,	PUNCT
fnp-3166	457	40	schwabenland	schwabenland	PROPN
fnp-3166	457	41	m	m	PROPN
fnp-3166	457	42	,	,	PUNCT
fnp-3166	457	43	sumner	sumner	PROPN
fnp-3166	457	44	magruder	magruder	PROPN
fnp-3166	457	45	d	d	PROPN
fnp-3166	457	46	,	,	PUNCT
fnp-3166	457	47	bonn	bonn	PROPN
fnp-3166	457	48	s	s	PROPN
fnp-3166	457	49	,	,	PUNCT
fnp-3166	457	50	prinz	prinz	PROPN
fnp-3166	457	51	m	m	PROPN
fnp-3166	457	52	,	,	PUNCT
fnp-3166	457	53	gerloff	gerloff	PROPN
fnp-3166	457	54	c	c	PROPN
fnp-3166	457	55	,	,	PUNCT
fnp-3166	457	56	püschel	püschel	PROPN
fnp-3166	457	57	k	k	PROPN
fnp-3166	457	58	,	,	PUNCT
fnp-3166	457	59	krasemann	krasemann	PROPN
fnp-3166	457	60	s	s	PROPN
fnp-3166	457	61	,	,	PUNCT
fnp-3166	457	62	aepfelbacher	aepfelbacher	PROPN
fnp-3166	457	63	m	m	PROPN
fnp-3166	457	64	,	,	PUNCT
fnp-3166	457	65	glatzel	glatzel	ADJ
fnp-3166	457	66	m.	m.	NOUN
fnp-3166	457	67	neuropathology	neuropathology	NOUN
fnp-3166	457	68	of	of	ADP
fnp-3166	457	69	patients	patient	NOUN
fnp-3166	457	70	with	with	ADP
fnp-3166	457	71	covid-19	covid-19	PROPN
fnp-3166	457	72	in	in	ADP
fnp-3166	457	73	germany	germany	PROPN
fnp-3166	457	74	:	:	PUNCT
fnp-3166	457	75	a	a	DET
fnp-3166	457	76	post	post	ADJ
fnp-3166	457	77	-	-	ADJ
fnp-3166	457	78	mortem	mortem	ADJ
fnp-3166	457	79	case	case	NOUN
fnp-3166	457	80	series	series	NOUN
fnp-3166	457	81	.	.	PUNCT
fnp-3166	458	1	lancet	lancet	PROPN
fnp-3166	458	2	neurol	neurol	PROPN
fnp-3166	458	3	.	.	PUNCT
fnp-3166	459	1	2020	2020	NUM
fnp-3166	460	1	nov;19(11):919	nov;19(11):919	NOUN
fnp-3166	460	2	-	-	PUNCT
fnp-3166	460	3	929	929	NUM
fnp-3166	460	4	.	.	PUNCT
fnp-3166	461	1	doi	doi	NOUN
fnp-3166	461	2	:	:	PUNCT
fnp-3166	461	3	10.1016	10.1016	NUM
fnp-3166	461	4	/	/	SYM
fnp-3166	461	5	s1474	s1474	PROPN
fnp-3166	461	6	-	-	PROPN
fnp-3166	461	7	4422(20)30308	4422(20)30308	NUM
fnp-3166	461	8	-	-	PUNCT
fnp-3166	461	9	2	2	NUM
fnp-3166	461	10	.	.	PUNCT
fnp-3166	462	1	epub	epub	NOUN
fnp-3166	462	2	2020	2020	NUM
fnp-3166	462	3	oct	oct	PROPN
fnp-3166	462	4	5	5	NUM
fnp-3166	462	5	.	.	PUNCT
fnp-3166	462	6	pmid	pmid	NOUN
fnp-3166	462	7	:	:	PUNCT
fnp-3166	462	8	33031735	33031735	NUM
fnp-3166	462	9	;	;	PUNCT
fnp-3166	462	10	pmcid	pmcid	NOUN
fnp-3166	462	11	:	:	PUNCT
fnp-3166	462	12	pmc7535629	pmc7535629	X
fnp-3166	462	13	.	.	PUNCT
fnp-3166	463	1	matute	matute	PROPN
fnp-3166	463	2	c	c	PROPN
fnp-3166	463	3	,	,	PUNCT
fnp-3166	463	4	palma	palma	PROPN
fnp-3166	463	5	a	a	PRON
fnp-3166	463	6	,	,	PUNCT
fnp-3166	463	7	serrano	serrano	NOUN
fnp-3166	463	8	-	-	PUNCT
fnp-3166	463	9	regal	regal	PROPN
fnp-3166	463	10	mp	mp	PROPN
fnp-3166	463	11	,	,	PUNCT
fnp-3166	463	12	maudes	maude	NOUN
fnp-3166	463	13	e	e	PROPN
fnp-3166	463	14	,	,	PUNCT
fnp-3166	463	15	barman	barman	NOUN
fnp-3166	463	16	s	s	PART
fnp-3166	463	17	,	,	PUNCT
fnp-3166	463	18	sánchez	sánchez	NOUN
fnp-3166	463	19	-	-	PUNCT
fnp-3166	463	20	gómez	gómez	NOUN
fnp-3166	463	21	mv	mv	PROPN
fnp-3166	463	22	,	,	PUNCT
fnp-3166	463	23	domercq	domercq	NOUN
fnp-3166	463	24	m	m	PROPN
fnp-3166	463	25	,	,	PUNCT
fnp-3166	463	26	goebels	goebels	PROPN
fnp-3166	463	27	n	n	CCONJ
fnp-3166	463	28	,	,	PUNCT
fnp-3166	463	29	dalmau	dalmau	PROPN
fnp-3166	463	30	j.	j.	PROPN
fnp-3166	463	31	n	n	PROPN
fnp-3166	463	32	-	-	PUNCT
fnp-3166	463	33	methyl	methyl	NOUN
fnp-3166	463	34	-	-	PUNCT
fnp-3166	463	35	d	d	NOUN
fnp-3166	463	36	-	-	PUNCT
fnp-3166	463	37	aspartate	aspartate	ADJ
fnp-3166	463	38	receptor	receptor	NOUN
fnp-3166	463	39	antibodies	antibodie	VERB
fnp-3166	463	40	in	in	ADP
fnp-3166	463	41	autoimmune	autoimmune	ADJ
fnp-3166	463	42	encephalopathy	encephalopathy	ADJ
fnp-3166	463	43	alter	alter	PROPN
fnp-3166	463	44	oligodendrocyte	oligodendrocyte	PROPN
fnp-3166	463	45	function	function	NOUN
fnp-3166	463	46	.	.	PUNCT
fnp-3166	464	1	ann	ann	PROPN
fnp-3166	464	2	neurol	neurol	PROPN
fnp-3166	464	3	.	.	PUNCT
fnp-3166	465	1	2020	2020	NUM
fnp-3166	465	2	may;87(5):670	may;87(5):670	X
fnp-3166	465	3	-	-	PUNCT
fnp-3166	465	4	676	676	NUM
fnp-3166	465	5	.	.	PUNCT
fnp-3166	466	1	doi	doi	NOUN
fnp-3166	466	2	:	:	PUNCT
fnp-3166	466	3	10.1002	10.1002	NUM
fnp-3166	466	4	/	/	SYM
fnp-3166	466	5	ana.25699	ana.25699	PROPN
fnp-3166	466	6	.	.	PUNCT
fnp-3166	467	1	epub	epub	PROPN
fnp-3166	467	2	2020	2020	NUM
fnp-3166	467	3	feb	feb	PROPN
fnp-3166	467	4	24	24	NUM
fnp-3166	467	5	.	.	PUNCT
fnp-3166	468	1	pmid	pmid	NOUN
fnp-3166	468	2	:	:	PUNCT
fnp-3166	468	3	32052483	32052483	NUM
fnp-3166	468	4	.	.	PUNCT
fnp-3166	469	1	meinhardt	meinhardt	PROPN
fnp-3166	469	2	j	j	PROPN
fnp-3166	469	3	,	,	PUNCT
fnp-3166	469	4	radke	radke	PROPN
fnp-3166	469	5	j	j	PROPN
fnp-3166	469	6	,	,	PUNCT
fnp-3166	469	7	dittmayer	dittmayer	PROPN
fnp-3166	469	8	c	c	X
fnp-3166	469	9	,	,	PUNCT
fnp-3166	469	10	franz	franz	PROPN
fnp-3166	469	11	j	j	PROPN
fnp-3166	469	12	,	,	PUNCT
fnp-3166	469	13	thomas	thomas	PROPN
fnp-3166	469	14	c	c	PROPN
fnp-3166	469	15	,	,	PUNCT
fnp-3166	469	16	mothes	mothe	VERB
fnp-3166	469	17	r	r	PROPN
fnp-3166	469	18	,	,	PUNCT
fnp-3166	469	19	laue	laue	X
fnp-3166	469	20	m	m	PROPN
fnp-3166	469	21	,	,	PUNCT
fnp-3166	469	22	schneider	schneider	PROPN
fnp-3166	469	23	j	j	PROPN
fnp-3166	469	24	,	,	PUNCT
fnp-3166	469	25	brünink	brünink	PROPN
fnp-3166	469	26	s	s	PROPN
fnp-3166	469	27	,	,	PUNCT
fnp-3166	469	28	greuel	greuel	NOUN
fnp-3166	469	29	s	s	PROPN
fnp-3166	469	30	,	,	PUNCT
fnp-3166	469	31	lehmann	lehmann	PROPN
fnp-3166	469	32	m	m	PROPN
fnp-3166	469	33	,	,	PUNCT
fnp-3166	469	34	hassan	hassan	PROPN
fnp-3166	469	35	o	o	NOUN
fnp-3166	469	36	,	,	PUNCT
fnp-3166	469	37	aschman	aschman	PROPN
fnp-3166	469	38	t	t	PROPN
fnp-3166	469	39	,	,	PUNCT
fnp-3166	469	40	schumann	schumann	PROPN
fnp-3166	469	41	e	e	PROPN
fnp-3166	469	42	,	,	PUNCT
fnp-3166	469	43	chua	chua	PROPN
fnp-3166	469	44	rl	rl	PROPN
fnp-3166	469	45	,	,	PUNCT
fnp-3166	469	46	conrad	conrad	PROPN
fnp-3166	469	47	c	c	PROPN
fnp-3166	469	48	,	,	PUNCT
fnp-3166	469	49	eils	eil	NOUN
fnp-3166	469	50	r	r	NOUN
fnp-3166	469	51	,	,	PUNCT
fnp-3166	469	52	stenzel	stenzel	PROPN
fnp-3166	469	53	w	w	PROPN
fnp-3166	469	54	,	,	PUNCT
fnp-3166	469	55	windgassen	windgassen	NOUN
fnp-3166	469	56	m	m	PROPN
fnp-3166	469	57	,	,	PUNCT
fnp-3166	469	58	rößler	rößl	ADJ
fnp-3166	469	59	l	l	NOUN
fnp-3166	469	60	,	,	PUNCT
fnp-3166	469	61	goebel	goebel	NOUN
fnp-3166	469	62	hh	hh	PROPN
fnp-3166	469	63	,	,	PUNCT
fnp-3166	469	64	gelderblom	gelderblom	PROPN
fnp-3166	469	65	hr	hr	PROPN
fnp-3166	469	66	,	,	PUNCT
fnp-3166	469	67	martin	martin	PROPN
fnp-3166	469	68	h	h	PROPN
fnp-3166	469	69	,	,	PUNCT
fnp-3166	469	70	nitsche	nitsche	PROPN
fnp-3166	469	71	a	a	X
fnp-3166	469	72	,	,	PUNCT
fnp-3166	469	73	schulz	schulz	PROPN
fnp-3166	469	74	-	-	PUNCT
fnp-3166	469	75	schaeffer	schaeffer	PROPN
fnp-3166	469	76	wj	wj	PROPN
fnp-3166	469	77	,	,	PUNCT
fnp-3166	469	78	hakroush	hakroush	NOUN
fnp-3166	469	79	s	s	PROPN
fnp-3166	469	80	,	,	PUNCT
fnp-3166	469	81	winkler	winkler	PROPN
fnp-3166	469	82	ms	ms	PROPN
fnp-3166	469	83	,	,	PUNCT
fnp-3166	469	84	tampe	tampe	PROPN
fnp-3166	469	85	b	b	PROPN
fnp-3166	469	86	,	,	PUNCT
fnp-3166	469	87	scheibe	scheibe	NOUN
fnp-3166	469	88	f	f	PROPN
fnp-3166	469	89	,	,	PUNCT
fnp-3166	469	90	körtvélyessy	körtvélyessy	PROPN
fnp-3166	469	91	p	p	X
fnp-3166	469	92	,	,	PUNCT
fnp-3166	469	93	reinhold	reinhold	PROPN
fnp-3166	469	94	d	d	PROPN
fnp-3166	469	95	,	,	PUNCT
fnp-3166	469	96	siegmund	siegmund	PROPN
fnp-3166	469	97	b	b	PROPN
fnp-3166	469	98	,	,	PUNCT
fnp-3166	469	99	kühl	kühl	NOUN
fnp-3166	469	100	aa	aa	PROPN
fnp-3166	469	101	,	,	PUNCT
fnp-3166	469	102	elezkurtaj	elezkurtaj	PROPN
fnp-3166	469	103	s	s	PROPN
fnp-3166	469	104	,	,	PUNCT
fnp-3166	469	105	horst	horst	PROPN
fnp-3166	469	106	d	d	PROPN
fnp-3166	469	107	,	,	PUNCT
fnp-3166	469	108	oesterhelweg	oesterhelweg	VERB
fnp-3166	469	109	l	l	NOUN
fnp-3166	469	110	,	,	PUNCT
fnp-3166	469	111	tsokos	tsokos	PROPN
fnp-3166	469	112	m	m	PROPN
fnp-3166	469	113	,	,	PUNCT
fnp-3166	469	114	ingold	ingold	PROPN
fnp-3166	469	115	-	-	PUNCT
fnp-3166	469	116	heppner	heppner	PROPN
fnp-3166	469	117	b	b	PROPN
fnp-3166	469	118	,	,	PUNCT
fnp-3166	469	119	stadelmann	stadelmann	PROPN
fnp-3166	469	120	c	c	AUX
fnp-3166	469	121	,	,	PUNCT
fnp-3166	469	122	drosten	drosten	PROPN
fnp-3166	469	123	c	c	NOUN
fnp-3166	469	124	,	,	PUNCT
fnp-3166	469	125	corman	corman	PROPN
fnp-3166	469	126	vm	vm	PROPN
fnp-3166	469	127	,	,	PUNCT
fnp-3166	469	128	radbruch	radbruch	ADJ
fnp-3166	469	129	h	h	NOUN
fnp-3166	469	130	,	,	PUNCT
fnp-3166	469	131	heppner	heppner	PROPN
fnp-3166	469	132	fl	fl	PROPN
fnp-3166	469	133	.	.	PUNCT
fnp-3166	470	1	olfactory	olfactory	PROPN
fnp-3166	470	2	transmucosal	transmucosal	PROPN
fnp-3166	470	3	sars	sars	PROPN
fnp-3166	470	4	-	-	PUNCT
fnp-3166	470	5	cov-2	cov-2	PART
fnp-3166	470	6	invasion	invasion	NOUN
fnp-3166	470	7	as	as	ADP
fnp-3166	470	8	a	a	DET
fnp-3166	470	9	port	port	NOUN
fnp-3166	470	10	of	of	ADP
fnp-3166	470	11	central	central	ADJ
fnp-3166	470	12	nervous	nervous	ADJ
fnp-3166	470	13	system	system	NOUN
fnp-3166	470	14	entry	entry	NOUN
fnp-3166	470	15	in	in	ADP
fnp-3166	470	16	individuals	individual	NOUN
fnp-3166	470	17	with	with	ADP
fnp-3166	470	18	covid-19	covid-19	PROPN
fnp-3166	470	19	.	.	PUNCT
fnp-3166	471	1	nat	nat	PROPN
fnp-3166	471	2	neurosci	neurosci	PROPN
fnp-3166	471	3	.	.	PUNCT
fnp-3166	472	1	2020	2020	NUM
fnp-3166	472	2	nov	nov	PROPN
fnp-3166	472	3	30	30	NUM
fnp-3166	472	4	.	.	PUNCT
fnp-3166	473	1	doi	doi	NOUN
fnp-3166	473	2	:	:	PUNCT
fnp-3166	473	3	10.1038	10.1038	NUM
fnp-3166	473	4	/	/	SYM
fnp-3166	473	5	s41593	s41593	PROPN
fnp-3166	473	6	-	-	PUNCT
fnp-3166	473	7	020	020	NUM
fnp-3166	473	8	-	-	PUNCT
fnp-3166	473	9	00758	00758	NUM
fnp-3166	473	10	-	-	SYM
fnp-3166	473	11	5	5	NUM
fnp-3166	473	12	.	.	PUNCT
fnp-3166	474	1	epub	epub	NOUN
fnp-3166	474	2	ahead	ahead	ADV
fnp-3166	474	3	of	of	ADP
fnp-3166	474	4	print	print	NOUN
fnp-3166	474	5	.	.	PUNCT
fnp-3166	475	1	pmid	pmid	NOUN
fnp-3166	475	2	:	:	PUNCT
fnp-3166	475	3	33257876	33257876	NUM
fnp-3166	475	4	.	.	PUNCT
fnp-3166	476	1	mendiola	mendiola	PROPN
fnp-3166	476	2	as	as	ADP
fnp-3166	476	3	,	,	PUNCT
fnp-3166	476	4	ryu	ryu	PROPN
fnp-3166	476	5	jk	jk	PROPN
fnp-3166	476	6	,	,	PUNCT
fnp-3166	476	7	bardehle	bardehle	PROPN
fnp-3166	476	8	s	s	PROPN
fnp-3166	476	9	,	,	PUNCT
fnp-3166	476	10	meyer	meyer	PROPN
fnp-3166	476	11	-	-	PUNCT
fnp-3166	476	12	franke	franke	PROPN
fnp-3166	476	13	a	a	PRON
fnp-3166	476	14	,	,	PUNCT
fnp-3166	476	15	ang	ang	PROPN
fnp-3166	476	16	kk	kk	PROPN
fnp-3166	476	17	,	,	PUNCT
fnp-3166	476	18	wilson	wilson	PROPN
fnp-3166	476	19	c	c	PROPN
fnp-3166	476	20	,	,	PUNCT
fnp-3166	476	21	baeten	baeten	PROPN
fnp-3166	476	22	km	km	PROPN
fnp-3166	476	23	,	,	PUNCT
fnp-3166	476	24	hanspers	hanspers	PROPN
fnp-3166	476	25	k	k	PROPN
fnp-3166	476	26	,	,	PUNCT
fnp-3166	476	27	merlini	merlini	PROPN
fnp-3166	476	28	m	m	PROPN
fnp-3166	476	29	,	,	PUNCT
fnp-3166	476	30	thomas	thomas	PROPN
fnp-3166	476	31	s	s	PROPN
fnp-3166	476	32	,	,	PUNCT
fnp-3166	476	33	petersen	petersen	PROPN
fnp-3166	476	34	ma	ma	PROPN
fnp-3166	476	35	,	,	PUNCT
fnp-3166	476	36	williams	williams	PROPN
fnp-3166	476	37	a	a	PROPN
fnp-3166	476	38	,	,	PUNCT
fnp-3166	476	39	thomas	thomas	PROPN
fnp-3166	476	40	r	r	PROPN
fnp-3166	476	41	,	,	PUNCT
fnp-3166	476	42	rafalski	rafalski	ADJ
fnp-3166	476	43	va	va	PROPN
fnp-3166	476	44	,	,	PUNCT
fnp-3166	476	45	meza	meza	PROPN
fnp-3166	476	46	-	-	PUNCT
fnp-3166	476	47	acevedo	acevedo	PROPN
fnp-3166	476	48	r	r	PROPN
fnp-3166	476	49	,	,	PUNCT
fnp-3166	476	50	tognatta	tognatta	NOUN
fnp-3166	476	51	r	r	NOUN
fnp-3166	476	52	,	,	PUNCT
fnp-3166	476	53	yan	yan	PROPN
fnp-3166	477	1	z	z	PROPN
fnp-3166	477	2	,	,	PUNCT
fnp-3166	477	3	pfaff	pfaff	PROPN
fnp-3166	477	4	sj	sj	PROPN
fnp-3166	477	5	,	,	PUNCT
fnp-3166	477	6	machado	machado	PROPN
fnp-3166	477	7	mr	mr	PROPN
fnp-3166	477	8	,	,	PUNCT
fnp-3166	477	9	bedard	bedard	PROPN
fnp-3166	477	10	c	c	PROPN
fnp-3166	477	11	,	,	PUNCT
fnp-3166	477	12	rios	rios	PROPN
fnp-3166	477	13	coronado	coronado	PROPN
fnp-3166	477	14	pe	pe	PROPN
fnp-3166	477	15	,	,	PUNCT
fnp-3166	477	16	jiang	jiang	PROPN
fnp-3166	477	17	x	x	PROPN
fnp-3166	477	18	,	,	PUNCT
fnp-3166	477	19	wang	wang	PROPN
fnp-3166	477	20	j	j	PROPN
fnp-3166	477	21	,	,	PUNCT
fnp-3166	477	22	pleiss	pleis	VERB
fnp-3166	477	23	ma	ma	PROPN
fnp-3166	477	24	,	,	PUNCT
fnp-3166	477	25	green	green	PROPN
fnp-3166	477	26	aj	aj	PROPN
fnp-3166	477	27	,	,	PUNCT
fnp-3166	477	28	zamvil	zamvil	PROPN
fnp-3166	477	29	ss	ss	PROPN
fnp-3166	477	30	,	,	PUNCT
fnp-3166	477	31	pico	pico	PROPN
fnp-3166	477	32	ar	ar	PROPN
fnp-3166	477	33	,	,	PUNCT
fnp-3166	477	34	bruneau	bruneau	PROPN
fnp-3166	477	35	bg	bg	PROPN
fnp-3166	477	36	,	,	PUNCT
fnp-3166	477	37	arkin	arkin	PROPN
fnp-3166	477	38	mr	mr	PROPN
fnp-3166	477	39	,	,	PUNCT
fnp-3166	477	40	akassoglou	akassoglou	PROPN
fnp-3166	477	41	k.	k.	PROPN
fnp-3166	477	42	transcriptional	transcriptional	ADJ
fnp-3166	477	43	profiling	profiling	NOUN
fnp-3166	477	44	and	and	CCONJ
fnp-3166	477	45	therapeutic	therapeutic	ADJ
fnp-3166	477	46	targeting	targeting	NOUN
fnp-3166	477	47	of	of	ADP
fnp-3166	477	48	oxidative	oxidative	ADJ
fnp-3166	477	49	stress	stress	NOUN
fnp-3166	477	50	in	in	ADP
fnp-3166	477	51	neuroinflammation	neuroinflammation	NOUN
fnp-3166	477	52	.	.	PUNCT
fnp-3166	478	1	nat	nat	PROPN
fnp-3166	478	2	immunol	immunol	NOUN
fnp-3166	478	3	.	.	PUNCT
fnp-3166	479	1	2020	2020	NUM
fnp-3166	479	2	may;21(5):513	may;21(5):513	PROPN
fnp-3166	479	3	-	-	PUNCT
fnp-3166	479	4	524	524	NUM
fnp-3166	479	5	.	.	PUNCT
fnp-3166	480	1	doi	doi	NOUN
fnp-3166	480	2	:	:	PUNCT
fnp-3166	480	3	10.1038	10.1038	NUM
fnp-3166	480	4	/	/	SYM
fnp-3166	480	5	s41590	s41590	PROPN
fnp-3166	480	6	-	-	PUNCT
fnp-3166	480	7	020	020	NUM
fnp-3166	480	8	-	-	PUNCT
fnp-3166	480	9	0654	0654	NUM
fnp-3166	480	10	-	-	PUNCT
fnp-3166	480	11	0	0	NUM
fnp-3166	480	12	.	.	PUNCT
fnp-3166	481	1	epub	epub	NOUN
fnp-3166	481	2	2020	2020	NUM
fnp-3166	481	3	apr	apr	PROPN
fnp-3166	481	4	13	13	NUM
fnp-3166	481	5	.	.	PUNCT
fnp-3166	482	1	erratum	erratum	PROPN
fnp-3166	482	2	in	in	ADP
fnp-3166	482	3	:	:	PUNCT
fnp-3166	482	4	nat	nat	NOUN
fnp-3166	482	5	immunol	immunol	NOUN
fnp-3166	482	6	.	.	PUNCT
fnp-3166	482	7	2020	2020	NUM
fnp-3166	482	8	sep;21(9):1135	sep;21(9):1135	PROPN
fnp-3166	482	9	.	.	PUNCT
fnp-3166	483	1	pmid	pmid	NOUN
fnp-3166	483	2	:	:	PUNCT
fnp-3166	483	3	32284594	32284594	NUM
fnp-3166	483	4	;	;	PUNCT
fnp-3166	483	5	pmcid	pmcid	ADJ
fnp-3166	483	6	:	:	PUNCT
fnp-3166	483	7	pmc7523413	pmc7523413	PROPN
fnp-3166	483	8	.	.	PUNCT
fnp-3166	484	1	moll	moll	PROPN
fnp-3166	484	2	nm	nm	PROPN
fnp-3166	484	3	,	,	PUNCT
fnp-3166	484	4	rietsch	rietsch	NOUN
fnp-3166	484	5	am	be	AUX
fnp-3166	484	6	,	,	PUNCT
fnp-3166	484	7	ransohoff	ransohoff	PROPN
fnp-3166	484	8	aj	aj	PROPN
fnp-3166	484	9	,	,	PUNCT
fnp-3166	484	10	cossoy	cossoy	VERB
fnp-3166	484	11	mb	mb	NOUN
fnp-3166	484	12	,	,	PUNCT
fnp-3166	484	13	huang	huang	PROPN
fnp-3166	484	14	d	d	PROPN
fnp-3166	484	15	,	,	PUNCT
fnp-3166	484	16	eichler	eichler	PROPN
fnp-3166	484	17	fs	fs	PROPN
fnp-3166	484	18	,	,	PUNCT
fnp-3166	484	19	trapp	trapp	PROPN
fnp-3166	484	20	bd	bd	PROPN
fnp-3166	484	21	,	,	PUNCT
fnp-3166	484	22	ransohoff	ransohoff	PROPN
fnp-3166	484	23	rm	rm	PROPN
fnp-3166	484	24	.	.	PUNCT
fnp-3166	485	1	cortical	cortical	ADJ
fnp-3166	485	2	demyelination	demyelination	NOUN
fnp-3166	485	3	in	in	ADP
fnp-3166	485	4	pml	pml	PROPN
fnp-3166	485	5	and	and	CCONJ
fnp-3166	485	6	ms	ms	NOUN
fnp-3166	485	7	:	:	PUNCT
fnp-3166	485	8	similarities	similarity	NOUN
fnp-3166	485	9	and	and	CCONJ
fnp-3166	485	10	differences	difference	NOUN
fnp-3166	485	11	.	.	PUNCT
fnp-3166	486	1	neurology	neurology	NOUN
fnp-3166	486	2	.	.	PUNCT
fnp-3166	487	1	2008	2008	NUM
fnp-3166	487	2	jan	jan	PROPN
fnp-3166	487	3	29;70(5):336	29;70(5):336	PROPN
fnp-3166	487	4	-	-	PUNCT
fnp-3166	487	5	43	43	NUM
fnp-3166	487	6	.	.	PUNCT
fnp-3166	488	1	doi	doi	NOUN
fnp-3166	488	2	:	:	PUNCT
fnp-3166	488	3	10.1212/01.wnl.0000284601.54436.e4	10.1212/01.wnl.0000284601.54436.e4	NUM
fnp-3166	488	4	.	.	PUNCT
fnp-3166	489	1	pmid	pmid	NOUN
fnp-3166	489	2	:	:	PUNCT
fnp-3166	489	3	17914063	17914063	NUM
fnp-3166	489	4	.	.	PUNCT
fnp-3166	490	1	paterson	paterson	PROPN
fnp-3166	490	2	rw	rw	PROPN
fnp-3166	490	3	,	,	PUNCT
fnp-3166	490	4	brown	brown	PROPN
fnp-3166	490	5	rl	rl	PROPN
fnp-3166	490	6	,	,	PUNCT
fnp-3166	490	7	benjamin	benjamin	PROPN
fnp-3166	490	8	l	l	PROPN
fnp-3166	490	9	,	,	PUNCT
fnp-3166	490	10	nortley	nortley	PROPN
fnp-3166	490	11	r	r	NOUN
fnp-3166	490	12	,	,	PUNCT
fnp-3166	490	13	wiethoff	wiethoff	NOUN
fnp-3166	490	14	s	s	PROPN
fnp-3166	490	15	,	,	PUNCT
fnp-3166	490	16	bharucha	bharucha	PROPN
fnp-3166	490	17	t	t	PROPN
fnp-3166	490	18	,	,	PUNCT
fnp-3166	490	19	jayaseelan	jayaseelan	PROPN
fnp-3166	490	20	dl	dl	PROPN
fnp-3166	490	21	,	,	PUNCT
fnp-3166	490	22	kumar	kumar	PROPN
fnp-3166	490	23	g	g	PROPN
fnp-3166	490	24	,	,	PUNCT
fnp-3166	490	25	raftopoulos	raftopoulo	NOUN
fnp-3166	490	26	re	re	PROPN
fnp-3166	490	27	,	,	PUNCT
fnp-3166	490	28	zambreanu	zambreanu	PROPN
fnp-3166	490	29	l	l	NOUN
fnp-3166	490	30	,	,	PUNCT
fnp-3166	490	31	vivekanandam	vivekanandam	NOUN
fnp-3166	490	32	v	v	NOUN
fnp-3166	490	33	,	,	PUNCT
fnp-3166	490	34	khoo	khoo	PROPN
fnp-3166	490	35	a	a	X
fnp-3166	490	36	,	,	PUNCT
fnp-3166	490	37	geraldes	geraldes	INTJ
fnp-3166	490	38	r	r	NOUN
fnp-3166	490	39	,	,	PUNCT
fnp-3166	490	40	chinthapalli	chinthapalli	PROPN
fnp-3166	490	41	k	k	PROPN
fnp-3166	490	42	,	,	PUNCT
fnp-3166	490	43	boyd	boyd	PROPN
fnp-3166	490	44	e	e	PROPN
fnp-3166	490	45	,	,	PUNCT
fnp-3166	490	46	tuzlali	tuzlali	VERB
fnp-3166	490	47	h	h	NOUN
fnp-3166	490	48	,	,	PUNCT
fnp-3166	490	49	price	price	NOUN
fnp-3166	490	50	g	g	NOUN
fnp-3166	490	51	,	,	PUNCT
fnp-3166	490	52	christofi	christofi	NOUN
fnp-3166	490	53	g	g	PROPN
fnp-3166	490	54	,	,	PUNCT
fnp-3166	490	55	morrow	morrow	PROPN
fnp-3166	490	56	j	j	PROPN
fnp-3166	490	57	,	,	PUNCT
fnp-3166	490	58	mcnamara	mcnamara	PROPN
fnp-3166	490	59	p	p	PROPN
fnp-3166	490	60	,	,	PUNCT
fnp-3166	490	61	mcloughlin	mcloughlin	PROPN
fnp-3166	490	62	b	b	PROPN
fnp-3166	490	63	,	,	PUNCT
fnp-3166	490	64	lim	lim	PROPN
fnp-3166	490	65	st	st	PROPN
fnp-3166	490	66	,	,	PUNCT
fnp-3166	490	67	mehta	mehta	PROPN
fnp-3166	490	68	pr	pr	PROPN
fnp-3166	490	69	,	,	PUNCT
fnp-3166	490	70	levee	levee	NOUN
fnp-3166	490	71	v	v	NOUN
fnp-3166	490	72	,	,	PUNCT
fnp-3166	490	73	keddie	keddie	PROPN
fnp-3166	490	74	s	s	PART
fnp-3166	490	75	,	,	PUNCT
fnp-3166	490	76	yong	yong	PROPN
fnp-3166	490	77	w	w	PROPN
fnp-3166	490	78	,	,	PUNCT
fnp-3166	490	79	trip	trip	NOUN
fnp-3166	490	80	sa	sa	PROPN
fnp-3166	490	81	,	,	PUNCT
fnp-3166	490	82	foulkes	foulkes	PROPN
fnp-3166	490	83	ajm	ajm	PROPN
fnp-3166	490	84	,	,	PUNCT
fnp-3166	490	85	hotton	hotton	VERB
fnp-3166	490	86	g	g	PROPN
fnp-3166	490	87	,	,	PUNCT
fnp-3166	490	88	miller	miller	PROPN
fnp-3166	490	89	td	td	PROPN
fnp-3166	490	90	,	,	PUNCT
fnp-3166	490	91	everitt	everitt	X
fnp-3166	490	92	ad	ad	NOUN
fnp-3166	490	93	,	,	PUNCT
fnp-3166	490	94	carswell	carswell	PROPN
fnp-3166	490	95	c	c	PROPN
fnp-3166	490	96	,	,	PUNCT
fnp-3166	490	97	davies	davies	PROPN
fnp-3166	490	98	nws	nws	PROPN
fnp-3166	490	99	,	,	PUNCT
fnp-3166	490	100	yoong	yoong	PROPN
fnp-3166	490	101	m	m	PROPN
fnp-3166	490	102	,	,	PUNCT
fnp-3166	490	103	attwell	attwell	ADJ
fnp-3166	491	1	d	d	NOUN
fnp-3166	491	2	,	,	PUNCT
fnp-3166	491	3	sreedharan	sreedharan	PROPN
fnp-3166	491	4	j	j	PROPN
fnp-3166	491	5	,	,	PUNCT
fnp-3166	491	6	silber	silber	PROPN
fnp-3166	491	7	e	e	PROPN
fnp-3166	491	8	,	,	PUNCT
fnp-3166	491	9	schott	schott	PROPN
fnp-3166	491	10	jm	jm	PROPN
fnp-3166	491	11	,	,	PUNCT
fnp-3166	491	12	chandratheva	chandratheva	VERB
fnp-3166	491	13	a	a	PRON
fnp-3166	491	14	,	,	PUNCT
fnp-3166	491	15	perry	perry	PROPN
fnp-3166	491	16	rj	rj	PROPN
fnp-3166	491	17	,	,	PUNCT
fnp-3166	491	18	simister	simister	PROPN
fnp-3166	491	19	r	r	PROPN
fnp-3166	491	20	,	,	PUNCT
fnp-3166	491	21	checkley	checkley	NOUN
fnp-3166	491	22	a	a	NOUN
fnp-3166	491	23	,	,	PUNCT
fnp-3166	491	24	longley	longley	PROPN
fnp-3166	491	25	n	n	CCONJ
fnp-3166	491	26	,	,	PUNCT
fnp-3166	491	27	farmer	farmer	PROPN
fnp-3166	491	28	sf	sf	PROPN
fnp-3166	491	29	,	,	PUNCT
fnp-3166	491	30	carletti	carletti	PROPN
fnp-3166	491	31	f	f	PROPN
fnp-3166	491	32	,	,	PUNCT
fnp-3166	491	33	houlihan	houlihan	PROPN
fnp-3166	491	34	c	c	PROPN
fnp-3166	491	35	,	,	PUNCT
fnp-3166	491	36	thom	thom	PROPN
fnp-3166	491	37	m	m	PROPN
fnp-3166	491	38	,	,	PUNCT
fnp-3166	491	39	lunn	lunn	PROPN
fnp-3166	491	40	mp	mp	PROPN
fnp-3166	491	41	,	,	PUNCT
fnp-3166	491	42	spillane	spillane	PROPN
fnp-3166	491	43	j	j	PROPN
fnp-3166	491	44	,	,	PUNCT
fnp-3166	491	45	howard	howard	PROPN
fnp-3166	491	46	r	r	PROPN
fnp-3166	491	47	,	,	PUNCT
fnp-3166	491	48	vincent	vincent	NOUN
fnp-3166	491	49	a	a	PRON
fnp-3166	491	50	,	,	PUNCT
fnp-3166	491	51	werring	werring	NOUN
fnp-3166	491	52	dj	dj	NOUN
fnp-3166	491	53	,	,	PUNCT
fnp-3166	491	54	hoskote	hoskote	VERB
fnp-3166	491	55	c	c	NOUN
fnp-3166	491	56	,	,	PUNCT
fnp-3166	491	57	jäger	jäger	PROPN
fnp-3166	491	58	hr	hr	PROPN
fnp-3166	491	59	,	,	PUNCT
fnp-3166	491	60	manji	manji	PROPN
fnp-3166	491	61	h	h	PROPN
fnp-3166	491	62	,	,	PUNCT
fnp-3166	491	63	zandi	zandi	PROPN
fnp-3166	491	64	ms	ms	PROPN
fnp-3166	491	65	.	.	PROPN
fnp-3166	492	1	the	the	DET
fnp-3166	492	2	emerging	emerge	VERB
fnp-3166	492	3	spectrum	spectrum	NOUN
fnp-3166	492	4	of	of	ADP
fnp-3166	492	5	covid-19	covid-19	PROPN
fnp-3166	492	6	neurology	neurology	NOUN
fnp-3166	492	7	:	:	PUNCT
fnp-3166	492	8	clinical	clinical	ADJ
fnp-3166	492	9	,	,	PUNCT
fnp-3166	492	10	radiological	radiological	ADJ
fnp-3166	492	11	and	and	CCONJ
fnp-3166	492	12	laboratory	laboratory	NOUN
fnp-3166	492	13	findings	finding	NOUN
fnp-3166	492	14	.	.	PUNCT
fnp-3166	493	1	brain	brain	NOUN
fnp-3166	493	2	.	.	PUNCT
fnp-3166	494	1	2020	2020	NUM
fnp-3166	494	2	oct	oct	PROPN
fnp-3166	494	3	1;143(10):3104	1;143(10):3104	PROPN
fnp-3166	494	4	-	-	PUNCT
fnp-3166	494	5	3120	3120	NUM
fnp-3166	494	6	.	.	PUNCT
fnp-3166	495	1	doi	doi	NOUN
fnp-3166	495	2	:	:	PUNCT
fnp-3166	495	3	10.1093	10.1093	NUM
fnp-3166	495	4	/	/	SYM
fnp-3166	495	5	brain	brain	NOUN
fnp-3166	495	6	/	/	SYM
fnp-3166	495	7	awaa240	awaa240	PROPN
fnp-3166	495	8	.	.	PUNCT
fnp-3166	496	1	pmid	pmid	NOUN
fnp-3166	496	2	:	:	PUNCT
fnp-3166	496	3	32637987	32637987	NUM
fnp-3166	496	4	;	;	PUNCT
fnp-3166	496	5	pmcid	pmcid	NOUN
fnp-3166	496	6	:	:	PUNCT
fnp-3166	496	7	pmc7454352	pmc7454352	PROPN
fnp-3166	496	8	.	.	PUNCT
fnp-3166	497	1	peterson	peterson	PROPN
fnp-3166	497	2	jw	jw	PROPN
fnp-3166	497	3	,	,	PUNCT
fnp-3166	497	4	bö	bö	PROPN
fnp-3166	497	5	l	l	NOUN
fnp-3166	497	6	,	,	PUNCT
fnp-3166	497	7	mörk	mörk	PROPN
fnp-3166	497	8	s	s	PROPN
fnp-3166	497	9	,	,	PUNCT
fnp-3166	497	10	chang	chang	PROPN
fnp-3166	497	11	a	a	PROPN
fnp-3166	497	12	,	,	PUNCT
fnp-3166	497	13	trapp	trapp	PROPN
fnp-3166	497	14	bd	bd	PROPN
fnp-3166	497	15	.	.	PROPN
fnp-3166	497	16	transected	transect	VERB
fnp-3166	497	17	neurites	neurite	NOUN
fnp-3166	497	18	,	,	PUNCT
fnp-3166	497	19	apoptotic	apoptotic	ADJ
fnp-3166	497	20	neurons	neuron	NOUN
fnp-3166	497	21	,	,	PUNCT
fnp-3166	497	22	and	and	CCONJ
fnp-3166	497	23	reduced	reduce	VERB
fnp-3166	497	24	inflammation	inflammation	NOUN
fnp-3166	497	25	in	in	ADP
fnp-3166	497	26	cortical	cortical	ADJ
fnp-3166	497	27	multiple	multiple	ADJ
fnp-3166	497	28	sclerosis	sclerosis	NOUN
fnp-3166	497	29	lesions	lesion	NOUN
fnp-3166	497	30	.	.	PUNCT
fnp-3166	498	1	ann	ann	PROPN
fnp-3166	498	2	neurol	neurol	PROPN
fnp-3166	498	3	.	.	PUNCT
fnp-3166	499	1	2001	2001	NUM
fnp-3166	499	2	sep;50(3):389	sep;50(3):389	NOUN
fnp-3166	499	3	-	-	PUNCT
fnp-3166	499	4	400	400	NUM
fnp-3166	499	5	.	.	PUNCT
fnp-3166	500	1	doi	doi	NOUN
fnp-3166	500	2	:	:	PUNCT
fnp-3166	500	3	10.1002	10.1002	NUM
fnp-3166	500	4	/	/	SYM
fnp-3166	500	5	ana.1123	ana.1123	PROPN
fnp-3166	500	6	.	.	PUNCT
fnp-3166	501	1	pmid	pmid	NOUN
fnp-3166	501	2	:	:	PUNCT
fnp-3166	501	3	11558796	11558796	NUM
fnp-3166	501	4	.	.	PUNCT
fnp-3166	502	1	pichler	pichler	PROPN
fnp-3166	502	2	a	a	PROPN
fnp-3166	502	3	,	,	PUNCT
fnp-3166	502	4	khalil	khalil	PROPN
fnp-3166	502	5	m	m	PROPN
fnp-3166	502	6	,	,	PUNCT
fnp-3166	502	7	langkammer	langkammer	PROPN
fnp-3166	502	8	c	c	AUX
fnp-3166	502	9	,	,	PUNCT
fnp-3166	502	10	pinter	pinter	PROPN
fnp-3166	502	11	d	d	PROPN
fnp-3166	502	12	,	,	PUNCT
fnp-3166	502	13	ropele	ropele	PROPN
fnp-3166	502	14	s	s	PART
fnp-3166	502	15	,	,	PUNCT
fnp-3166	502	16	fuchs	fuchs	PROPN
fnp-3166	502	17	s	s	PART
fnp-3166	502	18	,	,	PUNCT
fnp-3166	502	19	bachmaier	bachmaier	VERB
fnp-3166	502	20	g	g	NOUN
fnp-3166	502	21	,	,	PUNCT
fnp-3166	502	22	enzinger	enzinger	NOUN
fnp-3166	502	23	c	c	NOUN
fnp-3166	502	24	,	,	PUNCT
fnp-3166	502	25	fazekas	fazekas	PROPN
fnp-3166	502	26	f.	f.	PROPN
fnp-3166	503	1	the	the	DET
fnp-3166	503	2	impact	impact	NOUN
fnp-3166	503	3	of	of	ADP
fnp-3166	503	4	vascular	vascular	ADJ
fnp-3166	503	5	risk	risk	NOUN
fnp-3166	503	6	factors	factor	NOUN
fnp-3166	503	7	on	on	ADP
fnp-3166	503	8	brain	brain	NOUN
fnp-3166	503	9	volume	volume	NOUN
fnp-3166	503	10	and	and	CCONJ
fnp-3166	503	11	lesion	lesion	NOUN
fnp-3166	503	12	load	load	NOUN
fnp-3166	503	13	in	in	ADP
fnp-3166	503	14	patients	patient	NOUN
fnp-3166	503	15	with	with	ADP
fnp-3166	503	16	early	early	ADJ
fnp-3166	503	17	multiple	multiple	ADJ
fnp-3166	503	18	sclerosis	sclerosis	NOUN
fnp-3166	503	19	.	.	PUNCT
fnp-3166	504	1	mult	mult	PROPN
fnp-3166	504	2	scler	scler	NOUN
fnp-3166	504	3	.	.	PUNCT
fnp-3166	505	1	2019	2019	NUM
fnp-3166	505	2	jan;25(1):48	jan;25(1):48	PROPN
fnp-3166	505	3	-	-	PUNCT
fnp-3166	505	4	54	54	NUM
fnp-3166	505	5	.	.	PUNCT
fnp-3166	506	1	doi	doi	NOUN
fnp-3166	506	2	:	:	PUNCT
fnp-3166	506	3	10.1177/1352458517736149	10.1177/1352458517736149	NUM
fnp-3166	506	4	.	.	PUNCT
fnp-3166	507	1	epub	epub	PROPN
fnp-3166	507	2	2017	2017	NUM
fnp-3166	507	3	oct	oct	NOUN
fnp-3166	507	4	13	13	NUM
fnp-3166	507	5	.	.	PUNCT
fnp-3166	508	1	pmid	pmid	NOUN
fnp-3166	508	2	:	:	PUNCT
fnp-3166	508	3	29027843	29027843	NUM
fnp-3166	508	4	.	.	PUNCT
fnp-3166	509	1	pitsch	pitsch	PROPN
fnp-3166	509	2	j	j	PROPN
fnp-3166	509	3	,	,	PUNCT
fnp-3166	509	4	kamalizade	kamalizade	PROPN
fnp-3166	509	5	d	d	PROPN
fnp-3166	509	6	,	,	PUNCT
fnp-3166	509	7	braun	braun	PROPN
fnp-3166	509	8	a	a	NOUN
fnp-3166	509	9	,	,	PUNCT
fnp-3166	509	10	kuehn	kuehn	PROPN
fnp-3166	509	11	jc	jc	PROPN
fnp-3166	509	12	,	,	PUNCT
fnp-3166	509	13	gulakova	gulakova	PROPN
fnp-3166	509	14	pe	pe	PROPN
fnp-3166	509	15	,	,	PUNCT
fnp-3166	509	16	rüber	rüber	PROPN
fnp-3166	509	17	t	t	PROPN
fnp-3166	509	18	,	,	PUNCT
fnp-3166	509	19	lubec	lubec	PROPN
fnp-3166	509	20	g	g	PROPN
fnp-3166	509	21	,	,	PUNCT
fnp-3166	509	22	dietrich	dietrich	PROPN
fnp-3166	509	23	d	d	PROPN
fnp-3166	509	24	,	,	PUNCT
fnp-3166	509	25	von	von	PROPN
fnp-3166	509	26	wrede	wrede	PROPN
fnp-3166	509	27	r	r	PROPN
fnp-3166	509	28	,	,	PUNCT
fnp-3166	509	29	helmstaedter	helmstaedter	NOUN
fnp-3166	509	30	c	c	NOUN
fnp-3166	509	31	,	,	PUNCT
fnp-3166	509	32	surges	surge	VERB
fnp-3166	509	33	r	r	NOUN
fnp-3166	509	34	,	,	PUNCT
fnp-3166	509	35	elger	elger	PROPN
fnp-3166	509	36	ce	ce	PROPN
fnp-3166	509	37	,	,	PUNCT
fnp-3166	509	38	hattingen	hattingen	PROPN
fnp-3166	509	39	e	e	PROPN
fnp-3166	509	40	,	,	PUNCT
fnp-3166	509	41	vatter	vatter	PROPN
fnp-3166	509	42	h	h	NOUN
fnp-3166	509	43	,	,	PUNCT
fnp-3166	509	44	schoch	schoch	PROPN
fnp-3166	509	45	s	s	PROPN
fnp-3166	509	46	,	,	PUNCT
fnp-3166	509	47	becker	becker	PROPN
fnp-3166	509	48	aj	aj	PROPN
fnp-3166	509	49	.	.	PROPN
fnp-3166	509	50	drebrin	drebrin	NOUN
fnp-3166	509	51	autoantibodies	autoantibody	NOUN
fnp-3166	509	52	in	in	ADP
fnp-3166	509	53	patients	patient	NOUN
fnp-3166	509	54	with	with	ADP
fnp-3166	509	55	seizures	seizure	NOUN
fnp-3166	509	56	and	and	CCONJ
fnp-3166	509	57	suspected	suspect	VERB
fnp-3166	509	58	encephalitis	encephalitis	NOUN
fnp-3166	509	59	.	.	PUNCT
fnp-3166	510	1	ann	ann	PROPN
fnp-3166	510	2	neurol	neurol	PROPN
fnp-3166	510	3	.	.	PUNCT
fnp-3166	511	1	2020	2020	NUM
fnp-3166	511	2	jun;87(6):869	jun;87(6):869	NOUN
fnp-3166	511	3	-	-	PUNCT
fnp-3166	511	4	884	884	NUM
fnp-3166	511	5	.	.	PUNCT
fnp-3166	512	1	doi	doi	NOUN
fnp-3166	512	2	:	:	PUNCT
fnp-3166	512	3	10.1002	10.1002	NUM
fnp-3166	512	4	/	/	SYM
fnp-3166	512	5	ana.25720	ana.25720	NOUN
fnp-3166	512	6	.	.	PUNCT
fnp-3166	513	1	epub	epub	NOUN
fnp-3166	513	2	2020	2020	NUM
fnp-3166	513	3	apr	apr	NOUN
fnp-3166	513	4	10	10	NUM
fnp-3166	513	5	.	.	PUNCT
fnp-3166	514	1	pmid	pmid	NOUN
fnp-3166	514	2	:	:	PUNCT
fnp-3166	514	3	32196746	32196746	NUM
fnp-3166	514	4	.	.	PUNCT
fnp-3166	515	1	ramaglia	ramaglia	PROPN
fnp-3166	515	2	v	v	PROPN
fnp-3166	515	3	,	,	PUNCT
fnp-3166	515	4	sheikh	sheikh	PROPN
fnp-3166	515	5	-	-	PUNCT
fnp-3166	515	6	mohamed	mohamed	PROPN
fnp-3166	515	7	s	s	PROPN
fnp-3166	515	8	,	,	PUNCT
fnp-3166	515	9	legg	legg	PROPN
fnp-3166	515	10	k	k	PROPN
fnp-3166	515	11	,	,	PUNCT
fnp-3166	515	12	park	park	NOUN
fnp-3166	515	13	c	c	PROPN
fnp-3166	515	14	,	,	PUNCT
fnp-3166	515	15	rojas	rojas	PROPN
fnp-3166	515	16	ol	ol	PROPN
fnp-3166	515	17	,	,	PUNCT
fnp-3166	515	18	zandee	zandee	PROPN
fnp-3166	515	19	s	s	PROPN
fnp-3166	515	20	,	,	PUNCT
fnp-3166	515	21	fu	fu	PROPN
fnp-3166	515	22	f	f	PROPN
fnp-3166	515	23	,	,	PUNCT
fnp-3166	515	24	ornatsky	ornatsky	ADJ
fnp-3166	515	25	o	o	PROPN
fnp-3166	515	26	,	,	PUNCT
fnp-3166	515	27	swanson	swanson	PROPN
fnp-3166	515	28	ec	ec	PROPN
fnp-3166	515	29	,	,	PUNCT
fnp-3166	516	1	pitt	pitt	PROPN
fnp-3166	516	2	d	d	PROPN
fnp-3166	516	3	,	,	PUNCT
fnp-3166	516	4	prat	prat	NOUN
fnp-3166	516	5	a	a	PRON
fnp-3166	516	6	,	,	PUNCT
fnp-3166	516	7	mckee	mckee	PROPN
fnp-3166	516	8	td	td	PROPN
fnp-3166	516	9	,	,	PUNCT
fnp-3166	516	10	gommerman	gommerman	PROPN
fnp-3166	516	11	jl	jl	PROPN
fnp-3166	516	12	.	.	PUNCT
fnp-3166	516	13	multiplexed	multiplexed	ADJ
fnp-3166	516	14	imaging	imaging	NOUN
fnp-3166	516	15	of	of	ADP
fnp-3166	516	16	immune	immune	ADJ
fnp-3166	516	17	cells	cell	NOUN
fnp-3166	516	18	in	in	ADP
fnp-3166	516	19	staged	stage	VERB
fnp-3166	516	20	multiple	multiple	ADJ
fnp-3166	516	21	sclerosis	sclerosis	NOUN
fnp-3166	516	22	lesions	lesion	NOUN
fnp-3166	516	23	by	by	ADP
fnp-3166	516	24	mass	mass	ADJ
fnp-3166	516	25	cytometry	cytometry	NOUN
fnp-3166	516	26	.	.	PUNCT
fnp-3166	517	1	elife	elife	NOUN
fnp-3166	517	2	.	.	PUNCT
fnp-3166	518	1	2019	2019	NUM
fnp-3166	518	2	aug	aug	NOUN
fnp-3166	518	3	1;8	1;8	NUM
fnp-3166	518	4	:	:	PUNCT
fnp-3166	518	5	e48051	e48051	ADJ
fnp-3166	518	6	.	.	PUNCT
fnp-3166	519	1	doi	doi	NOUN
fnp-3166	519	2	:	:	PUNCT
fnp-3166	519	3	10.7554	10.7554	NUM
fnp-3166	519	4	/	/	SYM
fnp-3166	519	5	elife.48051	elife.48051	PROPN
fnp-3166	519	6	.	.	PUNCT
fnp-3166	520	1	pmid	pmid	PROPN
fnp-3166	520	2	:	:	PUNCT
fnp-3166	520	3	31368890	31368890	NUM
fnp-3166	520	4	;	;	PUNCT
fnp-3166	520	5	pmcid	pmcid	ADJ
fnp-3166	520	6	:	:	PUNCT
fnp-3166	520	7	pmc6707785	pmc6707785	NOUN
fnp-3166	520	8	.	.	PUNCT
fnp-3166	521	1	rauschenberger	rauschenberger	ADJ
fnp-3166	521	2	v	v	PROPN
fnp-3166	521	3	,	,	PUNCT
fnp-3166	521	4	von	von	PROPN
fnp-3166	521	5	wardenburg	wardenburg	PROPN
fnp-3166	521	6	n	n	PROPN
fnp-3166	521	7	,	,	PUNCT
fnp-3166	521	8	schaefer	schaefer	PROPN
fnp-3166	521	9	n	n	CCONJ
fnp-3166	521	10	,	,	PUNCT
fnp-3166	521	11	ogino	ogino	PROPN
fnp-3166	521	12	k	k	PROPN
fnp-3166	521	13	,	,	PUNCT
fnp-3166	521	14	hirata	hirata	ADJ
fnp-3166	521	15	h	h	NOUN
fnp-3166	521	16	,	,	PUNCT
fnp-3166	521	17	lillesaar	lillesaar	NOUN
fnp-3166	521	18	c	c	NOUN
fnp-3166	521	19	,	,	PUNCT
fnp-3166	521	20	kluck	kluck	PROPN
fnp-3166	521	21	cj	cj	PROPN
fnp-3166	521	22	,	,	PUNCT
fnp-3166	521	23	meinck	meinck	PROPN
fnp-3166	521	24	hm	hm	INTJ
fnp-3166	521	25	,	,	PUNCT
fnp-3166	521	26	borrmann	borrmann	PROPN
fnp-3166	521	27	m	m	PROPN
fnp-3166	521	28	,	,	PUNCT
fnp-3166	521	29	weishaupt	weishaupt	NOUN
fnp-3166	521	30	a	a	NOUN
fnp-3166	521	31	,	,	PUNCT
fnp-3166	521	32	doppler	doppler	NOUN
fnp-3166	521	33	k	k	NOUN
fnp-3166	521	34	,	,	PUNCT
fnp-3166	521	35	wickel	wickel	PROPN
fnp-3166	521	36	j	j	PROPN
fnp-3166	521	37	,	,	PUNCT
fnp-3166	521	38	geis	geis	PROPN
fnp-3166	521	39	c	c	NOUN
fnp-3166	521	40	,	,	PUNCT
fnp-3166	521	41	sommer	sommer	PROPN
fnp-3166	521	42	c	c	NOUN
fnp-3166	521	43	,	,	PUNCT
fnp-3166	521	44	villmann	villmann	PROPN
fnp-3166	521	45	c.	c.	PROPN
fnp-3166	521	46	glycine	glycine	NOUN
fnp-3166	521	47	receptor	receptor	NOUN
fnp-3166	521	48	autoantibodies	autoantibody	NOUN
fnp-3166	521	49	impair	impair	VERB
fnp-3166	521	50	receptor	receptor	NOUN
fnp-3166	521	51	function	function	NOUN
fnp-3166	521	52	and	and	CCONJ
fnp-3166	521	53	induce	induce	VERB
fnp-3166	521	54	motor	motor	NOUN
fnp-3166	521	55	dysfunction	dysfunction	NOUN
fnp-3166	521	56	.	.	PUNCT
fnp-3166	522	1	ann	ann	PROPN
fnp-3166	522	2	neurol	neurol	PROPN
fnp-3166	522	3	.	.	PUNCT
fnp-3166	523	1	2020	2020	NUM
fnp-3166	523	2	sep;88(3):544	sep;88(3):544	NOUN
fnp-3166	523	3	-	-	PUNCT
fnp-3166	523	4	561	561	NUM
fnp-3166	523	5	.	.	PUNCT
fnp-3166	524	1	doi	doi	NOUN
fnp-3166	524	2	:	:	PUNCT
fnp-3166	524	3	10.1002	10.1002	NUM
fnp-3166	524	4	/	/	SYM
fnp-3166	524	5	ana.25832	ana.25832	PROPN
fnp-3166	524	6	.	.	PUNCT
fnp-3166	525	1	epub	epub	PROPN
fnp-3166	525	2	2020	2020	NUM
fnp-3166	525	3	jul	jul	PROPN
fnp-3166	525	4	20	20	NUM
fnp-3166	525	5	.	.	PUNCT
fnp-3166	526	1	pmid	pmid	NOUN
fnp-3166	526	2	:	:	PUNCT
fnp-3166	526	3	32588476	32588476	NUM
fnp-3166	526	4	.	.	PUNCT
fnp-3166	527	1	reichard	reichard	PROPN
fnp-3166	527	2	rr	rr	PROPN
fnp-3166	527	3	,	,	PUNCT
fnp-3166	527	4	kashani	kashani	PROPN
fnp-3166	527	5	kb	kb	PROPN
fnp-3166	527	6	,	,	PUNCT
fnp-3166	527	7	boire	boire	X
fnp-3166	527	8	na	na	PROPN
fnp-3166	527	9	,	,	PUNCT
fnp-3166	527	10	constantopoulos	constantopoulos	PROPN
fnp-3166	527	11	e	e	PROPN
fnp-3166	527	12	,	,	PUNCT
fnp-3166	527	13	guo	guo	PROPN
fnp-3166	527	14	y	y	PROPN
fnp-3166	527	15	,	,	PUNCT
fnp-3166	527	16	lucchinetti	lucchinetti	PROPN
fnp-3166	527	17	cf	cf	NOUN
fnp-3166	527	18	.	.	PUNCT
fnp-3166	528	1	neuropathology	neuropathology	NOUN
fnp-3166	528	2	of	of	ADP
fnp-3166	528	3	covid-19	covid-19	PROPN
fnp-3166	528	4	:	:	PUNCT
fnp-3166	528	5	a	a	DET
fnp-3166	528	6	spectrum	spectrum	NOUN
fnp-3166	528	7	of	of	ADP
fnp-3166	528	8	vascular	vascular	NOUN
fnp-3166	528	9	and	and	CCONJ
fnp-3166	528	10	acute	acute	ADJ
fnp-3166	528	11	disseminated	disseminate	VERB
fnp-3166	528	12	encephalomyelitis	encephalomyelitis	NOUN
fnp-3166	528	13	(	(	PUNCT
fnp-3166	528	14	adem)-like	adem)-like	ADP
fnp-3166	528	15	pathology	pathology	NOUN
fnp-3166	528	16	.	.	PUNCT
fnp-3166	529	1	acta	acta	PROPN
fnp-3166	529	2	neuropathol	neuropathol	PROPN
fnp-3166	529	3	.	.	PUNCT
fnp-3166	530	1	2020	2020	NUM
fnp-3166	531	1	jul;140(1):1	jul;140(1):1	NOUN
fnp-3166	531	2	-	-	PUNCT
fnp-3166	531	3	6	6	NUM
fnp-3166	531	4	.	.	PUNCT
fnp-3166	531	5	doi	doi	NOUN
fnp-3166	531	6	:	:	PUNCT
fnp-3166	531	7	10.1007	10.1007	NUM
fnp-3166	531	8	/	/	SYM
fnp-3166	531	9	s00401	s00401	NOUN
fnp-3166	531	10	-	-	PUNCT
fnp-3166	531	11	020	020	NUM
fnp-3166	531	12	-	-	PUNCT
fnp-3166	531	13	02166	02166	NUM
fnp-3166	531	14	-	-	PUNCT
fnp-3166	531	15	2	2	NUM
fnp-3166	531	16	.	.	PUNCT
fnp-3166	532	1	epub	epub	NOUN
fnp-3166	532	2	2020	2020	NUM
fnp-3166	532	3	may	may	AUX
fnp-3166	532	4	24	24	NUM
fnp-3166	532	5	.	.	PUNCT
fnp-3166	533	1	pmid	pmid	NOUN
fnp-3166	533	2	:	:	PUNCT
fnp-3166	533	3	32449057	32449057	NUM
fnp-3166	533	4	;	;	PUNCT
fnp-3166	533	5	pmcid	pmcid	NOUN
fnp-3166	533	6	:	:	PUNCT
fnp-3166	533	7	pmc7245994	pmc7245994	ADJ
fnp-3166	533	8	.	.	PUNCT
fnp-3166	534	1	reindl	reindl	PROPN
fnp-3166	534	2	m	m	PROPN
fnp-3166	534	3	,	,	PUNCT
fnp-3166	534	4	waters	water	VERB
fnp-3166	534	5	p.	p.	NOUN
fnp-3166	534	6	myelin	myelin	NOUN
fnp-3166	534	7	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	534	8	glycoprotein	glycoprotein	NOUN
fnp-3166	534	9	antibodies	antibodie	VERB
fnp-3166	534	10	in	in	ADP
fnp-3166	534	11	neurological	neurological	ADJ
fnp-3166	534	12	disease	disease	NOUN
fnp-3166	534	13	.	.	PUNCT
fnp-3166	535	1	nat	nat	PROPN
fnp-3166	535	2	rev	rev	VERB
fnp-3166	535	3	neurol	neurol	PROPN
fnp-3166	535	4	.	.	PUNCT
fnp-3166	536	1	2019	2019	NUM
fnp-3166	536	2	feb;15(2):89	feb;15(2):89	NOUN
fnp-3166	536	3	-	-	PUNCT
fnp-3166	536	4	102	102	NUM
fnp-3166	536	5	.	.	PUNCT
fnp-3166	537	1	doi	doi	NOUN
fnp-3166	537	2	:	:	PUNCT
fnp-3166	537	3	10.1038	10.1038	NUM
fnp-3166	537	4	/	/	SYM
fnp-3166	537	5	s41582	s41582	PROPN
fnp-3166	537	6	-	-	PUNCT
fnp-3166	537	7	018	018	NUM
fnp-3166	537	8	-	-	PUNCT
fnp-3166	537	9	0112	0112	NUM
fnp-3166	537	10	-	-	PUNCT
fnp-3166	537	11	x.	x.	NOUN
fnp-3166	537	12	pmid	pmid	PROPN
fnp-3166	537	13	:	:	PUNCT
fnp-3166	537	14	30559466	30559466	NUM
fnp-3166	537	15	.	.	PUNCT
fnp-3166	538	1	schreiner	schreiner	PROPN
fnp-3166	538	2	b	b	PROPN
fnp-3166	538	3	,	,	PUNCT
fnp-3166	538	4	becher	becher	PROPN
fnp-3166	538	5	b.	b.	PROPN
fnp-3166	538	6	perspectives	perspective	NOUN
fnp-3166	538	7	on	on	ADP
fnp-3166	538	8	cytokine	cytokine	NOUN
fnp-3166	538	9	-	-	PUNCT
fnp-3166	538	10	directed	direct	VERB
fnp-3166	538	11	therapies	therapy	NOUN
fnp-3166	538	12	in	in	ADP
fnp-3166	538	13	multiple	multiple	ADJ
fnp-3166	538	14	sclerosis	sclerosis	NOUN
fnp-3166	538	15	.	.	PUNCT
fnp-3166	539	1	swiss	swiss	ADJ
fnp-3166	539	2	med	med	ADJ
fnp-3166	539	3	wkly	wkly	ADV
fnp-3166	539	4	.	.	PUNCT
fnp-3166	540	1	2015	2015	NUM
fnp-3166	540	2	oct	oct	NOUN
fnp-3166	540	3	23;145	23;145	NUM
fnp-3166	541	1	:	:	PUNCT
fnp-3166	541	2	w14199	w14199	PROPN
fnp-3166	541	3	.	.	PUNCT
fnp-3166	541	4	doi	doi	NOUN
fnp-3166	541	5	:	:	PUNCT
fnp-3166	541	6	10.4414	10.4414	NUM
fnp-3166	541	7	/	/	SYM
fnp-3166	541	8	smw.2015.14199	smw.2015.14199	NOUN
fnp-3166	541	9	.	.	PUNCT
fnp-3166	542	1	pmid	pmid	NOUN
fnp-3166	542	2	:	:	PUNCT
fnp-3166	542	3	26495801	26495801	NUM
fnp-3166	542	4	.	.	PUNCT
fnp-3166	543	1	sechi	sechi	PROPN
fnp-3166	543	2	e	e	PROPN
fnp-3166	543	3	,	,	PUNCT
fnp-3166	543	4	markovic	markovic	PROPN
fnp-3166	543	5	sn	sn	PROPN
fnp-3166	543	6	,	,	PUNCT
fnp-3166	543	7	mckeon	mckeon	PROPN
fnp-3166	543	8	a	a	PROPN
fnp-3166	543	9	,	,	PUNCT
fnp-3166	543	10	dubey	dubey	PROPN
fnp-3166	543	11	d	d	PROPN
fnp-3166	543	12	,	,	PUNCT
fnp-3166	543	13	liewluck	liewluck	PROPN
fnp-3166	543	14	t	t	PROPN
fnp-3166	543	15	,	,	PUNCT
fnp-3166	543	16	lennon	lennon	PROPN
fnp-3166	543	17	va	va	PROPN
fnp-3166	543	18	,	,	PUNCT
fnp-3166	543	19	lopez	lopez	NOUN
fnp-3166	543	20	-	-	PUNCT
fnp-3166	543	21	chiriboga	chiriboga	NOUN
fnp-3166	543	22	as	as	ADP
fnp-3166	543	23	,	,	PUNCT
fnp-3166	543	24	klein	klein	PROPN
fnp-3166	543	25	cj	cj	PROPN
fnp-3166	543	26	,	,	PUNCT
fnp-3166	543	27	mauermann	mauermann	PROPN
fnp-3166	543	28	m	m	PROPN
fnp-3166	543	29	,	,	PUNCT
fnp-3166	543	30	pittock	pittock	PROPN
fnp-3166	543	31	sj	sj	PROPN
fnp-3166	543	32	,	,	PUNCT
fnp-3166	543	33	flanagan	flanagan	NOUN
fnp-3166	543	34	ep	ep	PROPN
fnp-3166	543	35	,	,	PUNCT
fnp-3166	543	36	zekeridou	zekeridou	ADJ
fnp-3166	543	37	a.	a.	NOUN
fnp-3166	543	38	neurologic	neurologic	ADJ
fnp-3166	543	39	autoimmunity	autoimmunity	NOUN
fnp-3166	543	40	and	and	CCONJ
fnp-3166	543	41	immune	immune	ADJ
fnp-3166	543	42	checkpoint	checkpoint	NOUN
fnp-3166	543	43	inhibitors	inhibitor	NOUN
fnp-3166	543	44	:	:	PUNCT
fnp-3166	543	45	autoantibody	autoantibody	VERB
fnp-3166	543	46	profiles	profile	NOUN
fnp-3166	543	47	and	and	CCONJ
fnp-3166	543	48	outcomes	outcome	NOUN
fnp-3166	543	49	.	.	PUNCT
fnp-3166	544	1	neurology	neurology	NOUN
fnp-3166	544	2	.	.	PUNCT
fnp-3166	545	1	2020	2020	NUM
fnp-3166	545	2	oct	oct	NOUN
fnp-3166	545	3	27;95(17):e2442	27;95(17):e2442	NUM
fnp-3166	545	4	-	-	PUNCT
fnp-3166	545	5	e2452	e2452	NOUN
fnp-3166	545	6	.	.	PUNCT
fnp-3166	546	1	doi	doi	NOUN
fnp-3166	546	2	:	:	PUNCT
fnp-3166	546	3	10.1212	10.1212	NUM
fnp-3166	546	4	/	/	SYM
fnp-3166	546	5	wnl.0000000000010632	wnl.0000000000010632	PROPN
fnp-3166	546	6	.	.	PUNCT
fnp-3166	547	1	epub	epub	PROPN
fnp-3166	547	2	2020	2020	NUM
fnp-3166	547	3	aug	aug	PROPN
fnp-3166	547	4	13	13	NUM
fnp-3166	547	5	.	.	PUNCT
fnp-3166	548	1	pmid	pmid	NOUN
fnp-3166	548	2	:	:	PUNCT
fnp-3166	548	3	32796130	32796130	NUM
fnp-3166	548	4	;	;	PUNCT
fnp-3166	548	5	pmcid	pmcid	ADJ
fnp-3166	548	6	:	:	PUNCT
fnp-3166	548	7	pmc7682911	pmc7682911	NOUN
fnp-3166	548	8	.	.	PUNCT
fnp-3166	549	1	serafini	serafini	PROPN
fnp-3166	549	2	b	b	PROPN
fnp-3166	549	3	,	,	PUNCT
fnp-3166	549	4	rosicarelli	rosicarelli	PROPN
fnp-3166	549	5	b	b	PROPN
fnp-3166	549	6	,	,	PUNCT
fnp-3166	549	7	franciotta	franciotta	NOUN
fnp-3166	549	8	d	d	NOUN
fnp-3166	549	9	,	,	PUNCT
fnp-3166	549	10	magliozzi	magliozzi	NOUN
fnp-3166	549	11	r	r	NOUN
fnp-3166	549	12	,	,	PUNCT
fnp-3166	549	13	reynolds	reynolds	PROPN
fnp-3166	549	14	r	r	NOUN
fnp-3166	549	15	,	,	PUNCT
fnp-3166	549	16	cinque	cinque	NOUN
fnp-3166	549	17	p	p	NOUN
fnp-3166	549	18	,	,	PUNCT
fnp-3166	549	19	andreoni	andreoni	PROPN
fnp-3166	549	20	l	l	NOUN
fnp-3166	549	21	,	,	PUNCT
fnp-3166	549	22	trivedi	trivedi	PROPN
fnp-3166	549	23	p	p	PROPN
fnp-3166	549	24	,	,	PUNCT
fnp-3166	549	25	salvetti	salvetti	PROPN
fnp-3166	549	26	m	m	PROPN
fnp-3166	549	27	,	,	PUNCT
fnp-3166	549	28	faggioni	faggioni	ADJ
fnp-3166	549	29	a	a	PRON
fnp-3166	549	30	,	,	PUNCT
fnp-3166	549	31	aloisi	aloisi	ADJ
fnp-3166	549	32	f.	f.	PROPN
fnp-3166	549	33	dysregulated	dysregulated	PROPN
fnp-3166	549	34	epstein	epstein	PROPN
fnp-3166	549	35	-	-	PUNCT
fnp-3166	549	36	barr	barr	PROPN
fnp-3166	549	37	virus	virus	PROPN
fnp-3166	549	38	infection	infection	NOUN
fnp-3166	549	39	in	in	ADP
fnp-3166	549	40	the	the	DET
fnp-3166	549	41	multiple	multiple	ADJ
fnp-3166	549	42	sclerosis	sclerosis	NOUN
fnp-3166	549	43	brain	brain	NOUN
fnp-3166	549	44	.	.	PUNCT
fnp-3166	550	1	j	j	PROPN
fnp-3166	550	2	exp	exp	NOUN
fnp-3166	550	3	med	med	PROPN
fnp-3166	550	4	.	.	PUNCT
fnp-3166	551	1	2007	2007	NUM
fnp-3166	551	2	nov	nov	PROPN
fnp-3166	551	3	26;204(12):2899	26;204(12):2899	PROPN
fnp-3166	551	4	-	-	PUNCT
fnp-3166	551	5	912	912	NUM
fnp-3166	551	6	.	.	PUNCT
fnp-3166	552	1	doi	doi	NOUN
fnp-3166	552	2	:	:	PUNCT
fnp-3166	552	3	10.1084	10.1084	NUM
fnp-3166	552	4	/	/	SYM
fnp-3166	552	5	jem.20071030	jem.20071030	X
fnp-3166	552	6	.	.	PUNCT
fnp-3166	553	1	epub	epub	NOUN
fnp-3166	553	2	2007	2007	NUM
fnp-3166	553	3	nov	nov	NOUN
fnp-3166	553	4	5	5	NUM
fnp-3166	553	5	.	.	PUNCT
fnp-3166	554	1	pmid	pmid	NOUN
fnp-3166	554	2	:	:	PUNCT
fnp-3166	554	3	17984305	17984305	NUM
fnp-3166	554	4	;	;	PUNCT
fnp-3166	554	5	pmcid	pmcid	NOUN
fnp-3166	554	6	:	:	PUNCT
fnp-3166	555	1	pmc2118531	pmc2118531	ADV
fnp-3166	555	2	.	.	PUNCT
fnp-3166	556	1	serafini	serafini	PROPN
fnp-3166	556	2	b	b	PROPN
fnp-3166	556	3	,	,	PUNCT
fnp-3166	556	4	rosicarelli	rosicarelli	PROPN
fnp-3166	556	5	b	b	PROPN
fnp-3166	556	6	,	,	PUNCT
fnp-3166	556	7	veroni	veroni	PROPN
fnp-3166	556	8	c	c	NOUN
fnp-3166	556	9	,	,	PUNCT
fnp-3166	556	10	mazzola	mazzola	PROPN
fnp-3166	556	11	ga	ga	PROPN
fnp-3166	556	12	,	,	PUNCT
fnp-3166	556	13	aloisi	aloisi	PROPN
fnp-3166	556	14	f.	f.	PROPN
fnp-3166	556	15	epstein	epstein	PROPN
fnp-3166	556	16	-	-	PUNCT
fnp-3166	556	17	barr	barr	PROPN
fnp-3166	556	18	virus	virus	NOUN
fnp-3166	556	19	-	-	PUNCT
fnp-3166	556	20	specific	specific	ADJ
fnp-3166	556	21	cd8	cd8	PROPN
fnp-3166	556	22	t	t	PROPN
fnp-3166	556	23	cells	cell	NOUN
fnp-3166	556	24	selectively	selectively	ADV
fnp-3166	556	25	infiltrate	infiltrate	VERB
fnp-3166	556	26	the	the	DET
fnp-3166	556	27	brain	brain	NOUN
fnp-3166	556	28	in	in	ADP
fnp-3166	556	29	multiple	multiple	ADJ
fnp-3166	556	30	sclerosis	sclerosis	NOUN
fnp-3166	556	31	and	and	CCONJ
fnp-3166	556	32	interact	interact	VERB
fnp-3166	556	33	locally	locally	ADV
fnp-3166	556	34	with	with	ADP
fnp-3166	556	35	virus	virus	NOUN
fnp-3166	556	36	-	-	PUNCT
fnp-3166	556	37	infected	infect	VERB
fnp-3166	556	38	cells	cell	NOUN
fnp-3166	556	39	:	:	PUNCT
fnp-3166	556	40	clue	clue	NOUN
fnp-3166	556	41	for	for	ADP
fnp-3166	556	42	a	a	DET
fnp-3166	556	43	virus	virus	NOUN
fnp-3166	556	44	-	-	PUNCT
fnp-3166	556	45	driven	drive	VERB
fnp-3166	556	46	immunopathological	immunopathological	ADJ
fnp-3166	556	47	mechanism	mechanism	NOUN
fnp-3166	556	48	.	.	PUNCT
fnp-3166	557	1	j	j	PROPN
fnp-3166	557	2	virol	virol	NOUN
fnp-3166	557	3	.	.	PUNCT
fnp-3166	558	1	2019	2019	NUM
fnp-3166	558	2	nov	nov	PROPN
fnp-3166	558	3	26;93(24):e00980	26;93(24):e00980	NUM
fnp-3166	558	4	-	-	SYM
fnp-3166	558	5	19	19	NUM
fnp-3166	558	6	.	.	PUNCT
fnp-3166	558	7	doi	doi	NOUN
fnp-3166	558	8	:	:	PUNCT
fnp-3166	558	9	10.1128	10.1128	NUM
fnp-3166	558	10	/	/	SYM
fnp-3166	558	11	jvi.00980	jvi.00980	NOUN
fnp-3166	558	12	-	-	PUNCT
fnp-3166	558	13	19	19	NUM
fnp-3166	558	14	.	.	PUNCT
fnp-3166	559	1	pmid	pmid	NOUN
fnp-3166	559	2	:	:	PUNCT
fnp-3166	559	3	31578295	31578295	NUM
fnp-3166	559	4	;	;	PUNCT
fnp-3166	559	5	pmcid	pmcid	ADJ
fnp-3166	559	6	:	:	PUNCT
fnp-3166	559	7	pmc6880158	pmc6880158	ADJ
fnp-3166	559	8	.	.	PUNCT
fnp-3166	560	1	starost	starost	PROPN
fnp-3166	560	2	l	l	NOUN
fnp-3166	560	3	,	,	PUNCT
fnp-3166	560	4	lindner	lindner	PROPN
fnp-3166	560	5	m	m	PROPN
fnp-3166	560	6	,	,	PUNCT
fnp-3166	560	7	herold	herold	PROPN
fnp-3166	560	8	m	m	PROPN
fnp-3166	560	9	,	,	PUNCT
fnp-3166	560	10	xu	xu	PROPN
fnp-3166	560	11	ykt	ykt	PROPN
fnp-3166	560	12	,	,	PUNCT
fnp-3166	560	13	drexler	drexler	PROPN
fnp-3166	560	14	hca	hca	PROPN
fnp-3166	560	15	,	,	PUNCT
fnp-3166	560	16	heß	heß	PROPN
fnp-3166	560	17	k	k	NOUN
fnp-3166	560	18	,	,	PUNCT
fnp-3166	560	19	ehrlich	ehrlich	PROPN
fnp-3166	560	20	m	m	NOUN
fnp-3166	560	21	,	,	PUNCT
fnp-3166	560	22	ottoboni	ottoboni	ADJ
fnp-3166	560	23	l	l	NOUN
fnp-3166	560	24	,	,	PUNCT
fnp-3166	560	25	ruffini	ruffini	PROPN
fnp-3166	560	26	f	f	PROPN
fnp-3166	560	27	,	,	PUNCT
fnp-3166	560	28	stehling	stehle	VERB
fnp-3166	560	29	m	m	PRON
fnp-3166	560	30	,	,	PUNCT
fnp-3166	560	31	röpke	röpke	PROPN
fnp-3166	560	32	a	a	X
fnp-3166	560	33	,	,	PUNCT
fnp-3166	560	34	thomas	thomas	PROPN
fnp-3166	560	35	c	c	PROPN
fnp-3166	560	36	,	,	PUNCT
fnp-3166	560	37	schöler	schöler	PROPN
fnp-3166	560	38	hr	hr	NOUN
fnp-3166	560	39	,	,	PUNCT
fnp-3166	560	40	antel	antel	PROPN
fnp-3166	560	41	j	j	PROPN
fnp-3166	560	42	,	,	PUNCT
fnp-3166	560	43	winkler	winkler	PROPN
fnp-3166	560	44	j	j	PROPN
fnp-3166	560	45	,	,	PUNCT
fnp-3166	560	46	martino	martino	PROPN
fnp-3166	560	47	g	g	PROPN
fnp-3166	560	48	,	,	PUNCT
fnp-3166	560	49	klotz	klotz	PROPN
fnp-3166	560	50	l	l	PROPN
fnp-3166	560	51	,	,	PUNCT
fnp-3166	560	52	kuhlmann	kuhlmann	PROPN
fnp-3166	560	53	t.	t.	NOUN
fnp-3166	560	54	extrinsic	extrinsic	ADJ
fnp-3166	560	55	immune	immune	ADJ
fnp-3166	560	56	cell	cell	NOUN
fnp-3166	560	57	-	-	PUNCT
fnp-3166	560	58	derived	derive	VERB
fnp-3166	560	59	,	,	PUNCT
fnp-3166	560	60	but	but	CCONJ
fnp-3166	560	61	not	not	PART
fnp-3166	560	62	intrinsic	intrinsic	ADJ
fnp-3166	560	63	oligodendroglial	oligodendroglial	ADJ
fnp-3166	560	64	factors	factor	NOUN
fnp-3166	560	65	contribute	contribute	VERB
fnp-3166	560	66	to	to	ADP
fnp-3166	560	67	oligodendroglial	oligodendroglial	ADJ
fnp-3166	560	68	differentiation	differentiation	NOUN
fnp-3166	560	69	block	block	NOUN
fnp-3166	560	70	in	in	ADP
fnp-3166	560	71	multiple	multiple	ADJ
fnp-3166	560	72	sclerosis	sclerosis	NOUN
fnp-3166	560	73	.	.	PUNCT
fnp-3166	561	1	acta	acta	PROPN
fnp-3166	561	2	neuropathol	neuropathol	PROPN
fnp-3166	561	3	.	.	PUNCT
fnp-3166	562	1	2020	2020	NUM
fnp-3166	562	2	nov;140(5):715	nov;140(5):715	NOUN
fnp-3166	562	3	-	-	PUNCT
fnp-3166	562	4	736	736	NOUN
fnp-3166	562	5	.	.	PUNCT
fnp-3166	563	1	doi	doi	NOUN
fnp-3166	563	2	:	:	PUNCT
fnp-3166	563	3	10.1007	10.1007	NUM
fnp-3166	563	4	/	/	SYM
fnp-3166	563	5	s00401	s00401	NOUN
fnp-3166	563	6	-	-	PUNCT
fnp-3166	563	7	020	020	NUM
fnp-3166	563	8	-	-	PUNCT
fnp-3166	563	9	02217	02217	NUM
fnp-3166	563	10	-	-	SYM
fnp-3166	563	11	8	8	NUM
fnp-3166	563	12	.	.	PUNCT
fnp-3166	564	1	epub	epub	NOUN
fnp-3166	564	2	2020	2020	NUM
fnp-3166	564	3	sep	sep	PROPN
fnp-3166	564	4	7	7	NUM
fnp-3166	564	5	.	.	PUNCT
fnp-3166	565	1	pmid	pmid	NOUN
fnp-3166	565	2	:	:	PUNCT
fnp-3166	565	3	32894330	32894330	NUM
fnp-3166	565	4	;	;	PUNCT
fnp-3166	565	5	pmcid	pmcid	ADJ
fnp-3166	565	6	:	:	PUNCT
fnp-3166	565	7	pmc7547031	pmc7547031	NOUN
fnp-3166	565	8	.	.	PUNCT
fnp-3166	566	1	takai	takai	PROPN
fnp-3166	566	2	y	y	PROPN
fnp-3166	566	3	,	,	PUNCT
fnp-3166	566	4	misu	misu	PROPN
fnp-3166	566	5	t	t	PROPN
fnp-3166	566	6	,	,	PUNCT
fnp-3166	566	7	kaneko	kaneko	PROPN
fnp-3166	566	8	k	k	PROPN
fnp-3166	566	9	,	,	PUNCT
fnp-3166	566	10	chihara	chihara	PROPN
fnp-3166	566	11	n	n	CCONJ
fnp-3166	566	12	,	,	PUNCT
fnp-3166	566	13	narikawa	narikawa	PROPN
fnp-3166	566	14	k	k	PROPN
fnp-3166	566	15	,	,	PUNCT
fnp-3166	566	16	tsuchida	tsuchida	PROPN
fnp-3166	566	17	s	s	PROPN
fnp-3166	566	18	,	,	PUNCT
fnp-3166	566	19	nishida	nishida	PROPN
fnp-3166	566	20	h	h	PROPN
fnp-3166	566	21	,	,	PUNCT
fnp-3166	566	22	komori	komori	PROPN
fnp-3166	566	23	t	t	PROPN
fnp-3166	566	24	,	,	PUNCT
fnp-3166	566	25	seki	seki	PROPN
fnp-3166	566	26	m	m	PROPN
fnp-3166	566	27	,	,	PUNCT
fnp-3166	566	28	komatsu	komatsu	PROPN
fnp-3166	566	29	t	t	PROPN
fnp-3166	566	30	,	,	PUNCT
fnp-3166	566	31	nakamagoe	nakamagoe	ADJ
fnp-3166	566	32	k	k	PROPN
fnp-3166	566	33	,	,	PUNCT
fnp-3166	566	34	ikeda	ikeda	PROPN
fnp-3166	566	35	t	t	PROPN
fnp-3166	566	36	,	,	PUNCT
fnp-3166	566	37	yoshida	yoshida	PROPN
fnp-3166	566	38	m	m	PROPN
fnp-3166	566	39	,	,	PUNCT
fnp-3166	566	40	takahashi	takahashi	PROPN
fnp-3166	566	41	t	t	PROPN
fnp-3166	566	42	,	,	PUNCT
fnp-3166	566	43	ono	ono	PROPN
fnp-3166	566	44	h	h	PROPN
fnp-3166	566	45	,	,	PUNCT
fnp-3166	566	46	nishiyama	nishiyama	NOUN
fnp-3166	566	47	s	s	PART
fnp-3166	566	48	,	,	PUNCT
fnp-3166	566	49	kuroda	kuroda	PROPN
fnp-3166	566	50	h	h	PROPN
fnp-3166	566	51	,	,	PUNCT
fnp-3166	566	52	nakashima	nakashima	PROPN
fnp-3166	566	53	i	i	PROPN
fnp-3166	566	54	,	,	PUNCT
fnp-3166	566	55	suzuki	suzuki	PROPN
fnp-3166	566	56	h	h	PROPN
fnp-3166	566	57	,	,	PUNCT
fnp-3166	566	58	bradl	bradl	NOUN
fnp-3166	566	59	m	m	PROPN
fnp-3166	566	60	,	,	PUNCT
fnp-3166	566	61	lassmann	lassmann	PROPN
fnp-3166	566	62	h	h	NOUN
fnp-3166	566	63	,	,	PUNCT
fnp-3166	566	64	fujihara	fujihara	PROPN
fnp-3166	566	65	k	k	PROPN
fnp-3166	566	66	,	,	PUNCT
fnp-3166	566	67	aoki	aoki	PROPN
fnp-3166	566	68	m	m	PROPN
fnp-3166	566	69	;	;	PUNCT
fnp-3166	566	70	japan	japan	PROPN
fnp-3166	566	71	mog	mog	PROPN
fnp-3166	566	72	-	-	PUNCT
fnp-3166	566	73	antibody	antibody	NOUN
fnp-3166	566	74	disease	disease	NOUN
fnp-3166	566	75	consortium	consortium	NOUN
fnp-3166	566	76	.	.	PUNCT
fnp-3166	567	1	myelin	myelin	NOUN
fnp-3166	567	2	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	567	3	glycoprotein	glycoprotein	NOUN
fnp-3166	567	4	antibody	antibody	NOUN
fnp-3166	567	5	-	-	PUNCT
fnp-3166	567	6	associated	associate	VERB
fnp-3166	567	7	disease	disease	NOUN
fnp-3166	567	8	:	:	PUNCT
fnp-3166	567	9	an	an	DET
fnp-3166	567	10	immunopathological	immunopathological	ADJ
fnp-3166	567	11	study	study	NOUN
fnp-3166	567	12	.	.	PUNCT
fnp-3166	568	1	brain	brain	NOUN
fnp-3166	568	2	.	.	PUNCT
fnp-3166	569	1	2020	2020	NUM
fnp-3166	569	2	may	may	AUX
fnp-3166	569	3	1;143(5):1431	1;143(5):1431	NOUN
fnp-3166	569	4	-	-	PUNCT
fnp-3166	569	5	1446	1446	NUM
fnp-3166	569	6	.	.	PUNCT
fnp-3166	570	1	doi	doi	NOUN
fnp-3166	570	2	:	:	PUNCT
fnp-3166	570	3	10.1093	10.1093	NUM
fnp-3166	570	4	/	/	SYM
fnp-3166	570	5	brain	brain	NOUN
fnp-3166	570	6	/	/	SYM
fnp-3166	570	7	awaa102	awaa102	PROPN
fnp-3166	570	8	.	.	PUNCT
fnp-3166	571	1	pmid	pmid	PROPN
fnp-3166	571	2	:	:	PUNCT
fnp-3166	571	3	32412053	32412053	NUM
fnp-3166	571	4	.	.	PUNCT
fnp-3166	572	1	trapp	trapp	PROPN
fnp-3166	572	2	bd	bd	PROPN
fnp-3166	572	3	,	,	PUNCT
fnp-3166	572	4	vignos	vignos	PROPN
fnp-3166	572	5	m	m	PROPN
fnp-3166	572	6	,	,	PUNCT
fnp-3166	572	7	dudman	dudman	PROPN
fnp-3166	572	8	j	j	PROPN
fnp-3166	572	9	,	,	PUNCT
fnp-3166	572	10	chang	chang	PROPN
fnp-3166	572	11	a	a	PROPN
fnp-3166	572	12	,	,	PUNCT
fnp-3166	572	13	fisher	fisher	PROPN
fnp-3166	572	14	e	e	PROPN
fnp-3166	572	15	,	,	PUNCT
fnp-3166	572	16	staugaitis	staugaitis	PROPN
fnp-3166	572	17	sm	sm	PROPN
fnp-3166	572	18	,	,	PUNCT
fnp-3166	572	19	battapady	battapady	ADJ
fnp-3166	572	20	h	h	NOUN
fnp-3166	572	21	,	,	PUNCT
fnp-3166	572	22	mork	mork	PROPN
fnp-3166	572	23	s	s	PROPN
fnp-3166	572	24	,	,	PUNCT
fnp-3166	572	25	ontaneda	ontaneda	VERB
fnp-3166	572	26	d	d	PROPN
fnp-3166	572	27	,	,	PUNCT
fnp-3166	572	28	jones	jones	PROPN
fnp-3166	572	29	se	se	PROPN
fnp-3166	572	30	,	,	PUNCT
fnp-3166	572	31	fox	fox	PROPN
fnp-3166	572	32	rj	rj	PROPN
fnp-3166	572	33	,	,	PUNCT
fnp-3166	572	34	chen	chen	PROPN
fnp-3166	572	35	j	j	PROPN
fnp-3166	572	36	,	,	PUNCT
fnp-3166	572	37	nakamura	nakamura	PROPN
fnp-3166	572	38	k	k	PROPN
fnp-3166	572	39	,	,	PUNCT
fnp-3166	572	40	rudick	rudick	PROPN
fnp-3166	572	41	ra	ra	PROPN
fnp-3166	572	42	.	.	PUNCT
fnp-3166	573	1	cortical	cortical	ADJ
fnp-3166	573	2	neuronal	neuronal	ADJ
fnp-3166	573	3	densities	density	NOUN
fnp-3166	573	4	and	and	CCONJ
fnp-3166	573	5	cerebral	cerebral	ADJ
fnp-3166	573	6	white	white	ADJ
fnp-3166	573	7	matter	matter	NOUN
fnp-3166	573	8	demyelination	demyelination	NOUN
fnp-3166	573	9	in	in	ADP
fnp-3166	573	10	multiple	multiple	ADJ
fnp-3166	573	11	sclerosis	sclerosis	NOUN
fnp-3166	573	12	:	:	PUNCT
fnp-3166	573	13	a	a	DET
fnp-3166	573	14	retrospective	retrospective	ADJ
fnp-3166	573	15	study	study	NOUN
fnp-3166	573	16	.	.	PUNCT
fnp-3166	574	1	lancet	lancet	PROPN
fnp-3166	574	2	neurol	neurol	PROPN
fnp-3166	574	3	.	.	PUNCT
fnp-3166	575	1	2018	2018	NUM
fnp-3166	575	2	oct;17(10):870	oct;17(10):870	NOUN
fnp-3166	575	3	-	-	PUNCT
fnp-3166	575	4	884	884	NUM
fnp-3166	575	5	.	.	PUNCT
fnp-3166	576	1	doi	doi	NOUN
fnp-3166	576	2	:	:	PUNCT
fnp-3166	576	3	10.1016	10.1016	NUM
fnp-3166	576	4	/	/	SYM
fnp-3166	576	5	s1474	s1474	PROPN
fnp-3166	576	6	-	-	PROPN
fnp-3166	576	7	4422(18)30245	4422(18)30245	NOUN
fnp-3166	576	8	-	-	NOUN
fnp-3166	576	9	x.	x.	ADJ
fnp-3166	576	10	epub	epub	PROPN
fnp-3166	576	11	2018	2018	NUM
fnp-3166	576	12	aug	aug	PROPN
fnp-3166	576	13	22	22	NUM
fnp-3166	576	14	.	.	PUNCT
fnp-3166	577	1	pmid	pmid	NOUN
fnp-3166	577	2	:	:	PUNCT
fnp-3166	577	3	30143361	30143361	NUM
fnp-3166	577	4	;	;	PUNCT
fnp-3166	577	5	pmcid	pmcid	ADJ
fnp-3166	577	6	:	:	PUNCT
fnp-3166	577	7	pmc6197820	pmc6197820	NOUN
fnp-3166	577	8	.	.	PUNCT
fnp-3166	578	1	van	van	PROPN
fnp-3166	578	2	nierop	nierop	PROPN
fnp-3166	578	3	gp	gp	PROPN
fnp-3166	578	4	,	,	PUNCT
fnp-3166	578	5	van	van	PROPN
fnp-3166	578	6	luijn	luijn	PROPN
fnp-3166	578	7	mm	mm	PROPN
fnp-3166	578	8	,	,	PUNCT
fnp-3166	578	9	michels	michels	PROPN
fnp-3166	578	10	ss	ss	PROPN
fnp-3166	578	11	,	,	PUNCT
fnp-3166	578	12	melief	melief	PROPN
fnp-3166	578	13	mj	mj	PROPN
fnp-3166	578	14	,	,	PUNCT
fnp-3166	578	15	janssen	janssen	PROPN
fnp-3166	578	16	m	m	PROPN
fnp-3166	578	17	,	,	PUNCT
fnp-3166	578	18	langerak	langerak	PROPN
fnp-3166	578	19	aw	aw	INTJ
fnp-3166	578	20	,	,	PUNCT
fnp-3166	578	21	ouwendijk	ouwendijk	PROPN
fnp-3166	578	22	wjd	wjd	PROPN
fnp-3166	578	23	,	,	PUNCT
fnp-3166	578	24	hintzen	hintzen	PROPN
fnp-3166	578	25	rq	rq	NOUN
fnp-3166	578	26	,	,	PUNCT
fnp-3166	578	27	verjans	verjans	PROPN
fnp-3166	578	28	gmgm	gmgm	NOUN
fnp-3166	578	29	.	.	PUNCT
fnp-3166	579	1	phenotypic	phenotypic	ADJ
fnp-3166	579	2	and	and	CCONJ
fnp-3166	579	3	functional	functional	ADJ
fnp-3166	579	4	characterization	characterization	NOUN
fnp-3166	579	5	of	of	ADP
fnp-3166	579	6	t	t	NOUN
fnp-3166	579	7	cells	cell	NOUN
fnp-3166	579	8	in	in	ADP
fnp-3166	579	9	white	white	ADJ
fnp-3166	579	10	matter	matter	NOUN
fnp-3166	579	11	lesions	lesion	NOUN
fnp-3166	579	12	of	of	ADP
fnp-3166	579	13	multiple	multiple	ADJ
fnp-3166	579	14	sclerosis	sclerosis	NOUN
fnp-3166	579	15	patients	patient	NOUN
fnp-3166	579	16	.	.	PUNCT
fnp-3166	580	1	acta	acta	PROPN
fnp-3166	580	2	neuropathol	neuropathol	PROPN
fnp-3166	580	3	.	.	PUNCT
fnp-3166	581	1	2017	2017	NUM
fnp-3166	581	2	sep;134(3):383	sep;134(3):383	NOUN
fnp-3166	581	3	-	-	PUNCT
fnp-3166	581	4	401	401	PROPN
fnp-3166	581	5	.	.	PUNCT
fnp-3166	581	6	doi	doi	NOUN
fnp-3166	581	7	:	:	PUNCT
fnp-3166	581	8	10.1007	10.1007	NUM
fnp-3166	581	9	/	/	SYM
fnp-3166	581	10	s00401	s00401	NOUN
fnp-3166	581	11	-	-	PUNCT
fnp-3166	581	12	017	017	NUM
fnp-3166	581	13	-	-	PUNCT
fnp-3166	581	14	1744	1744	NUM
fnp-3166	581	15	-	-	SYM
fnp-3166	581	16	4	4	NUM
fnp-3166	581	17	.	.	PUNCT
fnp-3166	582	1	epub	epub	NOUN
fnp-3166	582	2	2017	2017	NUM
fnp-3166	582	3	jun	jun	PROPN
fnp-3166	582	4	17	17	NUM
fnp-3166	582	5	.	.	PUNCT
fnp-3166	583	1	pmid	pmid	NOUN
fnp-3166	583	2	:	:	PUNCT
fnp-3166	583	3	28624961	28624961	NUM
fnp-3166	583	4	;	;	PUNCT
fnp-3166	583	5	pmcid	pmcid	ADJ
fnp-3166	583	6	:	:	PUNCT
fnp-3166	583	7	pmc5563341	pmc5563341	NOUN
fnp-3166	583	8	.	.	PUNCT
fnp-3166	584	1	van	van	PROPN
fnp-3166	584	2	noort	noort	PROPN
fnp-3166	584	3	jm	jm	PROPN
fnp-3166	584	4	,	,	PUNCT
fnp-3166	584	5	bsibsi	bsibsi	PROPN
fnp-3166	584	6	m	m	PROPN
fnp-3166	584	7	,	,	PUNCT
fnp-3166	584	8	gerritsen	gerritsen	PROPN
fnp-3166	584	9	wh	wh	PROPN
fnp-3166	584	10	,	,	PUNCT
fnp-3166	584	11	van	van	PROPN
fnp-3166	584	12	der	der	PROPN
fnp-3166	584	13	valk	valk	PROPN
fnp-3166	584	14	p	p	NOUN
fnp-3166	584	15	,	,	PUNCT
fnp-3166	584	16	bajramovic	bajramovic	PROPN
fnp-3166	584	17	jj	jj	PROPN
fnp-3166	584	18	,	,	PUNCT
fnp-3166	584	19	steinman	steinman	PROPN
fnp-3166	584	20	l	l	PROPN
fnp-3166	584	21	,	,	PUNCT
fnp-3166	584	22	amor	amor	PROPN
fnp-3166	584	23	s.	s.	PROPN
fnp-3166	584	24	alphab	alphab	PROPN
fnp-3166	584	25	-	-	PUNCT
fnp-3166	584	26	crystallin	crystallin	PROPN
fnp-3166	584	27	is	be	AUX
fnp-3166	584	28	a	a	DET
fnp-3166	584	29	target	target	NOUN
fnp-3166	584	30	for	for	ADP
fnp-3166	584	31	adaptive	adaptive	ADJ
fnp-3166	584	32	immune	immune	ADJ
fnp-3166	584	33	responses	response	NOUN
fnp-3166	584	34	and	and	CCONJ
fnp-3166	584	35	a	a	DET
fnp-3166	584	36	trigger	trigger	NOUN
fnp-3166	584	37	of	of	ADP
fnp-3166	584	38	innate	innate	ADJ
fnp-3166	584	39	responses	response	NOUN
fnp-3166	584	40	in	in	ADP
fnp-3166	584	41	preactive	preactive	ADJ
fnp-3166	584	42	multiple	multiple	ADJ
fnp-3166	584	43	sclerosis	sclerosis	NOUN
fnp-3166	584	44	lesions	lesion	NOUN
fnp-3166	584	45	.	.	PUNCT
fnp-3166	585	1	j	j	PROPN
fnp-3166	585	2	neuropathol	neuropathol	PROPN
fnp-3166	585	3	exp	exp	PROPN
fnp-3166	585	4	neurol	neurol	NOUN
fnp-3166	585	5	.	.	PUNCT
fnp-3166	586	1	2010	2010	NUM
fnp-3166	586	2	jul;69(7):694	jul;69(7):694	NOUN
fnp-3166	586	3	-	-	PUNCT
fnp-3166	586	4	703	703	NUM
fnp-3166	586	5	.	.	PUNCT
fnp-3166	587	1	doi	doi	NOUN
fnp-3166	587	2	:	:	PUNCT
fnp-3166	587	3	10.1097	10.1097	NUM
fnp-3166	587	4	/	/	SYM
fnp-3166	587	5	nen.0b013e3181e4939c	nen.0b013e3181e4939c	NOUN
fnp-3166	587	6	.	.	PUNCT
fnp-3166	588	1	pmid	pmid	NOUN
fnp-3166	588	2	:	:	PUNCT
fnp-3166	588	3	20535035	20535035	NUM
fnp-3166	588	4	.	.	PUNCT
fnp-3166	589	1	veroni	veroni	PROPN
fnp-3166	589	2	c	c	PROPN
fnp-3166	589	3	,	,	PUNCT
fnp-3166	589	4	serafini	serafini	NOUN
fnp-3166	589	5	b	b	PROPN
fnp-3166	589	6	,	,	PUNCT
fnp-3166	589	7	rosicarelli	rosicarelli	PROPN
fnp-3166	589	8	b	b	PROPN
fnp-3166	589	9	,	,	PUNCT
fnp-3166	589	10	fagnani	fagnani	ADJ
fnp-3166	589	11	c	c	NOUN
fnp-3166	589	12	,	,	PUNCT
fnp-3166	589	13	aloisi	aloisi	ADJ
fnp-3166	589	14	f.	f.	PROPN
fnp-3166	589	15	transcriptional	transcriptional	PROPN
fnp-3166	589	16	profile	profile	NOUN
fnp-3166	589	17	and	and	CCONJ
fnp-3166	589	18	epstein	epstein	PROPN
fnp-3166	589	19	-	-	PUNCT
fnp-3166	589	20	barr	barr	PROPN
fnp-3166	589	21	virus	virus	PROPN
fnp-3166	589	22	infection	infection	NOUN
fnp-3166	589	23	status	status	NOUN
fnp-3166	589	24	of	of	ADP
fnp-3166	589	25	laser	laser	NOUN
fnp-3166	589	26	-	-	PUNCT
fnp-3166	589	27	cut	cut	VERB
fnp-3166	589	28	immune	immune	ADJ
fnp-3166	589	29	infiltrates	infiltrate	NOUN
fnp-3166	589	30	from	from	ADP
fnp-3166	589	31	the	the	DET
fnp-3166	589	32	brain	brain	NOUN
fnp-3166	589	33	of	of	ADP
fnp-3166	589	34	patients	patient	NOUN
fnp-3166	589	35	with	with	ADP
fnp-3166	589	36	progressive	progressive	ADJ
fnp-3166	589	37	multiple	multiple	ADJ
fnp-3166	589	38	sclerosis	sclerosis	NOUN
fnp-3166	589	39	.	.	PUNCT
fnp-3166	590	1	j	j	PROPN
fnp-3166	590	2	neuroinflammation	neuroinflammation	PROPN
fnp-3166	590	3	.	.	PUNCT
fnp-3166	591	1	2018	2018	NUM
fnp-3166	591	2	jan	jan	PROPN
fnp-3166	591	3	16;15(1):18	16;15(1):18	PROPN
fnp-3166	591	4	.	.	PUNCT
fnp-3166	592	1	doi	doi	PROPN
fnp-3166	592	2	:	:	PUNCT
fnp-3166	592	3	10.1186	10.1186	NUM
fnp-3166	592	4	/	/	SYM
fnp-3166	592	5	s12974	s12974	NOUN
fnp-3166	592	6	-	-	PUNCT
fnp-3166	592	7	017	017	NUM
fnp-3166	592	8	-	-	PUNCT
fnp-3166	592	9	1049	1049	NUM
fnp-3166	592	10	-	-	SYM
fnp-3166	592	11	5	5	NUM
fnp-3166	592	12	.	.	PUNCT
fnp-3166	593	1	pmid	pmid	NOUN
fnp-3166	593	2	:	:	PUNCT
fnp-3166	593	3	29338732	29338732	NUM
fnp-3166	593	4	;	;	PUNCT
fnp-3166	593	5	pmcid	pmcid	NOUN
fnp-3166	593	6	:	:	PUNCT
fnp-3166	593	7	pmc5771146	pmc5771146	PROPN
fnp-3166	593	8	.	.	PUNCT
fnp-3166	594	1	wisniewski	wisniewski	PROPN
fnp-3166	594	2	ke	ke	PROPN
fnp-3166	594	3	,	,	PUNCT
fnp-3166	594	4	wisniewski	wisniewski	PROPN
fnp-3166	594	5	hm	hm	PROPN
fnp-3166	594	6	,	,	PUNCT
fnp-3166	594	7	wen	wen	PROPN
fnp-3166	594	8	gy	gy	PROPN
fnp-3166	594	9	.	.	PROPN
fnp-3166	594	10	occurrence	occurrence	NOUN
fnp-3166	594	11	of	of	ADP
fnp-3166	594	12	neuropathological	neuropathological	ADJ
fnp-3166	594	13	changes	change	NOUN
fnp-3166	594	14	and	and	CCONJ
fnp-3166	594	15	dementia	dementia	NOUN
fnp-3166	594	16	of	of	ADP
fnp-3166	594	17	alzheimer	alzheimer	PROPN
fnp-3166	594	18	’s	’s	PART
fnp-3166	594	19	disease	disease	NOUN
fnp-3166	594	20	in	in	ADP
fnp-3166	594	21	down	down	ADP
fnp-3166	594	22	’s	’s	PART
fnp-3166	594	23	syndrome	syndrome	NOUN
fnp-3166	594	24	.	.	PUNCT
fnp-3166	595	1	ann	ann	PROPN
fnp-3166	595	2	neurol	neurol	PROPN
fnp-3166	595	3	1985	1985	NUM
fnp-3166	595	4	;	;	PUNCT
fnp-3166	595	5	17	17	NUM
fnp-3166	595	6	:	:	PUNCT
fnp-3166	595	7	278–82	278–82	NOUN
fnp-3166	595	8	.	.	PUNCT
fnp-3166	596	1	doi	doi	NOUN
fnp-3166	596	2	:	:	PUNCT
fnp-3166	596	3	10.1002	10.1002	NUM
fnp-3166	596	4	/	/	SYM
fnp-3166	596	5	ana.410170310	ana.410170310	PROPN
fnp-3166	596	6	.	.	PUNCT
fnp-3166	596	7	yeung	yeung	PROPN
fnp-3166	596	8	msy	msy	PROPN
fnp-3166	596	9	,	,	PUNCT
fnp-3166	596	10	djelloul	djelloul	PROPN
fnp-3166	596	11	m	m	PROPN
fnp-3166	596	12	,	,	PUNCT
fnp-3166	596	13	steiner	steiner	PROPN
fnp-3166	596	14	e	e	PROPN
fnp-3166	596	15	,	,	PUNCT
fnp-3166	596	16	bernard	bernard	PROPN
fnp-3166	596	17	s	s	PROPN
fnp-3166	596	18	,	,	PUNCT
fnp-3166	596	19	salehpour	salehpour	PROPN
fnp-3166	596	20	m	m	NOUN
fnp-3166	596	21	,	,	PUNCT
fnp-3166	596	22	possnert	possnert	VERB
fnp-3166	596	23	g	g	NOUN
fnp-3166	596	24	,	,	PUNCT
fnp-3166	596	25	brundin	brundin	ADJ
fnp-3166	596	26	l	l	NOUN
fnp-3166	596	27	,	,	PUNCT
fnp-3166	596	28	frisén	frisén	VERB
fnp-3166	596	29	j.	j.	PROPN
fnp-3166	596	30	dynamics	dynamic	NOUN
fnp-3166	596	31	of	of	ADP
fnp-3166	596	32	oligodendrocyte	oligodendrocyte	ADJ
fnp-3166	596	33	generation	generation	NOUN
fnp-3166	596	34	in	in	ADP
fnp-3166	596	35	multiple	multiple	ADJ
fnp-3166	596	36	sclerosis	sclerosis	NOUN
fnp-3166	596	37	.	.	PUNCT
fnp-3166	597	1	nature	nature	NOUN
fnp-3166	597	2	.	.	PUNCT
fnp-3166	598	1	2019	2019	NUM
fnp-3166	598	2	feb;566(7745):538	feb;566(7745):538	ADV
fnp-3166	598	3	-	-	PUNCT
fnp-3166	598	4	542	542	NUM
fnp-3166	598	5	.	.	PUNCT
fnp-3166	599	1	doi	doi	NOUN
fnp-3166	599	2	:	:	PUNCT
fnp-3166	599	3	10.1038	10.1038	NUM
fnp-3166	599	4	/	/	SYM
fnp-3166	599	5	s41586	s41586	PROPN
fnp-3166	599	6	-	-	PUNCT
fnp-3166	599	7	018	018	NUM
fnp-3166	599	8	-	-	PUNCT
fnp-3166	599	9	0842	0842	NUM
fnp-3166	599	10	-	-	PUNCT
fnp-3166	599	11	3	3	NUM
fnp-3166	599	12	.	.	PUNCT
fnp-3166	600	1	epub	epub	PROPN
fnp-3166	600	2	2019	2019	NUM
fnp-3166	600	3	jan	jan	PROPN
fnp-3166	600	4	23	23	NUM
fnp-3166	600	5	.	.	PUNCT
fnp-3166	601	1	erratum	erratum	PROPN
fnp-3166	601	2	in	in	ADP
fnp-3166	601	3	:	:	PUNCT
fnp-3166	601	4	nature	nature	NOUN
fnp-3166	601	5	.	.	PUNCT
fnp-3166	602	1	2019	2019	NUM
fnp-3166	602	2	feb	feb	NOUN
fnp-3166	602	3	5	5	NUM
fnp-3166	602	4	;	;	PUNCT
fnp-3166	602	5	:	:	PUNCT
fnp-3166	602	6	pmid	pmid	NOUN
fnp-3166	602	7	:	:	PUNCT
fnp-3166	602	8	30675058	30675058	NUM
fnp-3166	602	9	;	;	PUNCT
fnp-3166	602	10	pmcid	pmcid	ADJ
fnp-3166	602	11	:	:	PUNCT
fnp-3166	602	12	pmc6420067	pmc6420067	NOUN
fnp-3166	602	13	.	.	PUNCT
fnp-3166	603	1	younger	young	ADJ
fnp-3166	603	2	ds	ds	PROPN
fnp-3166	603	3	.	.	PROPN
fnp-3166	603	4	postmortem	postmortem	PROPN
fnp-3166	603	5	neuropathology	neuropathology	NOUN
fnp-3166	603	6	in	in	ADP
fnp-3166	603	7	covid-19	covid-19	PROPN
fnp-3166	603	8	.	.	PUNCT
fnp-3166	603	9	brain	brain	NOUN
fnp-3166	603	10	pathol	pathol	NOUN
fnp-3166	603	11	.	.	PUNCT
fnp-3166	604	1	2020	2020	NUM
fnp-3166	604	2	oct	oct	NOUN
fnp-3166	604	3	23	23	NUM
fnp-3166	604	4	:	:	PUNCT
fnp-3166	604	5	e12915	e12915	NUM
fnp-3166	604	6	.	.	PUNCT
fnp-3166	605	1	doi	doi	NOUN
fnp-3166	605	2	:	:	PUNCT
fnp-3166	605	3	10.1111	10.1111	NUM
fnp-3166	605	4	/	/	SYM
fnp-3166	605	5	bpa.12915	bpa.12915	NOUN
fnp-3166	605	6	.	.	PUNCT
fnp-3166	606	1	epub	epub	NOUN
fnp-3166	606	2	ahead	ahead	ADV
fnp-3166	606	3	of	of	ADP
fnp-3166	606	4	print	print	NOUN
fnp-3166	606	5	.	.	PUNCT
fnp-3166	607	1	pmid	pmid	NOUN
fnp-3166	607	2	:	:	PUNCT
fnp-3166	607	3	33098141	33098141	NUM
fnp-3166	607	4	;	;	PUNCT
fnp-3166	607	5	pmcid	pmcid	NOUN
fnp-3166	607	6	:	:	PUNCT
fnp-3166	607	7	pmc7645938	pmc7645938	ADV
fnp-3166	607	8	.	.	PUNCT
fnp-3166	608	1	zrzavy	zrzavy	PROPN
fnp-3166	608	2	t	t	PROPN
fnp-3166	608	3	,	,	PUNCT
fnp-3166	608	4	hametner	hametner	PROPN
fnp-3166	608	5	s	s	PROPN
fnp-3166	608	6	,	,	PUNCT
fnp-3166	608	7	wimmer	wimmer	PROPN
fnp-3166	608	8	i	i	PROPN
fnp-3166	608	9	,	,	PUNCT
fnp-3166	608	10	butovsky	butovsky	ADJ
fnp-3166	608	11	o	o	NOUN
fnp-3166	608	12	,	,	PUNCT
fnp-3166	608	13	weiner	weiner	NOUN
fnp-3166	608	14	hl	hl	NOUN
fnp-3166	608	15	,	,	PUNCT
fnp-3166	608	16	lassmann	lassmann	PROPN
fnp-3166	608	17	h.	h.	PROPN
fnp-3166	608	18	loss	loss	NOUN
fnp-3166	608	19	of	of	ADP
fnp-3166	608	20	'	'	PUNCT
fnp-3166	608	21	homeostatic	homeostatic	ADJ
fnp-3166	608	22	'	'	PUNCT
fnp-3166	608	23	microglia	microglia	NOUN
fnp-3166	608	24	and	and	CCONJ
fnp-3166	608	25	patterns	pattern	NOUN
fnp-3166	608	26	of	of	ADP
fnp-3166	608	27	their	their	PRON
fnp-3166	608	28	activation	activation	NOUN
fnp-3166	608	29	in	in	ADP
fnp-3166	608	30	active	active	ADJ
fnp-3166	608	31	multiple	multiple	ADJ
fnp-3166	608	32	sclerosis	sclerosis	NOUN
fnp-3166	608	33	.	.	PUNCT
fnp-3166	609	1	brain	brain	NOUN
fnp-3166	609	2	.	.	PUNCT
fnp-3166	610	1	2017	2017	NUM
fnp-3166	610	2	jul	jul	PROPN
fnp-3166	610	3	1;140(7):1900	1;140(7):1900	NUM
fnp-3166	610	4	-	-	SYM
fnp-3166	610	5	1913	1913	NUM
fnp-3166	610	6	.	.	PUNCT
fnp-3166	611	1	doi	doi	NOUN
fnp-3166	611	2	:	:	PUNCT
fnp-3166	611	3	10.1093	10.1093	NUM
fnp-3166	611	4	/	/	SYM
fnp-3166	611	5	brain	brain	NOUN
fnp-3166	611	6	/	/	SYM
fnp-3166	611	7	awx113	awx113	NOUN
fnp-3166	611	8	.	.	PUNCT
fnp-3166	612	1	pmid	pmid	NOUN
fnp-3166	612	2	:	:	PUNCT
fnp-3166	612	3	28541408	28541408	NUM
fnp-3166	612	4	;	;	PUNCT
fnp-3166	612	5	pmcid	pmcid	ADJ
fnp-3166	612	6	:	:	PUNCT
fnp-3166	612	7	pmc6057548	pmc6057548	ADJ
fnp-3166	612	8	.	.	PUNCT
fnp-3166	613	1	zrzavy	zrzavy	PROPN
fnp-3166	613	2	t	t	PROPN
fnp-3166	613	3	,	,	PUNCT
fnp-3166	613	4	machado	machado	PROPN
fnp-3166	613	5	-	-	PUNCT
fnp-3166	613	6	santos	santos	PROPN
fnp-3166	613	7	j	j	PROPN
fnp-3166	613	8	,	,	PUNCT
fnp-3166	613	9	christine	christine	PROPN
fnp-3166	613	10	s	s	PROPN
fnp-3166	613	11	,	,	PUNCT
fnp-3166	613	12	baumgartner	baumgartner	PROPN
fnp-3166	613	13	c	c	PROPN
fnp-3166	613	14	,	,	PUNCT
fnp-3166	613	15	weiner	weiner	NOUN
fnp-3166	613	16	hl	hl	NOUN
fnp-3166	613	17	,	,	PUNCT
fnp-3166	613	18	butovsky	butovsky	NOUN
fnp-3166	613	19	o	o	NOUN
fnp-3166	613	20	,	,	PUNCT
fnp-3166	613	21	lassmann	lassmann	PROPN
fnp-3166	613	22	h.	h.	PROPN
fnp-3166	613	23	dominant	dominant	ADJ
fnp-3166	613	24	role	role	NOUN
fnp-3166	613	25	of	of	ADP
fnp-3166	613	26	microglial	microglial	ADJ
fnp-3166	613	27	and	and	CCONJ
fnp-3166	613	28	macrophage	macrophage	ADJ
fnp-3166	613	29	innate	innate	ADJ
fnp-3166	613	30	immune	immune	ADJ
fnp-3166	613	31	responses	response	NOUN
fnp-3166	613	32	in	in	ADP
fnp-3166	613	33	human	human	ADJ
fnp-3166	613	34	ischemic	ischemic	ADJ
fnp-3166	613	35	infarcts	infarct	NOUN
fnp-3166	613	36	.	.	PUNCT
fnp-3166	614	1	brain	brain	NOUN
fnp-3166	614	2	pathol	pathol	NOUN
fnp-3166	614	3	.	.	PUNCT
fnp-3166	615	1	2018	2018	NUM
fnp-3166	615	2	nov;28(6):791	nov;28(6):791	PROPN
fnp-3166	615	3	-	-	PUNCT
fnp-3166	615	4	805	805	NUM
fnp-3166	615	5	.	.	PUNCT
fnp-3166	616	1	doi	doi	NOUN
fnp-3166	616	2	:	:	PUNCT
fnp-3166	616	3	10.1111	10.1111	NUM
fnp-3166	616	4	/	/	SYM
fnp-3166	616	5	bpa.12583	bpa.12583	NOUN
fnp-3166	616	6	.	.	PUNCT
fnp-3166	617	1	epub	epub	PROPN
fnp-3166	617	2	2017	2017	NUM
fnp-3166	617	3	dec	dec	PROPN
fnp-3166	617	4	28	28	NUM
fnp-3166	617	5	.	.	PUNCT
fnp-3166	618	1	pmid	pmid	NOUN
fnp-3166	618	2	:	:	PUNCT
fnp-3166	618	3	29222823	29222823	NUM
fnp-3166	618	4	;	;	PUNCT
fnp-3166	618	5	pmcid	pmcid	ADJ
fnp-3166	618	6	:	:	PUNCT
fnp-3166	618	7	pmc6334527	pmc6334527	PROPN
fnp-3166	618	8	.	.	PUNCT
fnp-3166	619	1	copyright	copyright	NOUN
fnp-3166	619	2	:	:	PUNCT
fnp-3166	619	3	©	©	PROPN
fnp-3166	619	4	2021	2021	NUM
fnp-3166	619	5	the	the	DET
fnp-3166	619	6	author(s	author(s	NOUN
fnp-3166	619	7	)	)	PUNCT
fnp-3166	619	8	.	.	PUNCT
fnp-3166	620	1	this	this	PRON
fnp-3166	620	2	is	be	AUX
fnp-3166	620	3	an	an	DET
fnp-3166	620	4	open	open	ADJ
fnp-3166	620	5	access	access	NOUN
fnp-3166	620	6	article	article	NOUN
fnp-3166	620	7	distributed	distribute	VERB
fnp-3166	620	8	under	under	ADP
fnp-3166	620	9	the	the	DET
fnp-3166	620	10	terms	term	NOUN
fnp-3166	620	11	of	of	ADP
fnp-3166	620	12	the	the	DET
fnp-3166	620	13	creative	creative	ADJ
fnp-3166	620	14	commons	common	NOUN
fnp-3166	620	15	attribution	attribution	NOUN
fnp-3166	620	16	4.0	4.0	NUM
fnp-3166	620	17	international	international	ADJ
fnp-3166	620	18	license	license	NOUN
fnp-3166	620	19	(	(	PUNCT
fnp-3166	620	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-3166	620	21	)	)	PUNCT
fnp-3166	620	22	,	,	PUNCT
fnp-3166	620	23	which	which	PRON
fnp-3166	620	24	permits	permit	VERB
fnp-3166	620	25	unrestricted	unrestricted	ADJ
fnp-3166	620	26	use	use	NOUN
fnp-3166	620	27	,	,	PUNCT
fnp-3166	620	28	distribution	distribution	NOUN
fnp-3166	620	29	,	,	PUNCT
fnp-3166	620	30	and	and	CCONJ
fnp-3166	620	31	reproduction	reproduction	NOUN
fnp-3166	620	32	in	in	ADP
fnp-3166	620	33	any	any	DET
fnp-3166	620	34	medium	medium	NOUN
fnp-3166	620	35	,	,	PUNCT
fnp-3166	620	36	provided	provide	VERB
fnp-3166	620	37	the	the	DET
fnp-3166	620	38	original	original	ADJ
fnp-3166	620	39	author	author	NOUN
fnp-3166	620	40	and	and	CCONJ
fnp-3166	620	41	source	source	NOUN
fnp-3166	620	42	are	be	AUX
fnp-3166	620	43	credited	credit	VERB
fnp-3166	620	44	,	,	PUNCT
fnp-3166	620	45	a	a	DET
fnp-3166	620	46	link	link	NOUN
fnp-3166	620	47	to	to	ADP
fnp-3166	620	48	the	the	DET
fnp-3166	620	49	creative	creative	ADJ
fnp-3166	620	50	commons	common	NOUN
fnp-3166	620	51	license	license	NOUN
fnp-3166	620	52	is	be	AUX
fnp-3166	620	53	provided	provide	VERB
fnp-3166	620	54	,	,	PUNCT
fnp-3166	620	55	and	and	CCONJ
fnp-3166	620	56	any	any	DET
fnp-3166	620	57	changes	change	NOUN
fnp-3166	620	58	are	be	AUX
fnp-3166	620	59	indicated	indicate	VERB
fnp-3166	620	60	.	.	PUNCT
fnp-3166	621	1	the	the	DET
fnp-3166	621	2	creative	creative	ADJ
fnp-3166	621	3	commons	common	NOUN
fnp-3166	621	4	public	public	ADJ
fnp-3166	621	5	domain	domain	NOUN
fnp-3166	621	6	dedication	dedication	NOUN
fnp-3166	621	7	waiver	waiver	NOUN
fnp-3166	621	8	(	(	PUNCT
fnp-3166	621	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-3166	621	10	)	)	PUNCT
fnp-3166	621	11	applies	apply	VERB
fnp-3166	621	12	to	to	ADP
fnp-3166	621	13	the	the	DET
fnp-3166	621	14	data	datum	NOUN
fnp-3166	621	15	made	make	VERB
fnp-3166	621	16	available	available	ADJ
fnp-3166	621	17	in	in	ADP
fnp-3166	621	18	this	this	DET
fnp-3166	621	19	article	article	NOUN
fnp-3166	621	20	,	,	PUNCT
fnp-3166	621	21	unless	unless	SCONJ
fnp-3166	621	22	otherwise	otherwise	ADV
fnp-3166	621	23	stated	state	VERB
fnp-3166	621	24	.	.	PUNCT